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Abstract
Abstract
ES-62 is a filarial nematode excretory secretory glycoprotein of mass 57.8 kDa, 
from tlie rodent filarial Acanthocheilonema viteae. ES-62 has been
shown to possess immimomodulatoiy capabilities, some of which can be 
attributed to the phosphorylcholine moieties that are attached to certain of the 
carbohydrate chains of ES-62. Studies of the effects of ES-62 on B lymphocytes 
have shown that ES-62 downregulates B lymphocyte activation by selectively 
targeting protein kinases, such as ErkMAPKinase, downstream of the B cell 
receptor resulting in immunosuppression of the host immune system. ES-62 has 
been shown to have a similar effect in T lymphocytes.
This thesis describes the search for str uctural information about ES-62. Tliree 
main techniques were employed to characterise the low resolution structure o f 
ES-62; bioinformatics, analytical ultracentrifugation (AUC) and small angle X- 
ray scattering (SAXS). Bioinformatics techniques identified six proteins 
homologous to ES-62 on the basis of primary structure and six proteins 
homologous on the basis of secondary structure. Homology modelling of ES-62 
in its entirety was not possible due to a lack of structural information about the 
six proteins homologous to ES-62 on the basis of amino acid sequence. 
However, residues 252-343 of ES-62 were modelled due to the homology of this 
region with residues 74-168 of a leucyl aminopeptidase fr om Aeromonas 
proteolytica for which the structure is known.
AUC and SAXS techniques demonstrated that ES-62 exists mainly in a 
tetrameric state and is slightly elongated in stmcture. A low resolution stmcture 
of ES-62 was also obtained using DAMMIN (Svergun, 1999), a computer 
program which allows the ab initio determination of a three-dimensional 
structure from the small angle scattering cui*ve of a protein.
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In addition, this thesis describes the establishment of two recombinant ES-62 
expression systems, one of which was unsuccessful due to the aggregation of the 
expressed protein and the other, while producing rES-62, was contaminated by 
the presence of a compound absorbing at 260 nm resulting in the rES-62 
produced being unsuitable for biochemical or biophysical studies.
The search for the receptor through which ES-62 interacts with cells and the fate 
of ES-62 following this interaction are also discussed. These studies demonstrate 
that ES-62 binds to specific proteins on the surface of different immune system 
cells but unfoitunately attempts to identify these proteins have not so far yielded 
a definitive answer. ES-62 has also been shown to locate to both the nucleus and 
cytoplasm following interaction with cells and appears to be present in different 
forms in these two locations. This demonstrates that ES-62 is internalised 
following receptor binding and may induce some of its immunomodulatory 
effects through interactions with intracellular proteins. Its presence in the nucleus 
of cells could explain the modulation of transcription factors shown to occur in B 
lymphocytes following exposure to ES-62.
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Chapter 1 : Introduction
1. Introduction
1.1. Tropical Diseases
Tropical diseases kill 17.3 million people annually worldwide (W.H.O., 1997) 
and hinder the development, socially and economically, of the countries affected. 
Figure 1-1 shows the deaths attributable to tropical diseases compared with those 
caused by a number of other diseases. The majority of those affected by tropical 
diseases live in the developing world, where the numbers affected are increasing 
due to urbanisation and industrialisation, which provide ripe breeding grounds 
for the vectors of these tropical diseases. However, the developed world is 
currently facing an increasing risk of infection as international travel makes 
contact with these diseases increasingly likely.
To aid countries affected by tropical diseases in their fight against infection and 
in their activities to minimise the suffering of those affected, the World Health 
Organisation (W.H.O.) has set up the division for Control of Tropical Diseases 
(CTD). The CTD mandate is to eradicate or control a number of tropical diseases 
including Chagas disease, lymphatic filariasis, malaria, African trypanosomiasis, 
leishmaniasis, schistosomiasis, intestinal parasites, dengue and dengue 
haemorrhagic fever (W.H.O, 1998). In this regard, the CTD has had some 
success in achieving a limited level of control of many of these diseases. 
However, the situation regarding infection and disease treatment remains serious.
This thesis focuses on the excretory-secretory protein ES-62, from the filarial 
parasite Acanthocheilonema viteae, a rodent filarial parasite used in the study of 
human filariasis. Filariasis is one of tlie few tropical diseases classified as 
potentially eradicable (W.H.O., 1999b).
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Developed World
1985 1990 1997
1 1
Total: 12 millionTotal: 11.5 millionTotal: 11 million
Developing World
Total: 37 million Total: 38 million Total: 40 million
Figure 1-1: Causes of death in the developed and developing world in 1985, 
1990 and 1997. Deaths classified as due to infectious/parasitic disease (O), 
perinatal/maternal causes (D  ), cancer ( |  ), circulatory system diseases 
respiratory system diseases (Q) or other/unknown causes (Q). Source: 
World Health Organisation; http://www.who.org/whr
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1.2. Filariasis
Filariasis is the name given to the range of diseases caused by filarial nematodes. 
There are eight distinct species of filarial nematode wliich give rise to filariasis in 
humans; Wuchereria bancrofti, Brugia malayi, Brugia timori, Onchocerca 
volvulus, Loa loa, Dipetalonema streptocerca, Mansonella ozzardi and 
Mansonella perstans (Evered el al., 1987). Table 1-1 shows the characteristics of 
these eight species. Tlnee of these species, W. bancrofti, B. malayi and O. 
volvulus, are the major causes of morbidity in the tropics (W.H.O., 1995b).
Currently approximately 150 million people demonstrate clinical symptoms of 
infection with filarial nematodes including skin lesions, elephantiasis and 
blindness. The clinical manifestations o f filarial diseases vary not only between 
species of filarial nematode, but can also vary between people infected with the 
same parasite species (Kazura et al., 1993). In addition to those displaying 
clinical symptoms there are many more people infected who display no clinical 
symptoms while a further billion people are estimated to be at risk of contracting 
filarial diseases (W.H.O., 1998). Despite the large numbers of people affected by 
filariasis there are few effective treatments available for filarial infection and 
presently no hope for a vaccine.
Human filarial infections demonstrate a number of common features. Firstly, the 
filarial parasites all result in long term/chronic infection (Vanamail et al., 1996) 
wherein the adult worms are able to survive and reproduce sexually within the 
host’s lymphatic vessels or tissues for ten years or longer. This is thought to be 
achieved through immunomodulation of the host immune system. Secondly, the 
immune response mounted by the host against the pai’asite is complex. This is 
due to the chionic nature of infection and also to the multicellular nature of 
filarial parasites, which gives rise to a vast array of antigens being presented to 
the host immune system. This complex immune response is believed to be 
responsible for the majority of the clinical manifestations of filarial diseases and 
could explain the differences observed in clinical manifestations between people 
infected with the same parasitic species. Finally, the parasites are incapable of
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completing an entire lifecycle within the host; an anthropod intermediate vector 
is required (Kazura et al., 1993).
Species Vector Disease Caused Symptoms
Wuchereria
bancrofti
Mosquitoes: 
Culex fatigans, 
Aedes, & 
Anopheles
Bancroftian fllariasis Fever, lymphangitis, 
lymphadenitis, lymphocele, 
abscess formation, 
elephantiasis
Brugia malayi Mosquitoes: 
Mansonia, 
Anopheles & 
Aedes
Malayan fllariasis Fever, lymphangitis, 
lymphadenitis, lymphocele, 
abscess formation, 
elephantiasis
Brugia timori Mosquitoes: 
Anopheles & 
Barbirostris
Malayan fllariasis Fever, lymphangitis, 
lymphadenitis, lymphocele, 
abscess formation, 
elephantiasis
Onchocerca
volvulus
Black Fly: 
Simulium
Onchocerciasis Nodule formation, acute 
inflammatory response, 
pruritis, onchodermatisis, 
blindness, lymphedema
Loa loa Mango flies: 
Clrrysops
Loiasis Edema of conjunctivea & 
lids, localised subcutaneous 
edema.
Dipetalonema
streptocerca
Midges:
Culicoides
Dermatitis Pruritic dermatltia, 
hypopigmented macules, 
inguinal adrenopathy
Mansonella
ozzard
Midges:
Culicoides
Non-pathogenic Some cases of allergic 
symptoms, but generally 
non-pathogenic
Mansonella
Persians
Midges:
Culicoides
Non-pathogenic Some cases of allergic 
symptoms, but generally 
non-pathogenic
Table 1-1: Characteristics of the various species of filarial nematode that 
infect humans.
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1.2.1. Lymphatic Filariasis
Lymphatic filariasis is attributable to infection with the lymphatic dwelling 
parasites, Wuchereria bancrofti, Brugia malayi and Brugia timori. Over 120 
million people are affected by lymphatic filariasis, 90 % of whom are infected 
with W. bancrofti. Figure 1-2 highlights the areas where lymphatic filariasis is 
prevalent. Approximately one third of those affected live in India, one third in 
Africa and the remainder in south-east Asia, the Pacific and the Americas 
(W.H.O., 1998). Urbanisation in these areas has led to an increase in the number 
of affected individuals. It is expected that the number of infected individuals will 
continue to rise due to the continuing rapid and unplanned growth of cities, 
which creates breeding sites for the mosquitoes that transmit the disease.
• à
Figure 1-2: Worldwide prevalence of lymphatic filariasis [image from 
W.H.O. web site, httD://www.who.int/ctd/filariasis/librarv/countries4.htmll 
Red areas show endemic regions, pink areas show areas of uncertain status 
and green areas show non endemic areas.
Transmission of the parasite species responsible for lymphatic filariasis is 
achieved via the female mosquitoes of the Anopheles, Aedes, Culex and 
Mansonia species. These mosquitoes are the anthropod intermediate vector, 
which is essential for completion of the lifecycle of the parasite and acts to 
transmit the parasite Ifom one host to another. There are 4 stages of parasite 
development that occur specifically in either the host or the vector. The final 
stage of which is the development of adult parasitic worms within the host
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(Evered et al., 1987). These adult worms live within the lymphatics of the 
mammalian host, most frequently within the lymphatics of the lower extremities 
and are approximately 40-100 mm in length and 0.1-0.3 mm in diameter. Sexual 
reproduction of the adult worms leads to the release of thousands of microfilariae 
(mf, first stage larvae or LI) by the female adult worms into the bloodstream of 
the mammalian host. These microfilariae are approximately 250 pm in length 
and possess an acellular sheath. The m f can then be ingested via a bloodmeal into 
the mosquito vector where they exsheath to form the L2 stage of parasitic 
development and penetrate the midgut of the mosquito. From here they migrate 
to the thoracic musculature and finally into the mouthparts of the mosquito as 
third stage larvae (L3). The development from LI to L3 within the female 
mosquito takes approximately 10-14 days. The larvae can then be transmitted to 
another mammalian host when the mosquito takes a bloodmeal. Following 
transmission to a mammalian host the L3 larvae migrate into the lymphatics 
where they undergo two further molts to form fourth stage larvae (L4) and adult 
worms respectively. Sexually mature adult worms appear after 9-12 months 
(Kazura et al., 1993). A diagrammatic representation of the lifecycle of the 
parasites responsible is shown in Figure 1-3.
Adult Worms
INSECT
bloodmeal
MicrofilariaeInfective Larvae
bloodmeal
MAN
Larval Development
Figure 1-3: Lifecycle of parasites responsible for lymphatic filariasis or 
onchocerciasis. These constitute three main parasites that infect humans; W. 
bancrofti, B. malayi and O, volvulus. Insect is the mosquito in the case of 
lymphatic filariasis and the blackfly in the case of onchocerciasis.
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1.2.1.1. Clinical Manifestations
Lymphatic filariasis can be divided into two distinct groups. The first, termed 
lymphatic filaiiasis, is caused by adult or developing adult woims in the 
lymphatics of the host. The second, termed occult filariasis, is caused by host 
immune hyper-responsiveness to microfilariae. A general pattern of the clinical 
symptoms showing the sequence of events following infection can be discerned 
as prepatent period, asymptomatic microfilaraemia and acute and chronic clinical 
filariasis. The timescale of this sequence depends on the species of parasite with 
which the individual is infected (Evered et ah, 1987). As discussed, tliree 
parasites are responsible for causing lymphatic filariasis. Those individuals 
infected with Brugia malayi or Brugia timori are classified as suffering from 
Brugian filariasis while those infected with Wuchereria bancrofti suffer from 
Bancroftian filaiiasis.
1.2.1.1.1. B rug ian  F ilariasis
The acute clinieal manifestations of Brugian filariasis often initiate with 
lymphadenitis in the inguinal region. This is usually self-healing but can develop 
into retrograde lymphangitis in which the lymph node becomes infected, 
spreading to the whole thigh or even limb. This can lead to lymphodema of the 
foot and ankle and the iifiècted lymph node may form an abscess and deteriorate 
into an ulcer. Although these ulcers heal spontaneously they typically leave 
scarring. For patients infected with B. timori the symptoms are as above, but the 
node affected can move from the inguinal node which is the first to be affected to 
other lower nodes in subsequent attacks (Evered et al., 1987), (UNDP et a l,
1997).
Recurrence of these acute symptoms leads to incomplete resolution of the 
lymphoedema and the disease progresses to the chronic stage. Chronic clinical 
manifestations include lymphoedema of the leg below the knee and, less 
frequently, of the arm below the elbow. The affected limb usually swells to 
approximately twice its normal size and the skin may become thickened, as 
shown in Figure 1-4 (a).
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Figure 1-4: Swelling of the limbs (a) and the male genitalia (b) occurs in 
lymphatic filariasis [images from the W.H.O. web page, TDR image library; 
httn://www.who.int/tdr/media/image.htmK (a) image number: ID9902948, 
credit line: WHO/TDR/Crump, (b) image number: ID9902980, credit line: 
WHO/TDR/Crump]
1.2.1.1.2. Bancroftian Filariasis
The acute phase of bancroftian filariasis is marked by swelling of the male 
genitalia due to the effects of W. bancrofti on the lymphatics of this region. 
Symptoms include tenderness, pain which may be excruciating and possibly 
fever. The extent of the swelling of the male genitalia is shown in Figure 1-4 (b).
The chronic phase of bancroftian filariasis occurs when the acute attacks fail to 
completely heal and in time a hydrocele develops. This can develop further to 
scrotial elephantiasis, but this is a rare occurrence (Evered et al., 1987; UNDP et 
al., 1997). Lymphoedema and elephantiasis can also occur in bancroftian 
fllariasis but with less frequency than in brugian filariasis.
The chronic stages of lymphatic filariasis are surprisingly painless. However, the 
psychological effects are in some ways far worse especially as those severely 
affected become a burden to their families and community. There is also an
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asymptomatic form of lymphatic filariasis, which is characterised by the 
presence of millions of microfilariae in the bloodstream and adult worms in the 
lymphatics but no clinical symptoms. However, these outwardly healthy 
individuals often have kidney and lymphatic damage (UNDP et al., 1997).
1.2.2. Onchocerciasis
Onchocerciasis is an immune-mediated disease caused by the filarial parasite 
Onchocerca volvulus. Onchocerciasis is the world’s second major infectious 
cause of blindness and presents its largest public health problem in Africa, where 
99 % of the 20 million people infected worldwide are located and a further 100 
million are at risk of infection (W.H.O., 1995a). Figure 1-5 highlights the areas 
in Africa affected by onchocerciasis.
Figure 1-5: Prevalence of onchocerciasis in Africa [image from the W.H.O. 
web site, httD://www.who.int/ocD/siides/SetE/d0025.htm. Credit line: 
OCP/AFGCAVHO]
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Onchocerciasis is transmitted between mammalian hosts by the female blackfly 
{Simulium damnosum species) which, in a similar way to the mosquitoes 
responsible for transmitting lymphatic filariasis, requires a bloodmeal after 
mating. The adult worms of O. volvulus when sexually mature form spherical 
bundles consisting of 2-3 female worms (23-70 mm in length and 275-325 gm in 
diameter) and 1-2 male worms. These bundles are found in subcutaneous nodules 
called onchocercomata. Following mating, the female O. volvulus worms release 
millions of microfilariae that migrate out of the nodule through the host tissue 
and congregate in the dermis of the host. The microfilariae may then be ingested 
during a bloodmeal by the blackfly. The ingested microfilariae migrate within 
the vector to the thoracic muscles and mature into infective larvae over the 
course of approximately 6 - 8  days. The infective laiTae (440-700 gm in length,
12-19 gm in diameter) then migrate to the head of the blackfly where they can be 
tiansmitted to a new host when the vector takes a bloodmeal. It takes between 7 
and 34 months fi'om infection of the mammalian host with the infective larvae 
for adult worms to develop and secrete microfilariae. The lifecycle of filarial 
parasites, including O. volvulus, is shown in Figure 1-3 (Kazura et al., 1993).
1.2.2.1. Clinical Manifestations
The clinical manifestations of O. volvulus ar e thought to be associated with the 
destruction of the microfilariae of O. volvulus in the skin and eye tissues. These 
manifestations include nodule formation, rashes, lesions, intense itching, 
depigmentation of the skin and lymphadenitis, resulting in hanging groin and 
genital elephantiasis (Evered et al., 1987). Clinical manifestations arise in 
individuals 1-3 years after infection with O. volvulus. Early stages of 
onchocerciasis in the skin can be identified by the localisation of inflammatory 
cells around the adult worms forming an onchocercomata, a fibrous stincture that 
encases the worms, and an increase in dermal fibroblasts and mast cells. The 
onchocercomata are visible, 0 .5 -10  cm in diameter, but rarely cause pain. Later 
stages of the disease include onchocercal dermatitis. This involves recruitment of 
inflammatory cells to the dermis where the microfilariae are located and leads to 
loss of elastic fibres and eventually advanced atrophy of the epideimis. Localised
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onchocerciasis (Sowda) can also occur due to a severe inflammatory reaction to 
the microfilariae. It occurs mostly in young men and consists of an increase in 
pigmentation of the skin, generally of the legs (Evered et al., 1987).
Onchocerciasis in the ocular tissues follows a similar course with the infiltrate of 
plasma cells, eosinophils and mast cells followed by vessel dilation and 
thickening leading to blindness. This occurs most commonly in males, who tend 
to have heavier infections. Three types of ocular lesions can occur: the first is 
puncate keratitis (opaqueness of the cornea) which rarely affects vision. The 
second is sclerosing keratitis, an immune reaction to microfilariae in the cornea, 
leading to vasculai’isation of the cornea and blindness. The third is chorioretinitis, 
a non-granulomatous inflammatory reaction to microfilariae, which also causes 
blindness (Evered et al., 1987). All of the symptoms mentioned suggest the 
presence of a chronic inflammatory response to the presence of the parasite in the 
host tissues and this is why onchocerciasis is believed to be an immune -mediated 
disease.
1,3. Filarial Antigens
A comprehensive overview of filarial parasitic antigens and the research cairied 
out in this area is given by Harnett & Parkliouse, (1995).
Filarial paiasitic antigens, which are very immunogenic, have been classified 
into tliree groups; surface antigens, somatic antigens and excretory-secretory 
antigens (Harnett & Parkhouse, 1995). Although some antigens can be classified 
into more than one of these groups, most are unique to one. Filarial parasites 
proceed through several developmental stages on their way to adulthood. The 
surface antigens vary in their stage specificity - some antigens are only exposed 
at certain developmental stages whereas others are exposed continually (Harnett 
& Parkhouse, 1995). The level o f expression can also vary with development 
(Maizels et al., 1983; Phillipp et ah, 1980). In addition, the antigens exposed can 
vary depending on the sex of the parasite (this is the case for A. viteae 
(Baschong, 1985)) and is thought to be due to different environmental
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requirements of the different sexes. Study of filarial antigens to determine 
immunoprophylactic and immunodiagnostic antigens has been confined to 
surface antigens, which are more viable potential vaccines due to their direct 
exposure to the immune system. Surface antigens are also more successful in 
diagnostic assays than somatic and ES antigens as these latter classes of antigen 
demonstrate cross-reactivity between human filarial species (Cabeira et al.,
1989; Harnett & Parkliouse, 1995; Phillipp et ah, 1984). However, ES antigens, 
antigenic during infection, aie now starting to be considered as an alternative to 
the more traditional source o f vaccine material.
1.3.1. Surface Antigens
Surface molecules of filarial parasites are antigenic dming infection. Analysis of 
these antigens has revealed that some are cross-reactive but usually only between 
closely related species (Harnett & Parkhouse, 1995; Maizels et al., 1985b). The 
range of surface antigens on many of the filarial parasites has been identified, but 
as yet they have not been characterised in tenus of function. Surface antigens 
may be identified by radiolabelling of surface molecules (e.g. via 
radioiodination) followed by separation of the labelled molecules using sodium 
dodecyl sulphate polyacrylamide gel electiophoresis (SDS-PAGE) (Harnett & 
Pai'khouse, 1995; Selkirk et al., 1990; Tamashiro et al., 1986). Often one or two 
main molecular weight species can be identified, but this may be due to the 
different ways in which the molecules react to the radiolabelling rather than a 
measure of abundance. Two cloned and sequenced antigens of O. volvulus have 
been screened against the sequence databanks but no match has been found. 
Hence although screening of sequences of antigens against the databank may be 
successful in some cases and is a more rapid method of identifying function, in 
some cases it may be necessary to characterise each individually. In addition to 
the surface antigens of filarial parasites, various host molecules have also been 
detected at the parasitic surface (Egwang et al., 1988; Forsyth et al., 1984a; 
Harnett & Parkliouse, 1995). It is thought that these host molecules may play a 
role in masking the parasite from the host immune system (Harnett & Parkhouse,
1995). For example, the host protein albumin, found on the smface of blood and
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skin microfilariae, is thought to be involved in inliibiting eosinophil peroxidase 
mediated oxidative damage (Forsyth et ah, 1984b).
Some of the surface antigens of filarial parasites have been shown to be 
glycosylated. This is most often observed in adult parasite surface antigens in 
comparison with those from microfilariae. The location of expression of the 
carbohydrate moiety has been found to vary with the sex of the parasite and is 
only found on the copulatory bell of adult male worms compared to a more 
general distribution in females (Ortega-Pierres et ah, 1986).
1.3.2. Excretory-Secretory Antigens
The excretory-secretory (ES) products of filarial parasites are released by the 
parasite via the excretory or anal pore, mouth, female reproduction tract or the 
cuticle (Harnett & Pai'khouse, 1995), into the bloodstream of the parasitised host 
and can be isolated from the blood or urine of an infected individual. ES products 
are highly antigenic. Similarly to surface antigens, ES antigens aie both stage- 
and sex-specific (Hainett et al., 1986; Parkhouse & Clark, 1983). This stage 
specificity is demonstrated by many parasites, for example A. viteae (Hai'nett et 
al., 1989). ES products are now starting to be considered as a potential source of 
vaccine material. ES products can be identified by SDS-PAGE with 2D 
electrophoresis yielding the most accurate identification.
Examination of ES products of a range of parasites has revealed a high degree of 
glycosylation of these products. For example, one ES product fromri. suum 
possesses 22 % carbohydrate by mass (Stromberg, 1979). The presence of 
carbohydrate on these molecules can be demonstrated by chemical analysis, 
carbohydrate staining using dyes specific for carbohydrate, use of sugar cleavage 
enzymes or use of biosynthetic labelling of the ES products with [ ^H] 
glucosamine (Harnett et al., 1990; Kwan-Lim et al., 1989; Meghji & Maizels, 
1986). Many of the ES products of filai'ial parasites have also been demonstrated 
to contain phosphorylcholine using a radioimmunoassay employing two anti-PC 
monoclonal antibodies, TEPC-15 as capture and Bpl, labelled with [^^ I^], as an
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indicator (Harnett et ah, 1990). The PC moiety has been shown to be attached to 
the carbohydrate molecules of the glycosylated ES products although the method 
of attachment is currently unknown (Harnett et ah, 1993; Houston et a i, 1997;
Houston & Harnett, 1996). A considerable amount of cross-reactivity occurs 
between species, this is thought to be attributable to PC being a common epitope 
associated with a lai ge range of parasitic ES products. Carbohydrate is also a 
common epitope and contributes to the cross-reactivity observed between 
different species of filarial parasite. Host molecules such as albumin and 
immunoglobulin have also been identified in the ES products of filarial parasites 
(Kaushal ei a l, 1982; Maizels et al., 1985a; Ngu et al., 1981). It is thought that 
the host molecules may be ingested at some point in tlie parasitic lifecycle and 
are then secreted, as they are not needed.
ES products of many filarial parasites have been studied in some detail and to 
date a function has been determined only for a few of these molecules. These ES 
products include proteinases that digest proteins, trypsin-like proteins (A. 
simplex) (Matthews, 1982) and collagenases with a metal requirement {B. malayi 
and O. volvulus) (Petralanda et al., 1986). The role of the proteinases is thought 
to be related to tissue penetration and migration (Hinsk & Ivey, 1976; Knox &
Kennedy, 1988; Petralanda et al., 1986). This hypothesis is substantiated by the 
reduced presence or absence of these proteinases in the non-migratory stages of 
the parasite (Petralanda et al., 1986). Acetylcholinesterase is also secreted by a 
range of pai asitic nematodes. The possible function of this ES product is to 
interfere with the host immune system by degrading acetylcholine. Acetylcholine 
increases the release of histamine, which in turn exacerbates inflammatory 
immune responses, which form part o f the Thl immune response. Degradation of 
acetylcholine by parasitic products would lead to a decrease in the levels of 
histamine and thus a decrease in the inflammatory response which forms part of 
the Thl immune response (Rang et al., 1998). This may provide a survival 
advantage to the parasite by promoting the bias of the host immune response to 
parasite to a Th2 response. People with chr onic parasitic infection demonstrate a 
Th2 bias in their immune response (Allen & Macdonald, 1998; Stewart et al.,
1999). Other functions of ES products identified include superoxide dismutase,
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to detoxify the contents of neutrophils and eosinopMl granules (Rhoads, 1983;
Walter et a l, 1987), interaction with complement to aid parasite survival by 
fixing complement at a site distant from the parasite (Staniunas & Hammerberg,
1982), release of a chemotactic agent to attract neutropliils away from the 
parasites (Bruschi et ah, 1989; Harnett & Parkhouse, 1995) and interference with 
the lymphocytic response of the host immune system inhibiting responses to 
antigen (Faubert, 1976; Harnett & Harnett, 1999a). The role of ES products in 
immunomodulation of the host immime response can be further higlilighted by 
their suppressive effects on T cell proliferation (Allen & Macdonald, 1998; Lai et 
n/.,, 1990). Peripheral blood lymphocytes from people infected with filarial 
nematodes are known not to proliferate in response to parasitic antigen, while 
proliferation responses to other antigens are unimpaired (Allen & Macdonald,
1998; Nutman et ah, 1987a). Injection of ES products into mice results in a 
similar decrease in T cell proliferation thus suggesting that it is the ES products
■that induce this effect in the case of filarial infection (Allen & Macdonald, 1998).
1,4, Filarial Nematode Modulation o f the Host Immune 
Response
Immune responses to pathogens are mediated by a range of immune system cells. 
These cells originate from pluripotent haemaopoeitic stem cells in the bone 
marrow and divide to produce lymphoid stem cells and myeloid stem cells. The 
lymphoid stem cells give rise to T and B lymphocytes which are distinguishable 
by their site of differentiation and their antigen receptors (Janeway & Travers,
1996).
T cells, which differentiate in the thymus, are responsible for the cellular arm of 
the immune system. The activation of these cells in the draining lymphoid organs 
forms the first step in the adaptive immune response. This activation takes the 
form of the recognition of a specific antigeniMHC complex which leads to the
'production of armed antigen specific effector T cells (Janeway & Travers, 1996).
During the initial activation of naïve CD4 T cells, differentiation occurs leading
............ ...
Some pathogens have evolved to exploit the immune system by generating an 
immune response that is beneficial to them rather than to the host. Filarial 
parasites are one such example and have developed specific techniques to 
counter the immune defences of the host. These techniques involve the 
excretory-secretory products of the parasites, identified as including proteinases, 
protease inhibitors and antioxidants (Pastrana et ah, 1998). It is thought that 
these ES products aid the misdirection of the immune system to yield a Th2/anti-
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to the cells becoming either T h l, inflammatory, effector cells or Th2, helper, 
effector cells. This differentiation is influenced greatly by the cytokines present 
at the early stages of this immune response (Janeway & Travers, 1996). The 
differing capabilities for pathogens to interact with the different cells of the 
innate immune response influences the cytokines present and thus can influence 
the form that the adaptive immune response takes. IL-12 and IFNy, produced by 
macrophages and NK cells in the early stages of immune responses, promote Thl 
cell differentiation. In addition, IFNy inhibits proliferation of Th2 cells. IL-4 and 
IE-10, produced by, amongst others, mast cells and macrophages and B IB  cells, 
lead to the differentiation of T cells into Th2 cells. IL-4 promotes this 
differentiation while the combination of IL-4 and lL-10 inhibits generation of 
Thl cells. The nature and amount of antigen also affects the differentiation of 
CD4 T cells. A large amount of antigen or strongly interacting antigen induces a 
T h l, inflammatory response, while a small amount of antigen or weakly 
interacting antigen leads to a Th2 bias (Janeway & Travers, 1996).
B cells, which differentiate in the bone marrow, are responsible for the humoral 
arm of the immune system and on activation differentiate into antibody secreting 
plasma cells. The antigen receptors o f B cells are membrane bound versions of 
the antibodies they secrete when activated. On binding antigen, the B cell antigen
, sreceptors transmit a signal to the cell interior and deliver antigen to intracellular 
sites where it can be processed and presented by MHC class II molecules on the 
B cell sur face. This complex of antigen with MHC molecule can then be 
recognised by helper T cells which assist in the differentiation of B cells to 
plasma cells (Janeway & Travers, 1996).
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inflammatory response. This response is characteristic of filarial infection and 
appears to allow the establishment o f chronic infection (Mahanty & Nutman,
1995; Winkler et a i, 1998). Treatment o f parasitic diseases with DEC or 
iveimectin leads to a re-establishment of the Thl response in infected individuals 
resulting in clearance of the parasites and microfilariae (Diksliit et al., 1995).
1.4.1. Thl/T h2 Polarisation
Downregulation of the host immune response and Thl/Th2 polarisation is a 
marker of filariasis (Allen & Macdonald, 1998; Elkhalifa et al., 1991; Nutman et 
al., 1987a). Amicrofilaremic individuals exhibit a Thl response to the filarial 
parasite that leads to a strong T cell response and is characterised by lL-2 and 
IFNy cytokines. It is thought that this Thl response, an inflamrnatory response, is 
responsible for the symptoms, such as limb swelling and skin lesions (Pastrana et 
al., 1998; Soboslay et al., 1999), exhibited by amicrofilaremic individuals. The 
majority of infected individuals however, are asymptomatic microfilarémie and 
demonstrate a polarisation in the Thl/Th2 balance in favour of a Th2 response 
(Soboslay et a l, 1999). This appeal’s to provide a survival advantage to the 
parasite, which can sui'vive for greater than ten years in the host. The Th2 
response is characterised by the presence of IL-4, IL-5 and IL-10 cytokines and 
also high IgG4 and IgE levels (Soboslay et al., 1999).
The decreased or abrogated Thl response observed in asymptomatic 
microfilarémie patients could arise via a number of mechanisms; tolerance, 
immunosuppression, genetic factors in the host, imbalance of antigen-specific 
Thl/Th2 subpopulations or a combination of two or more of these (Mahanty & 
Nutman, 1995). The tolerance hypothesis is considered unlikely if tolerance is 
considered only to be clonal deletion, however, tolerance can also be defined as 
T-cell anergy that can occur in a mature immune system (Maizels & Lawrence,
1991). Responses to parasite antigens have been shown to be restored following 
treatment thus it is unlikely that a deletion of cells specific for parasitic antigens 
is occurring, whether T cell anergy is a possible alternative is yet to be 
determined. One possible exception to this is in the case of children born of a
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mother who is positive for the presence of microfilariae. These children possess a 
decreased response to parasitic antigen (Kazura et ah, 1993), and may be an 
example of tolerance in the form of clonal deletion rather than T cell anergy.
This exception occuis as a result of the neo-natal exposure of the children’s 
immune system to the parasitic antigens and thus more closely resembles 
elimination of self-reactive T cells which occui s by clonal deletion than tolerance 
induced following exposure of a matuie immune system to parasitic antigen.
1.4.2. Antibody Responses
Antibody responses to filarial disease depend on the parasitilogical status of the 
individuals and not on clinical symptoms. All infected individuals exhibit B cell 
hyporesponsiveness to the parasite while B cell responses to other immune 
challenges remains unehanged (Kumiawan-Atmadja et ah, 1998; Marley et ah,
1995; Nicolas et ah, 1999; Nutman et ah, 1987b). Individuals with detectable 
levels of adult wonns possess higher filarial specific IgG4 and lower IgG3 and 
IgE levels than individuals free of adult worms. IgG4 is unable to fix 
complement and does not interact with macrophages, other phagocytes, mast 
cells or basophils. lgG3 can both fix complement and bind macrophages and 
other phagocytes while IgE, although unable to fix complement, can bind 
macrophages, other phagocytes, mast cells and basophils. These factors perhaps 
provide a survival advantage to the parasite by limiting the pro -infiammatoiy 
immune response mounted against it. Those individuals with no adult worms but 
with microfilariae have low filarial specific IgGl and lgG2 levels. Both IgGl 
and 2 can fix complement, IgGl can also bind macrophages and other 
phagocytes. These properties, giving a strong immune response, ar e perhaps 
responsible for the lack of adult worms.
1.4.3. Cytokines
As mentioned, infection with filarial parasites generally leads to a Th2 immune 
response, thus cytokines such as IL-4, IL-5 and IL-10 are induced early in 
infection (Pastrana et ah, 1998; Soboslay et ah, 1999). The presence of these
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cytokines on activation of CD4 T cells leads to the bias of the differentiation of 
these cells in the direction of a Th2 response. Nitric oxide (NO) is also involved 
in the host response to parasitic infection. NO is cytotoxic to both microfilariae 
and to adult worms and it is believed to play a role in the elimination of 
microfilariae in infected individuals (Winkler et ah, 1998).
The imbalance of antigen-specific Thl/Th2 subpopulations is currently the 
favourite hypothesis for the survival of filai'ial parasites within the host. This is 
supported by IL-10, the cytokine secreted in a Tli2 response, downregulating the 
Thl response in cells (Mahanty & Nutman, 1995). Research shows that mice 
deficient in C lq  (of the complement cascade) have a decreased clearance of 
parasites that can be attributable to the C lq  depletion. This in turn leads to an 
upregulation of the levels of IFNy, an important cytokine in the Thl response, 
further demonstrating the important role cytokines play in the host response to 
filarial infection (Taylor et ah, 1998). The hyporesponsiveness of the 
microfilarémie individual is restricted to parasitic antigens. Responses to non- 
parasitic antigens aie normal (Mahanty & Nutman, 1995).
Filarial parasites have also been found to secrete a homologue of tlie human 
proinflammatory cytokine macrophage inhibitory factor (MIF) (Pastrana et aL,
1998). This homologue is chemotactic for human immune system cells raising 
the question of why filarial parasites would want to attract the cells they need to 
avoid in order to survive. One theory is that the attraction of macrophages by 
filarial parasites is the first step in a process that allows alteration of the host 
immune response (Pastrana et a i, 1998). Production of homologues of host 
molecules involved in immune signalling with the aim of diverting tlie immune 
response, is a trick employed by a number of pathogens including poxvirus 
which secretes a chemokine, cytomegalovirus which interferes with Class 1 MHC 
molecule expression and EBV which secretes a IL-10 homologue.
1s
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1.4.4. The Role of Phosphorylcholme
Excretory-secretory proteins from filarial nematodes all possess a PC moiety that 
has been shown to be important in the immunomodulatoiy role which ES 
products are believed to play (Harnett & Parkliouse, 1995; Houston & Harnett,
1999b). Studies of PC-containing bacteria have demonstrated the ability of PC to 
interact with cells of the adaptive immune system independently of antigen 
receptors and cause polyclonal activation of the B cells. This interaction can 
occur via the PAF (platelet activating factor) receptor. Bacteria with PC on then 
surface are known to be dependent on the interaction between PC and the PAF 
receptor for invasion of cells (Harnett & Harnett, 1999b). Use of PAF receptor 
agonists, which block binding of PC-containing bacteria to the PAF receptor, 
have confirmed the role of the PAF receptor in the invasion of immune cells by 
these pathogens.
Filarial nematode PC-containing ES proteins cause a down regulation of B cell 
proliferation associated with ligation of the antigen receptor (Deehan et ah,
1998a; Harnett & Harnett, 1993). The receptors for these ES products aie 
unknown, but recent research has demonstrated that ES-62, the model ES 
product employed in this thesis, can bind cell membranes from a number of cell 
types with receptor-like affinity and in a PC dependent mamier (Harnett, M.M. &
Harnett W., Unpublished). This raises the possibility of PC receptors acting as 
receptors for ES products. The PAF receptor, employed, as described above, by 
PC containing bacteria, is one possible receptor tlirough which tliese ES products 
could be inducing their effects.
The presence of PC on a pathogen can often present a disadvantage for the 
pathogen, as the innate immune system is rapidly directed against PC. This acts 
as a crucial host protection mechanism against certain invasive pathogens 
(Hainett & Harnett, 1999b). However, the PC on ES products of filarial 
nematodes appears to have a role in promoting the longevity o f filarial 
nematodes within the host. It would appeal' thus that the presence of a PC moiety 
on a pathogen might not always be disadvantageous.
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1.4.5. Secondary Effects o f Infection with Filarial Parasites
Filai'ial pai'asites can survive for ten years or more within the host. It has been 
suggested that the filai iae induce a semi-permanent state of immunological 
unresponsiveness and that this results in the host becoming tolerant to the worm 
burden thus displaying minimal responsiveness to parasite antigens. People 
infected with filai'ial par asites who possess this tolerance to the worm buiden are 
asymptomatic. If tliis tolerant state should break down, the host can mount an 
immime response to the parasite, which results in skin lesions, limb swelling and 
elephantiasis. This has implications for vaccine development, as it is necessary to 
ascertain that the antigens used in a vaccine will not induce these symptoms.
Infection with filarial parasites causes a variety of effects in the host immune 
response not all of which are solely related to the filarial infection. Filai'ial 
infection is known to induce a Tli2 type response and to modulate the host 
iimmine response. Reported incidents of high levels of bacterial infections, for 
example lepromatous leprosy, in filai'ial endemic areas led to research into the 
effects of infection with filarial parasites in terms of bacterial infections. Many 
mycobacterial infections induce Thl responses allowing the body to rid itself of 
infection whereas Th2 responses result in active infection. Studies have shown 
that infection with mycobacteria and filai'ial parasites causes an increase in the 
symptoms and severity of the mycobacterial infection. This demonstrates that 
filai'ial infection is capable of modulating the immune response to a concun ent 
infection (Stewait et al, 1999).
While immuno suppression of the host can be seen to occur upon infection with 
filarial pai'asites there is also evidence tliat some immune system cells are 
required for growth of the filarial parasites. Research has shown that host NK 
cells are required for the growth of the B. malayi pai asite. This demonstrates the 
level of immunomodulation, achieved by filai'ial parasites, o f the host immune 
response with both the downi egulation of the protective branch of the immune 
system and the promotion o f immune system cells essential for parasite growth 
(Babuc^n/, 1998).
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1.4.6. Protective Immunity
Protective immunity is immunity to re-infection with a previously encountered 
pathogen and as such it is the goal of vaccine developers. Protective immunity in 
the case of filarial parasitic infection is stimulated by L3 larvae and demonstrates 
some cross reactivity between species. Dead L3 larvae do not induce this 
protective immunity thus the active immunogen is believed to be either secreted 
or produced post-infection. Protective immunity induced by L3 larvae can be 
achieved either by vaccination witli irradiated L3 lai'vae or by prolonged 
exposure to filarial parasites. Either way this protective immunity results in a 
decrease in the worm burden on the infected individual (Elelmy et aL, 2000;
Maizels & Lawrence, 1991; SclirempfEppstein et al., 1997). Triple vaccination 
with irradiated L3 larvae results in protection against infection for six months.
Other parasite derived molecules can induce strong humoral responses.
Superoxide dismutase (SOD) is one such molecule. Research has shown that 
SODs may participate in the immune evasion of filarial infection, this coupled 
with the strong humoral immune response that they invoke makes them an ideal 
target for anti-filarial vaccines (Lattemann et al., 1999).
1,5, Acanthocheilonema Viteae
Human filarial parasites are very host specific and thus are difficult to maintain 
in animals (Lucius & Textor, 1995). It is therefore necessary to employ a model 
system. A. viteae, a rodent filarial nematode which dwells in the subcutaneous 
tissues of its host, is the par asite used in this thesis and by other groups as a 
model system for the study of filariasis. A. viteae reproduces in a narrow 
spectrum of rodents (Lucius & Textor, 1995), the host employed ïoxA.viteae in 
this thesis was the jird, a Syrian hamster. A .viteae is employed as a model 
system for filariasis as it exhibits many similarities to human filarial infection.
The course of infection of A. viteae in jirds parallels chronic human filarial 
infection as the adult rt. viteae filariae develop well in the jird, are long living 
and produce high levels of microfilariae which are present throughout the life of 
the infected host. In addition the antibody responses of the jird to A. viteae vary
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during the period of infection (Lucius et al., 1987) which parallels the human 
antibody response to human filarial parasites.
The similarities between A. viteae and human filarial parasites are not restricted 
to the course of infection within the respective hosts. A.viteae shares antigens 
with O. volvulus (Nogami et ah, 1986), one of the human filarial parasites. In 
addition, the major ES product of A. viteae, ES-62, is homologous to an 
expressed sequence tag (EST) from O. volvulus and B. malayi and also contains 
PC (phosphoiylcholine) an common component of human filarial ES products.
ES-62, in a similar fashion to the ES products of B. malayi, is located 
predominately in the gut of the parasite (Wenger et al., 1988) and possesses an 
epitope present on the circulating antigens of B. malayi (Maizels et al., 1987),
O .volvulus (Harnett et al., 1989) and W. bancrofti (Dissanayake et al., 1984).
Research into the infection of golden hamsters with A. viteae revealed that the 
cellular response of the host to mitogens decreases during infection (Weiss &
Tanner, 1981). This is similar to the depression of the host cellular immune 
system observed in some individuals infected with lymphatic filariasis and 
onchocerciasis (Nutman er a/., 1987c; Ottesen, 1984; Soboslay cr o/., 1991).
A. viteae infection is currently used as a model system for the screening of 
filai'icidal drugs (Zahner & Schares, 1993) and has potential for use in the 
characterisation and screening of candidate vaccine antigens as protection against 
A. viteae in jirds can be induced by vaccination with irradiated L3 larvae (Lucius 
et al., 1991; Tanner & Weiss, 1981). A. viteae is thus a good model system for 
the study of human filarial infection.
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1.6. ES-62
ES products are produced by the parasite whilst within its maminalian host and 
are secreted by both L4 stage parasites and adult worms. ES products are 
believed to play an immunomodulatory role in the host and the PC moiety found 
on these ES products supports this hypothesis as PC is a known 
immunomodulator.
ES-62 is the major ES product of the rodent filai'ial parasite A. viteae, located 
predominately in the parasite gut. It has a mass of 57.8 kDa and is employed as a 
model for the study of the origin, fate and action of filarial ES products. ES-62 is 
used as a model system for human filarial ES products for thiee reasons: the first 
is that it is readily purified in sufficient quantities for study, the second is that it 
contains a PC moiety that is also present on human filarial ES products (Harnett 
et ah, 1989) and finally it is a homologue of molecules secreted by human filarial 
nematodes, such as B. malayi (Harnett et al., 1999a). ES-62 also possesses an 
epitope present on circulating antigens of B. malayi (Maizels et al., 1987),
O. volvulus (Harnett et al., 1989) and W. bancrofti (Dissanayake et al., 1984).
1.6.1. Biochemical Characteristics of ES-62
ES-62 has been cloned, its DNA sequenced and this sequence utilised to derive 
the amino acid sequence of ES-62. To provide independent confirmation of the 
DNA derived amino acid sequence, ti'yptic peptides of ES-62 were subjected to 
Q-TOF sequencing, a mass spectroscopy (MS) technique (Flarnett et al., 1999b). 
Figure 1-6 shows the DNA sequence and the derived amino acid sequence. The 
overlined portions highlight tliose peptides defined by MS sequencing. Gel 
filtration studies of native ES-62 have indicated tliat it is likely to be a tetramer 
with a molecular weight of 248 kDa (Harnett et al., 1999a). A sequence motif 
very similar to that seen in C-reactive protein has also been identified in ES-62 
and is shown in Figure 1-6. Tliis motif in C-reactive protein binds PC non- 
covalently. The presence of this sequence in ES-62 suggests that it is possibly 
binding PC non-covalently and then transferring it to its site, of attacliment on the
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N“glycans. Sequence homology searches have shown ES-62 to possess a region 
homologous to aminopeptidases as shown in Figure 1-6. Studies involving the 
incubation of ES-62 with leucine-7-amino-4-methylcoumarin, an aminopeptidase 
substrate (Acosta et a i, 1998), confirmed that ES-62 does possess 
aminopeptidase activity (Harnett et aL, 1999b). Recent homology searches 
(discussed in Chapter 3) have shown ES-62 to possess high full-length homology 
to haematopoietic switch 2  and switch 2 -related proteins, to a murine and human 
aminopeptidase, a glutamate carboxypeptidase precursor and a human liver 
annexin-like protein. The function of the haematopoietic switch proteins is not 
fully known but they are known to possess carboxypeptidase activity (Chen &
Talmage, 1998). The lack of available information on these proteins makes it 
difficult to predict the function of ES-62 on the basis of these homologies.
However, the high level of aminopeptidase and carboxypeptidase activity seen in 
these proteins might suggest a role for peptidase activity in the function of ES- 
62.
Further analysis of the sequence of ES-62 has also revealed the presence of 
leucine rich motifs, shown in Figure 1-6, which may play a role in the interaction 
of ES-62 molecules with other ES-62 molecules, resulting in multimerisation.
Amino acids that form two putative metal co-ordination sites have also been 
identified and can be seen in Figure 1-6. The residues that form the putative 
metal coordination sites are conserved in the six identified homologous protein 
mentioned above. Inductively coupled plasma atomic emission spectroscopy 
(discussed in Chapter 5) showed a strong magnesium signal for native ES-62 
suggesting a requirement for this metal ion and substantiating the presence of 
possible metal co-ordination sites.
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1 M L  L f f S g  T F F F  L V T L 1 4
1 ATAAATATGCTA CTCAATTCCTCG ACATTTTTCTTC TTGGTCACCCTA 48
15  T V V L g A a  A V L P D K  T V A P 3 0
49  ACTGTCGTTTTG GGOGCAGCTGTC CTTCCGGACAAA ACTGTCGCTCCG 96
31  K N Y I  Q E T F  G K E V  A E L I 4 6
97  AAGAATTATATC CAAGAAACGTTC GGGAAGGAAGTT GCCGAATTAATC 144
47  Q Y I T  K G E E  V G L A  Y Q W L 6 2
1 4 5  CAGTATATTACT AAAGGTGAAGAA GTTGGATTAGCT TATCAATGGCTT 192
63  S K L V  D G F G  H R M V  G S D S 7 8
1 9 3  AGCAAATTGGTC GATGGCTTTGGA CATCGTATGGTT GGTTCCGATAGC 2 4 0
7 9  L E K S  l A F L  E E S L  K N D N 9 4
2 4 1  TTGGAAAAATCG ATTGCTTTCTTA GAAGAAAGCTTG AAAAATGATAAT 2 8 8
9 5  F D K V  H T E E  V P N L  P H W V  11 0
2 8 9  TTTGATAAGGTG CACACCGAGGAA GTACCAAACTTG CCACATTGGGTT 3 3 6
1 1 1  R G N D  V V E M  l E P R  N Q R L  1 2 6
3 3 7  CGTGGAAACGAC GTTGTCGAAATG ATTGAACCACGA AATCAACGGCTC 3 8 4
1 2 7  N V L A  I G G S  E P A S  A T G E  14 2
3 8 5  AATGTGCTTGCT ATTGGTGGATCT GAACCAGCTAGT GCGACCGGAGAA 4 3 2
1 4 3  V T V I  Y D L D  D V K P  D D V R  1 5 8
4 3 3  GTGACAGTTATT TATGATCTTGAT GATGTCAAGCCT GATGATGTCCGT 4 8 0
1 5 9  G K I V  V T A Q  T F A G  Y P L T  17 4
4 8 1  GGCAAGATTGTT GTGACGGCACAA ACATTTGCTGGT TATCCGTTAACG 5 2 8
1 7 5  L K Y R  R S V K  L F E Q  L G A I  1 9 0
5 2 9  CTTAAATATCGT CGATCAGTAAAA TTATTTGAACAA TTAGGTGCCATT 5 7 6
1 9 1  G V L V  K S I T  S F S I  N S P H  2 0 6
5 7 7  GGTGTTCTGGTC AAATCAATAACA TCATTTTCCATT AATTCACCTCAT 6 2 4
2 0 7  T G T G  A E N r  T I P A  A C L T  2 2 2
6 2 5  ACCGGCACTGGT GCAGAAAATACA ACAATTCCTGCT GCATGTTTAACG 6 7 2
2 2 3  l E E A  E M L E  R L Y R  S G K K  2 3 8
6 7 3  ATTGAGGAAGCT GAAATGCTTGAA CGATTGTATAGG AGCGGCAAAAAG 7 2 0
2 3 9  I V I R  M D M K  S H Y E  E P I W  2 5 4
7 2 1  ATCGTAATCCGA ATGGATATGAAA TCACATTATGAG GAACCTATAAAT 7 6 8
2 5 5  S S N L  I F E I  T G S E  R P S E  2 7 0
7 6 9  TCCAGCAATCTT ATCTTTGAAATT ACCGGTAGTGAA CGACCATCTGAA 8 1 6
2 7 1  V V L L  S A 0  V D S W D  V G Q G  2 8 6
8 1 7  GTGGTACTATTA TCGGCACATGTG GACAGTTGGGAT GTTGGACAAGGA 8 6 4
2 8 7  A L |p| D G A G C  A V V W  S A L H  3 0 2  
8 6 5  GCATTGGATGAT GGTGCTGGTTGT GCTGTTGTATGG AGTGCTTTGCAT 9 1 2
3 0 3  S L K K  L A E R  N P K F  K P K R  3 1 8
9 1 3  TCATTAAAAAAA TTAGCCGAAAGA AATCCAAAATTC AAACCAAAACGG 9 6 0
3 1 9  T I R G  I F W T  S E @ Q  G Y G G 3 3 4
9 6 1  ACAATTCGAGGC ATATTTTGGACA TCGGAAGAACAA GGATATGGGGGT 1 0 0 8
_.J
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3 3 5  A K H Y  Y I T H  K N D S  P E K F  3 5 0
1 0 0 9  GCAAAACATTAC TACATAACACAT AAAAATGATTCA CCGGAAAAATTT 1 0 5 6
3 5 1  Y F V S  E T g  T G T F K  S T N W  3 6 6
1 0 5 7  TATTTTGTATCT GAAACGGATACA GGAACATTCAAA TCAACCAATTGG 1 1 0 4
3 6 7  L A H L  S F S G  D K K S  M L R L  3 8 2
1 1 0 5  CTTGCGCATCTT TCATTCAGTGGT GATAAAAAATCT ATGCTGCGACTT 1 1 5 2
3 8 3  K E I T  R L L S  R N G I  A L G L  3 9 8
1 1 5 3  AAAGAAATAACA CGTTTATTGAGC AGAAATGGTATA GCGCTTGGATTG 1 2 0 0
3 9 9  I  N S  S  V Q G D  V T F W  A K D G  4 1 4
1 2 0 1  ATAAATAGCTCA GTACAGGGTGAC GTTACTTTTTGG GCAAAAGATGGC 1 2 4 8
4 1 5  I P S V  N Y I P  D K A  V D Y Y F 4 3 0
1 2 4 9  ATACCATCAGTT AATTATATACCT GACAAGGCTGTC GATTATTATTTC 1 2 9 6
4 3 1  Y F H 0  T A G D Ÿ M T V L K D G 4 4 6
1 2 9 7  TATTTTCATCAT ACTGCTGGCGAT TACATGACAGTA TTGAAGGATGGC 1 3 4 4
4 4 7  D L E Y  T T S I  F A T L  G H V I  4 6 2
1 3 4 5  GATTTAGAATAT ACAACATCAATT TTTGCCACTTTG GGCCATGTAATC 1 3 9 2
4 6 3  A N M D  D W G S  D P N Q  P Q Q L  4 7 8
1 3 9 3  GCTAATATGGAT GATTGGGGAAGT GATCCTAATCAG CCACAGCAGCTT 1 4 4 0
4 7 9  N S K Q  S T T E  K S D R  K K L  4 9 3
1 4 4 1  AATTCCAAACAA TCCACTACTGAG AAATCTGATCGT AAAAAGCTATAA 1 4 8 8
Figure 1-6: DNA and derived amino acid sequence of ES-62. The arrow 
marks the start of the mature protein sequence, the sequence before this is a 
signal sequence, which dictates that ES-62 is secreted. Bold residues show 
those residues that constitute the leucine rich regions, residues in bold italics 
show the glycosylation sites, boxed residues are those involved in the 
formation of metal co-ordination sites, red residues show the region of ES- 
62 homologous to aminopeptidases and underlined residues show the region 
of ES-62 homologous to the PC binding region of C-reactive protein 
(residues 56-81 of human C-reactive protein (Harnett et al., 1999a)). 
Overlined residues show the peptides defined by MS sequencing.
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Mass spectroscopy studies have shown ES-62 to consist of 6 % carbohydrate and 
suggest the presence of at least 1 -2 PC groups. Studies characterising the 
carbohydrate content of ES-62 (Haslam et a l ,  1997) have identified three types 
of N-glycan structures; (I) high mannose; more analogous to fungal than 
bacterial PC-containing glycans, (2) those fully trimmed to the mannosyl core 
and fucosylated and (3) those with a trimannosyl core substituted with GlcNAcs, 
with or without core fucosylation. The latter of the three classes is the only one 
known to have PC attached (Haslam et aL, 1997). Figure 1-7 shows examples of 
the carbohydrate structures of these three classes.
Figure 1-7: Examples of the three classes of N-glycan structures identified 
on ES-62 (Haslam et al., 1997). (1) High mannose type structures, (2) those 
fully trimmed to the mannosyl core and sub-stoichometrically fucosylated, 
(3) those with a trimannosyl core with or without core fucosylation and 
carrying 1-4 additional N-acetylglucosamine residues. The third class of N- 
glycan structures shown is the only class found to be substituted with 
phosphorylcholine. O  -  N-acetylglucosamine, - Fucose, O - Mannose.
Studies on the processing of ES-62 through the endoplasmic reticulum and Golgi 
provides evidence that the PC groups are attached to the N-glycan structures in 
the Golgi and that this attachment occurs only if the glycan has been correctly 
processed. Incubation of worms with tunicamycin, an antibiotic which inhibits 
N-type glycosylation, results in non-glycosylated ES-62 which contains no PC 
and is only partially secreted. This demonstrates clearly that PC is attached to 
ES-62 via an N-linked glycan (Houston & Harnett, 1996). Further studies
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incubating worms with brcfcldin A (which inhibits transport from the ER to the 
Golgi), N-dcocy-l-dcoxynojirimycin (dNM) (which inhibits a-glucosidasc I in 
the ER) or 1-dcoxymannojirimycin (dMM) (which inhibits a-mannosidasc I in 
the Golgi, as shown in Figure 1-8), have also shown that PC is attached via N- 
linkcd glycans as each of these inhibitors prevents attachment of PC (Harnett et 
al., 1993; Houston et al., 1997; Houston & Harnett, 1999a). These studies also 
suggest that PC attachment is a post-ER event, probably occurring in the medial 
Golgi where the substrate for transfer is MangGlcNAcg or MangGlcNAcj. This 
association of PC with N-linked glycans is not seen in humans and thus could 
represent a target for chemotherapeutic agents (Houston & Harnett, 1999a).
Cis Golgi
dMM
Mannosidase I
Figure 1-8: 1-deoxymannojirimycin (dMM) inhibits a-mannosidase I in the 
Golgi, inhibiting processing of the glycans on ES-62 and preventing the 
addition of PC to ES-62. O -M an n ose , H I-N-acetylglucosamine.
The source of the PC attached to ES products of filarial nematodes has yet to be 
identified (Houston & Harnett, 1999a). Wov^Q\Qr, A.viteae filarial nematodes 
grown in choline-ffee media still produce ES-62 that possesses PC (Vanamail et 
al., 1996). This suggests that the worms make PC by an as yet unidentified 
pathway rather than obtain it from the host. While the source of PC for the
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worms remains elusive, studies have shown that attachment of PC is blocked by 
hemicholinium 3; an inhibitor of choline kinase which is the first enzyme in the 
Kennedy pathway. The Kennedy pathway, shown in Figure 1-9, is a metabolic 
pathway for the synthesis of phosphatidylcholine. Choline kinase catalyses the 
phosphorylation of choline as the first step in the transfer of PC from CDP- 
choline to DAG. This demonstrates that the phosphorylation of choline is 
essential for attachment of PC to ES-62 but there is no evidence that the rest of 
the pathway is involved (Houston & Harnett, 1999b).
ATP CTP Diacylglycerol
Choline ► Phosphorylcholine ► CDP-Choline ► Phosphatidylcholine
1 2 3
Figure 1-9: The Kennedy pathway for the metabolic synthesis of 
phosphatidylcholine. 1, 2 and 3 represent the three enzymes, choline kinase, 
phosphocholine cytidylyltransferase and choline phosphotransferase 
respectively, that catalyse the Kennedy pathway. Hemicholinium 3, an 
inhibitor of choline kinase, inhibits the phosphorylation of choline , the first 
step in the Kennedy pathway.
1.6.2. Effects o f ES-62 on the Immune System
ES-62 is immunogenic, studies have shown its systemic half-life, as estimated by 
clearance, to be 2-7 hours in naïve animals and 30 minutes in 4-10 week infected 
animals. This correlates with the clearance of antigen by antibody in the infected 
animals (Harnett et al., 1989). The effects of ES-62 on the immune system have 
been studied in depth due to the finding, observed in many studies spanning 
several decades, that filarial infection appears to promote defects in the host 
immune response (Harnett & Harnett, 1993). As ES products are found 
circulating freely in the bloodstream they were considered a good candidate for 
an immunomodulatory molecule. In vitro studies have shown that ES-62 inhibits 
polyclonal activation of murine B cells and that this effect can be mimicked by 
PC conjugated to BSA or PC alone (Harnett & Harnett, 1993). This suggested
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that the PC moiety is responsible for some of the immunomodulatory activity of 
ES-62 and is further substantiated by the knowledge that PC can interact with B 
cells via a receptor which is not the B cell receptor (Bach et al., 1983). However, 
the protein and carbohydrate content of ES-62 must also be important for 
function, as not all of the effects induced by ES-62 can be mimicked by PC 
conjugated to BSA or PC alone. Further, whilst PC alone is immunomodulatory, 
it is approximately two orders of magnitude less effective than when complexed 
to ES-62 (Harnett & Harnett, 1993).
The PC moiety is commonly found on ES products of all filarial parasites and the 
data to date suggests that PC-ES molecules play an important role in the 
immunomodulation of T and B cells obseiwed during filarial parasitic infection.
Studies have shown definitively that host exposure to PC-ES products during the 
course of a filarial infection leads to the loss of ability of B cells to respond to 
antigen. The extent of the role of the PC moiety itself is not fully known 
although studies showing that PC and PC conjugated to BSA can mimic many of 
the effects of ES-62 in both B and T cells suggest it has a large role to play.
1.6.3. Mechanism of Immunomodulatory Effects on B cells
ES-62 elicits effects on a number of different cells of the immune system. The 
best studied of these is the effects of ES-62 on B cells. The normal state of B cell 
signalling and the effects induced by ES-62 aie discussed in this section.
i .  6,3. L B Cell Signalling
Activation of B cells leads to proliferation and differentiation of these cells to 
form plasma cells and memory cells. These processes require many different 
signals from a number of immunoregulatory receptors on different cells.
The antigen receptor on B lymphocytes consists of a membrane immunoglobulin 
(mig) molecule and two glycoproteins, Iga and Ig|3. Iga and IgP form two 
heterodimers and are non-covalently associated with the mIg molecule. This is 
shown in Figure 1 -1 0 .
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Figure 1-10: The B cell receptor with its accessory molecules Iga and Igp.
Stimulation of cells via the B cell receptor (BcR) leads to activation of second 
messenger systems. However, mig has no intrinsic catalytic activity. Iga and Igp 
also possess no intrinsic catalytic activity however, they do contain ITAM 
(Immunoreceptor Tyrosine based Activation Motif) motifs, similar to those in the 
CD3 complex components of the T cell receptor, which allow interaction with 
protein tyrosine kinases to activate downstream signalling cascades (Cambier et 
al., 1994; Cushley & Harnett, 1993). The Iga and Igp therefore constitute an 
integral part of the BcR signalling complex.
Following antigen recognition by the BcR and receptor crosslinking, the first 
intracellular event is activation of the src-family protein tyrosine kinases (PTK) 
(approximately 15- 60  seconds after receptor ligation) resulting in tyrosine 
phosphorylation of the ITAM motifs of Iga and Igp . This results in recruitment 
of further PTKs which, once activated, tyrosine phosphorylate a variety of 
cellular substrates following which the BcR signalling pathway diverges into 3 
major biochemical pathways (Cambier et al., 1994; Cushley & Harnett, 1993). 
The first of these is the tyrosine phosphorylation and activation of phospholipase 
Cy (PLCy). PLCy, once activated, hydrolyses phospholipids leading to the
J
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formation of IP3 (inositol trisphosphate) and DAG (diacylglycerol). IP3 and DAG 
are second messengers which each activate specific protein kinase C (PKC) 
isoforms leading to redistribution of PKC to the plasma membrane, and influence 
gene transcription. In addition, IP3 also induces release of calcium from 
intracellular stores and influx of extracellular’ calcium, which leads to 
modification of DNA transcription.
The second pathway is the Ras-MAPK pathway. This pathway is activated by the 
formation of active Ras approximately 1-2 minutes after receptor ligation. Ras is 
activated by transition from a GDP to a GTP bound state (Harwood & Cambier,
1993). This process is regulated by VAV, a GTPase exchange protein (Bustelo et 
ah, 1992; Gulbins et al., 1993), GAP, a GTPase activating protein (Gold et ah,
1992), SOS, a guanine nucleotide exchange factor and Grb2, an adaptor 
molecule (Feig, 1993). Ras specifically regulates c-Raf, which in tuin regulates 
serine/tlireonine phosphorylation of MEK and ultimately tyrosine/threonine 
phosphorylation of MAPK. MAPK is known to influence gene expression due to 
its ability to activate Fos and Myc -  proteins involved in regulation of gene 
expression. Thus activation of this pathway in response to antigen recognition 
influences gene expression within the B cell.
The third pathway involves the activation of phosphatidylinositol 3-kinase 
(PI3K) via tyrosine phosphoi’ylation by the PTK Lyn. PI3K, once activated, 
phosphorylates inositol phospholipids. This induces a variety of downstream 
effects including the activation of PKC which is not activated by either IP3 or 
DAG. PKC ^ can directly affect gene transcription but also acts as an alternative 
pathway through which MAPK can be activated. Figure 1-11 shows 
diagrammatically the complex nature of signalling Avithin B cells.
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Figure 1-11: The B cell receptor and its downstream signalling pathways.
Chapter 1 : Introduction______________________________________________________ 35
1,6.3.2. Effects o f ES--62 on B Cell Signalling
Studies have shown that ES-62 can elicit weak mitogenic effects on resting B 
cells but this effect can be achieved only at concentrations far in excess of 
physiological concentrations (Harnett et a l,  1999a). At physiological 
concentrations of ES-62, an abortive, non-productive activation of certain 
signalling molecules is induced leading to desensitisation of subsequent 
sustained proliferation signalling both in vitro and in vivo (Deehan et al., 1998a).
The effects induced by ES-62 are specific. ES-62 induces tyrosine 
phosphorylation activation of Lyn, Syk and Blk protein tyrosine kinase but not 
the protein tyrosine kinase, Fyn (Deehan et ah, 1998a). It also induces 
phosphorylation and activation of the Erk2 isoform of MAP kinase (MAPK)
(Deehan et al., 1998a) and decreases the total level and activity of cellular 
protein kinase C (PKC) by modulation of expression of PKC isoforms (Deehan 
et al., 1998b; Harnett & Harnett, 1993), ES-62 does not affect EPS induced 
activation of B cells nor does it modulate phosphatidyl-phospholipase C 
(PtdCho-PLC), -phospholipase D (-PLD) or choline-specific sphingomyelinase 
activity (Deehan et ah, 1998a; Harnett & Harnett, 1993). Figure 1-12 shows 
diagrammatically the abortive activation induced by ES-62.
The activation of protein tyrosine kinases and MAPK induced by ES-62 does not 
lead to polyclonal activation of B cells and subsequent proliferation but instead 
desensitises the cells to subsequent activation of PI3K, PKC and RasMAPK 
pathways and thus to cellular proliferation via the BcR (Harnett et al., 1999a).
This desensitisation is achieved by the recruitment of protein tyrosine 
phosphatases, such as SHP-1 and PAC-1, to sites of protein tyrosine kinase and 
MAPKinase activity.
As discussed in section 1.6.3.1, crosslinking of the BcR leads to protein tyrosine 
kinase activity and subsequent tyrosine phosphorylation of the ITAM motifs on 
the Iga and (3 chains of the BcR. This in turn leads to activation of a number of 
downstream signalling cascades; the tyrosine phosphorylation and activation of 
PLCy, the RasMAPK cascade and the activation of PI3K. ES-62 affects only the 
RasMAPK cascade and activation of PI3K. Activation of PLCy is unaffected.
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Figure 1-12: Abortive activation and BcR desensitisation by ES-62.
ES-62 polyclonalty activates certain protein tyrosine kinases (PTKs) and 
MAP kinase signal transduction elements in B lymphocytes. This activation 
does not lead to proliferation of the B lymphocytes, instead it desensitises the 
cells to subsequent activation via the antigen receptor.
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ES-62 alone doesn’t induce activity of either PI3K or Ras despite activating Lyn, 
Syk and Blk. This suggests that either the activity induced is insufficient for 
downstream signalling or that ES-62 also recruits unidentified signals that 
negatively modulate Ras and PI3K activity (Deehan et al., 1998a). For example, 
ES-62 has also been found to increase activity of GAP, a GTPase protein which 
catalyses the conversion of GTP to GDP. This protein acts to convert the active 
form of Ras (Ras-GTP) to its inactive form (Ras-GDP) which in tum blocks 
activation o f the MAPK pathway and hence Erk activation. Pre-treatment of B 
cells with ES-62 followed by anti-Ig stimulation caused a decrease in BcR- 
coupled PI3K and Ras activity (Deehan et al., 1998a). Erk MAPK is also 
desensitised by ES-62 due to recruitment of PAC-1, as mentioned above. Thus 
ES-62 invokes a two-pronged attack on the RasMAPK signalling cascade. The 
role of Erk in B cell proliferation is well characterised and this is one of the main 
methods ES-62 employs to inliibit proliferation in B cells (Deehan et al., 1998a; 
Flarnett et ah, 1999a).
- f '
ES-62 as mentioned earlier decreases the total level and activity of cellular PKC 
and selectively modulated expression of the PKC isofonns (Deehan et al., 1998b; 
Harnett & Harnett, 1993). PKC isoforms ai’e classed into three groups. The first 
of these is the conventional PKC isoforms (a, (3 and y) which are calcium, DAG 
and phospholipid dependent and as such are potential downstream targets of 
phospholipid derived second messengers. The second group is the novel PKC 
isoforms (ô, e, p and (j)) which are DAG dependent. The third group is the 
atypical PKC isoforms (^ and i/ X) which transduce PI3K mediated signals and 
are a downstream target of PI3K.
The effects on PKC isoform expression aie only observed following pre­
exposure of B cells to ES-62 followed by subsequent anti-Ig stimulation. 
Treatment with ES-62 alone causes only a veiy slight decrease in PKC 
expression and activity. ES-62 downregulates the a, (3, ô, ^ and i/A. PKC 
isoforms and inhibits the nuclear translocation of these isoforms which is 
essential for activation. ES-62 upregulates the y and e isofbrms. The differential 
sensitivity of PKC isoforms to downregulation may reflect their distinct
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subcellular locations and functional properties. The downregulatoiy effects of 
ES-62 on PKC isoforms are achieved by proteolysis. Studies have shown that 
PMSF and leupeptin, protease inhibitors, reduce PKC dovraregulation by ES-62.
Incubation of ES-62 pretreated cells with IL-4 prevents the dowmegulation of 
PKC a  and i/X isoforms. IL-4 can also act synergistically with ES-62 to produce 
B cell activation, raising the question as to whether B cells in vivo which 
encounter ES-62 in the presence of IL-4 are activated. Hyporesponsive filarial 
patients show greatly elevated levels of IgE and IgG4 which are both regulated 
by IL-4. These data suggest a role for IL-4 in the modulation of the immune 
response to filarial parasites.
1.6.4. Mechanism of Immunomodulatory Effects on T cells
The above section discusses the effects of ES-62 on B cells, this section 
discusses the effects ES-62 has on T cells. T cell signalling is similar to that of B 
cells and the effects induced by ES-62 are also similar. It is knovm from studies 
of patients infected with B. malayi that the PC-containing molecules of B. malayi 
inhibit the response of T cells to mitogens (Lai et ah, 1990). Recent studies have 
shown that ES-62 can render T cells anergic to activation by the T cell receptor 
(TcR) (Harnett et al., 1998). It achieves these effects in T cells in a similar way 
to its actions in B cells. ES-62 modulates the activity of the PTKs; Fyn, Lck and 
ZAP-70 in T cells in the same way that it modulates the activity of Syk and Blk 
in B cells (Harnett et a l, 1999a). This acts to disrupt the coupling of the T cell 
receptor to the downstr eam signalling cascades of phopholipase D, PKC, PI3K 
and Ras/MAPK (Harnett et al., 1998) in a similar fashion to the disruption of the 
PI3K, PKC and RasMAPK pathways in B cells. These findings suggest a role for 
ES-62 in the induction of T cell hyporesponsiveness, which is a key 
characteristic of filarial infection.
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1.6.5. Mechanism of Immunomodulatory Effects on Dendritic 
and Macrophage Cells
B and T cells are not the only immune system cells to be affected by ES-62.
ES-62 also modulates macrophage and dendritic cell function (Whelan et a l,
2000). Recent work, (Goodridge et a l, 2001), has shown that macrophages 
treated with ES-62 cannot subsequently be fully activated by EPS, causing 
decreases in IE-12, IL-6 and TNF-a cytokine production but no alteration in 
nitric oxide (NO) production. This has implications for the Thl/Th2 balance of T 
cells produced. ÏL-12, IL-6 and TNF-a promote a Thl bias in the Thl/Th2 
balance thus a decrease in these cytokines results in a Th2 bias. This is, as 
mentioned previously, the bias typically seen in infected individuals displaying 
no pathological signs of disease.
Similarly, recent work on dendritic cells (Whelan et al., 2000) has demonstrated 
that ES-62 also has an effect on these cells. Dendritic cells can, by process of 
specific maturation, drive the immune response to a Thl or Th2 type response.
Maturation of dendritic cells occur s following exposure to microbial agents when 
dendritic cells produce immunostimulatory cytokines and up-regulate expression 
of MHC I, MHC II and costimulatory molecules. Tins results in the dendritic 
cells becoming more efficient antigen presenting cells (APCs) and provides 
crucial elements for selective activation of T cells to drive a Thl or Th2 
response. ES-62 can induce the maturation of dendritic cells which have the 
capacity to induce a Tli2 response, the classical immune response observed in 
those infected with filarial parasites (Whelan et al., 2000).
1.6.6. Ex vivo Studies on the Effects of ES-62 on Immune 
System Cells
Most of the effects that ES-62 has on immune cells have been revealed by work 
done in vitro. Studies using mini-pumps to deliver ES-62 at physiological 
concentrations over a two week period have tried to address this (Goodridge et 
al., 2001; Wilson et al, 2002). These ex vivo studies, where cells are exposed to 
ES-62 in vivo but stimulated in vitro, have shown a decrease in proliferation in
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splenic B cells and nodal cells but not in peritoneal B1 cells. Changes in 
expression of cell surface markers have also been observed with decreases in 
CD 19, 40, 80 & 86 and MHC II occurring in splenic cells. These cell surface 
markers all act as co-receptors or co-stimulatory molecules for B cells. The 
observed decrease in expression of these molecules thus suggests a 
desensitisation of the B cells to antigen and co-stimulatory molecules and hence 
in the ability to be activated and to activate T cells. This correlates with the 
known de sensitisation effect of ES-62 on B cells. Macrophages show suppressed 
levels of IE-12, IL-6 and TNF-a similarly to those findings from in vitro studies.
Nitric oxide production is not found to be affected. Preliminary data from 
Goodridge et a l (unpublished) have suggested that these decreases in cytokine 
production, observed following ES-62 treatment, are the result of the disruption 
of IE-12 niRNA expression by modulation of EPS induced Erk MAPK and NF- 
kB signalling by ES-62.
Studies of mitochondrial potential following ES-62 tieatment have revealed that 
ES-62 is not inducing apoptosis, as an increase in mitochondrial potential is 
observed. Apoptosis is preceded by a decrease in mitochondrial potential due to 
the breakdown of the membrane systems within the mitochondria. Anergy is not 
preceded by a decrease in mitochondrial potential thus it is possible that anergy 
not apoptosis is induced by ES-62.
Ex vivo results corroborate the earlier in vitro work and reinforce the premise that 
cell populations respond differently to ES-62. It is therefore important to take 
into account the amount of ES-62 that each cell population would come in 
contact with in the case of filarial infection of a host when assessing the effects 
ES-62 has on the immime system.
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1.7. Approaches to Control o f Filariasis
1.7.1. Lymphatic Filariasis
There are two main strategies for treatment and control of lymphatic filariasis as 
outlined by the W.H.O division of Control of Tropical Diseases. These strategies 
are to stop the spread of infection and to alleviate suffering of infected 
individuals. The first of these can be split into two; treatment of entire 
communities for lymphatic filariasis (chemotherapy) and vector control. The 
second of these is aimed at educating communities, where lymphatic filariasis is 
a problem, about strategies that can aid those already infected (W.H.O., 1996; 
W.H.O., 1998).
1,7. L L  Clinical Diagnosis
Clinical diagnosis of infected members o f an endemic commimity has always 
been restricted by the sensitivity of the assays available combined with the 
periodicity of the filar ial parasites. The assays measure circulating or ur inary 
parasitic products with the aim of confirming infection of both symptomatic 
individuals and asymptomatic individuals and to attempt to identify a 
relationship between antigen levels and levels of infection, i.e. worm bur den 
(Harnett et ah, 1990). The periodicity of the parasites means that the density of 
the microfilariae in the peripheral bloodstream varies over the course of the day 
such that it is greatest at peak biting times i.e. evening/night. For this reason.
coupled with the restriction on sensitivity exhibited by the assays, night blood 
samples are often required when trying to assess the infected state of members of 
an endemic community. Night collection of samples is not an ideal situation as 
clinics are shut at night and those collecting the samples are exposed to infection 
with parasitic disease.
The assays are usually antibody-based which can present problems due to the 
sensitivity of these antibodies to the antigens. They are also affected by the 
antigen to wliich the antibody is specific. Parasitic smTace antigens are less
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cross-reactive amongst human filarial species and are thus ideal for diagnostic 
assays. However, many of the excretoiy-secretory parasitic products are also 
highly immunogenic and are present at much higher levels both within the 
bloodstream and urine of the patient, the urine being easier and less hazardous to 
collect. The high levels of these excretory-secretoiy products makes them ideal 
diagnostic tai'gets. Unfortunately heavy glycosylation and the presence of 
phosphorylcholine moieties means that many of the antibodies raised against 
these products are not species specific.
During the last decade two monoclonal antibody (mAb) ELIS As have been 
developed which are sufficiently sensitive to detect infected individuals from 
blood samples collected during the day. As these mAbs are against adult worm 
circulating antigens (CFA), these ELISAs can detect both microfilarémie (mf+) 
and amicrofilaremic (mf-) individuals (Nicolas et al., 1997).
The W.H.O. has also developed diagnostic and epidemiological assessment tools, 
which include three direct higlily sensitive and specific diagnostic methods. The 
first involves analysis of daytime finger-prick blood samples using monoclonal 
antibodies specific for W. bancrofti antigens. The second and third methods are 
similar in that they both employ PGR to detect parasitic DNA, which while both 
specific and sensitive, requires a laboratory with a high level o f quality control 
(W.H.O., 1999a). One of the methods is directed towards testing human blood 
for the presence of parasitic DNA whilst the other is concerned with testing the 
vector (mosquitoes) for the presence of parasitic DNA. These tests can detect W. 
bancrofti, B. malayi and B. timori. The techniques of detection described so far 
are targeted at detecting microfilariae in the blood or urine; however, it is also 
possible to visualise living adult W. bancrofti worms present in the scrotal area 
of infected individuals using ultrasound (Dreyer et al., 1998; Noroes et al.,
1997). Live adult worms exliibit a ‘dance’ pattern of movement within their nests 
in the lymphatic vessels of the spermatic cords of infected individuals.
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1.7.1.2, Vector Control
There is a range of strategies aimed at decreasing the transmission of lymphatic 
filariasis by tai'geting the vector. The most simple of these include bednets and 
curtains impregnated with insecticides and long-lasting indoor insecticide sprays.
There is also some evidence that ivermectin can be used in vector control.
Studies have shown that mosquitoes fed on ivermectin-treated mice or 
ivermectin/sugar mix either die themselves or the infective lai'vae within them 
die. The level of ivermectin needed to kill the mosquitoes varies between 
species. However, studies have shown that even at concentrations insufficient to 
kill the vector there is still a reduction in transmission of the parasite. This is 
thought to occur due to the proposed effect of ivermectin on the development of 
the microfilariae (Wilson, 1993).
Another method of vector control involves the use of the toxin-producing 
bacterium Bacillus sphaericus. This bacterium kills mosquito larvae and thus is 
an effective method of control against lymphatic filariasis. However, the bacteria 
do not act on blackfly larvae and thus cannot be used against onchocerciasis 
(Cheong & Yap, 1985; Hougard et ah, 1993). The survival of these bacteria has 
been shown to be increased by the presence of polluted as opposed to clean 
water, which makes it eminently useable, in the countries affected by filariasis.
The bacteria also have the environmental benefit of being harmless to non-target 
organisms. This method of vector control has been employed in the clearance of 
lymphatic filariasis from Japan, South Korea, Taiwan and China.
1.7.1.3. Chemotherapy
Chemotherapy of communities in areas of endemic lymphatic filariasis has one 
main aim; to decrease the level of circulating microfilariae so that transmission 
rates are reduced and symptoms of those affected are relieved. For the past five 
decades diethylcarbamazine (DEC), a microfilaricidal compound, has been used 
to treat lymphatic filariasis (W.H.O., 1996; W.H.O., 1998). Unfortunately its use 
is contra-indicated for areas where onchocerciasis and loiasis are also present as 
it can induce severe and dangerous adverse reactions by rapidly killing the
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Onchocerca or Loa loa microfilariae (Ottesen et a l, 1997). Recent studies have 
shown ivermectin, a microfilaricide used in treatment of onchoceriasis (Shan et 
a l, 2001), and albendazole to be successful in treatment of lymphatic filariasis.
DEC, ivermectin and albendazole all cause reductions in microfilariae levels 
although the timescale over which this occui's and the length of time that the 
effects last varies.
DEC treatment of lymphatic filariasis suppresses microfilaremia and appears to 
have some macrofilaricide effects. Treatment with ivermectin is more rapid than 
treatment with DEC and is as successful in lowering the microfilariae level.
However, ivermectin has no macrofilaricide effects. Combined treatment of 
lymphatic filariasis with DEC and ivermectin is more successful in lowering 
microfilariae levels than either individually, but co-administration of ivermectin 
with DEC appears to interfere with the macrofilaricidal action of DEC (Dreyer et 
a l, 1998).
Albendazole, a potent broad-spectrum antihelmintlc agent, has already been 
shown to have antifilarial activity in onchocerciasis and loiasis (Ismail et a l,
1998) and studies have recently been cairied out to assess its effects on 
lymphatic filariasis both alone and in conjunction with DEC or ivermectin. These 
studies indicated that multiple doses of albendazole have both micro- and 
macrofilaricidal activity and that combined treatment of ivermectin and 
albendazole was the most successful treatment in terms of rapid and sustained 
clearance of microfilariae from the bloodstream (Ismail et a l, 1998). Mass use of 
a single dose of albendazole in conjunction with ivermectin would have many 
benefits; not only does this combination treat lymphatic filariasis, but it would be 
safe to use in areas where onchocerciasis and loiasis are also present. The broad- 
specti'um effect of albendazole means it would also act to reduce the prevalence 
and intensity of intestinal worms in the community. Although further studies to 
assess the adverse effects, safety, cost and availability in endemic areas are still 
required, this new combination of antifilarial drugs could be the new strategy to 
aid eradication of filariasis.
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As well as chemotherapy the W.H.O. have identified the need to educate 
endemic communities about tlie benefits to be gained from rigorous local 
hygiene of affected limbs. Studies have shown that much of the progression of 
symptoms such as elephantiasis and hydrocele are due to bacterial and fungal 
infections of the tissues with compromised lymphatic function. Rigorous hygiene 
of these areas can reduce or even eliminate the infections thus easing the 
symptoms and alleviating suffering of the affected individual (W.H.O., 1999a).
1.7.2. Onchocerciasis
The Onchocerciasis Control Programme (OCP) launched in 1975 and covering 
eleven West African countries, has the sole objective of eliminating 
onchocerciasis, a public health and socio-economic problem. Onchocerciasis is 
currently under full control in the OCP area, although outside this area there are 
an estimated 15 million people infected with O. volvulus.
1.7.2,7. Clinical Diagnosis
Clinical diagnosis of onchocerciasis relies on antibody-based assays which, due 
to the lack of circulating antigen and poor specificity of antibodies, are 
inaccurate and unreliable. Development of recombinant antigens has led to 
antibody assays based on these antigens which are more sensitive and specific 
for identification of human onchocerciasis infection than earlier assays based on 
mixes of native antigens.
At present diagnosis of onchocerciasis infection is based on identification of 
microfilariae in skin snips. Unfortunately this method is incapable of identifying 
individuals with low levels of microfilariae in their skin and also prevents early 
detection of infection for rapid treatment. Further to the diagnostic problems 
associated with skin snips, this metliod also presents problems in that the 
equipment required is expensive and carries a risk of transmission of blood-borne 
viruses between patients. Alternative diagnostic procedures include topical 
application of a DEC cream with examination of the skin 48 hours later
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(localised papular reaction indicates death of microfilariae in the skin) (Weil et 
a l, 2000) and use of PCR teclmology. PCR detection of O. volvulus presents the 
same problems as those discussed for PCR detection of W. bancrofti, B. malayi 
and B. timori and has the further disadvantage that skin snips are still required to 
obtain the samples for diagnosis (Chandrashekar et a i, 1995).
Development of a rapid, sensitive diagnostic assay, which does not require the 
collection of samples via skin snips, is desperately needed. Recently, a rapid 
format card test has been developed which detects IgG4 antibodies to 
recombinant O. volvulus antigen Ovl6. Initial trials of this diagnostic test have 
proved encouraging with a sensitivity of 90.6 % and a high level specificity for 
O. volvulus. It is hoped this test signals an end to the collection of skin snips 
(Weil a/., 2000).
L 7,2,2, Vector Control
Initially the OCP was based solely on vector control of Simulium damnostim, the 
blackfly vector of O. volvulus. Larvae were destroyed by the widespread aerial 
spraying of larvicides on the breeding sites of the blackfly, along the banks of 
fast flowing rivers. The reasoning behind this use of laiwicide was that if  the 
transmission of the parasite could be interrupted for longer than adult parasites 
can survive in the host then onchoceriasis could be eliminated.
Vector control faced two main obstacles; the first was that the border of the OCP 
area was invaded by infective blackflies from outwith the OCP. This problem 
was overcome by extending the borders to allow the core area to be protected. 
The second obstacle was that the blackfly became resistant to the initial 
insecticide used. This was overcome by identifying seven insecticides, one of 
which is a biological insecticide, that are used in rotation.
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i .  7.2.5. Chemotherapy
In 1987 the pharmaceutical company Merck, Sharp and Dohme offered 
ivermectin free of charge for ‘as long as needed’. This allowed the OCP to adopt 
a two-pronged approach to the elimination of onchocerciasis and also allowed 
clinicians in endemic areas outside the OCP to treat infected people. Ivermectin 
has been shown to have prophylactic activity against O. volvulus if  given on the 
day of infection (Chandrashekar et ah, 1995). However, this action is of little use 
in treating those already infected although it does provide strong support for 
early treatment of onchocerciasis and provision of ivermectin for those in 
endemic areas who do not display clinical symptoms as yet. A study on the 
effects of large scale ivermectin treatment on the transmission of O. volvulus 
demonstrated that after eight annual treatments the prevalence and intensity of 
O. volvulus infection had decreased by 90 % despite the lack of vector control in 
the study area. This study also demonstrated that ivermectin acted on the adult 
worms, decreasing their reproductive capability by approximately 92 %
(Boussinesq et ah, 1997).
At present ivermectin is used within the OCP in conjunction with vector control 
programmes and outwith the OCP on its own. The OCP has treated 1.5 million 
infected people, prevented 125,000-200,000 people from going blind, protected 
30 million people at risk of infection and made 25 million hectares of land 
available for settlement. The OCP is due to come to conclusion in 2002 and the 
two related projects; OEPA (Onchocerciasis Elimination Programme in the 
Americas) and the APOC (African Programme for Onchocerciasis Control) are 
expected to allow the global elimination of onchocerciasis as a public health 
problem by 2008. Recently a breakthrough has been made concerning the 
treatment of onchocerciasis. Research has shown that there are bacteria 
abundantly present in the tissues of O. volvulus worms (Werren, 1997). Killing 
of these bacteria through treatment with antibiotics, such as tetracyclin, has been 
shown to result in the death of the parasite as well (Kennedy & Harnett, 2001).
Trials are currently underway in Ghana which, if successful, could result in 
treatment becoming available in 2002.
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l.S. Aims
The aim of this thesis was to employ a combination of tecliniques, from 
biophysics to cellular signalling, to obtain structural information about the filarial 
nematode excretory-secretory glycoprotein ES-62 and to attempt to identify its 
receptor on cells of the immune system.
Structural information about a filarial nematode excretoiy-secretoiy protein 
would allow the rational design of drugs to target these proteins and thus be used 
to treat filariasis and drugs which could mimic excretory-secretory proteins and 
be used as immunosuppressants to treat transplant patients and in inflammatory 
diseases. Structural information about ES proteins could also potentially aid 
receptor identification and further understanding of the interaction of these 
proteins with cells of the immune system. In addition vaccine development could 
be aided by the structural characterisation of a potential vaccine molecule.
Identification of the receptor for ES-62 would allow further elucidation of the 
mechanism of action of ES-62 which can then be related to the mechanism of 
action of ES proteins of human filarial species. Identification of the receptor for 
ES-62 would also aid the development of chemotherapeutic agents for the 
treatment of human filariasis and would allow study of the native agonists of this 
receptor and its cellular role. As discussed in section 1.7, lymphatic filariasis and 
onchocerciasis are targets for elimination by the World Health Organisation 
(W.H.O.). Currently there is no effective vaccine available for these diseases and 
few effective treatments, thus the development of new chemotherapeutic agents 
and vaccines are imperative.
ES-62 was employed in this thesis as a model for the ES proteins of human 
filariasis. ES-62, as discussed previously, shows many similarities to these 
proteins and is the major ES protein of A. viteae, the rodent filarial parasite 
employed as a model system for the study of human filariasis. The effects of ES- 
62 on B cell signalling have been studied in detail aiding identification of 
potential receptors.
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ES-62, as previously discussed, is a glycoprotein and is only available in 
relatively small quantities, these factors make it a difficult target for structural 
determination by crystallography. It was thus decided to use a different approach 
to obtain structural information about ES-62 and thi’ee main techniques were 
employed.
The first of these was the use of bioinformatic programs to identity homologous 
proteins, predict the secondary structure of ES-62 and attempt to model its 
tertiary structure. Bioinformatic programmes were employed as the first step to 
obtaining structural information as the identification of a homologous protein 
would be extremely useful for modelling the structure of ES-62 and could also 
potentially provide functional information about ES-62. Bioinformatic 
programmes could be employed in the structural characterisation of ES-62 as the 
DNA and amino acid sequences are known (Harnett et al., 1999b) as is the 
structural of the carbohydrate chains of ES-62 (Haslam et al., 1997). A number 
of biophysical techniques, such as circular dichroism (CD) and inductively 
coupled plasma atomic emission spectroscopy (ICP-AES), were employed to 
obtain experimental structural data about ES-62 which could then be used to 
assess the accuracy of the data obtained from the bioinfonnatic programmes. CD 
studies of ES-62 provided information about the secondary structure content of 
ES-62 which was used to assess the predicted secondary structure of ES-62.
ICP-AES determines the presence of metal ions within a protein and this 
information was then used to assess the accuracy of predictions regarding 
putative metal co-ordination sites within ES-62.
The second approach used was analytical ultracentrifugation (AUC) to establish 
the stoichometry and self-interaction constant for native ES-62. AUC was 
employed as it requires small quantities of protein for analysis and can analyse 
glycoproteins easily. AUC also analyses the proteins in a solution state as 
opposed to a crystal state, and thus provides data on the low resolution shape and 
size of a protein in a physiologically relevant environment.
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The third technique employed was small angle X-ray scattering (SAXS). This 
technique was used to obtain information about the overall shape of ES-62 and to 
perform tertiary structui’e modelling, based on the experimentally obtained 
scattering curve, using the programme DAMMIN (Svergun, 1999). SAXS 
complements the information obtained from AUC studies and again requires 
small quantities of the protein for analysis. Similarly to AUC, SAXS analyses 
proteins in solution rather than in a crystal state,
ES-62 is glycosylated and possesses phosphoiylcholine moieties. In order to 
investigate the contribution that each of the components of ES-62 (protein, 
carbohydrate and PC) make to the immunomodulatory potential of ES-62, the 
establishment of two different expression systems was attempted. The first of 
these was a bacterial expression system in E, coli to allow the study of the 
protein component of ES-62 alone. The second was a baculovirus expression 
system in SF9 insect cells to allow the study of glycosylated ES-62 without its 
phosphorylcholine moieties. The establishment of recombinant expression 
systems would also allow crystallographic studies of ES-62 in the future by 
alleviating the limiting factor of the production of milligram quantities of ES-62 
and in the case of bacterial expression removing the problematic carbohydrate 
moieties. The structural information obtained from friture crystallographic 
studies could be used to examine any differences between the solution and 
crystalline structure of ES-62.
Finally an attempt was made to identify the receptor for ES-62 on a number of 
immune system cells to further aid understanding of the way in which ES-62 
induces its immunomodulatory effects. This information could be used to aid 
both the development of vaccines and chemotherapeutic agents for treatment of 
filarial disease and in the development of immunomodulatory drugs.
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2. Materials and Methods for Biochemical Analysis 
and Expression Systems
2.1. Isolation of Native ES-62
Native ES-62 was obtained by sacrificing infected jirds and harvesting the adult 
A. viteae worms. The harvested worms were then kept in tissue culture flasks 
containing RPMI 1640 (GIBCO BRL, Paisley, UK) complete medium at 37 '"C 
in an atmosphere of 5 % CO2 / 95 % air, where they secreted ES-62 into the 
media. To obtain the secreted ES-62 the media was collected and filtered through 
a 0.22 pm membrane filter to remove the adult worms. The media was then 
concentrated and transferred to PBS (5.5 mM potassium chloride, 145 mM 
sodium chloride, 8 mM disodium hydrogen orthophosphate, 1.5 mM sodium 
dihydrogen orthophosphate) pH 7.0 using an ultrafiltration cell (Amicon) with a 
10 kDa cut-off membrane (PM 10). To further concentrate the ES-62, centrifugal 
concentrators (Amicon) with a 100 kDa cut-off membrane were used. This 
concentrated sample was then subjected to FPLC purification using a Superose 6 
column. Elution of the Superose 6 column with PBS pH 7.0 produced a single 
peak on the FPLC spectrophotometer trace (recorded at 280 nm). Analysis of the 
eluted samples by SDS PAGE and Western blotting determined that 95 % of the 
protein eluted was ES-62 (Harnett & Harnett, 1993).
2.2, Cell Culture
2.2.1. SF9 Cell Culture
The insect cell line, SF9, was cultured following the manufacturers insti’uctions 
(PharMingen, 1999) using TMN-FH and protein free insect media (PharMingen,
BD Biosciences, Cowley, Oxford)) supplemented with penicillin (100 U ml"')
(GIBCO BRL, Paisley, UK) and streptomycin (100 pg ml"') (GIBCO BRL,
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Paisley, UK). Cells were transferred from fully supplemented to protein free 
media following manufacturers instructions (PharMingen, 1999).
2.2.2. Culture of Cell Lines
U937, WEHI, Daudi, Jurkat, REH, 207, 697, Ramos and Naim 6 cell lines were 
cultured in RPMI 1640 supplemented with 5 % (v/v) heat inactivated fetal calf 
serum, penicillin (100 U ml"') and streptomycin (100 pg m f') at 37°C in 5 % 
CO2 /9 5  % humidified air.
2J. PCR
PCR, polymerase chain reaction, is a technique used to amplify minute quantities 
of specific DNA using primers (Saiki et a l, 1985). PCR can also be used to add 
small sequences of DNA, such as restriction digestion sites, to the ends of target 
DNA. In this study PCR was used to amplify the ES-62 sequence within the 
pBluescript (Stratagene) vector and add appropriate restriction digestion sites to 
the ends of the sequence to allow cloning of ES-62 into either the pET 19b or 
pAcGP67-B vector. In order to perform PCR some knowledge of the sequence of 
the DNA to be amplified is required such that suitable primers can be designed.
2.3.1. Primer Design
PCR primers are usually between 15 and 30 bases in length, and are designed to 
bind to the DNA on either side of the region of interest. The primers usually have 
no greater than 50 % G+C content and should not contain sequences that could 
flip back on themselves forming secondary structure. In addition the primers 
should also not contain complementary regions in order to avoid the formation of 
primer dimers. All of the primers discussed below were obtained from Oswel 
(Oswel DNA Service, Lab 5005, Medical and Biological Sciences Building, 
University of Southampton, Boldrewood, Bassett Crescent East, Southampton 
SOI6 7PX).
Chapter 2: Materials and Methods_____________________________________________ ^
2.3.1.L pET19b
To clone ES-62 into pET 19b, ES-62 needed to be amplified from pBluescript 
(Stratagene) and Nde I and Bam HI restriction digestion sites had to be added 
onto the ends of ES-62. As the sequence of ES-62 was known, primers were 
designed to include the Nde I and Bam HI restriction digest site at either the N or 
C terminal regions. The sense primer, ES-62 sense, consisted of 14 bases of the 
N-terminal of ES-62 starting after the secretion signal with the restriction digest 
site for Nde I preceding it and 7 random bases. The antisense primer, ES-62 anti, 
consisted of the last 15 bases of the C-terminal of ES-62 with the restriction 
digest site for Bam HI attached to the end and six random bases. The sequences 
of the two primers aie shown in Table 2-1.
2,3J.2, pAcGP67-B
To clone ES-62 into pAcGP67-B, the vector used in overexpression in SF9 cells, 
its DNA sequence needed to be amplified from pBluescript (Stratagene) and 
Bam HI and Eco RI restriction digest sites added onto the ends. PCR primers 
were designed that would add these restriction digest sites onto the appropriate 
ends of ES-62. The sense primer, BAC sense, consisted of the first fourteen bases 
of the N-terminal of ES-62, starting after the secretion signal, preceded by the 
sequence for the Bam HI restriction digest site and seven random bases. The 
antisense primer, BAC antisense, consisted of the last fifteen bases of ES-62 with 
the sequence for the restiiction digest site for Eco RI attached to the end followed 
by six random bases. These two primers are shown in Table 2-1.
ES-62 sense CGTCGTCCATATGGCAGCTGTCCTTCC
ES-62 anti GCATTTTTCGATATTCCTAGGACGACC
BAC sense CGTCGTCGGATCCGCAGCTGTCCTTCC
BAC antisense GCATTTTTCGATATTCTTAAGACGACC
Table 2-1: Sequences of the PCR primers used to amplify the ES-62 
sequence and add restriction digestion sites to allow cloning of ES-62 into 
pET 19b and pAcGF67-B.
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2.3.2. Program Design
PGR reactions involve the use of a number of components. The template for the 
amplification of ES-62 in both PGR reactions was the pBluescript construct 
containing the ES-62 insert. Other vital components for the reaction are lOx 
buffer (containing 500 mM potassium chloride, 100 mM Tris-HGl (pH 9.0) and 1 
% Triton X-100), MgGli (essential as divalent cations are cofactors for Taq 
polymerase with magnesium the best source of divalent cations for this purpose), 
deoxyribonucleotide triphosphates (dNTPs) and Taq polymerase (a thermostable 
DNA polymerase that replicates DNA at an optimal temperature of 74 °G). 25 
pmol of each relevant primer was used in each PGR reaction. The annealing 
temperature of the primers, supplied in the data sheet from Oswel, is of vital 
importance, as this is required to design the PGR program, discussed below.
There are three steps to PGR; the first is a dénaturation step to yield single 
stranded DNA, the second is an annealing step during which the primers bind to 
the single stranded DNA and the final step is the extension step during which 
time the DNA is amplified. For the PGR amplification of ES-62 a low initial 
annealing temperature was employed for two cycles to increase the starting 
material without imposing too stringent criteria for binding. The annealing 
temperature was then raised to 5 °G below the lowest of the annealing 
temperatures supplied with the two primers.
PGR reactions were set up as follows; 20-40 ng of template DNA was mixed 
with 1 pi of 25 pmol/pl primers (either ES-62 sense and antisense or BAG sense 
and antisense), 2.5 pi of lOx PGR buffer (Promega), 1 pi of 10 mM dNTPs 
(Promega), 1.5 pi of 25 mM MgCh and 0.5 pi Taq (Promega) in a total volume 
of 25 pi. The reactions were pipetted to mix and then run in a thermocycler using 
the relevant program, depending on the primers used, described in Table 2-2.
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Step Time
(minutes)
Temperature (°C) 
ES-62 sense and 
antisense
Temperature (°C) 
BAG sense and 
antisense
1 1 94 94
2 1 37 37
3 2 72 72
1 1 94 94
2 1 53 53
3 2 72 72
2 cycles
25 cycles
Table 2-2: PCR protocols for the thermocycler for both sets of primers.
2,4. Restriction Digests
Restriction digests were performed to allow ligation to be carried out and also to 
allow identification of vector constructs containing the ES-62 insert. Restriction 
digests performed for the purpose of ligation of ES-62 into pET 19b were carried 
out as follows. Two reactions were set up, one containing 3 pg of ES-62/pGEM- 
T Easy construct DNA and the second containing 3 pg of pET 19b vector DNA 
along with 3 pi lOx buffer B (Boehringer Mannheim) and 10 U BamHI 
(Boehringer Mannheim) in a total volume of 30 pi made up with dH20. The 
mixture was incubated at 37 °C for 20 minutes and then 10 U of Ndel 
(Boehringer Mannheim) was added. The reaction was incubated at 37 °C for a 
further hour and then a further 5 U of Ndel was added to each tube. The reaction 
was then incubated at 37 °C for a further 2 hours. 1 pi shrimp alkaline 
phosphatase (Promega) was then added to the Eppendorf tube containing the pET 
19b digested DNA to remove the 5’ phosphate to prevent recircularisation of the 
pET 19b vector. DNA loading buffer was added to the reactions and they were 
run on 1 % low melt agarose gels.
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Restriction digests performed for the purpose of ligation of ES-62 into AcGP67- 
B were carried out as follows. Two reactions were set up, one containing 3 pg of 
ES-62/pGEM-T Easy construct DNA and the second containing 3 pg pAcGP67- 
B vector DNA along with 2.5 pi lOx buffer B and 10 U Bam HI in a total volume 
of 25 pi made up with dHzO. The mixture was incubated at 37 °C for 1 hour and 
then 10 U of Eco RI (Boehiinger Mannheim) was added. The reaction was then 
incubated at 37 °C for a further 3 hours. DNA loading buffer was added to the 
reactions and they were run on 1 % low melt agarose gels.
Restriction digests performed for the identification of positive colonies of ES-62 
in pET 19b were performed as follows; 20 pi DNA from a miniprep of the 
colony of interest was incubated with 3 pi 1 Ox buffer B, 10 U Bam HI, 10 U Nde 
I and dEhO to a total volume of 30 pi. The reaction was incubated at 37 
overnight and then run on a 1 % agarose gel to identify colonies in which the 
restriction digestion had led to the release of an insert the coiTect size for ES-62.
Restriction digests performed for the identification of positive colonies of ES-62 
in pAcGP67-B were performed as follows; 5 pi DNA from a miniprep of the 
colony of interest was incubated with 2.5 pi lOx buffer B (Boehringer 
Mannheim), 10 U Bam HI (Boehringer Mannheim), 10 U Eco RI (Boehringer 
Mannheim) and dEEO to a total volume of 25 pi. The reaction was incubated at 
37 °C for 3 hours and then run on a 0.7 % agarose gel to identify colonies in 
which the restriction digestion had led to the release of an insert of the correct 
size for ES-62.
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2.5. Cloning
2.5.1. Cloning for Initial Sequence Identification
ES-62 was cloned into pBluescript (Stratagene) as described by Harnett et al.
(1999) for sequencing purposes by W. Harnett et ah.
2.5.2. Cloning for Expression in a Bacterial Expression 
System
In order to clone ES-62 into the pET 19b bacterial expression vector (Novagen) 
it was necessary to attach the appropriate restriction enzyme cleavage sites to the 
ends of the ES-62 sequence. This was achieved using PCR (as detailed in section 
2.3). To overcome the problems of digesting restriction digest sites at the ends of 
fragments o f DNA, the PCR product was first ligated into pGEM-T Easy 
(Promega) before cloning into pET19b.
2.5.2.1. Ligation
2.5.2.1.1. pGEM-T Easy
The ES-62 PCR fragment, obtained from pBluescript, was blunt end ligated into 
pGEM-T Easy. 1 pi of lOx ligation buffer (Promega) was mixed with 1 pi of 
pGEM-T Easy vector (50 ng), 3 pi of PCR fragment (150 ng), 1 pi of T4 DNA 
ligase (Promega) (3 Weiss units) and 4 pi of deionised water. The reaction was 
incubated overnight at 4 °C.
2.5.2.1.2. pET19b
The insert from pGEM-T Easy, isolated by restriction enzyme digestion as 
detailed in section 2.4, was ligated into the pET19b vector, which had been 
subject to restriction enzyme digestion by Nde I and Bam HI as detailed in 
section 2.4. The digested pGEM-T Easy and pET 19b vectors were run on a low
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melt agarose gel (1 %). The bands representing the ES-62 fragment from the 
pGEM-T Easy vector and the digested pET 19b vector were cut out of the gel 
and placed in Eppendorf tubes. The Eppendorf tubes were centrifuged briefly to 
collect the gel slices at the base of the tubes. The gel slices were then heated to 
65 °C until melted and again centrifuged briefly to collect the gel at the base of 
the tubes. The ligation reaction was then set up as follows; 2 pi of low salt lOx 
buffer (Boehringer Mannlieim) was mixed with 0.5 pi of pET vector band, 3 pi 
of ES-62 band and 11.5 pi deionised water. 1 pi T4 DNA ligase and 2 pi 10 mM 
ATP (Promega) were added to the reaction after the gel had cooled. The reaction 
was incubated at 16 ‘^ C overnight.
2.5.2.2, Transformation
2.5.2.2,L pGEM-TEasy
The ligation reaction was transformed into JM109 (Promega) competent cells. 1 
pi of the ligation reaction was gently mixed, by flicking, with 50 pi of competent 
cells. The cells were left on ice for 20 minutes to allow the DNA to complex with 
calcium and deposit on the cells and also to aid membrane ruffling which 
increases ease of uptake of DNA into the cells. The cells were then heat shocked 
for 45 seconds at 42 °C to induce uptake of DNA into the cells. The cells were 
then returned to ice for 2 minutes. 950 pi of room temperature SOC medium 
(Promega) was added to the cells and the cells incubated for 1.5 hours at 37 °C 
with shaking. The cells were then pelleted by centrifuging briefly and most of the 
supernatant decanted leaving -100 pi remaining. The pellet was resuspended in 
the remaining 100 pi and then plated out onto an L broth/IPTG/ampicillin/X-Gal 
agar plate to allow for selection of recombinant transformants using blue/white 
screening.
2.5.2.2.2, pET19b
Transformation of the pET 19b constructs was performed as described in section 
2.5.2.2.1 except Novablue (Novagen) competent cells were used in place of
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JM109 competent cells and the Novablue competent cells were plated out onto L 
broth/ampicillin (50 pg/ml) agar plates. Positive colonies were identified by 
growing small cultures of some of the colonies, minipreping to isolate the vector 
DNA and performing restriction digests with Nde I and Bam HI to establish 
whether the vector contained the ES-62 insert. Six positives were selected for 
expression purposes and transformed into BL21 (DE3) cells (Novagen), as 
described for transformation of the pET 19b construct into Novablue competent 
cells.
2,5,2,3, Minipreps
Minipreps were canied out using a QIAprep Spin Miniprep kit (Qiagen) and the 
following protocol. Buffers PI, P2, N3, PB, PE and EB are supplied as part of 
the kit. An overnight culture was obtained by inoculating 5 ml L broth containing 
5 gl 100 mg ml“^ ampicillin with the colony of interest and growing overnight at 
37 ‘'C in a shaking incubator. Following incubation 3 ml of the overnight culture 
was spun (1.5 ml at a time) in an Eppendorf tube at 13500 rpm for 10 minutes in 
a bench top centrifuge. The pellet was resuspended in 250 gl of buffer PI which 
contains RNase A to remove any RNA contaminants. The cells were then 
subjected to alkaline lysis by addition of 250 gl of buffer P2 and the Eppendorf 
tube gently inverted 4-6 times. The sample was then neutralised by addition of 
350 gl of buffer N3, which also contains a high salt concentration that causes 
precipitation of denatured proteins, chromosomal DNA and cellular debris, and 
the Eppendorf tube inverted 4-6 times. The mixture was next centrifuged at 
13500 rpm for 10 minutes in a bench top centrifuge to pellet the precipitated 
proteins, chromosomal DNA and cellular debris. The supernatant, containing the 
plasmid DNA, was added to a Qiaprep spin column, the column was centrifuged 
for 30-60 seconds at 13500 rpm in a bench top centrifuge and the flow through 
was discarded. In those cells with high nuclease activity or high carbohydrate 
content (i.e SOLR strain used in initial cloning with pBluescript and JM109 cells 
used in the blunt end cloning step into the pGEM-T Easy vector, but not 
Novablue or BL21 (DE3) cells) a further step was including at this point. This 
further step involved the addition of 500 gl of buffer PB to the column, which
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removes any endonucleases. The column was then spun again for 30-60 seconds 
at 13500 rpm in a bench top centrifuge and the flow through discarded. The next 
step, for all cell lines, was to add 750 jrl of buffer PE to the column and again 
centrifuge for 30-60 seconds at 13500 rpm in a bench top centrifuge. This step 
removes the salts from the sample. The flow through was discarded and the 
column spun for a further minute at 13500 rpm in a bench top centrifuge to 
remove residual wash buffer. The Qiaprep column was then placed into an 
Eppendorf tube and 50 |il of buffer EB was added to the centre of the column.
The column was left to stand for 1 minute and then spun for a minute at 13500 
rpm in a bench top centrifuge. The Qiaprep column was then discarded and 1/10 
volume of the eluate volume of 2 M sodium acetate and 2 volumes of the eluate 
volume of ethanol were added to the Eppendorf tube containing the eluate from 
the column. The sample was then stored at -20 '’C for a minimum of 30 minutes. 
Following incubation at -20 ‘‘C the sample was centrifuged for 30 minutes at 
13500 rpm at 4 °C. The supernatant was discarded and the pellet washed in 70 % 
ethanol. The wash supernatant was then discarded and the pellet air dried and 
resuspended in 30 p,l of TE buffer (10 mm Tris pH 7.5 and 1mm EDTA).
2.5.2.4. Glycerol Stocks
Glycerol stocks of the cultures were made by mixing 500 pi sterile 80 % glycerol 
with 500 pi of culture medium from the overnight culture in sterile capped 
Eppendorf tubes. Glycerol stocks were stored at -70 ""C.
2.5.3. Cloning for Expression in Insect Expression System
The restriction enzyme digestion sites at the ends of the insert in pET 19b were 
not suitable for cloning into the pAcGP67-B vector for baculovirus expression.
Thus PCR was carried out as described in section 2.3 using primers which 
contained appropriate restriction digest sites for cloning into pAcGP67-B 
(PharMingen). As with cloning in pET 19b, the PCR insert was cloned first into 
PGEM-T Easy, and in this case sequenced, before being cloned into pAcGP67-B.
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2.5.3.1, Ligation
2.5.3.1 A. pGEM- T Easy
The ES-62 PCR fragment was ligated into pGEM-T Easy as detailed in section
2.5.2.1.1.
2.5.3.1.2. pAcGP67-B
The insert from pGEM-T Easy, isolated by restriction enzyme digestion as 
detailed in section 2.4, was ligated into the pAcGP67-B vector, which had been 
subject to restriction enzyme digestion by Eco RI and Bam HI as detailed in 
section 2.4. The digested pGEM-T Easy and pAcGP67-B were run on a low melt 
agarose gel (1 %). The bands representing the ES-62 fragment from the pGEM-T 
Easy vector and the digested pAcGP67-B were cut out of the gel and placed in 
Eppendorf tubes. The Eppendorf tubes were centrifuged briefly to collect the gel 
slices at the base of the tubes. The gel slices were then heated to 65 °C until 
melted and again centrifuged briefly to collect the gel at the base of the tubes.
The ligation reaction was then set up as follows; 2 pi of low salt lOx buffer was 
mixed with 2 pi of the pAcGP67~B vector band, 2 pi of the ES-62 band and 11 
pi deionised water. 1 pi of T4 DNA ligase and 2 pi of 10 mM ATP were added 
to the reaction after the gel cooled. The reaction was incubated at 16 °C 
overnight.
2.5.3.2, Transformation
2.5.3.2.1. pGEM- T Easy
The pGEM-T Easy ligation with ES-62 was transformed into JM109 competent 
cells as detailed in section 2.5.2.2.I.
2.5.3.2.2. pAcGP67~B
The pAcGP67-B ligation with ES-62 was transformed into Novablue competent 
cells. 1.7 pi of a 1:20 dilution of (3-mercaptoethanol was added to 100 pi of
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Novablue cells on ice. The cells were incubated on ice for 10 minutes swirling 
every 2 minutes. After die 10 minute incubation, 1 pi of ligation reaction mix 
was added to the cells and they were incubated on ice for 30 minutes. Cells were 
then heat shocked for 50 seconds at 42° C followed by 2 minutes incubation on 
ice. 900 pi of SOC medium, preheated to 37 °C, was added to the cells and they 
were incubated for 1 hour at 37 °C with shaking. The cells were then spun at 
4000 rpm for 10 minutes and the supernatant removed. The pellet was 
resuspended in the residual media, plated onto an L broth/ampicillin (100 pl/ml) 
agar plate and incubated at 37 °C overnight.
Following successful cloning of ES-62 into pAcGF67-B, as determined by 
restriction digestion with Bam HI and Eco RI, the next step was to make 
recombinant virus. This was achieved by homologous recombination of the 
pAcGP67-B vector containing the insert with BaculoGold DNA (PharMingen)
(for method see section 2.7). The BaculoGold DNA has been modified such that 
if homologous recombination with the vector does not occur' then the viral DNA 
cannot form infectious particles as it is missing vital genes that are present on the 
vector along with the insert of interest. Thus any infectious viral particles which 
form following homologous recombination must contain the vector and therefore 
the insert as well.
2,6, Sequencing
The ES-62 inserts from the pET 19b and pAcGP67-B vector constructs were 
sequenced to ensure no errors had arisen from the PCR amplification of ES-62. 
The ES-62 insert from pET 19b was sequenced whilst in pET 19b while the ES- 
62 insert from pAcGP67-B was sequenced whilst in pGEM-T Easy. Sequencing 
in both cases was carried out using the T7 for’ward primer and some internal 
primers used to sequence ES-62 initially (Harnett et al., 1999). 100 pi of 63 ng 
p l'V f the pET 19b and the pGEM-T Easy vector constructs were sent to PNACL 
(Protein and Nucleic Acid Chemistry Laboratory, CMHT, Hodgkin Building, 
University of Leicester, Leicester) along with 10 pi of 1 pmol pl'^ of four of the 
internal ES-62 primers and of the T7 promoter and terminator primers.
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2,7. Homologous Recombination
Homologous recombination is the method by which the pAcGP67-B vector that 
has been identified as containing an ES-62 insert, is combined with baculovirus 
DNA to enable formation of recombinant virus particles. As mentioned 
previously the baculovirus DNA with which the vector is combined has been 
genetically manipulated such that it can only form virus particles if  it combines 
with the vector DNA. Homologous recombination of the vector containing ES-62 
and the BaculoGold DNA was performed according to manufacturers 
instructions (PharMingen, 1999).
2,8, Amplification
Amplification of the viral stock to obtain larger quantities of high titre virus was 
performed according to the manufacturer’s instructions (PharMingen, 1999), 
with the exception that the cells were incubated for 5 days instead of 3 and that 
the cellular debris were spun out at 5000 x g instead of 10000 x g.
2,9, Plaque Assays
The method detailed in the manufacturers instructions (PharMingen, 1999) was 
complicated to set up and unsuccessful in determining the titre of the amplified 
stocks, thus a modified version of this plaque assay was employed as detailed 
below. 1x10^ cells were plated in each well of a 6 well plate and allowed to 
attach for 30 minutes at room temperature. The media was then removed from 
the cells and 1 ml of fresh TMN-FH media added to each well. 1 ml of virus was 
added to the first well and mixed well, 100 pi was then taken from this well and 
added to the next well and so on to give serial dilutions of 10^, 10 ,^ 10 ,^ 10  ^and 
10  ^with one well containing no virus. The cells were then incubated for 1 hour at 
room temperature, rocking gently. 12 ml of 1.6 % Agarplaque (PharMingen) in 
protein free media, per 6 well plate, was prepared and kept at 42 °C. 12 mis of 
TMN-FH media, per 6 well plate, was also warmed to 42 °C. After 1 hour 
incubation the same volume of TMN-FH media was added to the 1.6 % 
Agarplaque solution (i.e. 12 ml media to 12 ml Agarplaque) to give a 0.8 %
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Agarplaque solution. The solution was mixed well and kept at 42 °C. The 
innoculum was removed from each well of the 6 well plate and the cells in each 
well overlaid, carefully, with 3 ml of 0.8 % Agarplaque. The plates were rocked 
gently to prevent formation of a fluid layer under the Agarplaque from any 
residual media and then wrapped in Saran wrap and incubated at 27 °C for 4-5 
days. After 4-5 days each well was overlaid with 1 ml neutral red dye solution (9 
ml 0.8 % Agarplaque in protein free media, 1 ml filtered neutral red dye per 6 
well plate) and incubated overnight at 27 °C. The plaques were clearly visible the 
following day. The viral titre was determined by counting the number of plaques 
in a well containing approximately 50 plaques. The viral titre was then expressed 
as pfu ml'^ of original stock, e.g. if 48 plaques were counted in the 10  ^dilution 
well then the viral titre was 4.8 x 10*" pfii m f \
2,10, Expression o f Recombinant ES-62
2.10.1. Bacterial Expression System
Once colonies that contained the ES-62 insert within the pET 19b vector had 
been identified and glycerol stocks made of these colonies, as detailed in section 
2.5.2.4, the next step was to see if  recombinant ES-62 was being produced. 5 ml 
L broth containing ampicillin at 100 pg mf^ was inoculated with a stab from a 
glycerol stock and grown at 37 °C in a shaking incubator until the optical density 
at 600 nm in a 1 cm pathlength cuvette was 0.6. IPTG was then added at a final 
concentration of 1 mM and the culture left to grow for 3 hours. Cells were 
pelleted by centrifuging at 6000 x g for 10 minutes and the pellets resuspended in 
2x loading buffer, run on a SDS PAGE gel and Coomassie Blue stained (sections 
2.14 & 2.19).
Once expression of recombinant ES-62 was established, a larger scale expression 
was performed and cells were lysed to ascertain whether the recombinant protein 
was soluble or insoluble. Further, in order to establish the start of the log phase 
of growth of the bacteria, which is the point at which expression should be 
induced by addition of IPTG, a growth curve for BL21 (DE3) cells transfected
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with the pET 19b/ES-62 construct was obtained. This growth curve showed that 
the log phase of growth for these cells started when the optical density at 600 nm 
was approximately 0.7. Large scale bacterial expression of ES-62 was then 
performed as follows; an overnight culture was obtained by inoculating 20 ml L- 
broth containing ampicillin at 100 pg mf^ with a stab from the glycerol stock and 
growing overnight at 37 °C in a shaking incubator. 1 L of L-broth containing 
ampicillin at 100 pg ml"^  was inoculated with the 20 ml overnight culture and 
then grown at 37 °C in a shaking incubator for approximately 2 houi's until the 
optical density at 600 nm was 0.7. IPTG was then added at a final concentration 
of 1 mM and the culture allowed to grow for a further 3 hours. The cells were 
then pelleted by centrifugation at 6000 x g for 10 minutes and lysed using 
sonication (6 x 30 s bursts) or cell disruption. The lysed cells were then 
centrifuged at 6000 x g for 10 minutes and a sample of both the cell pellet (which 
contains nuclear and membrane material along with inclusion bodies that contain 
any insoluble proteins) and the supernatant (which contains soluble proteins from 
the cytosol of the cells) run on a S0S-PAGE gel.
A number of different growth conditions, as listed in Table 2-3, were attempted 
using the expression protocol above to optimise expression of soluble 
recombinant ES-62.
Growth Temperature (°C) IPTG concentration (mM) Induction time (hours)
37 1,0.5,0.25, 0.1 3
30 1,0.5, 0.25,0.1 4
25 1,0.5, 0.25, 0.1 5
16 1,0.5, 0.25, 0.1 -18
Table 2-3: Growth and induction conditions for expression trials of bacterial 
recombinant ES-62. Cells were grown in L broth containing 100 pg ml^ 
ampicillin at 37 ° C  until an optical density at 600 nm of 0.7 was reached. 
IPTG was then added at the appropriate concentration and the growth 
temperature altered accordingly.
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In all expression trials, the BL21 (DE3) cells were grown at 37 °C until induction 
(addition of IPTG) and then the temperature was adjusted as detailed in Table 
2-3. The quantity of soluble expressed recombinant ES-62 produced was 
assessed by lysing the cells and running samples of hoth the pellet and 
supernatant on a SDS-PAGE gel. In addition to the above conditions leaky 
expression was also tested for by growing uninduced cells for 48 hours at 20 °C.
The cells were then harvested and the quantity of expressed recombinant ES-62 
produced assessed as detailed above.
From the expression conditions tested, optimal expression of soluble 
recombinant ES-62 was found to occur when the BL21 (DE3) cells, containing 
the ES-62/pET 19b construct, were grown at 37 °C, induced using IPTG at a 
final concentration of 0.1 mM then incubated at 25 °C for a further 4-5 hours.
The bacterial cells were then harvested as described previously.
2.10.2. Baculovirus Expression System
Once colonies that contained the ES-62 insert within the pAcGP67-B vector had 
been identified, homologous recombination performed to obtain recombinant 
virus particles containing the DNA for ES-62 and the virus particles amplified to 
a sufficiently high titre as advised in the manufacturers instructions 
(PharMingen, 1999), SF9 cells were infected with different amounts of the 
recombinant virus, known as different multiplicities of infection (MCI). The 
MCI is calculated by dividing the number of virus particles by the number of 
cells infected. SF9 cells were infected at MOIs of 3, 7 and 10 to determine the 
optimum MOI for expression of reeombinant ES-62.
From the conditions tested, optimal expression of recombinant ES-62 was 
achieved when cells were infected at an MOI of 10. To obtain recombinant ES- 
62, 2x10^ SF9 cells grown in protein free media were seeded onto a 150 mm 
tissue culture flask in a total of 30 ml of protein free media. The cells were 
allowed to bed down for 1 hour and then infected with high titre recombinant 
baculovirus at an MOI of 10. Cells were incubated at 27 °C for 2 days and the
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supernatant then harvested, as the pAcGP67-B vector in which ES-62 was cloned 
has a secretion signal and thus the recombinant protein will be secreted. Any 
cells present in the supernatant were pelleted by centrifugation at 5000 x g for 5 
minutes. The supernatant was then cleared further by centrifugation at 10000 x g 
for 10 minutes. The virus particles present in the supernatant were then removed 
by centrifugation of the supernatant at 50000 x g for 1 hour. Recombinant ES-62 
was isolated from the supernatant by purification techniques discussed in section 
2 . 12.
2A1, Refolding o f Insoluble Bacterial Recombinant ES-62
The insolubility of the bacterial recombinant ES-62 (section 5.1.3) resulted in the 
development of a protocol to refold the protein. Many different refolding 
protocols were tried, the method described here was the most successful method 
identified for refolding of ES-62.
Cells from 1 L of bacterial culture, grown and induced as described in section 
2.10.1, were pelleted by centrifugation at 6000 x g for 10 minutes. The pellet was 
resuspended in 50 ml buffer 1 (50 mM sodium acetate, 5 mM EDTA, 5 % (w/v) 
sucrose), frozen and thawed twice, and then sonicated (6 x 30 s bursts) in 10 ml 
aliquots to lyse the cells. The lysed cells were then centrifuged at 6000 x g for 10 
minutes and the pellet, containing the insoluble material, washed once m 50 ml 
buffer 2 (50 mM sodium acetate, 5 mM EDTA, 0.1 % (v/v) Triton X-100), twice 
in 50 ml buffer 3 (50 mM sodium acetate, 5 mM EDTA, 2 M urea) and once in 
50 ml dH20. The pellet was then solubilised by addition of 20-25 ml buffer 4 
(100 mM sodium acetate, 8 M urea, 10 mM DTT) followed by incubation at 37 
°C for 1 hour in a shaking incubator (250 rpm). The solubilised pellet was then 
diluted to 0.01 -  0.5 mg m f \  in buffer 5, (100 mM sodium acetate, 5 mM 
EDTA, 8 M urea), as assessed by a Bradford protein assay. The solubilised 
protein solution was then dialysed against 100 volumes of buffer 6 (100 mM 
sodium acetate, 50 mM sodium chloride). Modifications to this protocol are 
discussed in Chapter 5.
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2,12, Purification
Purification of recombinant protein depends on the characteristics of the protein 
in question and on whether or not it has been expressed with a tag e.g. a GST or 
5 -histidine tag. If the protein is known to have a substrate for which it has a 
reasonably high affinity or if it has been expressed with a tag then affinity 
chromatography is usually the purification method of choice. However, if there is 
no known substrate or tag then other purification methods based on the physical 
characteristics of the protein are used.
2.12.1. Affinity Chromatography
This method was used to purify the bacterial recombinant ES-62, The bacterial 
expression system employed for production of recombinant ES-62 attached a 
cleavable histidine tag to the N-terminal of the protein. The histidine tag shows 
strong affinity towards divalent cations (such as nickel, zinc and copper) and this 
affinity was exploited to allow purification of the recombinant material. After 
harvesting the cells by centrifugation as discussed in section 2.10, the cells were 
resuspended in 20 mM imidazole, 50 mM sodium acetate, 300 mM sodium 
chloride and lysed using sonication (6 x 30 s bui'sts). The lysed cells were then 
centrifuged at 13000 x g for 25 minutes, the supernatant filtered, adding DNase 
(Promega) if the supernatant was very viscous, and then loaded onto the metal 
chelate column for purification. Unbound proteins were washed off and the target 
protein recovered by elution with imidazole. Imidazole binds tightly to divalent 
cations and thus competes with the histidine tags for binding to the divalent 
cations on the column, dislodging the tags and allowing elution of the 
recombinant protein. A UV detector was used to monitor elution of the proteins 
from the column. This method was employed to purify both the soluble 
recombinant protein and the refolded recombinant material. Table 2-4 shows the 
steps in the purification protocol and the buffers employed at each stage. The 
method described in Table 2-4 was altered as detailed in the figure legend only 
during optimisation of the purification protocol. A fui ther alteration to this 
protocol was to include LDAO, a mild detergent, in all the buffers at 
concentrations of either 0.01, 0.05 or 0.1 % (v/v).
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Loading of greater than 5 ml of lysed crude bacterial preparation was achieved 
by adding in multiple repeats of steps 6 and 7 until the appropriate volume was 
loaded. This is not recommended if the crude bacterial preparation has a high 
concentration of expressed protein as the column will be overloaded.
Step Description Solutions loaded onto column
1 Clean column to regenerate 480 mM NaCl 
100 mM EDTA
2 Wash column dHzO
3 Charging of column with 
divalent cations
100 mM NiS0 4
4 Removal of unbound 
divalent cations
1. dHzO
2. 480 mM NaCl
3. 500 mM imidazole
5 Equilibrate column 500 mM NaOAc 
480 mM NaCl 
20 mM imidazole
6 Load sample 5 ml of crude bacterial preparation
7 Wash to remove unbound 
sample
500 mM NaOAc 
480 mM NaCl 
60 mM imidazole
8 Elution of bound material 500 mM NaOAc 
480 mM NaCl 
500 mM imidazole
9 Clean column to regenerate 480 mM NaCl 
100 mM EDTA
Table 2-4: Protocol for affinity purification of bacterially expressed 
recombinant ES-62. Note that at step 8, elution of the bound proteins was 
also attempted using an imidazole gradient from 60 mM to 500 mM or with 
2 steps, first to 20 mM imidazole and then to 750 mM imidazole. Elution 
from the column was monitored using an inline UV detector.
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2.12.2. Ion Exchange
Ion exchange clrromatography was used to purify baculovirus expressed 
recombinant ES-62. The pi of wild type ES-62 and recombinant ES-62 was 
determined experimentally (section 2.33) to be approximately 5.6. Thus the 
recombinant protein has a negative charge when in PBS (5.5 mM potassium 
chloride, 145 mM sodium chloride, 8 mM disodium hydrogen orthophosphate,
1.5 mM sodium dihydrogen orthophosphate) at pH 7.2, the buffer condition in 
which wild type ES-62 is stable. Anion exchange was therefore performed on the 
crude baculovirus preparation with the aim that the recombinant ES-62 would 
bind to the column and could be eluted in a pur e state by increasing salt 
concentration. The crude baculovirus supernatant from infected cells was 
concentrated in an ultrafiltration stirred cell (Amicon) and dialysed overnight 
into pH 7.0 phosphate buffer (3.2 mM potassium chloride, 9.6 mM disodium 
hydrogen orthophosphate, 1.9 mM potassium dihydrogen orthophosphate) prior 
to loading on to the column. The column used was a POROS 20HQ column 
(PerSeptive Bio systems). The column was equilibrated in 10 column volumes of 
phosphate buffer, 5 ml of the sample was loaded and then the column washed 
with 10 column volumes of 45 mM NaCl to remove any unbound material. The 
two steps of loading and washing were repeated 3 or 4 times. Following the 
removal of any unbound material, elution of proteins from the column was 
achieved using a salt gradient starting at 45 mM NaCl and running to 300 mM 
NaCl. A UV detector was used to monitor the elution of proteins from the 
column. The fractions collected were tested for the presence of ES-62 by 
Western blotting (section 2.16) to identify the salt concentration at which 
recombinant ES-62 was eluted. The column was cleaned to allow reuse by 
washing with a salt gradient starting at 300 mM NaCl, finishing at 1.5 M NaCl.
2.12.3. Gel Filtration
Gel filtration was used to attempt to separate tetrameric ES-62 from monomeric 
ES-62 after the anion exchange purification step. A Superose 12 (HR 10/30)
(Pharmacia Biotech) column with a bed volume of 24 ml was attached to a 
Pharmacia Biotech FPLC pump. The column was equilibrated at 0.4 ml min"*
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with filtered and degassed phosphate buffer pH 7,0 (50 mM disodium hydrogen 
orthophosphate, 50 mM potassium dihydrogen orthophosphate, 150 mM NaCl).
200 pi of sample was then loaded onto the column and 30 ml phosphate buffer 
pH 7.0 run through the column at 0.4 ml min \  0.5 ml fractions were collected 
starting immediately after the sample was loaded. Each fraction passed through 
an inline detector and the absorbance trace at 280 nm was plotted on a chart 
recorder. The fractions constituting each peak detected were pooled, filtered and 
then tested for the presence of recombinant ES-62 using Western blotting 
procedures (section 2.16).
2.12.4. Filtration
An ultrafiltration stirred cell (Amicon) with 30 kDa (YM 30) and 100 kDa (YM 
100) cut-off membranes was used to attempt to concentrate and partially pur ify 
recombinant ES-62 from cleared baculovirus supernatant from infected SF9 
insect cells (recombinant ES-62 should be the major protein secreted into the 
media). The cleared supernatant was spun through the YM 100 membrane first 
until only 15-20 ml were remaining and the filtrate collected. The YM 100 
membrane is a 100 kDa cut off membrane, thus all proteins below 100 kDa in 
mass should pass through it leaving only proteins greater than 100 kDa retarded 
by the membrane. The aim of this procedure was to enable the separation of 
tetrameric recombinant ES-62 from monomeric recombinant ES-62. The 15-20 
ml retarded by the membrane were washed with PBS pH 7.0 (5.5 mM potassium 
chloride, 145 mM sodium chloride, 8 mM disodium hydrogen orthophosphate,
1.5 mM sodium dihydrogen orthophosphate). PBS was added to the sample 
increasing the volume to 120 ml and the sample then spun down again to 15-20 
ml, the filtrate again being collected. This process was repeated once more and 
the 15-20 ml remaining then removed from the stirred cell, filtered and stored, 
sterile, at 4 °C. The collected filtrate from the YM 100 membrane was placed in 
a stirred cell and spun thiough a YM 30 membrane until only 15-20 ml was 
remaining. The YM 30 membrane allows proteins smaller than 30 kDa in mass to 
pass though it and retards those greater than 30 kDa enabling small molecular 
weight, <30kDa, contaminants of the sample to be removed. The 15-20 ml
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sample retarded by the membrane was washed in PBS as before and then 
removed from the stiiTed cell, filtered and stored, sterile, at 4 °C. The samples 
were tested for the presence of ES-62 using Western blotting techniques (section 
2.16).
2,13. Agarose Gel Electrophoresis
Low melt agarose (Boehringer Mannheim) was dissolved by heating in TAE 
buffer (40 mM tris base, 5.51 % (v/v) glacial acetic acid, 1 mM EDTA, pH 8) at 
an appropriate percentage (w/v) for the DNA fragments to be visualised. 
Ethidium bromide (1.5 gg mf^) was added to the solution once it had cooled 
slightly. The gel mixtuie was then poured immediately using agarose gel 
electrophoresis equipment (BioRad) according to manufacturer’s guidelines. 
Samples were run at 100 volts until sufficiently separated. Samples were 
visualised using a UV light source and photographs were taken of the images 
obtained.
2.14. SDS Polyacrylamide Gel Electrophoresis (SDS- 
PAGE)
Tris-glycine SDS polyacrylamide gels for gel electrophoresis of proteins were 
prepared and run using the solutions and protocols as described by Harlow & 
Lane, (1988), Laemmli, (1970) and Sambrook et al.  ^ (1989).
2.15. Polyacrylamide Gel Electrophoresis
Tris-glycine polyaciylamide gels for gel electrophoresis of proteins under non­
denaturing and non-reducing conditions were prepared and run as described in 
section 2.14 except SDS and (3-mercaptoethanol were excluded from all the 
buffers used and the samples were not boiled prior to loading.
Chapter 2: Materials and Methods 73
2.16. Western Blotting
Gels were transferred to either nitrocellulose or PVDF membrane (activated in 
methanol) using gel transfer apparatus (Biorad). Transfer was achieved either 
overnight at 40 mA or for 1 hour at 100 volts and variable current in transfer 
buffer (200 mM glycine, 25 mM tris in 800 ml dHiO, 200 ml methanol). 
Membranes were blocked in 10 % skimmed powdered milk or 1 % BSA for a 
minimum of 1 hour, but preferably overnight. Antibody dilutions were made up 
in 1 % skimmed milk powder or 0.1 % BSA in TBS-T (500 mM sodium 
chloride, 20 mM tris, 0.001 % Tween-20). Antibody incubations were typically 
left for 3 hours at room temperature or overnight at 4°C for primary antibodies, 
and 1 hour at room temperature for secondary antibodies. Membranes were 
washed between the antibody incubations and after the secondary antibody 
incubation twice for 15 minutes and 3 times for 5 minutes with TBS-T. 
Membranes were developed using Amersham ECL visualisation technology for 
secondary antibodies that were HRP conjugates and using NBT BCIP substrate 
tablets (Sigma) for secondary antibodies that were alkaline phosphatase 
conjugates. BSA or skimmed milk powder was used depending on the 
recommendation supplied on the antibody data sheet.
2.16.1. Antibodies
The following antibodies were used in Western blotting;
Antibody Supplier Concentration
Rabbit anti-ES-62 W. Harnett 100 pg ml '
Anti-rabbit-HRP Sigma 1:3000 dilution
Anti-rabbit-HRP Amersham Pharmacia 1:2000 dilution
Anti-rabbit-alkaline phosphatase Amersham Pharmacia 1:30000 dilution
TEPC-15 (anti-PC) Sigma 10 pg ml '
Anti-mouse IgA-alkaline phosphatase Amersham Pharmacia 1:30000 dilution
Anti-TLR2-biotin Insight Technology Ipg ml '
Anti-TLR-4-biotin Insight Technology Ipg ml '
Anti-biotin New England Biolabs 1:2000 dilution
Anti-mouse-HRP Amersham Pharmacia 1:4000 dilution
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Anti p65 and p50 (NFkB subunits) Santa Cruz technology 1:1000 dilution
Anti phospho p44/42 MAPK (Erk) New England Biolabs 1:1000 dilution
Anti phospho JNK Promega 1:1000 dilution
Anti phospho p38 Santa Cruz 1:1000 dilution
Anti P44/p42 MAPK New England Biolabs 1:1000 dilution
Anti SAPK/JNK New England Biolabs 1:2000 dilution
2.17. Far Western Blotting
Far Western blotting was carried out as described for Western blotting in section 
2.16, except that a biotin conjugate of ES-62 was used in place of the primary 
antibody. A secondary antibody, anti-biotin conjugated to HRP (horse-radish 
peroxidase) was used as normal.
2.18. Slot Blotting
Slot blots were performed using slot blotting apparatus (Scotlab, UK) connected 
to a vacuum pump. The apparatus was set up according to manufacturer’s 
guidelines with nitrocellulose, pre-wetted in transfer buffer (200 mM glycine, 25 
mM tris in 800 ml dHiO, 200 ml methanol), as the membrane onto which the 
proteins were transferred. Blocking of the nitrocellulose and antibody 
incubations were performed as described in section 2.16.
2.19. Gel Staining
A variety of methods can be used to stain SDS polyacrylamide gels in order to 
visualise the protein bands. Tris glycine SDS polyacrylamide gels were run as 
detailed in section 2.14. Staining of the gels was then performed using one of the 
three following methods. Silver staining (the most sensitive gel staining 
protocol), zinc staining or Coomassie Blue staining (least sensitive).
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2.19.1. Silver Stain
Silver staining of SDS-PAGE gels was accomplished with the ten steps detailed 
in Table 2-5.
Step Time (minutes) T reatment
1 30 20 % (v/v) trichloroacetic acid (TCA)
2 10 50 % (v/v) methanol; 10 % (v/v) acetic acid
3 20 20 % (v/v) methanol; 5 % (v/v) acetic acid
4 10 8 % (v/v) gluteraldehyde
5 2 x 2 dHzO
6 20 0.25 % (w/v) silver nitrate
7 2x  1 dHzO
8 2-10 2.5 % (w/v) sodium carbonate; 0.1 % (v/v) 
formaldehyde
9 30 10 % (v/v) glycerol; 5 % (v/v) acetic acid
10 -60 Gel drier at 80 °C
Table 2-5: Silver staining protocol
2.19.2. Zinc Stain
SDS-PAGE gels were zinc stained using the BioRad zinc stain and destain kit for 
electrophoresis. The gel was incubated in the buffers supplied according to 
manufacturers guidelines. The stained gel was then dried using a gel drier for 45 
minutes at 80 °C.
2.19.3. Coomassie Stain
SDS-PAGE gels were incubated in Coomassie blue dye (50 % (v/v) methanol, 10 
% (v/v) acetic acid, 0.05 % (v/v) Coomassie Blue (R250)) for 1 hour and 
destained (50 % (v/v) methanol, 10 % (v/v) acetic acid) until a clear background 
was obtained. The stained gel was then dried using a gel drier for 45 minutes at 
80 °C.
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2.20. Preparation of Splenic Mononuclear Cells
Spleens from Balb/c mice were pressed through mesh in 9 ml red cell removal 
buffer (0.168 M ammonium chloride) per 3 spleens. The cell suspension was 
transferred to a 15 ml tube (Falcon), underlaid with 1 ml fetal calf serum (FCS)
(GIBCO BRL, Paisley, UK) and incubated on ice for 7 minutes. The supernatant 
was then removed to a 15 ml tube, underlaid with 1 ml FCS and spun at 1500 
rpm for 7 minutes at 4 °C. The supernatant was discarded and the pellet 
resuspended in 9 ml (per 3 spleens) dead cell removal buffer (DCRB) (250 niM 
sorbitol, 38.5 mM glucose, 12.5 % (v/v) balanced salt solution (BSS) (200 mM 
sodium chloride, 5 mM potassium chloride, 3 mM calcium chloride, 1.68 mM 
magnesium sulphate, 3.36 mM potassium dihydrogen orthophosphate, 2.24 mM 
dipotassium hydrogen orthophosphate, 20 mM HEPES, pH 7.2)). BSS containing 
5 % (v/v) FCS was added to dead cell removal columns (glass pipettes with small 
cotton wool plug) during the final centrifugation step to pre-wet the columns.
The cells in DCRB were passed thr ough the dead cell removal columns (1 
column per 3 spleens) into 1 ml of BSS containing 5 % FCS on ice. The cell 
suspension was then centrifuged at 1500 rpm for 7 minutes at 4 °C and the pellet 
re suspended in 5 ml BSS containing 5 % (v/v) FCS and kept on ice.
2.21. Preparation o f Splenic B Cells
Splenic cells were prepared as described above (section 2.20) and the total 
number of cells obtained determined as described in section 2.22. The splenic 
cells were pelleted by centrifugation at 1400 rpm for 5 minutes at 4 °C and then 
resuspended in cold MACS (5.5 mM potassium chloride, 145 mM sodium 
chloride, 8 mM disodium hydrogen orthophosphate, 1.5 mM sodium dihydrogen 
orthophosphate, 0.5 % w/v bovine serum albumin, 2 mM EDTA) buffer at a 
concentration of 2 x 10  ^cell / ml. 100 fxl CD43 positive beads / 2 x 10  ^cells 
were added to the resuspended cells and the cells incubated for a minimum of 20 
minutes at 4 °C. To prepare the CS depletion column (Miltenyi Biotec Ltd) for 
use the column was washed via the side syringe using 10 ml cold MACS buffer.
A sheathed needle (No. 23 gauge) with the end of the sheath removed was then 
attached to the column and 50 ml MACS buffer passed through the column and
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discarded. 1 ml MACS buffer was then added to the splenic cell / bead mix, the 
mix passed though nitex gauze, loaded onto the CS depletion column and the 
eluate collected. The CS depletion column was then washed with 40 ml cold 
MACS buffer and the eluate collected. The eluates were then pooled and the cells 
were counted (section 2.20). The cells were then pelleted by centrifugation at 
1400 rpm for 10 minutes at 4 °C, resuspended in RPMI media at the required 
concentration for the experiment and allowed to rest at 4 °C before being used in 
experiments.
2.22. Cell Counting
Cells were counted in a haemocytometer (Neubauer, Assistent, Germany). 10 pi 
of the cell suspension was added to 10 pi of trypan blue and the solution loaded 
onto the haemocytometer. The number of cells, in two blocks of 16 squaies, was 
counted. This gave the number of cells x lO'^  per ml of sample. Multiplication of 
this value by the total volume of the sample gave the total number of cells.
2.23. Preparation of Whole Cell Lysates
Cells were pelleted by centrifugation at 1200 rpm for 10 minutes and the pellet 
resuspended in 150 pi of 2x lysis buffer pH 7.5 (100 mM tris base, 300 mM 
sodium chloride, 4 % (v/v) NP40, 0.5 % (v/v) sodium deoxychelate, 2 mM 
EDTA) containing 1 pg mf^ of chymostatin, leupeptin, antipain and pepstatin A 
and 1 mM sodium ortho vanadate and 10 mM PMSF. The solution was 
transferred to an Eppendorf tube, vortexed well and left on ice for 20 minutes. 
The solution was then centrifuged at 10000 rpm for 10 minutes at 4 °C to remove 
cellular debris. The supernatant was removed and stored at -20 °C.
2.24. Biotinylation o f Cells
1x10^ cells were pelleted by centrifugation at 1200 rpm for 8 minutes. The 
pellet was washed 3 times in ice cold PBS (5.5 mM potassium chloride, 145 mM 
sodium chloride, 8 mM disodium hydrogen orthophosphate, 1.5 mM sodium
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dihydrogen orthophosphate) pH 7.2 and then resuspended in 0.5 ml PBS in a foil 
wi'apped universal tube. 1.5 ml of freshly prepared NHS-biotin solution (Pierce) 
at 4 mg ml"^  was added to the cells and they were incubated at room temperature 
for 30 minutes on a rocking platform. The cells were then pelleted by 
centrifugation at 1200 rpm for 8 minutes and washed 3 times in ice cold PBS to 
remove any unbound biotin.
2.25. Preparation of Biotinylated Cellular Membranes
Cells were biotinylated as described in section 2.24, pelleted by centrifugation at 
1500 rpm for 5 minutes and then resuspended in 1.5 ml of ice cold extraction 
buffer (50 mM HEPES pH 7.4, 5 mM calcium chloride, 140 mM sodium 
chloride, 1 % (v/v) octyl-p-D-glucopyranoside, 1 mM PMSF, 1 mM aprotonin, 1 
mM leupeptin) and snap frozen in liquid nitrogen. The sample was then thawed, 
homogenised in a glass homogeniser (20-30 strokes) and incubated on ice for 1 
hour. The extract was then centrifuged at 2000 rpm for 10 minutes, to pellet the 
nuclei and unbroken cells, and the pellet discarded. The supernatant was then 
centrifuged at 45000 x g for 1 hour at 4 °C and the supernatant retained as the 
membrane extract.
2.26. Preparation o f Cellular Cytosolic and Nuclear 
Fractions
Cells were washed twice with 10 ml ice cold TBS pH 7.6 (20 mM tris, 136 mM 
sodium chloride), pelleted by centrifugation at 1500 x g for 5 minutes and 
washed with 1 ml TBS before being transferred to an Eppendorf tube and 
pelleted again by centrifugation at 1500 x g for 5 minutes. The pellet was then 
resuspended by gentle pipetting in 400 pi of ice cold buffer A (10 mM HEPES 
pH 7.9, 10 mM potassium chloride, 1.5 mM magnesium chloride, 0.1 mM 
EDTA, 0.1 mM EGTA, 0.5 mM DTT, 0.15 mM spermine, 0.75 mM spermidine, 
1 pg ml"^  leupeptin, 1 pg mf^ aprotinin, 1 pg mf^ PMSF, 100 pM sodium 
orthovanadate) and the cells left to swell on ice for 15 minutes. 25 pi of 10 % 
NP-40 was then added, the samples vortexed vigorously for 10 s and centrifuged
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at 13000 X g for 30 s to pellet the nuclear material. The supernatant (cytosolic 
fraction) was removed and stored at -20 °C. The nuclear pellet was vortexed, 
resuspended in 50 p.1 ice cold buffer B (20 mM HEPES pH 7.9, 25 % (v/v) 
glycerol, 0.4 mM sodium chloride, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 
pg mf^ leupeptin, 1 pg mf^ aprotinin, 1 pg ml"^  FMSF) and then mixed 
vigorously on a rocking platform for 15 minutes on ice. The nuclear extract was 
then centrifuged at 13000 x g for 5 minutes at 4 °C, the pellet discarded and the 
supernatant stored at -20 °C.
2.27. Synthetic Oligonucleotide DNA Labelling
A probe labelling mix (32 pi dHzO, 5 pi 1 Ox buffer H (Promega), 6 pi dNTP mix 
(Promega), 4 pi ds DNA (probe), 2 pi ^^P-oc-ATP (Amersham), 1 pi Klenow 
(DNA polymerase 2 U pf^ Boehringer Mannheim)) was prepared and incubated 
at 37 °C for 3 hours. 6 pi of DNA loading buffer (0.25 % (w/v) bromophenol 
blue, 40 % (w/v) sucrose) was then added to the probe mix and the probe mix run 
on a 8 % polyacrylamide gel (11 ml 30 % (w/v) polyacrylamide, 4 ml 5x TBE 
(446 mM tris base, 444 mM boric acid, 10 mM EDTA, pH 8.0), 25 ml dHzO,
100 pi 30 % (w/v) ammonium persulphate, 34 pi TEMED) in 0.5x TBE at 20 
mA for 1-2 hours. The labelled probe was then identified by autoradiography, cut 
out of the gel, placed in an Eppendorf tube and incubated overnight in T/E buffer 
(10 mM tris pH 8.0, 1 mM EDTA) at 37 °C to allow elution of the labelled probe 
fr om the gel.
2.28. Electro-Mobility Shift Assay (EMSA)
A binding assay mix (10 pg sample protein, 10 pi 4x buffer (80 mM HEPES pH 
7.9, 4 mM magnesium chloride, 0.4 mM EDTA, 2 mM dithiothreitol, 40 % (v/v) 
glycerol), 2 pi poly-dldC (1 mg ml'^ Pharmacia), 1 pi ^^P-labelled probe made up 
to 40 pi in dH20) was prepared for each sample, including a control containing 
no protein, and incubated at room temperature for 30 minutes. 3 pi DNA loading 
buffer (0-25 % (w/v) bromophenol blue, 40 % (w/v) sucrose) was then added to 
each sample binding assay mix and the samples mn  on a 6 % polyacrylamide gel
Chapter 2: Materials and Methods_____________________________________________ ^
(8 ml 30 % (w/v) polyacrylamide, 4 ml 5x TBE (446 mM tris base, 444 mM 
boric acid, 10 mM EDTA, pH 8.0), 28 ml dHiO, 100 pi 30 % (w/v) ammonium 
persulphate, 34 pi TEMED) in 0.5x TBE at 20 mA until the dye front neared the 
end of the gel. One gel plate was then removed and the gel fixed in fixing 
solution (2 methanol : 1 acetic acid : 1 glycerol : 6 water (v/v)) for 20 minutes.
The gel was then dried in a gel drier for 1-2 hours at 80 °C and developed using 
autoradiography.
2.29. Incubation o f Cells with Native and Radiolabelled 
Native ES-62
1x10^ cells per timepoint were placed into a well of a 24 well plate in 1 ml of 
RPMI 1640 medium supplemented with 5 % (v/v) heat inactivated fetal calf 
serum, penicillin (100,U mf^) and streptomycin (100 mg mf^). ES-62 (2 pg ml'*) 
was added to each well and the cells incubated at 37 '"C in 5 % COi/OS % 
humidified air for the appropriate times. After each timepoint cells were added to 
14 ml RPMI 1640 medium supplemented as before and pelleted by 
centrifugation at 1500 rpm for 5 minutes. Nuclear and cytosolic fractions were 
then made from the cells as described in section 2.26.
2.30. Immunoprécipitation with a FITC Conjugate of 
ES-62
Whole cell lysate preparations were pre-cleared by the addition of 50 pi of 50 % 
protein L washed slurry followed by incubation for 1 hour at 4 °C on a rotator. 
Samples were then centrifuged at 13000 ipm for 10 minutes, the pellet discarded 
and ES-62-FITC (5 pg ml'^) added to the supernatant. The sample (wrapped in 
tin foil because ES-62-FITC is light sensitive) was then incubated for 2 hours at 
4 °C on a rotator. 50 pi of washed protein L slurry was incubated with 1 pg of 
anti-FITC antibody (Sigma-Aldrich) for 2 hours at 4 on a rotator concurrently. 
The anti-FITC/protein L sluriy was then centrifuged (13000 rpm for 7 minutes) 
to pellet the beads and the beads then washed in PBS pH 7.2 and added to the
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membrane sample that had been incubated with ES-62-FITC. The sample was 
then incubated overnight at 4 °C on a rotator before being centrifuged to pellet 
the beads. The beads were then washed 3 times in PBS pH 7.2, resuspended in 50 
pi of 2 X gel loading buffer and boiled to release the immunoprecipitated proteins 
from the beads. The beads were then pelleted by centrifugation and the 
supernatant loaded onto a SDS-PAGE gel.
2.31. Circular Dichroism
Far “ UV circular dichroism spectm for native ES-62 at 1.0 mg ml'* in 10 mM, 
pH 7.0 sodium phosphate, 150 mM sodium fluoride were obtained on station 3.1 
at the Synchrotron Radiation Source, Daresbuiy Laboratory and for native ES-62 
at 0.33 mg m f’ in 150 mM, pH 7.0 phosphate buffer in a 0.02 cm pathlengtli 
quartz cell on a JASCO J-600 spectropolarimeter at the Scottish CD Facility, 
University of Glasgow.
2.32. Inductively Coupled Plasma Atomic Emission 
Spectroscopy (ICP-AES)
I CP-AES uses high energy plasma to atomise the sample. High energy plasma is 
used in preference to a flame as a higher temperature can be obtained which 
reduces chemical and matrix interference. The precise natui'e of the high energy 
plasma compared to flames, which can vary greatly depending on conditions, 
means that the spectra o f several elements can be measured simultaneously if the 
protein contains multiple elements and that elements can be detected at much 
lower concentrations than when a flame is employed.
An inductively coupled plasma emission spectrum for wild type ES-62 at 1 pM, 
based on the monomeric mass of ES-62, in PBS (5.5 mM potassium chloride,
145 mM sodium chloride, 8 mM disodium hydrogen orthophosphate, 1.5 mM 
sodium dihydrogen orthophosphate) pH 7.0, was obtained at the Department of 
Chemistry, University of Edinburgh on a Thermo Jarrell Ash IRIS inductively 
coupled plasma atomic emission spectrometer. Standards containing iron.
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sulphur, zinc, copper, manganese, magnesium, potassium, cobalt and nickel at 
100,10, 5, 1, 0.5, 0.1, 0.05 and 0.01 ppm (parts per million) were used to 
calibrate the spectrometer prior to mmiing the sample.
2.33. Determination of the Isoelectric Point o f ES-62
The isoelectric point of ES-62 was determined by running a sample of ES-62 on 
a series of isoelectric focusing gels, initially with a pi range of pH 3 to pH 9 and 
then on a gel with a narrower pi range of pH 4 to pH 6.5. The gels and gel 
equipment used were the PhastGels and PhastSystem from Amersham Pharmacia 
Biotech. Gels were run according to manufacturers guidelines.
2.34. Monomerisation o f Wild Type ES-62
Wild type ES-62 was monomerised by sequential dialysis into buffers of 
decreasing pH. Wild type ES-62 at 570 pg ml'^ in PBS (5.5 mM potassium 
chloride, 145 mM sodium chloride, 8 mM disodium hydrogen orthophosphate,
1.5 mM sodium dihydrogen orthophosphate) pH 7.0 was dialysed into 0.1 M 
sodium phosphate pH 6.0, 0.1 M sodium acetate pH 5.5, 0.1 M sodium acetate 
pH 5.0 and finally into 0.1 M sodium phosphate pH 7.0. Each dialysis step was 
carried out for 3 hours and a 2 pg (4 pi) sample taken at each pH. Samples were 
mixed with 4 pi 2 x loading buffer (100 mM Tris pH 6.8, 20 % (v/v) glycerol, 
bromophenol blue) and loaded, without pre boiling, onto an 8 % (w/v) non­
denaturing polyacrylamide gel (contains no SDS). The gel was run until the dye 
fi*ont reached the bottom of the gel. The gel was then removed and stained with 
Coomassie blue dye (50 % (v/v) metlianol, 10 % (v/v) acetic acid, 0.05 % (v/v) 
Coomassie Blue (R250)) and destained (50 % (v/v) methanol, 10 % (v/v) acetic 
acid). The stained gel was then dried using a gel drier for 45 minutes at 80 °C.
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2.35. Calculation o f the Extinction Coefficient for ES-62
A Coomassie protein assay was carried out using BSA protein standards at 0.125,
0.25, 0.5, 0.75, 1, 1.5 and 2 mg ml'* to obtain a standard curve. The concentration 
of an aliquot of a sample of ES-62 was determined from the standard curve. The 
absorbance of the sample at 277 nm was measured and the extinction coefficient 
determined using the equation A=Ecl, where A is the absorbance at 277 nm, E 
the extinction coefficient (cm^ mg'^), c is the concentration (mg m f’) and 1 is the 
pathlength of the spectrophotometer (cm).
2.36. Spectroscopy o f BSA and BSA Conjugated to PC
Absorption spectra of denatured BSA, 0.67 mg mf% and BSA with PC 
conjugated to it, 0.5 mg m f \  were obtained using a wavelength scan from 150 
nm to 400 nm in a UNICAM UVA/IS spectrometer. Denatured BSA was used as 
the contr ol as BSA has to be denatured before PC can be conjugated to it.
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2.37. Suppliers
Supplier Materials
PharMingen; BD Biosciences, 21 
Between Towns Rd, Cowley, Oxford
SF9 insect cell line 
TMN-FH medium 
Protein-free insect cell medium 
PAcGP67-B vector 
BaculoGold DNA 
Agarplaque
Novagen: CN Biosciences (U.K.) Ltd, 
Boulevard Industrial Park, Padge Rd, 
Beeston, Nottingham
PET 19b vector 
SOC medium 
Novablue competent cells 
BL21 (DE3) competent cells
Gibco BRL: Paisley, U.K. All cell culture reagents
BioRad: BioRad House, Maylands 
Ave., Hemel Hampstead
Zinc Stain
Gel transfer apparatus.
Agarose gel electrophoresis apparatus
Promega: Delta House, Chilworth 
Research Centre, Southampton
PGEM-T Easy vector 
Ligation buffer 
T4 DNA ligase 
ATP
JM109 competent cells 
SOC medium 
10 X PCR buffer 
dNTPs 
Taq
Shrimp alkaline phosphatase 
1 Ox Buffer H
Boehringer Mannheim: Roche 
Diagnostics Ltd, Bell Lane, Lewes, 
East Sussex
Low salt 1 Ox buffer
Eco R1
Ndel
Bam HI
Buffer B
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Boehringer Mannheim: Roche 
Diagnostics Ltd, Bell Lane, Lewes, 
East Sussex
Low melt agarose 
Klenow
Qiagen: Boundary Court, Gatwick Rd, 
Crawley, West Sussex
QiaPrep spin miniprep kit
Am icon: Millipore (U.K.) Ltd, Units 3 
& 5, The Courtyards, Halters Lane, 
Watford
Ultrafiltration cell 
YM 100 membranes 
YM 30 membranes
Applied Biosystems: Lingley House,
120 Birch wood Boulevard, Warrington
POROS purification columns 
(PerSeptive Biosystems)
Superose 12 (HR 10/30) (Pharmacia 
Biotech)
Poly dldC (Pharmacia Biotech) 
PhastGels (Pharmacia Biotech) 
^^P-a-ATP (Amersham Pharmacia)
Sigma-Aldrich: Dorset, England Anti-FITC Antibody 
NBT-BCIP substrate
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3. Bioinformatics
There has been considerable research into the effects of ES-62 on the immune 
system (Deehan et al., 1998a; Deehan et ah, 1998b; Harnett & Harnett, 1999a;
Harnett et ah, 1995; Harnett et al., 1999a; Harnett & Harnett, 1993) and into the 
constituents of the carbohydrate chains and phosphorylcholine moieties that form 
part of ES-62 (Harnett et ah, 1994; Harnett et al., 1993; Haslam et al., 1999;
Haslam et al., 1997; Houston et al., 1997; Houston & Harnett, 1999a; Houston &
Harnett, 1999b). However, at the start o f this PhD project the only structur al 
information available for ES-62 were the amino acid and DNA sequences and the 
hypothesis that it existed in a tetrameric state. One of the aims of this PhD was to 
obtain structural information about ES-62 with the objective of identifying 
homologous proteins to aid elucidation of the function of ES-62 and to ultimately 
allow rational drug design both for the treatment of filarial diseases and for the 
development of immunosuppressive drugs. Three techniques were employed in 
the course of this PhD to obtain structural information abouf ES-62. The first of 
these techniques, bioinformatics, is discussed in this chapter. The discussion of 
bioinformatic techniques is further supplemented by a web page, written as part 
o f this PhD, which discusses the techniques employed
(http.7/crick.chem. ula.ac.uk/~clairea/bioinformatics/l 23 .html). In addition, a CD 
is included as part of this thesis containing the program RasMol (Sayle &
Mihier-White, 1995) and the PDB (Protein Data Bank) files for the structures of 
ES-62 obtained from bioinformatic techniques. Appendix 1 provides details of 
how to view these structures. The other two techniques employed, AUG and 
SAXS, are discussed in Chapter 4.
Bioinformatics is a computer-based method of obtaining information about a 
protein or gene of interest from the many protein and DNA databases available 
on the internet and from prediction programs, such as motif and secondary 
structure prediction programs, also available on the internet. The amino acid 
sequence of ES-62 was the starting point for the bioinformatics search for 
structural infoimation about ES-62.
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Proteins fold to enter a low energy state, believed to be fuelled by the need to 
pack hydrophobic residues into the interior of the molecule, away from contact 
with water (Rost, 1998). Chaperone proteins play a role in the folding of proteins 
ensuring that correct folding occurs and correcting misfolds. As the protein folds 
to enter a low energy state, predicting the tertiary structure of a protein from its 
primary sequence simply by identifying the structur’e with the lowest energy 
should be possible. However, the difference in energy between a folded and 
unfolded protein is only ~ 1 kcal mof^ (Rost, 1998). This small energy difference 
coupled with the complexities of protein folding, means that the determination of 
the folding of a protein solely fr om its primary amino acid sequence exceeds 
current computing power. That is not to say it is impossible to predict the tertiary 
structure of a protein from its amino acid sequence, simply that it is necessary to 
obtain further information about the protein, such as secondary structure 
information, homologous proteins or protein motifs present within the amino 
acid sequence, before the tertiary structure prediction can be performed.
Homology modelling is the prediction of the tertiary structure of a protein, based 
on the known structure of a homologous protein and has been utilised to predict 
the tertiary structure of between 10 and 30 % of protein sequences within the 
many protein databanks. Proteins that share at least 25-30 % pairwise sequence 
identity are highly likely to fold into similar structures (Rost, 1998; Rost &
Valencia, 1996). Thus the identification of a homologous protein can allow an 
accurate 3-dimensional model for a protein of interest to be generated. Wliile the 
prediction of the tertiary structure of a protein from its amino acid sequence and 
other information obtained through bioinformatics is rarely successful, the 
prediction of the secondary stmcture, solvent accessibility of constituent amino 
acids and the presence of transmembrane helices, binding sifes and motifs within 
a protein are widely performed and in the most part are reliable.
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3.1. Identification o f Homologous Proteins
3.1.1. Primary Sequence Homology
The first step in the search for structural information about ES-62 was the 
identification of homologous proteins. This was achieved through the use of 
databanks that contain the amino acid sequences of proteins and other relevant 
information, such as DNA sequence, protein function, protein family and the 
PDB file name of the 3-dimensional stmcture if this is known. One example of 
such a databank is Entrez (http://www.ncbi.nlm.nih.gov/Entrez/i , a molecular 
biology database and retrieval system developed by the NCBI (National Centre 
for Biotechnology Information).
A number of programs, such as PSI-BLAST, BLAST and Gapped BLAST 
(http://www.ncbi.nlm.nih.gov/BLAST/index.html) (Altschul & Koonin, 1998;
Altschul et ah, 1997), ar e available on the internet and can be used to search 
protein and DNA databases for sequence similarities (Altschul et al., 1997). PSI- 
BLAST was used to identify proteins homologous to ES-62, as this is the most 
sensitive of the tlnee programs. The iterative methodology it implements allows 
identification of distant homologues to the protein of interest (Altschul &
Koonin, 1998). PSI-BLAST works by using Gapped BLAST to generate gapped 
sequence alignments, comparing the amino acid sequence of the protein of 
interest with a protein database. The proteins identified as homologous by the 
Gapped BLAST algoritlmi are then aligned in a multiple alignment with the 
original sequence seiwing as a template. A profile is generated, representing the 
original sequence and taking into account differences between it and the proteins 
identified as homologous. This profile can then be re-compared to tlie protein 
database to see if any new proteins are identified and the whole process of 
generating a profile repeated. Tlris process can be repeated either a set number of 
times or until convergence is reached, where convergence is defined as the 
identification of no new proteins.
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For the initial identification of proteins homologous to ES-62 default settings in 
PSI-BLAST were employed and all protein databases were searched. The default 
settings employed in PSI-BLAST were m" (non redundant) database, Blosum62 
matrix and Gap costs of 11 for existence and 1 for extension. The results 
obtained were presented as a graphical display and as a list of homologous 
proteins. Further iterations, a vital part of PSI-BLAST, were performed, again 
using the default settings.
A multiple alignment of the homologous proteins identified by PSI-BLAST was 
then generated to allow easy identification of highly conserved regions. In 
addition, many of the secondary structure prediction programs use these multiple 
alignment files as input. Multiple alignments of ES-62 with the proteins 
identified as homologous by PSI-BLAST were performed using Mult Alin 
(Corpet, 1998) (http://prodes.toulouse.inra.fr/multalin/multalin.html). The 
sequences of the proteins identified as homologous were obtained from the links 
to the protein sequence entries in PSI-BLAST. These sequences, in FASTA 
format, were submitted to MultAlin along with the sequence for ES-62, taking 
care to avoid use of the word ‘protein’ in the header line of the sequences. This is 
essential as although use of ‘protein’ in the header line will not affect the 
generation of a multiple alignment, it will result in a serious error in the program 
PlotcoiT (used downstream of MultAlin), which will subsequently fail to run due 
to a misreading of the sequence header line as the designation of the secondary 
structure definition block. All optional parameters were left at the default settings 
except for the maximum line length option, which was set to 70 amino acids. The 
output was saved both as a gif file, by clicking on the graphic itself and selecting 
‘save image as’, and in m sf format by selecting the ‘results in text format’ option, 
copying this information to a blank file and saving as a .msf file.
3,1.2. Secondary Structure Homology
It is possible to identify homologues of the protein of interest on the basis of 
secondary structure using programs such as sss align (Stunock & Dryden, 1997)
(http://www.icmb.ed.ac.ulc/sss_align/sss align.html). sss align aligns proteins on
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the basis of secondary structure enabling the identification of proteins with 
similar secondary structure but little sequence identity, sss align bases its 
predictions on the parameters described in Table 3-1.
Parameter Description
-\nï\\Q filename This compulsory parameter takes the form of a PHD output file, 
a FASTA format sequence or SWISS/EMBL output file.
-pams 1-500 Specifies the Dayhoff PAM table to use. 1 specifies the strictest 
scoring, 500 the most relaxed.
-gapopen 1-100 This specifies the penalty for a single gap. The optimum value 
varies with the PAM table being used. The program will select 
an appropriate value automatically if one is not specified.
-gapextend 0-gapopen This specifies the penalty for extending an open gap. The 
program will select an appropriate value, based on the PAM table 
selected and the gapopen value, if one is not specified.
-qval 0-100 sss align has 2 scoring systems, a PAM table and a log odds 
table relating to the reliability of the predicted structure. This 
value allows the percentage use of each system to be specified. 
100 is all sequence, 0 is all secondary structure.
-summary 0-max Specifies the number of hits in the output summary list.
-align 0-max Specifies the number of sequences used in an alignment.
-dbname file_name Allows the specification of a user-defined database to search 
against. If none is supplied the default database is used which 
consists of 2000 sequences.
Table 3-1: sss align parameters. The only compulsory parameter is -infile 
but use of the -pams and -qval parameters is recommended in the program 
manual to increase the accuracy of the search. Wording in italics under the 
parameters heading indicates information that is supplied by the user.
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The first step in identifying proteins homologous to ES-62 using these criteria 
was to generate a secondary structure prediction for ES-62 using the secondary 
structure prediction program, PHD (Rost, 1996; Rost et al., 1995; Rost & Sander,
1993; Rost & Sander, 1994a; Rost & Sander, 1994b) (http://www.embl- 
heidelberg.de/predictprotein/predictprotein.html). The predicted secondary 
structure of ES-62 was then compared with the secondary structure of over 2000 
proteins for which the tertiary structur e is known and homologous proteins, on 
the basis of secondary stmcture, identified. A Dayhoff PAM value of 250 and a 
qval value of 75 were used. No gapopen or gapextend values were supplied and 
the default database, as supplied with sss align, was employed. The tei-tiary 
structures of the homologous proteins were then used to provide some insight 
into the possible tertiary structure o f ES-62.
Dayhoff PAM 250 is one of many amino acid scoring schemes. These schemes 
are an essential part of protein sequence alignment and database scanning. The 
most commonly used matrices are the Dayhoff matrix for 250 PAMS, as used in 
sss align and BLOSUM 62. The Dayhoff matrix is based on the likelihood of 
any amino acid mutating to any other amino acid and thus consists of the average 
ratio of the number of changes a particular amino acid underwent to the number 
of amino acids of that type in the database for each amino acid (Barton, 1996).
PAM is the percentage of acceptable point mutations per 10  ^years. A PAM of 
250, as used in sss align, means 1 amino acid in 5 remains unchanged. The 
amino acids vary in mutability thus 48 % of tryptophans, 41 % of cysteines, 20 
% of histidines and only 7 % of serines would remain unchanged. A PAM value 
o f250 lies near’ the limit of detection of distant relationships (Barton, 1996).
BLOSUM, blocks substitution matrix, is a matrix derived from ungapped 
alignments of short regions of related sequence. The sequences are clustered into 
groups within which the sequences are similar at a threshold value. The 
commonly used BLOSUM matrix, BLOSUM 62, is used in PSI-BLAST, where 
sequences are clustered into groups demonstrating 62 % identity. Substitution 
frequencies for each amino acid within each group are then calculated and these 
form the matrix from which amino acids can be scored (Barton, 1996).
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3.2. Secondary Structure Prediction
Prediction of the secondary structure of a protein from its primary amino acid 
sequence is a reliable method of gaining structural information about the protein 
o f interest. There are a number of prediction programs available that use different 
algorithms to generate the predictions. The question thus arises as to wliich of the 
prediction programs to use. Ideally, the solution to this question would be to 
generate a prediction using each of the different programs available and then 
compare the predictions obtained. It would be hoped that adopting this strategy 
would result in the generation of a number of similar predictions from which a 
consensus could be drawn, ideally providing increased accuracy. Unfortunately 
the input and output requirements for each of the prediction programs generally 
differs and thus this strategy is not easy to adopt. Jpred
(http://iura.ebi.ac.uk:8888/) overcomes these problems and allows predictions to 
be generated by a number of different prediction programs in a user friendly 
manner.
3,2.1. Jpred
Jpred (http://jura.ebi.ac.uk:8888/) (Cuff & Barton, 1999; Cuff et al., 1998a) is a 
consensus secondary structure prediction internet web server. It standardises the 
input and output requirements of six of the most commonly used prediction 
programs {Cuff et ah, 1998b; Cuff  et al., 1998a); PHD (Rost, 1996; Rost & 
Sander, 1993; Rost et al., 1994), PREDATOR (Frishman & Argos, 1996; 
Frishman & Argos, 1997), NNSSP (Salamov & Solovyev, 1995), DSC (King & 
Sternberg, 1996), MULPRED (Barton, 1994) and Zpred (Zvelebil et al., 1987). 
The results from all of the programs ar e then displayed adjacent to each other 
along with a computer generated consensus thus allowing a consensus prediction 
to be gained from either a single amino acid sequence or a multiple alignment of 
homologous sequences. Tests performed have shown that the Jpred consensus 
prediction is 1 % more accurate in predicting the corxect secondary structure than 
PHD, which has an accuracy of 71.9 % (Cuff et al., 1998b).
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The six secondary structur e prediction programs that form Jpred are based on 
different algorithms and strategies for predicting secondary structure. NNSSP is 
based on a nearest neighbour algorithm which assumes that the secondary 
structure of a primary sequence is the same as that of the closest primary 
sequence to it of loiown secondary structure (King, 1996; Salamov & Solovyev,
1995). PREDATOR is also based on a nearest neighbour algorithm but 
incorporates information from multiple sequence alignments, such as hydrogen 
bonding propensities, to enhance the predictions (Frishman & Argos, 1996;
Frishman & Argos, 1997; King, 1996). PHD (described in more detail in section 
3.2.2) is based on jury decision neural networks. Neural networks consist of 
processing units which are connected. The weights of these coimections are 
altered during the learning phase when correct information about classification is 
supplied. These comiections are adjusted until a good input-output mapping is 
obtained which can predict the test set reliably. PHD obtains two network 
predictions and enters these into a thud network to obtain a jury decision (King,
1996; Rost, 1996; Rost & Sander, 1993; Rost et a l, 1994). DSC employs a 
method of linear discrimination. This combines information from multiple 
alignments about the composition of the amino acid sequence with a set of 
concepts, which allow prediction of secondary structure. The information is 
processed using linear statistics (Heringa, 2000). MULPRED uses the consensus 
single sequence combination method. This consists of utilising a number of 
single sequence prediction methods, such as Lim (King, 1996; Lim, 1974) and 
GOR (Gamier et al., 1978; King, 1996), to obtain prediction profiles from which 
a consensus is taken. Finally Zpred generates a conservation number weighted 
prediction. The consensus prediction generated by Jpred is obtained by a 
‘majority wins’ methodology between NNSSP, PHD, PREDATOR and DSC as 
these four are the most modern and accur ate prediction methods. If the ma.]ority 
wins method fails due to a tie then the prediction from PHD for that amino acid 
is used as PHD has the highest accuracy of these four programs for prediction of 
correct secondary structure.
As mentioned Jpred can generate a prediction from either a single amino acid 
sequence or from a multiple alignment in the form of a .msf file. Multiple
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alignments have long been known to increase the accuracy of a secondary 
structure prediction thus if a single amino acid sequence is submitted, Jpred 
rapidly generates a multiple alignment by searching the sequence against the 
OWL (Bleasby et a l, 1994) database using BLAST, filtering the results and then 
generating a multiple alignment.
For prediction of the secondary structuie of ES-62, a .msf file was submitted to 
Jpred and 'aligned multiple sequences in msf format' was selected as the file 
format parameter. The msf requirements by Jpred are strict and so the consensus 
line at the bottom of the .msf file from MultAlin had to be deleted before 
submission. In order to increase the accuracy of the prediction, NNSSP was 
selected to run. The default setting is to predict the secondary structure without 
running NNSSP. To override the default setting there is a small button at the 
bottom of the page that can be selected. As it was known that the proteins 
homologous to ES-62 had no known structures from which to obtain information 
about ES-62, the option to perform an 'autoscan of Brookhaven database' was 
deselected.
The output from Jpred gives a list o f viewing options. The results were viewed 
by selecting either the Jalview (Java alignment viewer/editor) option or the html 
format option. To download the output to a Silicon Graphics Unix operating 
system workstation, option 8 'Gzipped tar file' was selected. This saves the 
output as a .tar.gz file which was ungzipped (using the command; gunzip 
filename) and then 'untared' (using the command; tar xffilename). This process 
gave a large list of files from which those of importance could be selected. The 
flies important for future steps in the bioinformatics process were the .ps 
(.amas.ps), .hssp and .phd files. These files were renamed and the remainder 
deleted. The .ps file, a postscript file containing the secondaiy structure 
prediction output from Jpred in graphical format, was viewed using the program 
ghostview. The .phd file is the secondary structure prediction from the secondary 
structure prediction program PHD. This file was used as input for the programs 
sss align and Plotcorr.
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3.2.2. PHD
PHD (http://www.cmbl-heidelberg.de/predictprotein/predictprotein.html) (Rost,
1996; Rost & Sander, 1993; Rost et al., 1994) is a secondary structure prediction 
program that uses jury decision neutral networks. The program is ‘trained’ using 
groups of amino acid sequences for which the secondary structure is known. As 
well as providing a secondaiy structure prediction, PHD also predicts the solvent 
accessibility for each amino acid residue and the likelihood that the residue will 
lie within a transmembrane helix. In conjunction with these three predictions 
PHD also scans the submitted protein sequence using the PROSITE database 
(Bairoch et al., 1997; Hofmann et al., 1999), which identifies any functional 
sequence motifs such as glycosylation sites and phosphorylation sites, and the 
ProDom database which identifies any domains within the protein that are 
homologous to domains detected in the SWISS-PROT database (Corpet et al.,
1998; Rost, 1996; Rost& Sander, 1998).
For the prediction of the secondaiy structure of ES-62, PHD was run as part of 
Jpred. In order to check that Jpred did not alter the running of PHD in any way 
PHD was also run separately from Jpred using all the default settings. The 
secondary structure prediction for ES-62 obtained by PHD mn within Jpred was 
very similar to that obtained from PHD mn in isolation. Therefore, the PHD 
output file (.phd) fi’om Jpred was used as the input file for Plotcon'.
3.2.3. Circular Dichroism
Circular dichroism (CD) was carried out to allow comparison of the predicted 
secondary stmcture content o f ES-62 with the experimentally deteimined 
secondary structure content. In addition to being a method used to determine the 
secondary structure content of a protein, CD is also a powerful tool for following 
conformational changes in proteins e.g. upon dénaturation (Kelly & Price, 1997;
Price, 1995). CD measures the differential absorption of right and left circularly 
polarised light. This difference in absorption gives distinctive spectra for a - 
helices, |3-sheets and random coils. The spectra obtained from the protein of 
interest can be broken down to determine the percentage o f oc-helices, (3-sheets
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and random coil constituting the protein (Kelly & Price, 1997; Price, 1995). CD 
experiments were carried out on ES-62 as described in Chapter 2.
3,3. Prediction o f the Spatial Orientation o f Secondary 
Structure Elements
3.3.1. TOPS
TOPS (Gilbert et ah, 1999; Westhead et ah, 1999) is a protein topology server 
available on the internet (http://www3.ebi.ac.uk/tops/). This program converts 
the information in a PDB (http://www.rcsb.org/PDB/) file into a pictorial list, 
known as a TOPS cartoon, showing the secondary structure from N to C termini. 
The TOPS cartoon describes the type of secondary structur e element i.e. helix or 
strand, where it is located on the protein backbone, its orientation and what other 
secondary structure elements it lies close to in 3-dimensional space. This 
information is essential for the prediction of the tertiary structure of a protein 
using the tertiary structure prediction program DRAGON. As TOPS generates 
these cartoons from the PDB files of proteins with known structures, the program 
itself is of little use for ES-62. However, it can be used to obtain a TOPS cartoon 
for a protein identified as homologous to the protein of interest on the basis of 
secondary structure (as discussed in 3.1.2). This cartoon can then be used as a 
template for the manually constructed TOPS diagram of the protein of interest.
To obtain a TOPS cartoon for the proteins identified as homologous to ES-62 on 
the basis of secondary structure, the PDB files for each homologous protein were 
downloaded from the Brookhaven database. The option ‘generate your own 
topology cartoons’ was selected on the input page followed by ‘submit a protein 
structure for cartoon calculation’. The PDB file for the protein for which a TOPS 
cartoon was desired (e.g. 1QJ2) was then uploaded from the computer and a 
TOPS cartoon was generated for that protein.
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3.3.2. Plotcorr
Plotcorr (Goebel et ah, 1994) is a program that predicts the spatial proximity of 
pairs of amino acids within a protein of interest. For this thesis the program was 
downloaded from httD://www.pdg.cnb.uam.es/pazos/plotcorr.html and run on a 
Silicon Graphics 0 2  workstation running IRIX 6. Recently a web-based version 
of Plotcorr has been developed and can be accessed at
http://www.pdg.cnb.uam.es:8081/pdg contactjpred.html. By predicting which 
amino acids in a protein are likely to lie close together in 3-dimensional space the 
user can then postulate which secondary structures lie close to each other in 
space and manually construct a TOPS cartoon. Unfortunately for large proteins 
the number of possible pairs of amino acids is extremely large and as a result the 
information obtained from Plotcorr is hard to decipher thus vastly increasing the 
difficulties in determining which secondary'structures lie close to one anotlier.
The input for Plotcorr is secondary structure information and a multiple 
alignment of the protein of interest. For ES-62 the secondary structure 
information was in the form of a PHD output file. The multiple aligmnent, 
required in hssp file format, was generated from the PHD file using the ‘to_hssp’ 
program supplied with PlotcoiT. This program is invoked using the command 
‘to hssp PHDfilename outputfilename.hssp’. Terms in italics are specified by the 
user and correspond to the respective files. Once the two input files were 
obtained, Plotcorr was run by supplying it with the names of the two input files 
i.e. ‘plotcorr outputfilename.hssp PHDfilename".
The output from Plotcorr, shown in Figure 3-1, takes the form of the amino acid 
sequence of the protein of interest displayed around the outside of a circle on the 
left hand side of the screen with lines connecting residues that Plotcorr has 
predicted to lie close to each other in 3-dimensional space. Selecting a point on 
the outside of the circle displays the residue, holding down the shift key allows 
more than 1 residue to be displayed at once. The four bars on the right hand side 
of the screen can be varied and alter the graphical display. The last two bars 
control residue variability and secondary structure prediction and thus do not
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affect the assessment of correlation between two amino acids. The first two bars 
on the right hand side of the output screen are the minimum and maximum 
values for the correlation coefficient. These values can be altered and lines will 
appear and disappear on the graphical display as only residues with a correlation 
value between the set maximum and minimum values will be displayed.
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Figure 3-1: Output screen from Plotcorr. On the left hand side is the amino 
acid sequence of ES-62 displayed on the outside of a circle. Lines within this 
circle link pairs of amino acids that lie close to one another. The four bars 
represent, from left to right, minimum correlation coefficient, maximum 
correlation coefficient, residue variability and secondary structure 
prediction.
The information obtainable from this program needs to be used in conjunction 
with the information from secondary structure predictions. The secondary 
structure prediction provides the order and type of secondary structure elements 
from the N to C terminus, along with residue numbers for the start and finish of 
each individual secondary structure feature. By using the predictions of Plotcorr
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as to which residues lie close together in space it is possible to establish the 
possible orientation of secondary structure featui'es with respect to each other.
This information is required for DRAGON, a tertiary structure prediction 
program used in this project.
3,4, Tertiary Structure Prediction
As mentioned previously, successful de novo prediction of tertiary structure from 
the primary sequence of a protein is not possible without further information 
about the protein, such as secondary structuie information or amino acid 
accessibility. The success rate and accuracy of these predictions with this 
information is greatly dependent on the amount and type of information 
available. The greater the amount of structural infonnation that can be supplied 
for the protein that is being modelled the greater the accuracy of the prediction.
A more successful method for generating a model of the tertiary structure of a 
protein is homology modelling. However, this requires a high level of homology 
between the protein of interest and a protein of knovra structure.
3.4.1. SWISS-MODEL
SWISS-MODEL nittp://www.expasv.org/swissmod/SWISS-MODEL.htmB 
(Peitsch, 1996) is an internet-based tertiary structure homology modelling 
program which has a good success rate in predicting the tertiary structure of 
proteins provided that there is a minimum of 25 % identity between the amino 
acid sequence of the protein of interest and that for a protein for which the 
structure is known. The small section of ES-62 (residues 252-343) which is 
homologous to a region (residues 74-168) of the leucyl aminopeptidase from 
Aeromonasproteolytica (PDB code 1 AMP) (Chevrier et al., 1996; Chevrier et 
ah, 1994; Schalk et al., 1992), was modelled using SWISS-MODEL by 
providing the amino acid sequence for this section of ES-62 and a modified 
version of the 1 AMP PDB file, containing only information about residues 74- 
168, as the template (this region shows 35 % identity to ES-62).
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3.4.2. DRAGON
DRAGON (Aszodi & Taylor, 1994a; Aszodi & Taylor, 1994b; Taylor & Aszodi,
1994) is a protein tertiary structure modelling program which can predict the 
tertiary structure of a protein from its amino acid sequence together with other 
structural information. The greater the amount of information supplied to 
DRAGON, such as solvent accessibility, secondary structure content, distance 
constraints and even homologous structures (although this is not a requirement of 
DRAGON), the more likely it is that the program will be able to predict a tertiary 
structure and the more accurate the resultant prediction. DRAGON was 
downloaded from http://mathbio.nimr.mrc.ac.uk/rmunro/dragon.html and 
installed on a Silicon Graphics 02 workstation running IRIX 6 for this project 
however, it can no longer be downloaded from this or any other site.
The files and parameters required as input for DRAGON are described in Table 
3-2. Essential input files are Alnfhm, Sstrfhm, Mastemo, Graph and Outfnm. The 
additional files serve to increase the reliability of the structural prediction if the 
information supplied is accurate. DRAGON requires other default files and 
values as input, but these are not altered in any way by the user and are supplied 
with the program. It is essential to ensure that these default files are located in the 
correct directoiy. A commands file, that takes the form of a list of the input 
parameters, directs DRAGON to all the information it requires to perform the 
prediction.
The commands file used to predict the tertiary structure of ES-62 was as follows;
Accfnm ES-62.accftim 
Alnfnm ES-62.msf 
Graph 1 
Masterno 1 
Outfnm ES-62b.out 
Restrfnm JPREDES-62.restr 
Sstrfnm JPRED2.sstrfhm
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Text in bold font is the parameter description, text in plain font is the user 
defined filename or input value. Typing "c füename.commands’ ran DRAGON. 
The output from this program was a PDB file which was viewed using the 
program Rasmol (Sayle & Milner-White, 1995).
Parameter Description
Accfnm A list o f the residues believed to be on the surface or buried in the 
protein. The information can be obtained from a number of 
sources, the predicted accessibility obtained from the Jpred 
prediction is one such source.
Alnfnm A multiple aligmnent file of the protein of interest with as many 
other similar proteins as possible.
Graph Tells DRAGON whether to run the program with a graphical 
interface or not, where 1 indicates a graphical interface.
Masterno Dictates which sequence in the multiple alignment is modelled 
(usually 1).
Outfnm Tells DRAGON what to call the output file and where to store it.
Restrfnm A distance restraints file that provides distances between amino 
acids pairs and a measure of the certainty of this information.
Sstrfiim A secondary structure file - this details what the secondary 
structures are and how they lie in relation to each other.
Homfiim A PDB file of a similar structure if  available.
Table 3-2: Input files and parameters for DRAGON along with a brief 
explanation of each. Essential files and parameters are Alnfnm, Sstrfnm, 
Masterno, Graph and Outfnm. There are other parameters and files that 
DRAGON requires to run but they are all default files and values.
Initially, the small region (residues 252-343) of ES-62 similar to a small region 
(residues 74-168) of the leucyl aminopeptidase from Aeromonas proteolytica for 
which there was a PDB file available (PDB code 1 AMP), was modelled using 
DRAGON. For this modelling a cut dovm version of the PDB file of the leucyl
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aminopeptidase from Aeromonas proteolytica, containing only the information 
for the relevant region, was submitted as the Homfnm input file for DRAGON.
In addition to this file Accfiim, Alnfhm, Outfnm, Restrlhm and Sstrfnm files 
were provided and values supplied for Graph and Masterno parameters. These 
parameters specified that the program was run with a graphical interface and that 
the sequence to be modelled was the first sequence in the multiple alignment. For 
modelling of ES-62 in its entirety there was no homology model available thus 
no Homfnm file was provided. Accfnm, Alnfnm, Outfnm, Restrfnm and Sstrfnm 
files were provided along with values for the Graph and Masterno parameters.
The program was again run with a graphical interface and the sequence modelled 
was the first sequence in the multiple alignment.
The Accfnm files were created from the Jpred output, which provided 
information about the accessibility of each residue. This information was 
transformed into a list of amino acid residues that were predicted either to be 
buried or to be on the surface of the molecule. The Alnfnm files were the msf 
output from the PSI-BLAST search of either the small section of ES-62 (residues 
252-343) which shows homology to the region of the leucyl aminopeptidase 
from Aeromonas proteolytica defined by residues 74-168, or ES-62 in its 
entirety. The Restrfnm files consisted of distance constraints between amino 
acids. These values were obtained using either the 1 AMP PDB file for the small 
region of ES-62 modelled or one of the protein structures identified by sss align 
as similar in secondaiy stmcture content to ES-62. The Sstrfhm files consisted of 
a list of the secondary structure elements of ES-62 and how they relate to each 
other e.g. the strands that make up a sheet and whether they lie parallel or 
antiparallel to each other. The information for these files was obtained Ifom a 
combination of the information obtained from Plotcorr and the TOPS diagrams 
for the protein stmctures identified by sss align as homologous to ES-62 on the 
basis of secondary structure. The contents of these files can been seen in 
Appendix 2.
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5.5. Results
3.5.1. Primary Sequence Analysis
The protein sequence of ES-62 was submitted to PSI-BLAST and the default 
setting used to search the non-redundant databases for proteins with amino acid 
sequence similarity to ES-62. PSI-BLAST identified six proteins with full length 
homology to ES-62; plasma glutamate carboxypeptidase (human) [GenBank 
sequence number: 5174627] (Gingras et al., 1999), aminopeptidase (human) 
[GenBank sequence number: 7706387](Liu et al., unpublished), hematopoietic 
lineage switch 2 related protein (rat) [GenBank sequence number: 3851632] 
(Chen & Talmage, 1998), liver annexin-like protein (rat) [GenBank sequence 
number: 7108713] (Servillo et al., unpublished), aminopeptidase (mouse) 
[GenBank sequence number: 5442032] (Liu et al., unpublished) and 
hematopoietic lineage switch 2 protein (mouse) [GenBank sequence number: 
9055234] (Chen & Talmage, 1998), which showed sequence similarity to ES-62. 
The level of similarity between these proteins and ES-62 is between 37 and 39 % 
as shown in Table 3-3. The multiple alignment of these proteins, performed using 
MultAlin, can be seen in Figure 3-2 and further highlights the level of similarity 
between the six proteins and ES-62.
Protein GenBank
Sequence
Number
% Homology 
with 
ES-62
Plasma glutamate carboxypeptidase (human) 5174627 38
Aminopeptidase (human) 7706387 37
Hematopoietic lineage switch 2 related 
protein (rat)
3851632 37
Liver annexin-like protein (rat) 7108713 39
Aminopeptidase (mouse) 5442032 38
Hematopoietic lineage switch 2 protein 
(mouse)
90552341 39
Table 3-3: Proteins with a high degree of primary sequence identity to ES-62.
Figure 3-2: Multiple alignment of ES-62 with the six proteins identified as 
homologous by PSI-BLAST as performed by MultAlin. Plasma is the plasma 
glutamate carboxypeptidase (human) [Genbank sequence number: 5174627] 
(Gingras et aL, 1999), Human (amino) is the aminopeptidase (human) 
[Genbank sequence number: 7706387 (Liu et a/., unpublished), switch(rel) is 
the hematopoietic lineage switch 2 related protein (rat) [Genbank sequence 
number: 3851632] (Chen & Tahnage, 1998), liver is the liver annexin-like 
protein (rat) [Genbank sequence number: 7108713] (Servillo et n/., 
unpublished). Mouse (amino) is the aminopeptidase (mouse) [Genbank 
sequence number: 5442032] (Liu et aL, unpublished) and Switch is the 
hematopoietic lineage switch 2 protein (mouse) [Genbank sequence number: 
9055234] (Chen & Talmage, 1998). Red residues show high homology (90 %), 
Blue residues show low homology (10 %) and black shows neutral residues. 
Symbols are as follows: ! is any one of I or V; $ is any one of L or M; % is any 
one of F or Y; # is any one of N, D, Q, E, B or Z.
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Figure 3-2: Multiple alignment of ES-62 with the six proteins identified as 
homologous by PSI-BLAST, as performed by MultAlin.
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In addition to the searches conducted using PSI-BLAST, searches were also 
performed of the nematode and filarial databases using the DNA sequence of ES- 
62. This identified several expressed sequence tags û'om B. malayi and O. 
volvulus that are homologous to ES-62.
3,5. i .  i .  M otif Searches
Motif searches carried out using Prosite identified a number of putative sites for 
glycosylation, phosphorylation, myristoylation and amidation. The four sites 
identified by Prosite as glycosylation sites are known to be glycosylated on wild 
type ES-62. A number of phosphorylation sites were identified by Prosite; eleven 
protein kinase C phosphorylation sites, nine casein kinase and three tyrosine 
kinase phosphorylation sites. Seven putative myristoylation sites and a putative 
amidation site were also identified. The identified Prosite motifs are shown in 
Figure 3-3.
1 M L Ij N S  S T F F F L V T L 14
1 ATAAATATGCTA CTCAATTCCTCG ACATTTTTCTTC TTGGTCACCCTA 48
15 T V V L G ^ A  A V L P D K T V A P 3 0
49 ACTGTCGTTTTG GGCGCAGCTGTC CTTCCGGACAAA ACTGTCGCTCCG 96
31 K N Y I Q E T F G 4 6
97 AAGAATTATATC CAAGAAACGTTC GGGAAGGAAGTT GCCGAATTAATC 14 4
47 I  T E G E E V G L A Y Q W L 62
1 4 5 CAGTATATTACT AAAGGTGAAGAA GTTGGATTAGCT TATCAATGGCTT 1 9 2
63 S K L V D G F G H R M V G S D S 78
1 9 3 AGCAAATTGGTC GATGGCTTTGGA CATCGTATGGTT GGTTCCGATAGC 2 4 0
79 L E K S I  A F L E E S L K N D N 94
2 4 1 TTGGAAAAATCG ATTGCTTTCTTA GAAGAAAGCTTG AAAAATGATAAT 2 8 8
95 F D K V H T E E V P N L P H W V 1 1 0
2 8 9 TTTGATAAGGTG CACACCGAGGAA GTACCAAACTTG CCACATTGGGTT 3 3 6
111 R G N D V V E M I  E P R N Q R L 1 2 6
3 3 7 CGTGGAAACGAC GTTGTCGAAATG ATTGAACCACGA AATCAACGGCTC 3 8 4
127 N V L A I  G G S E P A S A T G E 1 4 2
3 8 5 AATGTGCTTGCT ATTGGTGGATCT GAACCAGCTAGT GCGACCGGAGAA 4 3 2
1 4 3 V T V I Y D L D D V K P D D V R 1 5 8
4 3 3 GTGACAGTTATT TATGATCTTGAT GATGTCAAGCCT GATGATGTCCGT 4 8 0
1 5 9 G K I  V V T A Q T F A G Y P L T 1 7 4
4 8 1 GGCAAGATTGTT GTGACGGCACAA ACATTTGCTGGT TATCCGTTAACG 5 2 8
1 7 5 L K Y R R S V K L F E Q L G A I 1 9 0
5 2 9 CTTAAATATCGT CGATCAGTAAAA TTATTTGAACAA TTAGGTGCCATT 5 7 6
1 9 1 G V L V K S I  T S F S I N S P H 2 0 6
5 7 7 GGTGTTCTGGTC AAATCAATAACA TCATTTTCCATT AATTCACCTCAT 6 2 4
2 0 7 T G T G A E w r T I  P A A C L T 2 2 2
6 2 5 ACCGGCACTGGT GCAGAAAATACA ACAATTCCTGCT GCATGTTTAACG 6 7 2
2 2 3 I  E E A E M L E R L Y R S G K K 2 3 8
6 7 3 ATTGAGGAAGCT GAAATGCTTGAA CGATTGTATAGG AGCGGCAAAAAG 7 2 0
2 3 9 I  V I  R M D M K S H Y E E P I  N 2 5 4
7 2 1 ATCGTAATCCGA ATGGATATGAAA TCACATTATGAG GAACCTATAAAT 7 6 8
2 5 5 S S N L I  F E I T G S E R P S E 2 7 0
7 6 9 TCCAGCAATCTT ATCTTTGAAATT ACCGGTAGTGAA CGACCATCTGAA 8 1 6
2 7 1 V V L L S A S | V D S W D V G Q G 2 8 6
8 1 7 GTGGTACTATTA TCGGCACATGTG GACAGTTGGGAT GTTGGACAAGGA 8 6 4
2 8 7 A L P  D G A G C A V V W S A L H 3 0 2
8 6 5 GCATTGGATGAT GGTGCTGGTTGT GCTGTTGTATGG AGTGCTTTGCAT 9 1 2
3 0 3 S L K K L A E R N P K F K P K R 3 1 8
9 1 3 TCATTAAAAAAA TTAGCCGAAAGA AATCCAAAATTC AAACCAAAACGG 9 6 0
3 1 9 T I  R G I  F W T S E ^  Q G Y G G 3 3 4
9 6 1 ACAATTCGAGGC ATATTTTGGACA TCGGAAGAACAA GGATATGGGGGT 1 0 0 8
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3 3 5  A K H Y  Y I T H K N D S P E K F 3 5 0
1 0 0 9  GCAAAACATTAC TACATAACACAT AAAAATGATTCA CCGGAAAAATTT 1 0 5 6
3 5 1  Y F V S  E T g  T G T F K S T  N W 3 6 6
1 0 5 7  TATTTTGTATCT GAAACGGATACA GGAACATTCAAA TCAACCAATTGG 1 1 0 4
3 6 7  L A H L  S F S G  D K K S  M L R L  3 82
1 1 0 5  CTTGCGCATCTT TCATTCAGTGGT GATAAAAAATCT ATGCTGCGACTT 1 1 5 2
3 8 3  K E I T  R L L S  R N G I  A L G L  3 9 8
1 1 5 3  AAAGAAATAACA CGTTTATTGAGC AGAAATGGTATA GCGCTTGGATTG 1 2 0 0
3 9 9  I  N  S  S _____ Y_ _Q_ _G_ _D__ V T F _  _ W_ _ _ _A._._K D G 4 1 4
1 2 0 1  ATAAATAGCTCA GTACAGGGTGAC GTTACTTTTTGG GCAAAAGATGGC 1 2 4 8
4 1 5  ,_._V___ N__ Y  I  P D_ _ 4 30
1 2 4 9  ATACCATCAGTT AATTATATACCT GACAAGGCTGTC GATTATTATTTC 1 2 9 6
4 3 1  F H g  T A G D  Y M T V  L 4 4 6
1 2 9 7  TATTTTCATCAT ACTGCTGGCGAT TACATGACAGTA TTGAAGGATGGC 1 3 4 4
4 4 7  T T S I  F A T L  G H V I  4 6 2
1 3 4 5  GATTTAGAATAT ACAACATCAATT TTTGCCACTTTG GGCCATGTAATC 1 3 9 2
4 6 3  A N M D  D W G S  D P N Q  P Q Q L  4 7 8
1 3 9 3  GCTAATATGGAT GATTGGGGAAGT GATCCTAATCAG CCACAGCAGCTT 1 4 4 0
4 7 9  N S K Q  S T T E  K S D R  K K L  4 9 3
1 4 4 1  AATTCCAAACAA TCCACTACTGAG AAATCTGATCGT AAAAAGCTATAA 1 4 8 8
Figure 3-3: DNA and amino acid sequence of ES-62. The arrow marks the 
start of the mature protein sequence. Bold residues are those that constitute 
the leucine rich regions, residues in bold italics show the glycosylation sites, 
boxed residues are those involved in the formation of metal co-ordination 
sites, residues in the region of ES-62 homologous to aminopeptidases are
underlined (___ ) and residues in the region of ES-62 homologous to the PC
binding region of C-reactive protein (residues 56-81 of human C-reactive
protein (Harnett et aL, 1999a)) are underlined (___ ) .  Blue residues are
those predicted by Prosite to form a glycosylation site, green residues are 
those predicted by Prosite to form a PKC phosphorylation site, red residues 
(or red underlining) are those predicted by Prosite to form a casein kinase II 
phosphorylation site, residues are those predicted by Prosite to form
a tyrosine kinase phosphorylation site, cyan residues (or cyan underlining) 
are those predicted by Prosite to form a N-myristylation site and pink 
underlining shows residues predicted by Prosite to form an amidation site.
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3.5.2. Secondary Structure Homology 
3,5,2,1, sss align
sss_align (Sturrock & Dryden, 1997) compares a secondary structure prediction 
of the protein of interest, typically the output from PHD (Rost, 1996; Rost &
Sander, 1993; Rost et a l, 1994), to a database of the seeondary structures of 
2000 proteins. The identification of proteins similar to ES-62 in terms of 
secondary stmcture but not necessarily sequence is important in gaining 
structural information, such as the possible orientation of secondary stmctures in 
relation to each other, which is essential when constmcting a 3-dimensional 
model for ES-62. sss__align identified ES-62 as demonstrating secondary 
structure similarity, but not sequence similarity, to four proteins; pymvate 
ferredoxin oxidoreductase from Desulfovibrio africanus (PDB code IBOP), the 
ectodomain of human transferrin receptor (PDB code 1CX8), endocellulase from 
Clostridium cellulolyticum (PDB code IFCE) and carbon monoxide 
dehydrogenase from Pseudomonas carboxydovorans (PDB code 1QJ2). The 
structures of these proteins aie shown in Table 3-4. Homologous secondary 
structure elements have been coloured the same in Table 3-4 (ruiming from 
brown at the N-terminus to pink at the C-terminus). In all cases the homologous 
regions in the four proteins are smaller than ES-62. The structures shown in 
Table 3-4 appear to show little overall fold similarity which is surprising given 
that all four structures were identified as homologous to ES-62. A more objective 
measur e of shape similarity was obtained by comparison of the solution small 
angle X-ray scattering curves calculated (using CRYSOL (Svergun et a l, 1995)) 
from the atomic co-ordinates for the regions of the 4 proteins found to be 
homologous with ES-62 (i.e. those presented in Table 3-4) as shown in Figui'e 
3-4. By this criterion the homologous regions of IBOP and 1CX8 appear to have 
quite similar solution shapes; 1QJ2 is slightly different and IFCE is very 
different.
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Protein PDB 
accession code
Structure of homologous 
region
Pyruvate ferredoxin 
oxidoreductase from 
Desulfovibrio africanus 
(Rg = 26.4 Â; M = 41,958 Da)
Ectodomain of human transferrin 
receptor 
(Rg = 24.9 Â; M = 45,920 Da)
Endocellulase from Clostridium 
cellulolyticum 
(Rg = 22.5 Â; M = 50,799 Da)
Carbon monoxide dehydrogenase 
from Pseudomonas 
carboxydovorans 
(Rg = 26.5 Â; M = 44,794 Da)
IBOP
1CX8
IFCE
1QJ2
Table 3-4: Proteins with a high secondary structure identity to ES-62. The 
radius of gyration (Rg) was calculated, by O, Byron^ from atomic co­
ordinates using the program CRYSOL (Svergun et a/., 1995). The mass was 
calculated from the amino acid composition. Secondary structural elements 
are coloured according to their position in the primary sequence as follows:
Nx1 a2  a3  p 3jP 4  p5 :p6 p7 P18p19p20 a9
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Figure 3-4: Theoretical scattering curves for the four proteins (PDB
accession codes IBOP (—); 1CX8 (— ); IFCE (..... ); 1QJ2 predicted
to share a high degree of secondary structure homology with ES-62. The 
curves were calculated from the homologous region of the proteins using the 
software CRYSOL (Svergun et al., 1995).
3.5.3. Secondary Structure Prediction
Initially a number of different web-based secondary structure prediction 
programs, which all employ different methods of prediction, were used to gain 
secondary structure information about ES-62. Ultimately, one of these programs, 
Jpred, was used for all the secondary structure predictions of ES-62. Jpred was 
chosen as it is known to give a more accurate secondary structure prediction than 
other secondary structure prediction programs (Cuff & Barton, 1999; Cuff et al.,
1998a). In addition, as discussed previously, Jpred comprises a number of 
different secondary structure prediction programs and supplies the outputs from 
each of these in addition with final Jpred output. The overall content of 
secondary structure elements as predicted by Jpred is 26 % alpha helix, 21 % 
beta sheet and 53 % other. The Jpred secondary structure prediction for ES-62 is 
shown in Figure 3-5.
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Figure 3-5: Jpred secondary structure prediction for ES-62. Within the 
multiple alignment pale blue indicates hydrophobic residues; pale green -  
conserved polar residues; lower case letters -  small residues; red -  
conserved residues; blue text -  proline residues; red text -  histidine 
residues; boxed residues -  aliphatic (leucine, isoleucine or valine) residues 
and yellow -  cysteine residues. The props line at the base of the multiple 
alignment indicates residues or properties that are conserved; p -  conserved 
polar, h -  conserved hydrophobic, + - conserved positive or negative charge, 
s -  conserved small residue. Within the secondary structure prediction the 
program used to generate each prediction is listed at the start of each line on 
the left-hand side. Yellow arrows represent strands and the red cylinders 
represent helices. The three line boxed region following the secondary 
structure predictions provides information about the relative solvent 
accessibility of each amino acid. Those boxes coloured black in the Acc25 
line represent amino acids which are predicted to have a solvent accessibility 
of 25 %, those coloured black in the Acc5 line represent amino acids which 
are predicted to have a solvent accessibility of 5 % and those coloured black 
in the AccO line represent amino acids which are predicted to have a solvent 
accessibility of 0 %. Residues predicted to have a 0 % exposure to solvent 
are likely to be buried deep within the protein structure. It is these residues 
which constitute the Accfnm input file for DRAGON.
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3.5.4. Experimental Determination of Secondary Structure 
Content
The secondary structure content of ES-62 was determined experimentally by 
circular dichroism (CD) (as described in Chapter 2). Results from two CD 
experiments at different laboratories were very similar. The CD results indicate a 
higher percentage of a  helix than p sheet in the protein with approximately 40 % 
a  helix, 16 % p sheet and 16 % turn as shown in Table 3-5 and Figure 3-6.
% a-helix % p-sheet % turn % other
CD (Glasgow) 39.4 16.7 16.3 28.1
CD (Daresbury) 48 14 14 26
Table 3-5: Secondary structure content of wild type ES-62 from CD.
I - 4 -
- 8 -
-12
190 215 240 265165
Wavelengtii (nni)
Figure 3-6: A Far - UV circular dichroism spectrum for tetrameric wild type 
ES-62 at 0.33 mg ml'* in 150 mM phosphate buffer in a 0.02 cm pathlength 
quartz cell obtained on a JASCO J-600 spectropolarimeter at the Scottish 
CD Facility, University of Glasgow.
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3.5.5. Spatial Orientation of Secondary Structure Elements
Although Jpred predicts which secondary structural elements are present with 
respect to the amino acid sequence, it provides no information on the spatial 
orientation of these elements. Two methods were employed in an attempt to 
determine the orientation of the predicted secondary structural elements of ES-62 
in relation to each other. Initially the program Plotcorr was used as discussed in 
section 3.3.2. Although the information obtained from Plotcorr was limited and 
often difficult to interpret due to the large size of ES-62, it did provide 
information about a small region of ES-62 (residues 252-343) that shows 
homology to residues 74-168 of the leucyl aminopeptidase ixom Aeromonas 
proteolytica for which there is a known structure. The information provided was 
sufficient to enable input files for the tertiary structur e prediction program,
DRAGON, to be written and this small region of ES-62 modelled. The region 
modelled by DRAGON was then compared to the tertiary structure of residues 
74-168 of the leucyl aminopeptidase from Aeromonas proteolytica (see Figure 
3-8).
In the second method the highest ranked protein identified by sss align as 
showing secondary structure similarity to ES-62, carbon monoxide 
dehydrogenase from Pseudomonas carboxydovorans^ 1QJ2, was used as a model 
for ES-62 to gain information as to the orientation of the secondary structural 
elements of ES-62. This protein (1QJ2) was submitted to the web based, Protein 
Topology server as discussed in section 3.3.1. The TOPS cartoon created for 
1QJ2 was then used to predict which secondary structure elements in ES-62, as 
predicted by Jpred, might lie next to each other. The information from the TOPS 
cartoon was instrumental in the assembly of input files for the tertiary structure 
prediction program, DRAGON. The TOPS cartoon generated for 1QJ2 is shown 
in Figure 3-7.
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Figure 3-7: TOPS cartoon for chain B of the carbon monoxide 
dehydrogenase from Pseudomonas carboxydovorans, PDB code 1QJ2.
Circles represent helices, while triangles represent strands. The different 
sizes of the circles and triangles represent the sizes of the helices and 
strands. The direction of the triangle provides information regarding the 
parallel or antiparallel nature of strands within a sheet. The blue circles and 
triangles represent the section of chain B of 1QJ2, which shows a high 
degree of secondary structure homology to FS-62. This was the region used 
as a template for the construction of a TOPS cartoon for FS-62.
Figure 3-8: 3-dimensional models of residues 252-343 of ES-62 that show 
homology to residues 74-168 of the leucyl aminopeptidase from Aeromonas 
proteolytica, PDB code 1 AMP. Modelling was carried out using DRAGON (a) 
and SWISS-MODEL (b). (c) shows the 3-dimensional structure of residues 74- 
168 of the leucyl aminopeptidase from Aeromonas proteolytica, PDB code 
lAMP. Structural elements in all three images are coloured yellow for sheets 
and pink for helices. In (b) and (c) turns are coloured light blue. In (a) 
glycosylation sites on ES-62 are coloured green, residues involved in metal co­
ordination are coloured red and residues forming a leucine rich region are 
coloured blue. The PDB files for the model obtained using DRAGON and the 
homologous region of the leucyl aminopeptidase from Aeromonas proteolytica 
can be found on the CD included with this thesis. Details of how to view these 
molecules can be found in Appendix 1.
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3.5.6. Tertiary Structure Prediction
1.5.6./. DRAGON
The modelling of residues 252-343 of ES-62, similar to residues 74-168 of the 
leucyl aminopeptidase from Aeromonas proteolytica, was successful. The output 
from a number of runs was similar indicating the stability of the resultant model. 
Figure 3-8 shows the modelled structure of this small region of ES-62 obtained 
from DRAGON, a model of the same region obtained using SWISS-MODEL 
and the structure of residues 74-168 of the leucyl aminopeptidase from 
Aeromonas proteolytica.
\
(a) (b) (c)
Figure 3-8: 3-dimensional models
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In addition to modelling residues 252-343 of ES-62, the modelling of ES-62 in 
its entirety was also attempted. However, successive iterations of DRAGON did 
not yield similar models. Figure 3-9 shows the overlay of the models generated 
from successive iterations of DRAGON.
Figure 3-9: PDB files of the outputs from multiple iterations of DRAGON 
modelling ES-62 in its entirety. The outputs of 24 iterations are shown each 
coloured differently. As can be seen there is no conservation of structural 
elements between iterations. The PDB file for these outputs can be found on 
the CD included with this thesis. Details of how to view these output 
structures can be found in Appendix 1.
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The models obtained from the different iterations were assessed and ranked using 
a program called rank, supplied with DRAGON. The highest ranked model for 
ES-62 was then examined to ascertain whether the features ES-62 is known to 
possess, such as glycosylation sites, were located sensibly within the model e.g. 
ton the surface of the protein. This model with the features marked is shown in 
Figure 3-10.
Two of the four glycosylation sites could be located on the surface of the model 
with the other two sites slightly buried. Of the two leucine rich repeats, one was 
located on the surface and the other paifially on the surface. The two cysteines in 
ES-62 were 24.3 Â apart in the model, although it is unknown whether a 
disulphide bond links these cysteines. The five residues comprising the two metal 
co-ordination sites postulated to be present in ES-62 (Harnett et ah, 1999a), did 
not appear to form distinct clusters as might be expected in metal co-ordination 
sites.
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Figure 3-10: Highest ranked model generated by DRAGON for ES-62 in its 
entirety, p strands are coloured yellow and for a  helices are coloured pink. 
Glycosylation sites are coloured green, leucine rich regions -  blue, residues 
involved in metal co-ordination -  orange and cysteines are coloured cyan. 
The PDB file for this model can be found on the CD included with this 
thesis. Details of how to view this structure can be found in Appendix 1.
3.5,6,2, SWISS-MODEL
SWISS-MODEL, as mentioned previously, requires a protein with known 
structure that has a high level of homology with the protein of interest in order to 
work. Unfortunately there is no known homologous protein with a known 
structure that could allow the modelling of ES-62 in its entirety. However, 
residues 252-343 of ES-62 that demonstrate homology to residues 74-168 of the
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leucyl aminopeptidase from Aeromonas proteolytica for which there is a known 
structure, PDB code 1 AMP, was a candidate for modelling using SWISS- 
MODEL. The model of this region of ES-62 can be seen in Figure 3-8 (b) and is 
very similar to the model obtained for residues 252-343 of ES-62 using 
DRAGON. This overall similaiity suggested that the modelled structures for this 
region of ES-62 probably represents the actual structure of this region. As seen in 
Figure 3-3, residues 252-343 of ES-62 which are homologous to residues 74-168 
of the leucyl aminopeptidase from Aeromonas proteolytica contain a known 
glycosylation site, three of the residues involved in metal co-ordination and one 
of the two leucine rich regions of ES-62. It also contains fout' of the putative 
PKC phosphorylation sites, two putative casein kinase II phosphorylation sites 
and two putative N-myristylation sites predicted to be present by PRO SITE. The 
glycosylation site and leucine rich region appear to lie on the outside of the 
model. However, as this is only a small section of the whole protein it is not 
possible to determine if  this section of ES-62 lies on the surface when the 
complete structm e of ES-62 is considered.
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3,6, Discussion
Analysis of ES-62 using PSI-BLAST identified six proteins with alignment 
scores of greater than 200 indicating very low (approximately e"^ )^ E values. The 
E value is a parameter which describes the number of hits that can be expected to 
occui' by chance when searching the database, for example an E value of 1 would 
mean that 1 match with a similar score would be expected to occur by chance.
Small E values indicate that the protein identified is ti'uly homologous to the 
search protein and that the match has not occurred by chance. As shown in 
Figure 3-11(a), although particular regions [residues 112-119, 207-219, 230-243, 
271-345] have a greater identity than others, all six of the identified proteins 
show similarity to ES-62 along the full length of the sequence. This level of 
similarity suggests that these proteins possibly have related functions and 
structures. Unfortunately the structuies of these similar proteins are unknown 
thus obtaining a model of the structure of ES-62 is difficult as there is no obvious 
protein structure on which to base the model.
Closer examination of the six proteins identified as homologous to ES-62 reveals 
that these sequences show greater homology to each other than to ES-62 as 
shown in Figure 3-11(b). ES-62 shares 37-38 % identity with the other six 
proteins identified, while these proteins share between 84-99 % identity with 
each other. The six proteins can be further subdivided into groups, the members 
of these smaller groups showing greater homology with each other than to 
members outside these groups. This is most clearly shown when a phylogenetic 
tree is constructed of the six sequences as shown in Figure 3-12, More detailed 
analysis of the similarity of the sequences to each other is provided in Table 3-6.
This suggests that although ES-62 is related to these other proteins it is a more 
distant relation of this family. This could be explained by the species diiference, 
in that the six homologous proteins are mammalian proteins whereas ES-62 is a 
nematode protein.
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Plasma nKFLIFRFFGGVHLLSLCSGKflICKN6ISKRTFEElKEEIBSCG0V8KRIINLflVYGKflQNRSYERLRLLV0TV6PRLS6SKNLEKRIQI 
Human(amino) nKFLIFHFFGGVHlLSLCSGKniD(NGISKRTFEEIKEEIflSCGOVnKflIlNLRVYGKRQNRSYERLiM.LVDTVGPRLSGSK)I.EKRIQI 
S u lb c h tre l) MRFLFFLFVHWMlFSLGSGKRIYKSGVSQRTFQEIKEEIRMYEDVflKRII»B.RVYGKYQMRSYERLGLLVOTVGPflLSGSKHLEICflIQI 
L iv e r  ttRFLFFLFVflWHLFSLGSGKRIYKSGVSIIRTFQEIKEEIRMYEDVRKRXIHLRVYGKYQI«SYERLGLLVOTVa»RLSGSICHLEICRXQI 
nouse(amino) MRSLFFLFI— VHLLRLGSGKRVFKMGVSQRTFREIKEEimiYEOVRKRIINLRVYGKYQNRSYERLGLLVOTVEPRLSGSKMLEKRIQI 
Switch MRSLFFLFI— VHLLRLGSGKRVFKNGVSQRTFREIKEEim#YEDVRKRIIM.RVYGKYQMRSYERLGLLVDTVGPRLSGSKMLEKRiqi 
Consensus H rs L fF lF i. .VHLiaLgSGKR I f  KnG I SqRTFrEIKEEIRnyeDVRKRIINLRVYGKyQNRSYERLgLLVDTVGPRLSGSKNLEKAIQI
91 100 110 120 130 140 150 160 170 180I--------- +--------—4------------------1---------- 1------------------1----------------4.-----------------4----------------- 1---------------- 1
Plasma MYQMLOQOGLEKYHLEPVRIPHWERGEESRVMLEPRIHKIRILGLGSSIGTPPEGITREVLWTSFDELQRRASERRGKIWYNWYIWY 
Human(amino) MYQNLQQ0GLEKVHLEPVRIMWERGEESRVMLEPRIHKIRILGLGSSIGTPPEGITREVLWTSFDELQRRR9ERRGKIWYMIPYIMY 
S w itc h (re l)  MYQHLQQOGLEHVW-EQVRIPHHGRGEESRVHWPRIHKLRILGLGGSIGTPPEGITREVLWflSFVELQRRflSERRGKIWYHQPYTOY 
L iv e r  MYQHLQQDGLEMVHLEQVRIPHICRGEESRVHWPRIHtCLRILGLGGSIGTPPEGITREVLWflSFVELQRRflSEflRGKIWYIIQPYTDY 
House(amino) MYQNLQQOGLENVHLEQVRIPHItRGEESRVMLEPRIHKMRIL&GSSIGTPPGGITREVLWRSFDELQRRmSERRGKIIVYWQPYTGY 
Switch MYQHLQQ0GLEMVHLEQVRIPHHERGEESRV»1LEPRIW«:MRILGLGSSIGTPPGGITREVLWRSF0ELQRRRSERRGIŒIVYMQPYT6Y 
Consensus MYQNLQQDGLEnVHLEqVRIPHMERGEESRVHlePRIHKnRILGLGsSIGTPPgGlTRE VLWaSFdELQRRflSERRGKI I VYNQPYtgY
181 190 200 210 220 230 240 250 260 270
I ---------  -^---------4----------4---------- K--------- 4---------- ►----------1---------- 1
Plasma SRTVQYRTQGRVERRKVGRLRSLIRSVRSFSIYSPHTGIQEYQOGVPKIPTRCITVEOREMMSRMRSHGIKIVKKKMGmKTYPOTOSFN 
Human(amino) SRTVQYRTQ6RVERRKVGRLflSLIRSVRSFSIYSPHTGIQEYQ0GVPKIPTRCITVE0REMI1SRMHSHGIKIVIQLKMGflKTYP0TDSFM 
S w itc h (re l)  GKTVQYRERGRVEflflKVGflVRSLIRSVRSFSIYSPHTGHQGYQ0GVPKIPTRCITIEmEMMa«1flSRGDKIVIW.KMGRKTYP0TDSFR 
L iv e r  GKTVQYRERGRVERRKVGRVRSLIRSVRSFSIYSPHTGHQGYQOGVPKIPTRCIT lEOREMMSRTRSRGDKIVim-IOIGRKT YPOTDSFN 
Mouse(amino) EKTVQYRVUGRVEfWKVOlVRSLIQSVflSFSIYSPHTGIQKYQOGVPKIPTRCITVEDREMHSRMRSRGIIKIVmEMGRKTYPOTDSFM 
Switch EKTVQYRVQGRVERRKVGRVRSLIQSVRSFSIYSPHTGIQIOfQOGVPKIPTRCITVEDREMMSRMRSRGHKIVIHLEMGRKTYPOTDSFM 
Consensus ekTVQYRvqGRVERRKVGRvRSLIqSVRSFSIYSPHTGiQkYQDGVPKIPTRCIT!EDREMKSRMRSrGnKIVIhLeMGRKTYPDTDSFN
271 280 290 300 310 320 330 340 350 360I---------,------------  »----------1----------♦--------- ♦----------►----------1---------- 1
Plasma TVREITGSKYPEQWLVSGHLDSMOVGQGRnOOGGGRFISJtRLSLIKDLGLRPKRTLRLVLHTREEQGGVGRFQYYQLHKVNISMYSLV 
Human(amino) TVREITGSKYPEQWLVSGHLDSUOVGqGRtlDOGGGRFISHERLSLIKDLGLRPKRTLRLVLMTREEQGGVGRFQYYqLHKVNISNYSLV 
S w itc h (re l)  TVREITGSKYPEEWLVSGHLDSMOVGQGRLDOGGGWISUEra.SLVKOLGLRPKRTLRLVUITflEEQGGVGRSQYYELHKflNISKYSLV 
L iv e r  TVREITGSKYPEEWLVSGHLDSHDVGQGflLDOGGGflFISHERLSLVKOLGLRPKRTLRLVLHTHEEQGGVGRSUYYELHKBMISKYSLV 
Mouse(amino) TVREITGSMYPEEWLVSGHLDSWDVGQaM_IMKG6RFISWERLSLVKDLa_RPKRTLRLVLWTAEEQGGIGmSQYYELHKmNISKYSLV
Switch TVREITGSHYPE---------------------- OVGQGM.ODGGGRFISWERLSLVKM.GLRPKRTLRLVLWTREEQGGIGRSQYYELHKANISKYSLV
Consensus TVREITGSnYPE.wlvsghldsuOVGQGflSOOGGGRFIStfERLSL IKDLGLRPKRTLRLVUITREEQGGI GRsQYYILHKaNISkYSLV
361 370 380 390 400 410 420 430 440 450I------- -4.----------     ►----------1----------♦--------   »----------1
Plasma MESORGTFLPTGLQFTGSEKRRRIMEEYMSLLQPLNITQVLSHGEGTDINFHIQRGVPGRSLLODLYKYFFFHHSHGDTMTVMOPStWML 
Human(amino) ttESOHGTFLPTGLqFTGSEKRRfllMEEVttSLLQPLNITQVLSHGEGTOIMFHIQRGVPGRSLLDDLYKYFFFHHSHGDTMTVMDPWIIflV 
S w itc h (re l)  nERDSGTFLPTGLQFTG9M<RRRIMKEVMSLLQPLNITKVFMDflEGTDIMFHIQR6VPGRSLRD0LYKYFFFHHSHG0TMTflM0PKIWIV 
L iv e r  MEfWSGTFLPTGLQFTGSDKIWRIIIKFVMSLLOPLNITKVFMDflEGTDIMFMIQRGVPGflSLRDOLYKYFFFHHSHGOTMTflMOPKQHMV 
Mouse(amino) MFRDSGTFLPTGLQFTGS0KRRRIMKFVMHLLQPLHVTKVFSMGFGT0IMFHIQRGVPGRSLRD0LYKYFFFHHSHG0TMTVHDP1CQHMV 
Switch HEROSGTFLPTGLQFTGSmCRRRinKFVnNLLQPLNVTKVFSNGFGTDlM^UIQRGVPGRSLRDDLYKYFFFHHSHGDTHTSHIQSR 
Consensus MEaOsGTFLPTGLQFTGS#KRRRIMkEVMnLLQPLNITkVfsngEGTDIMFMIQRGVPGRSLrOOLYKYFFFIMSHGOTMT.mdpsr. . .
451 460 470 480 4W  500 510 520 530 540
I-------- 4--------—4.--------- ♦------ —4----------4.------- —4.----  4----------   1
Plasma LLLFGLLFLMLLQTHKKCCLGPRNSKKETFSCFHPGILGLQLHKTPLHITISSMSSSKHMSISCFLLLSFLILSKFSOSRKRMHSPLPPT 
Human(amino) RARVHRWSYWROMEEML— PRS 
S w itc h (re l)  RAAVWAWHYWROMEEML— PRS 
L iv e r  mRVMRVVRYVVmmtEML--PRS 
Mouse(amino) RRRVWRWRYWROMKML— PRS 
Switch
Consensus . . . . . . . . . . . . . . . . . . . . . p r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5M 1
I
Plasma T 
Human(amino)
S w itc h (re l)
L iv e r  
House*amino)
Switch  
Consensus .
Figure 3-11; (a) Multiple alignment of ES-62 and the six homologous 
proteins identified by PSI BLAST as performed by MultAlin. (b) Multiple 
alignment of the six proteins homologous to ES-62 alone as performed by 
MultAlin. Plasma is the plasma glutamate carboxypeptidase (human)
[Genbank sequence number: 5174627] (Gingras et al., 1999), Human 
(amino) is the aminopeptidase (human) [Genbank sequence number:
7706387 (Liu et al., unpublished), Switch(rel) is the hematopoietic lineage
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switch 2 related protein (rat) [Genbank sequence number: 3851632] (Chen 
& Talmage, 1998), liver is the liver annexin-like protein (rat) [Genbank 
sequence number: 7108713] (Servillo et at., unpublished). Mouse (amino) is 
the aminopeptidase (mouse) [Genbank sequence number: 5442032[ (Liu et 
at., unpublished) and Switch is the hematopoietic lineage switch 2 protein 
(mouse) [Genbank sequence number: 9055234] (Chen & Talmage, 1998). 
Red residues show high homology (90 %), Blue residues show low homology 
(10 %) and black shows neutral residues, symbols are as follows: ! is any one 
of I or V; $ is any one of L or M; % is any one of F orY; # is any one of N, D, 
Q, E, B or Z.
26.79
26.79
ES-62
0.18
3.9
3.36
Switch(rel)
Liver 
0.18
6.43
2.26
-Switch
— Mouse (amino) 1.32
3.33 Human (amino)
16.49 Plasma
Figure 3-12: Phylogenetic tree of ES-62 and the six homologous proteins 
identified by PSI-BLAST constructed by clustalw 
(http://iura.ebi.ac.uk:6543/cgi-bin/clustalw.cgi). Plasma is the plasma 
glutamate carboxypeptidase (human). Human (amino) is the 
aminopeptidase (human), Switch(rel) is the hematopoietic lineage switch 2 
related protein (rat). Liver is the liver annexin-like protein (rat). Mouse 
(amino) is the aminopeptidase (mouse) and Switch is the hematopoietic 
lineage switch 2 protein (mouse).
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The six proteins identified as homologous to ES-62 all show homology to the 
peptidase M20 family in the region of residues 253-376. In addition, these six 
proteins, with the exception of liver annexin-like protein, have all been classified 
as either amino or carboxypeptidases. It is possible that the liver annexin-like 
protein may be incoiTectly classified as PSI-BLAST and Entrez searches of this 
sequence do not identify other amiexin proteins. Further, the liver annexin-like 
protein shows no discernible homology to other annexin proteins. This suggests a 
common function for the six proteins homologous to ES-62.
ES-62 has been shown to possess aminopeptidase activity (Harnett et al., 1999b). 
However, ES-62 has not been identified as being homologous to M20 family 
members. In spite of this the region of the six proteins homologous to ES-62, 
identified as being homologous to the M20 family members, is one of the more 
highly conserved regions shared by ES-62 and the six proteins identified.
The classification of the six homologous proteins as peptidases, the similarity of 
a region of these proteins to the M20 peptidase region and the fact that this 
region of the identified proteins shows high homology with ES-62, all indicate 
that the aminopeptidase activity identified for ES-62 is not an artefact, but has 
biological significance. This aminopeptidase activity may be important in 
promoting the immunomodulatory role of ES-62. The peptidase role for ES-62 
further strengthens the hypothesis of a metal co-ordination site within ES-62 as 
many peptidases possess at least one metal ion often situated in the active site of 
the enzyme.
In addition to the six homologous proteins identified using PSI-BLAST, 
searching of filarial and nematode EST (expressed sequence tag) databases using 
the DNA sequence of ES-62 revealed several ESTs from B. malayi and O. 
volvulus homologous to ES-62. The ESTs identified as homologous were from 
female, male and microfilariae forms of the parasites. The identification of these 
ESTs demonstrates that while ES-62 is an excretory-secretoiy protein from a 
rodent filarial parasite, it is homologous to human filarial parasitic products. The 
use of ES-62 as a model for human filarial excretory-secretoiy products is 
therefore justified.
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3.6.1. Secondary Structure
In an attempt to gain some information as to the possible secondaiy structure 
elements which might constitute ES-62 a range of prediction programs were 
used. Jpred enabled a range of predictions to be both generated and easily 
compared from prediction programs which use different secondary structure 
prediction algorithms. Examination of the results of the secondary structure 
predictions from each of the programs used (Figure 3-5) indicates that despite 
using different algorithms, in general the secondaiy structure predictions 
generated by each program aie in agreement. In particular, PHD appears overall 
to agree with the Jpred, which has been shown to be the most accuiate prediction 
method (Cuff et al., 1998b). However, it should be noted that PHD does predict 
strands in some regions which aie assigned as helical by Jpred. The general 
consensus of PHD with tlie other predication programs and in particular with the 
Jpred consensus is of importance as the programs PlotcoiT and DRAGON are 
used downstream of PHD and thus their accuracy depends on the reliability the 
PHD output. As the prediction generated by PHD was similar overall to the other 
programs, it is fair to suppose that the input to these downstream programs is 
reliable.
The proteins identified as being homologous to ES-62 on the basis of secondaiy 
structure using sss_align did not appear to be similar to one other with respect to 
tertiary structure thus raising doubts over the accuracy and validity of this 
method of identification of homologous proteins. However, examination of the 
secondaiy structure of the proteins predicted to be homologous to ES-62 clearly 
indicated that the proteins identified shared similar secondary structure elements 
and that these elements were also present in the same order. The output of 
sss align indicating the secondary structure alignments with reference to ES-62 
is shown in Figure 3-13.
ES-62 aligned with pyruvate ferroxin oxidoreductase from D. africanus (PDB code: IBOP)
E E E E E E t t t t t t  E E E e e e e  HHHHHHH HHHHHHHHHH t t  e e  e e  
IBOP 1 6 4  NVPFMHFFDGFRTSHEIQKIEVLD YADMASLVNQKALAEFRAKSMNPEHPHVRGTAQ 2 2 0
E S -6 2  4 NSSTFFFLVTLTWLGAAVLPDKTVAPKNYIQETFGKEVAELIQYITKGEEVGL------------- 57
E E E E E E e e e e e e  EEE HHHHHHHhhHHHHHHHHHHh hh
HHHHHHHHHtthhhhhhhhHHHHHHHHHHHHHH e e e E E  t t  eE E E e t h h
IBOP 2 2 1  NPDIYFQGREAANPYYLKVPGIVAEYMQKVASLTGRSYKLFDYVGAPDAERVIVSMGSSC 2 8 0
E S -6 2  5 8  AYQWLSKLVDGFGHRMVGSDSLEKSIAFLEESLKNDNFDKVHTEEVPNLPHWVRGNDWE 1 1 7
hHHHHHHHHH e e e e  HHHHHHHHHHHHHH EE EEE e e e
h h h h h h h h h h h t t t  eEEEEE EEe h h h h h h h  t t  EEEEEE t
IBOP 2 8 1  ETIEEVINHLAAKGEK---------------IGLIKVRLYRPFVSEAFFAALPASAKVITVLDRTKEP 3 3 3
E S -6 2  1 1 8  MIEPRNQRLNVLAIGGSEPASATGEVTVI-YDLDDV---------------KPDDVRGKIWTAQTFA 1 6 9
e e  e e e e e e  EEEEE EE eE E E E E E eee
t  hhhhhHHHHHHHHt EEEEE HHHHHHHHH
IBOP 3 3 4  GAPGDPLYLDVCSAFVERGEAM PKILAGRYGLGSKEFS------------------- PAMVKSVYD 3 8 0
E S -6 2  1 7 0  GYPLTLKYRRSVKLFEQLGAIGVLVKSITSFSINSPHTGTGAENTTIPAACLTIEEAEML 2 2 9  
e e e e  HHHHHHHH e e e e e e e e E E E E E  hhhHHHHHHHHH
H H H tt EE t t  E E E E E E E E ett
IBOP 3 8 1  NMSGAKKNHFT VGIEDDVTGTSLPVDNAFADTTPKGTIQCQFWGLGADG----------------- 4 2 9
• • •  • • •  I *  • • • •  • •  # • • •• • • • • • •  * • • • • ! • •  # # # * * * #  *#*
E S -6 2  2 3 0  ERLYRSGKKIVIRMDMKSHYEEPINSSNLIFEITGSERPSEWLLSAHVDSWDVGQGALD 2 8 9  
HHHhh E E e e e  e e e e e e  EEEEEEEE
hhHHHHHHHHHHHHH EEEEEEE eeEEEEEEE
IBOP 4 3 0  ----------------TVGANKQAIKIIGDNTDL------- FAQGYFSYDSKKSGGITISHLRFGEKPIQST 4 7 8• | #I I • • • • • ! •  # ##
E S -6 2  2 9 0  DGAGCAWWSALHSLKKLAERNPKFKPKRTIRGIFWTSEEQGYGGAKHYYITHKNDSPEK 3 4 9  
eeeHHHHHHHHHHHHH EEEEEEEe EEEEEEE e
EEEE t t  t t t t  t t  e e E E e  HHHHHHH HHHHHHHHHtt
IBOP 4 7 9  YLVNRADYVACHNPAYVGIYDILEGIKDGGTFVLNSPWSSLEDMDKHLPSGIKRTIANKK 5 3 82 I . # » # 2 # • * I 2 * * * I * 22*2
E S -6 2  3 5 0  F----------------YFVSETDTGTFKSTNWL------------- AHLSFSGDKKSMLRL— KEITRLLSRNG 3 9 3
e  EEEEe e e  h h h h  EE e e  HHHHHHH HHHHHHHHH
EEEEE
l o o p  5 3 9  LKFYNID 5 4 5  
2 2 I 2 
E S -6 2  3 9 4  lALG LIN 4 0 0  
EEEEE
Chapter 3: Bioinformatics 128
Alignment of ES-62 with ectodomain of human transferrin receptor (PDB code: 1CX8)
HHHHHHHHHHHHHt HHHHHHHtt t t  HHHHHHHHHHHHHHhhtt
1CX8 1 2 4  WDDLKRKLSEKLDSTD FTSTIKLLNENSYVPREAGSQKDENLALYVENEFREFKLS 1 7 9
Z 2 # .  I 2 2 . . .  2 2 # I 2 # # # 2 2 #  # # # # | 2 | # • •  •
E S -6 2  3 8  FGKEVAELIQYITKGEEVGLAYQWLSKLVDGFGHRMVGSDSLEKSIAFLEESLKNDNFDK 97
HHHHHHHHHHHHH hhHHHHHHHhhh e e e e  HHHHHHHHHHHHHH
EE EEE EEEEEe EEEEE t t
1CX8 1 8 0  KVWRD------------ QHF VKIQVKDSAQNSVIIVDKNGRLVYLVEN-----------PGGYVAYSKA 2 2 5
•  I #  I #  *  #  •  •  I
E S -6 2  98  VHTEEVPNLPHWVRGNDWEMIEPRNQRLNVLAIGGSEPASATGEVTVIYDLDDVKPDDV 1 5 7
EE EEE EEEEE EEEEEe e e e e e e e
EEEEE EEE t t t  t t t t t  t t  EEEEE
1CX8 22  6 ATVTGKLVHANFGTKKDFEDLY-------------- TPVNGSIVIVR------------ AGKIT------------------- 2 6 3
# # #2 2  I # 2 #  # # I 2 I • • • • •
E S -6 2  1 5 8  RGKIWTAQTFAGYPLTLKYRRSVKLFEQLGAIGVLVKSITSFSINSPHTGTGAENTTIP 2 1 7  
EEEEEeEEEe e e e e  h h h h h h h h  e e e E E E E E e e e e e
HHHHHHHHHHtt EEEE t t t  t t
1CX8 2 6 4  ------------ FAEKVANAESLNAIGVLIYMDQTKFPIVNAELSFFG------HAHLGTGDPYTPGFP 3 1 4
. . .  2 2 2 2 2 2 I I I .  .  .  2 I 2 2 .  2 2 2 .
E S -6 2  2 1 8  AACLTIEEAEMLERLYRSGKKIVIRMDMKSHYEEPINSSNLIFEITGSERPSEWLLSAH 2 7 7  
hhhhhhHHHHHHHHHHh EEEEe e e e e e e  e e e e e e e e
eEEE HHHHHHHHHt t t  t t  EEE
1CX8 3 1 5  SFNHTQFPPSRSSGLPNIPVQTISRAAAEKLFGNMEGDCPSDWKTDSTCRMVTSESKNVK 3 7 4
E S -6 2  2 7 8  VDSWDVGQGALDDGAGC AWWSALHSLKKLA---------------------- ERNPKFKPKRTIRG 3 2 2
EEEhHHHHHHHHHh hh  eEEE
EEE e e e e  eeEEEEE EE t t  EEEEE t t t t h h h  HHHHH
1CX8 3 7 5  LTVSNVLK----EIKILNIFGVIKGFVEPDHYVWGAQRDAWGPGAAKSGVG-------- TALLL 4 2 7
• • • •  I I I I I * # # # » # • • •  # I• • •  • # I I # I # • • • !  ! • • • • • • • • •  # * # # * I
E S -6 2  3 2 3  IFWTSEEQGYGGAKHYYI— THKNDSPEKFYFVSETDTGTFKSTNWLAHLSFSGDKKSML 3 8 0  
EEEe EEEEE EE eeEEEEE e e  h h h h e e  e e  HHHHH
HHHHHHHHHHHt EEEE t  h h h h h h h  t t th h h h E E E E
1CX8 4 2 8  KLAQMFSDMVLKDG-------------FQPSRSIIFASWSAGDFGSVGATEWLEGYLSSLHLKAFTY 4 8 1
•  ! • • • • •  #  I *  #  #  «  »  I• I * # # » # * • • • ! • • •  • • «
E S -6 2  3 8 1  RLKEITRLLSRNGIALGLINSSVQGDVTFWAKDGIPSVNY--------- IPDKAVD YYFY 4 3 1
HHHHHHHHHHH e e e e e  e e e  eE EE E e e  EEEE
EE t t  EEEE HHHHHHHhtt t t  t
1CX8 4 8 2  INLDKAVLGTSNFKVSASPL LYTLIEKTMQNVKHPVTGQFLYQDSNWASKVEKLTL 5 3 7
I .  I I ' l l
E S -6 2  4 3 2  FHH TAGDYMTVLKDGDLEYTTSIFATLGHVIANMDDWGSDPNQPQQLNSKQSTTEK 4 8 7
EEe eeE E E E  e e e e  HHHHHHHeeeee
t
1CX8 5 3 8  DN 5 3 9
E S -6 2  4 8 8  SD 4 8 9
ES-62 aligned with endocellulase from C. cellulolyticum (PDB code: IFCE)
t t  eeHHHHHHHHHHHHHHHHHh hHHHHHHHHHHHHt t t t  hH H H tt
IFCE 4 3  VEAPDYGHVTTSEAMSYYMWLEAMHGRFSGDFTGFDKSWSVTEQYLIPTEKDQPNTSMSR 1 0 2
• • • I # 1 * 1 • • • • •• • • • • • •  • •  j * * » I » * I # * I # • •  * • • •  • •
E S -6 2  2 3  LPDKTVAPKNYIQETFGKEVAELIQYITKGEEVGLAYQWLSKLVDGFGHRMVGSDSLEKS 82
hhhHHHHHHHHHHHHHHHHH HHHHHHHHHHHH e e e e  HHHhh
t t  e e  t t  HHHHHHHH EE
IFCE 1 0 3  YDANKPATYAPEFQDPSKYPSPLDTSQPVGRDPINSQLTSAYGTSMLYGMHWIL------------  1 5 6• I # # 2 •• 2 2 I
E S -6 2  83   lAFLEESLKNDNFDKVHTEEVPNLPH 1 0 8
HHHHHHHHh EE
E t t  t t  EEEE t t  t t  EE EE t t  th h h h E E
IFCE 1 5 7  DVDNWYGFGARADGTSKPSYINTFQRGEQESTWETIPQPCWDEHKFGGQYGFLDLFTKDT 2 1 6
E S -6 2  1 0 9  WVRGNDWEMIEPRNQRLNVLAIGGSE— PASATGEVTVIYDLDDVKPDDVRGKIWTAQ 1 6 6  
E e e  e e e e e  eE E E E e eeE E eE E  e e e e e E E e e
eEEEE hHHHHHHHHhhhh h h h h h h t t t  HHHHH
IFCE 2 1 7  GTPAKQFKYTNAPDADARAVQATYW----------------------------------------ADQWAKEQGKSVSTSVG 2 5 8
E S -6 2  1 6 7  TFAGYPLTLKYRRSVKLFEQLGAIGVLVKSITSFSINSPHTGTGAENTTIPAACLTIEEA 2 2 6  
e  EEEE HHHHHHHH e e e e e e e e e e e e e  hhhhHHHHH
HHHHHHHH t t  e e ttE E E E E  EEEEE eEEE E
IFCE 2 5 9  KATKMGDYLRYSFFDKYFRKIGQPSQAGTGYDAAHYLLSWYYAWGGGIDSTWSWIIGSSH 3 1 8
• • • • • !  • I * *• • •  « * # * * » * I » * * * * I # »
E S -6 2  2 2 7  EMLERLYRSGKK--------------------- IVIRM DM KSHYEEPINSSNLIFEITGSERPSEW ------L 2 7 3
HHHHHHHH EEEEE EEEEEe EEE E
EE h h h h h h h h h  hhhhhHHHHHHHHHHHHHt EEE
IFCE 3 1 9  NHFGYQNPFAAWVLSTDANFKPKSSNGASDWAKSLDRQLEFYQWLQSAEGAIAGGATNSW 3 7 8
E S -6 2  2 7 4  LSAHVDSWD-------------- VGQGALDDGAGCAWWSALHSLKKLAERNPKFKPKRTIRGI------ 3 2 3
E E ee  eeeHHHHHHHHHHHHH eeE E E
t t t t  t t  E E ttE E E e  t t  t t  thhhhhhH H H H hhhhhhh HHHHHHH
IFCE 3 7 9  NGRYEAVPSGTSTFYGMGYVENPVYADPGSNTWFGMQVWSMQRVAELYYKTGDARAKKLL 4 3 8I . # I . 2 . I 2 # # 222 2 * • I 2 2 2 I 2 I 2**2# • 2 |
E S -6 2  3 2 4  FWTSEEQGYGGAKHYYITHKNDSPEKFYFVSETDTGTFKSTÎÏWLAHLSFSGDKKSMLRLK 3 8 3  
e e e  EEeeEEE e e e e e e e  e e  HHHHee e e  hHHHHHHH
HHHHHHHHtt EE t t  EEEeEEEEEE t t t  t t  EEEEEEEe
IFCE 4 3 9  DKWAKWINGEIKFNADGTFQIPSTIDWEGQPDTWNPTQGYTGNANLHVKWNYGTD 4 9 4
2 . . .  I 2 .  . 2     I .  2 .  .  .  .  2 2 I .  2 . 2 2
E S -6 2  3 8 4  EITRLLSRNGIALGLINSSVQGDVTFWAKDGIPSVN— YIPDKAVDYYFYFHHTAG 4 3 7  
HHHHHHHH E E e e e  EEE EEEEEE e  EEEEEEE
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ES-62 aligned with carbon monoxide dehydrogenase from P. 
carboxydovorans (PDB code: 1QJ2)
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Figure 3-13: Alignment of ES-62 with homologous proteins identified on the 
basis of secondary structure by sss align (Sturrock & Dryden, 1997).
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The analysis of the results from sss align suggest that although the secondary 
structure prediction program sss align was able to identity proteins containing 
similar secondary structure elements to those predicted for ES-62, the proteins 
identified did not share similar folds. This is perhaps not unexpected as it is clear 
that even when only a limited number of secondary structure elements are 
present, that the elements may arrange themselves in a multitude of different 
ways.
As discussed in section 3.5.4, the secondary structure of ES-62 was further 
examined by CD spectroscopy. The results obtained from CD are significantly 
different from those generated by the secondary structure prediction programs as 
shown in Table 3-7 below. This suggests either a disappointing failure of the 
secondary structure prediction programs to predict the secondary structure of ES- 
62 or serious inaccuracies in the CD studies. The CD studies were performed at 
two separate laboratories, both studies yielding very similar secondary structure 
content results. If the discrepancy between the CD results and the predicted 
secondary structure is taken to indicate that the predicted secondary structure is 
inaccurate, this finding has serious implications, as the secondary structure 
predictions are the basis for homologous secondary structure searches by 
sss align and for modelling using Plotcorr and DRAGON.
% a-helix % p-sheet % turn % other
CD (Glasgow) 39.4 16.7 16.3 28.1
CD (Daresbury) 48 14 14 26
Predicted by Jpred 26 21 0 53
Table 3-7: Comparison of the experimentally determined secondary 
structure content of ES-62 with the predicted secondary structure content.
The differences in the CD results and the secondary structure predictions could 
possibly be explained by limitations in secondary structure prediction or perhaps 
limited refolding of ES-62 upon tetramerisation (secondary structure prediction 
programs do not take into account quaternary structure information). In addition
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post-translational modifications to the protein (glycosylation and 
phosphoiylcholination) may stabilise secondary structure elements which would 
otherwise not be predicted as being stable (i.e. by JPred). As with the 
phosphorylation, myristylation and amidation sites suggested by the motif 
recognition program Prosite it is impossible to reasonably suggest the effects 
such post-translation modifications may have on either the structure or the way in 
which ES-62 induces its signalling effects without further structural information 
such as high resolution crystallographic data.
Modelling of both ES62 in its entirety and of residues 252-343 of ES-62 
(homologous to residues 74-168 of the leucyl aminopeptidase îm m  Aeromonas 
proteolyticd) was attempted (section 3.5.6). The modelling program DRAGON 
was employed to model both of these structures while SWISS-MODEL was only 
used to model residues 252-343 due to the lack of a suitable homologous model 
for the whole o f ES-62, DRAGON was unable to model the structur e of the 
monomer of ES-62, with multiple iterations of the program producing models 
which, by visual examination, did not appear similar.
In view of the discrepancy between the secondaiy stmcture predictions and the 
CD results discussed above, the failure of DRAGON may be due to inaccuracies 
in the secondary structure information available. In addition, ES-62 exceeds the 
recommended size limit for DRAGON of 300 residues (ES-62 contains 508 
residues). Further, it is possible and perhaps likely, that ES-62 folds as number of 
domains and DRAGON is not able to model multi-domain proteins (Aszodi &
Taylor, 1994a; Aszodi & Taylor, 1994b; Taylor & Aszodi, 1994), The 
quarternary structure of ES-62, atetrameric structure, is also likely to influence 
the tertiary structure of the ES-62 monomers. DRAGON is unable to model the 
tertiary structure of a protein taking into account any quaternary structur al 
influences. In contrast to modelling of the whole monomer, the models obtained 
from multiple iterations of DRAGON for residues 252-343 of ES-62 appear ed to 
be similar to one another. Further, modelling of this region using the homology 
modelling program SWISS-MODEL yielded a model which was similar to those 
produced by DRAGON. Using PSI-Blast the most similar structurally
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determined sequence to ES-62 identified was that of a leucyl aminopeptidase 
from Aeromonas proteolytica. A sequence alignment of this aminopeptidase with 
ES-62 is shown in Figure 3-14.
1 10 20 30 40 50 60 70
ESG2 WLLMSSTFFFLVTLTVVLGflflVLPDKTVflPKNYIOETFGKEVflELIQYITKGEEVGLHYQHLSKLVDGFG
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71 80 90 100 110 120 130 140
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t .... . . . ,d V a q G R ( IG  DaaGcRaVteai*• .rkLaErN.. FqPKRsIagiawa*EEqGirGaqdianqh
351 360 370 380 390 400 410 420
KNDSPEKFYFVSETOTGTFKSTNHLRHLSFSdokKSMLRLKEITRLLSRNGIRLGLINSSVQGDVTFWRK 
KSEGKNVVSRLQLDMTNYKGSRQDWF1T0Y1D ÎNFTQYLTQLMOEYLPSLTYGFDTCGYRCSDHRSUHN 
Kn#gk#kfsaiqeddTnCkgSa #dlahisdsgD cnfnqrLktinrellrngiaggdingsacgOhafMan
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Figure 3-14: Sequence alignment performed using MultAlin of ES-62 with 
the leucyl aminopeptidase from A. proteolytica. Residues involved in metal 
binding in the A. proteolytica structure are boxed. Red residues show high 
homology (90 %), blue residues show low homology (10 %) and black show 
neutral residues. Symbols are as follows: ! is any one of I or V; $ is any one 
of L or M; % is any one of F or Y; # is any one of N, D, Q, E, B or Z.
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In view of the above alignment, the model of this region produced by DRAGON 
was compared with that of the^. proteolytica leucyl aminopeptidase structure. 
The aim in comparing the two structures was to determine if the residues shown 
to be involved in zinc binding in the leucyl aminopeptidase structure and 
conserved in the ES-62 sequence were close together in space in the modelled 
structure. If these conserved residues are similarly spatially arranged this would 
add weight to the suggestion that these residues form a metal binding site in ES- 
62 (it has been postulated that ES-62 contains a metal binding site (Harnett et al., 
1999a)).
(a)
(b)
Figure 3-15: (a) Residues 74-168 of the leucyl aminopeptidase from /I. 
proteolytica structure (pdb code 1 AMP). Residues involved in zinc binding in 
this region are shown as His 97 in cyan. Asp 117 in red and Glu 152 in 
magenta. The two co-ordinated zinc atoms are shown in yellow, (b) Residues 
252-343 of ES-62, homologous to residues 74-168 of the leucyl 
aminopeptidase from A. proteolytica, with the conserved residues His 277 in 
cyan. Asp 287 in red and Glu 336 in magenta. Side chain positions of the 
conserved residues are not shown as they are not modelled by DRAGON.
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Overall the structure shown in Figure 3-15 (b) is similar to that shown in Figure
3-15 (a) in that it comprises a p-sheet region formed from three ^-strands and 
contains two helical regions, although the orientation of the helical regions with 
respect to the p-sheet region is different. Examination and comparison of the 
models shown in Figure 3-15 suggests that the residues involved in binding and 
co-ordinating the zinc atoms in the A. proteolytica leucyl aminopeptidase 
structure, although grouped together in the DRAGON modelled structure, do not 
appear to form a metal binding region. It would appear from the C a trace 
produced by DRAGON that the side chains of His 277 and Glu 336 extend away 
from each other and possibly into solvent. However, this model is only a portion 
of the whole protein and thus may be surrounded by the rest of the ES-62 
structure. Although DRAGON may have successfully modelled the general 
structure of this region of the ES-62 structme which is similar to that of the 
leucyl aminopeptidase from A. proteolytica, it is possible that the actual residue 
positions are not accurately provided by this model. The predicted C a positions 
of the conserved residues may be incorrect, as other residues in the structure may 
influence the folding of this region. As DRAGON modelled the region in 
isolation, it is possible that the lack of information from the remainder of ES-62 
in the folding of this region would lead to inaccuracies in the model shown. In 
addition, a relatively slight movement in the predicted C a positions would cause 
the predicted metal co-ordinating residues to be directed away from the possible 
solvent region.
In order to predict more accurate models of the structure of ES-62 it would be 
preferable to include in the input homologous structures which have greater 
similarity for a larger number of residues present in ES-62. Unfortunately, there 
are no high resolution structures for proteins which share full-length sequence 
homology with ES-62.
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4. Structural Studies on Native ES-62
In addition to the bioinformatics approach to gaining tertiary structural 
information discussed in Chapter 3, two biophysical techniques, analytical 
ultracentrifugation (AUC) and small angle X-ray scattering (SAXS) were 
employed to obtain the low resolution quarternary structure of ES-62. AUC 
provided an accurate value for the molecular weight for ES-62, information 
about its overall shape and information about the self-interaction of the 
monomeric form. SAXS was used to obtain a model of the overall shape of ES- 
62.
AUC experiments were carried out using a Beckman Optima XL-A analytical 
ulti’acentrifuge which measures the distribution of samples under gravitational 
force using absorbance optics. It was thus essential to calculate the extinction 
coefficient for ES-62 and to perform wavelength scans of the protein to 
determine the wavelength at which maximal absorbance occurs. A wavelength 
scan of ES-62 revealed that maximal absorbance occurred at a wavelength of 277 
nm as opposed to 280 mn, which is a typical wavelength for protein maximal 
absorbance. The concentration of the sample of ES-62 was determined via a 
Coomassie protein assay to be 0.437 mg m f \  The absorbance at 277 nm of this 
ES-62 sample was 0.883 in a 1 cm pathlength cell. Using the equation A=ecl, 
where A is the absorbance at 277 nm, e is the extinction coefficient (cm^ mg'^), c 
is the concentration (mg ml'^) and 1 is the pathlength of the spectrophotometer, in 
this case 1 cm, the extinction coefficient for wild type ES-62 was calculated to be 
2 cm^mg"  ^(2.31 x 10  ^cm'* M'*). This is a higher extinction coefficient than 
might normally be expected for a protein and was postulated to be the result of 
phosphorylcholine (PC) moieties attached to several of the carbohydrate chains 
of ES-62 (Harnett etaL, 1994).
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4.1, Analytical Ultracentrifugation (AUC)
Analytical ultracentrifugation is a biophysical technique that is utilised to obtain 
information about the molecular weight, homogeneity, size and shape, molecular 
interactions, changes in conformation and non-ideality of a macromolecule in 
solution. It is a definitive method for the determination of the molecular weight 
o f a protein as it does not require standards of known molecular weights and is 
not complicated by interactions between the protein and a medium such as 
polyacrylamide gel or size exclusion matrix. A brief introduction to AUC is 
given in this chapter, a more detailed description is given by Ralston, (1993) 
which is the source of all the equations defined below.
AUC experiments can be carried out in two modes -  sedimentation equilibrium 
(SE) and sedimentation velocity (SV). SE experiments are carried out at lower 
speeds whereby the molecules reach an equilibrium distribution from which 
information about the molecular mass and any self-interaction that is occurring 
can be obtained. SV experiments are performed at higher speeds and thus the 
molecules eventually sediment entirely to the base of the centrifugal cell. 
Analysis of this sedimentation leads to the determination of the sedimentation 
coefficient of the molecule, which is related to its overall shape. These two 
modes of AUC experimentation are described in more detail in sections 4.1.1 and 
4.1.2. AUC studies exploit the sedimentation of molecules that occui s when they 
are subjected to elevated gravitational force by rotating the sample in a rotor at 
high speed. The molecules in solution are acted upon by three forces that 
influence the behaviour of the molecules. These three forces, shown in Figure
4-1, are the sedimenting or gravitational force, Fs, the buoyant force, Fy and the 
frictional force, Ff.
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Constant velocity m
Figure 4-1: The three forces acting on a solute particle of mass m, moving 
with velocity jx, in a gravitational fîeld. Ff is the frictional force acting on the 
particle, Fb the buoyant force and F® the sedimenting or gravitational force.
Fs (N) is proportional to the mass and acceleration of the particle and is defined 
as;
2 M  2 r , = mù) r = — O) r N Equation 4-1
where m is the mass of a single particle (g), co is angular velocity (radians s‘ )^, r 
is the distance of the molecule from the centre of rotation (cm), M is the molar 
mass of the molecule (g mol'^) and N is Avogadro’s number (6 x 10^  ^mof^).
Fb (N) is related to the weight of fluid displaced by the particle and is defined as;
Equation 4-2
where mo is the mass of fluid displaced by the molecule (g).
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=  m v p  =  p  Equation 4-3
where v is the partial specific volume, the volumetric increment produced in a 
solution when a unit mass of the solute is added (ml g“*) and p is the density of 
the solvent (g mf^). v can be calculated from the amino acid content of the 
protein (Perkins, 1986).
Provided that the density of the solute is greater than that of the solvent the 
particle will sediment. Ff (N) is proportional to the velocity of the particle and is 
defined as;
F f  =  - f p  Equation 4-4
where f  is the frictional coefficient (g s " \  dependent on the size and shape of the 
particle, and p is the constant velocity with which the particle sediments (cm s'^).
These three forces rapidly balance in less than 10'  ^s as the solution reaches 
terminal velocity.
thus Equation 4-5
M  2 M — 2 r r \ ——CO r — ’■ ^-vpco — fu  =  0
N  N
The Svedberg equation results from the equivalence in forces;
J = = - 4 “  Equation 4-6
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where s is the sedimentation coefficient, the velocity of the particle per unit 
gravitational acceleration, which usually lies within the region of 1 -  1 0 0  x 1 0 "^  ^
s. Sedimentation coefficients are therefore usually expressed in Svedberg units,
S, where 1 S = 1 x 10'^  ^s.
4.1.1. Sedimentation Equilibrium Analysis
Investigation of a molecule using SE analysis involves the centrifugation of a 
small volume of sample at lower angular velocities than are required for SV 
experiments. During the experiment the solute sediments, increasing the solute 
concentration at the cell bottom resulting in diffusion of the solute towards to the 
top of the cell, opposing the process of sedimentation. Eventually the two 
processes, sedimentation and diffusion, reach equilibrium and at this point the 
concentration of the solute increases exponentially towards the cell bottom and 
ceases to alter with time. For a single, ideal, non-associating species the mass of 
the solute can be deteimined using Equation 4-7.
= Equation 4-7
where R is the gas constant (8.314 x 10  ^erg K"^  m o f \  T is the absolute 
temperatuie (K) and c is the concentration of the solute (g L'^). The slope of a 
plot of Inc against r  ^is proportional to the mass of the solute.
SE analysis using the absorbance optics of the Optima XL-A ultracenti’ifuge 
involves the direct use of the equilibrium distribution trace of the absorbing 
species for determination of experimental results. As a result o f this the 
absorbance data collected for the samples must be corrected for background 
absorption. This is achieved by centrifugation of the sample at speeds of greater 
than 40, 000 rpm, following attainment of equilibrium, to sediment the sample in 
its entirety to the base of the centrifugal cell. Any remaining absorbance is due to 
absorbing species other than the molecule under study. This absorbance value is
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subtracted from the equilibrium trace obtained for the molecule under 
investigation.
4.1. i .  i .  Data Analysis
Data obtained from SE experiments on ES-62 were analysed to obtain the 
apparent whole-cell weight-average molecular mass (Mw, app) and to examine the 
self-interaction of ES-62 implied by the observed elevated value of app above 
the known monomer molecular mass. The ASS0C4 model programmed within 
the ORIGIN curve fitting software supplied with the Optima XL-A was used to 
carry out these analyses. Mw, app was obtained by fitting the primary data with 
Equation 4-8 which describes the equilibrium distribution of a single 
thermodynamically ideal macromolecular solute.
= A  exp[^//.M(r^ -  r^ )^j + E  Equation 4-8
where Ar is the absorbance at radial position r and Ao is the absorbance at a 
reference point ro (cm); H is the constant co^(l-vp)/2RT and E is the optical 
baseline offset (obtained by overspeeding of the rotor).
This model is a subset of a broader model (Equation 4-9) which was used to 
analyse the self-interaction of ES-62. Equation 4-9 describes a self-associating 
system defined by up to thiee association constants (Kai, Ka3, Ka4 in units of 
(absorbance)'^"'^^) for oligomers composed of 112, 0 3 , 114 monomers (Kim et aL,
1977);
Aj. = exp[ln A^  + ~^o)\
+ expj «2 In Aj, + In Ka2 + «2- 7/.M(r^ “
Equation 4-9
+ exn % In A  +hi Ka^ + -  r^)\
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The accuracy of the model and the presence of non-ideality or aggregation in the 
sample under study can be assessed by the scatter of the residuals from the fitting 
of a model to the experimental data. A random distribution of points about the 
zero value indicates a good fit. The distribution of the residuals in a tick like 
pattern is indicative of aggregation in the sample while the distribution of the 
residuals in an arch pattern is indicative of non-ideality in the sample. The plot of 
Mw, app against concentration can also yield infoimation on self-association or 
non-ideality present in the system. A single ideal species is present if the 
molecular weight remains constant with changing concentration. A decrease in 
molecular weight following increasing concentration is indicative of non-ideality 
while an increase in molecular weight following increasing concentration is 
indicative of self-association (McRorie & Voelker, 1993).
4.1.2. Sedimentation Velocity Experimentation
In SV experiments the solute is placed within the cell and subjected to a high 
angular velocity which causes the rapid sedimentation of the solute to the cell 
bottom resulting in a depletion of solute at the meniscus. This results in a sharp 
boundary forming between the depleted meniscus and the sedimenting solute.
Monitoring of the movement of this boundary, in particular the rate of movement 
of the midpoint, rbnd, leads to the deteimination of the sedimentation coefficient, 
s, which is directly dependent on the mass of the particles and inversely on the 
frictional coefficient, s is defined as
j: s  —^  Equation 4-10(O r 0) r
where t is time (s).
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4.1,2,L Data Analysis
The program SEDFIT (Schuck & Demeler, 1999) was used to obtain 
sedimentation coefficients from the SV experimental data for ES-62. These 
sedimentation coefficients (st,b) are for ES-62 in PBS pH 7.4 at 4 °C.
Sedimentation coefficients are influenced by the density and viscosity of the 
buffer and thus in order to allow comparison of sedimentation coefficients from 
samples in different buffers at different temperatures, sedimentation coefficients 
are always converted (using Equation 4-11) to those that would be measured in 
water at 20 °C.
S20.W = ST,b Equation 4-11( l - v p ) T ' é  V20,w
The subscripts 2o,w and T,b refer to water at 20 °C and buffer at T °C respectively.
4.1.3. The Analytical Ultracentrifuge
A Beckman Optima XL-A AUC (Palo Alto, California) was employed for the 
studies described in this thesis. This centrifuge employs absorbance optics to 
measure the concentration distribution of the molecules within the centrifugal 
cell. This method of detection has increased sensitivity over other detection 
methods, such as schlieren and Rayleigh interference optics, and exhibits high 
reproducibility, the ability to scan at a wide range of wavelengths and the ability 
to perform baseline scans. Wavelengths from 190 to 800 nm can be employed 
and are emitted from a xenon flash lamp as the selected sector of the rotor passes 
between the light source and the detector (situated under the floor of the 
centrifugal chamber). A schematic diagram of this optical system is shown in 
Figure 4-3 while Figure 4-2 shows a typical plot of absorbance against radius 
obtained from the AUC. The rotor used for the AUC studies was a four hole 
An60Ti rotor. This rotor is capable of rotating of speeds up to 60k rpm (60, 000 
rpm) and is spun in a vacuum to minimise aerodynamic turbulence and frictional 
heating. It can accommodate three sample cells and one counterbalance reference 
cell required for the calibration of radial distance.
.
■
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AUC cells are typically constructed of a centrepiece made of reinforced epoxy or 
aluminium alloy sandwiched between two thick windows of optical grade quartz 
or sapphire all contained within an aluminium cell housing as shown in Figure 
4-4. The centrepiece consists of two or six sector shaped compartments in which 
the samples and reference buffers are placed. Schematic diagrams of these 
centrepieces can be seen in Figure 4-5. The compartments are sector shaped to 
avoid the convective disturbance which would result from sedimenting particles 
colliding with the walls of the compartments were they parallel. In SE 
experiments the column length, the distance from the meniscus to the cell base, is 
typically 1 - 3  mm, while in SV experiments the column length is typically 12 
mm. The differences in column length are due to the time taken to reach 
equilibrium; equilibrium is reached more rapidly in shorter columns as can be 
seen from Equation 4-12 (van Holde & Baldwin, 1958).
I = — Equat i on 4-12
where to.i is the time taken to reach equilibrium to within 0 .1%, ry -im is the 
column height, the distance fr om the meniscus to the base of the AUC cell (cm) 
and the diffusion constant D (cm^s'^) is -  2.7 xMO‘V(M "”)^ ^^ .
In SV experiments, equilibrium is not the aim thus time is not a constraining 
factor. In SV experiments the sample is sedimented to the cell base and this 
sedimentation monitored. A longer column length allows for the monitoring of 
sedimentation over a longer time period and hence greater acciuacy in the 
analysis of the experimental data.
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Figure 4-2: A typical plot of absorbance against radius obtained from 
measurement of distribution of molecules within an AUC cell (taken from 
Ralston, (1993)).
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Figure 4-3: Schematic diagram of the optical system of the Beckman Optima 
XL A analytical ultraeentrifuge (taken from Ralston, (1993)).
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Figure 4-4: Exploded view of an analytical ultracentrifugation cell, taken 
from the XLA manual (Beckman Instruments, 1992).
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Figure 4-5: Cross-sections of two and six channel centrepieces. Two channel 
centrepieces can be used for SE or SV runs, the volume of the sample and 
buffer used varies depending on the type of run. Six channel centrepieces 
are generally used only for SE runs.
4.1.4. Analytical Ultracentrifugation of ES-62
For SE experiments, six channel centrepieces were employed. Cells were 
assembled as shown in Figure 4-4 and tightened to 120 lb inch'^. The gaskets and 
screws were then inserted to fasten the lower window assembly and centrepiece 
into position allowing the cell to be loosened and the top window to be removed. 
80 pi of sample was then loaded into the right-hand wells and 90 pi of buffer into 
the left-hand wells as shown in Figure 4-5. The top window was then replaced
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and the whole ceil retightened to 120 lb inch'^. Nine samples of wild type ES-62 
in PBS pH 7.4 at concentrations of between 0.9 and 5.2 pM were loaded into six- 
channel Yphantis-type centrepieces (Yphantis, 1964) in this manner. The cells 
were then balanced to within 0.1 g and placed into the rotor. The cells were next 
aligned carefully to ensure that the widest part of the sample/buffer segment was 
furthest from the centre of the rotor and that the walls of the segment followed a 
radial path. The rotor was placed into the AUC and the monochromator locked 
into place. An initial run at a rotor speed of 3 k rpm was performed to check for 
leaks or cracked windows. The rotor speed was then increased to an appropriate 
speed for the sample being analysed and radial scans set up. The rotor speed 
chosen for SE experiments depends on the molecular weight of the sample. The 
graph shown in Figure 4-6 was used to select the speeds at which the sample 
should be spun. For ES-62 the estimated molecular weight is 57.8 kDa for the 
monomer and 231.2 kDa (4 x 57.8 kDa) for the tetramer thus the samples were 
spun at both 8  and 10 k rpm. The experiments were performed at 4 °C. The optics 
were programmed to scan from 5.8 to 7.2 cm with a step size of 0.001 cm and 10 
averages. Equilibrium was seen to be established when a perfect overlay of two 
scans acquired three hours apart was achieved. Once equilibrium was established 
at the various appropriate speeds and the data collected, the rotor was oversped to 
40 k rpm to sediment all the sample to the base of the cell and thus allow 
measurement of the optical baseline. This measurement allows any window 
imperfections or optical abnormalities to be taken into account during data 
analysis.
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Figure 4-6: Optimum speeds for SE runs can be estimated if either the 
molecular weight or sedimentation coefficient is known (taken from 
McRorie & Voelker, (1993)).
For SV experiments double sector cells were used. It is not possible to use six 
channel cells for SV experiments, as the volume that they hold is too small to 
allow good traces to be obtained. The double sector cells were assembled as 
shown in Figure 4-4 and tightened to 120 lb inch'^. 360 \i\ of sample was loaded 
into the right-hand chamber and 380 \i\ of buffer into the left-hand chamber 
through the two holes in the housing and centrepiece using a Hamilton (Reno, 
Nevada) syringe. The holes were then covered with gaskets and screws. Samples 
of wild type ES-62 in PBS (5.5 mM potassium chloride, 145 mM sodium 
chloride, 8  mM disodium hydrogen orthophosphate, 1.5 mM sodium dihydrogen 
orthophosphate) pH 7.4 at four concentrations between 1.7 and 6.9 piM were 
loaded into the double sector centrepieces. The cells were then balanced, inserted
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into the rotor and the rotor and monochi'omator placed into the ultraeentrifuge as 
described above. Experiments were performed at 4 °C. An initial scan was 
carried out at a rotor speed of 3 k rpm to check for leaks or cracked windows and 
then the rotor speed increased to 30 k rpm and scans programmed. Scans of the 
solute distribution were acquired for radial positions from 6.0 to 7.2 cm at a step 
size of 0.002 cm with 1 average. The scans were performed eveiy 15 minutes 
until 32 scans had been collected.
The partial specific volume of ES-62 (0.73 ml g'^) was calculated from the partial 
specific volumes of the constituent amino acids and carbohydrates (Perkins,
1986) using the program VBAR (Cohn & Edsall, 1943; Perkins, 1986) and the 
buffer density at 4 was calculated using the program SEDNTERP (Lane et ah,
1992).
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4.1.5. Results and Discussion 
4. L 5. i .  Sedimentation Equilibrium
SE data for ES-62 were analysed using the ASS0C4 model as described in 
section 4.1.1.1. Fitting of the primary data with Equation 4-8 gave good fits for 
all the samples as can be seen in Figure 4-7. The Mw, app values obtained are 
plotted in Figure 4-8 as a function of concentration at both 8  and 10 k rpm.
These data show that the mass measured greatly exceeds the monomeric mass of 
ES-62 (57.8 kDa, calculated from the known amino acid, carbohydrate and 
phosphorylcholine content) and is close to the calculated tetrameric mass of ES- 
62 (231.2 kDa). This increased mass indicates the presence of oligomers or high 
molecular weight aggregates. Mw, app does not change significantly with the 
change in rotor speed and in particular does not decrease at higher rotor speeds 
which would indicate the presence of aggregate. This indicates that the increase 
in mass, above that of monomer, is due to self-association.
In order to ascertain the stoichometry and strength of this interaction, tlie data 
were fitted with Equation 4-9. Fits were attempted with two plausible models; 
monomer-tetramer and dimer-tetramer. In the dimer-tetramer model, the 
association constant, Ka2-4, was fitted by setting the monomeric mass at twice the 
actual monomer mass (i.e. dimer mass) and then fitting a monomer-dimer model 
to the data. The fits obtained for each data set are shown in Figure 4-9. The 
monomer-tetramer model and dimer-tetramer model both gave good fits to the 
data. This indicates that tlie majority of the ES-62 sample is tetrameric with only 
a very small proportion of monomer or dimer. As the amount of monomer or 
dimer is minute it is very difficult to determine in which of these two states it 
exists. It would perhaps be possible to determine the state of this small 
proportion of ES-62 by carrying out a number of SE experiments with 
increasingly dilute samples but as the concentration decreases the data become 
increasingly difficult to analyse due to the small differential between the sample 
absorbance and the background absorbance.
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Figure 4-7: SE data for ES-62 fitted with Equation 4-7 (describing a single 
thermodynamically ideal species), (a) fits obtained for the 8 k rpm data; (b) fits 
obtained for the 10 k rpm data. The blue circles show the data points while the 
red line shows the model fitted. The residuals of the fit are shown above the raw 
fitted data.
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Figure 4-8: Apparent whole-cell weight-average molecular weight (Mw, app) 
plotted as a function of ES-62 monomer loading concentration from 
sedimentation equilibria obtained at rotor speeds of 8 k rpm (# )  and 10 k 
rpm (O). Arrows annotated m; d and t indicate the molecular weights of ES 
62 monomer, dimer and tetramer respectively. The errors marked are 
generated by the curve fitting software Origin and represent the 95 % 
confidence limits for each value determined.
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Figure 4-9 (a) Fits of the (i) dimer-tetramer and (ii) monomer-tetramer model to 
the 8 k rpm SE primary data. The blue circles show the data points while the red 
line shows the model fitted. The residuals of the fit are shown above the raw 
fitted data.
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Figure 4-9 (b): Fits of the (iii) dimer-tetramer and (iv) monomer-tetramer model 
to the 10 krpm SE primary data. The blue circles show the data points and the 
red line shows the model fitted. The residuals of the fit are shown above the raw 
fitted data.
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The Ka values obtained from the fits to each of the sedimentation equilibrium 
data sets were converted first to units of and then to dissociation constant 
(Kd) values. The conversion to units was achieved using Equation 4-13;
~  Equation 4-13
where Kacu is the association constant in units of Kuau is the association
constant in units of absorbance"\ £ is the extinction coefficient (cm"  ^M" )^ and 1 is 
the pathlength of the AUC cell centrepiece (1.2 cm).
The conversion to dissociation constants was achieved using Equation 4-14 
where Kd is the dissociation constant
Kd = —-— Equation 4-14
The Kd values determined at both 8  k and 10k rpm are plotted as a function of 
concentration in Figure 4-10, The infinite dilution dissociation constant of 50 nM 
for the dimer-tetramer model and 0.04 iiM^ for the monomer-tetramer model 
indicates a strong association between ES-62 molecules to foim tetramers. Thus, 
at concentrations used in all biophysical studies, the majority of ES-62 is 
tetrameric. This result supports earlier gel filtration studies on wild type ES-62 
(Harnett et ahy 1993) which suggested that ES-62 is tetiameric. The modelling of 
ES-62 as a mainly tetrameric system is of further interest as ES-62 has been 
shown to possess aminopeptidase activity (Harnett et n/., 1999a) and the 
biologically active foims of many aminopeptidases are dimeric or tetrameric 
(Acosta er a/., 1998; Taylor, 1993).
Figure 4-10: Dissociation constant (Kd) obtained from fitting (a) a dimer- 
tetramer model and (b) a monomer-tetramer model to each of the SE primary 
data sets plotted as a function of ES-62 monomer loading concentration and 
rotor speed (8 k rpm ( • ) ;  10 k rpm (O)) The errors marked are generated by 
the curve fitting software Origin and represent the 95 % confidence limits for 
each value determined.
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Figure 4-10: Dissociation constant (Kd) obtained from fitting (a) a dimer- 
tetramer model and (b) a monomer-tetramer model.
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4.1.5.2. Sedimentation Velocity
SV data for ES-62 were analysed using the program SEDFIT. The sedimentation 
coefficients generated from the data were converted to those that would be 
measured in water at 20 °C as described in section 4.1.2.1. Converted 
sedimentation coefficients of approximately 10 S were obtained for each of the 
ES-62 samples. These sedimentation coefficients are plotted as a function of 
concentration in Figure 4-11. The infinite dilution sedimentation coefficient 
obtained by extrapolation of these data to zero concentration is 9.85 S.
I-(/3
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ES-62 monomer loading concentration (pM)
Figure 4-11: Sedimentation coefficient as a function of ES-62 monomer 
loading concentration.
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The most compact shape for a particle is a sphere. A sphere with the same mass 
as monomeric ES-62, hydrated with 0.4 g water / g protein (a typical protein 
hydration (Squire & Himmel, 1979)) would have a sedimentation coefficient of 
4.6 S, while a sphere with the same mass as tetrameric ES-62, similarly hydrated, 
would have a sedimentation coefficient of 11.7 S. The experimental 
sedimentation coefficient obtained is larger than that predicted for the spherical 
hydrated monomer and smaller than that calculated for the spherical hydrated 
tetramer. This confirms that ES-62 is likely to be a tetramer and suggests that it is 
either noimally hydrated and slightly elongated in shape or highly hydrated and 
almost spherical.
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4.2. Small Angle X-Ray Scattering
Small angle X-ray scattering (S AXS) of a protein in solution allows information 
about the elongation and shape of the protein to be obtained. This information 
can be used to generate a stmctural model of the protein. A more recent 
development, in the form of three computer programs, allows ab initio low 
resolution structure determination of the protein. This development is important 
as a homologous structure is no longer essential in order to obtain a structural 
model of the protein of interest. The information gained from these programs 
could also be used to solve the phase problem if X-ray crystallography was 
employed to generate a high resolution structure. The benefit of using SAXS, ■.rr-'
where the protein is in solution, is that the structur al information obtained is for 
the protein in its native state rather than in a crystal. However, the resolution of 
the structural information is an order of magnitude less than that obtained from 
X-ray crystallography.
X-rays or neutrons are employed in small angle scattering. In this PhD only 
SAXS was carried out. X-rays are used for small angle scattering experiments as 
they have a wavelength of 0.15 nm which is smaller than the size of an atom. 
Scattering occurs in two forms; elastic and inelastic. In SAXS it is only elastic 
scattering that is measured. In a SAXS experiment a beam of X-rays is scattered 
from a protein solution. The elections in the atoms that make up the proteins 
absorb the energy provided by the X-rays and then re-emit the same amount of 
energy in a different direction. The scattering event involves interference from 
waves of energy emanating from 2 separate points. Elastic scattering, where the 
energy is unchanged, occurs in two forms; intramolecular i.e. where interference 
arises due to waves of energy emanating fr om 2  points within the particle and 
intermolecular i.e. where interference arises due to waves of energy emanating 
from 2 points within different paificles. In order to obtain structural information 
about a molecule it is only intramolecular scattering that is important. In 
intramolecular scattering interference can occur between X-rays emerging from 
atoms close together or far apart within the particle. The interference arising 
fr om atoms far apart in the molecule gives information about the elongation of
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the molecule while that arising from atoms close together provides information 
about the shape of the molecule. As the protein molecules are in solution they are 
subject to Brownian motion and thus adopt all possible orientations, unlike the 
case for crystallography where all the molecules are in the same orientation.
Thus the stmctural information obtained from SAXS is an average of all possible 
orientations.
The flexible carbohydrate chains on ES-62 coupled to restrictions on the amount 
of wild type ES-62 available meant that the determination of a high resolution 
structure for ES-62 by X-ray crystallography would be a difficult task. SAXS 
was employed as it was a method by which stmctural information pertaining to 
ES-62 could be obtained which would be physiological due to the sample being 
in solution rather than as a crystal. New developments have also led to ab initio 
low resolution structuie determination from small angle scattering data provided 
the data are of sufficiently high quality. The structure determination programmes 
that form the basis for this new technology are continually being developed 
increasing the accuracy and resolution of the models obtained.
4.2.1. Scattering Theory
A number of reviews have been published describing the theory behind SAXS 
(Perkins, 1988a; Perkins, 1988b). This section gives only a brief overview of the 
theory; all equations quoted were obtained from Perkins (1988a) and Perkins 
(1988b) or the references cited therein.
In SAXS the intensity of the scattering curve of a molecule is measured as a 
function of the scattering angle or the scattering vector, Q. The information 
gathered at small Q values, from atoms far apart in the molecules, leads to the 
determination of the radius of gyration (Rg, a measure of macromolecular 
elongation) while that collected at large Q values, from atoms close together in 
the molecule, gives more detailed shape information. A typical solution 
scattering curve is shown in Figure 4-12.
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Figure 4-12: A typical solution scattering curve. The Guiner region shows 
data obtained from scattering arising from interference between atoms far 
apart in the particle while the wide angle region shows data obtained from 
scattering arising from interference between atoms close together in the 
particle. [Image taken from Perkins (1988a)].
The relationship between the wavelength of radiation (X, nm), the separation of 
the scattering entities (d, nm) and the angle of diffraction (0) is defined by 
Bragg’s law;
A = 2dsm d Equation 4-15
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The scattering vector, Q, is often used in place of the scattering angle. Q is 
defined as
Q = 4:rsin d IÀ Equation 4-16
The resolution of the data collected is 2jt/Qmax where Qmax is the largest 
scattering vector (smallest atomic distance) measured.
.
The two important elements of solution scattering are the scattering properties of 
the molecule being studied and the spatial orientation of individual elements that 
scatter within the molecule. When the scattering angle, 20 (some X-ray workers 
replace 20 with Q where 20 = QÀ/2jt assuming sin 20 = 20) is zero the intensity 
is at a maximum and is a direct measure o f molecular mass. Wlien 20 (or Q) is 
not equal to zero the scattering intensity is described by the Debye equation:
sin(rj2)
p q
m )  =  2  2  fp fq  — ^  Equation 4-17
where fp and fq are the scattering lengths of the electrons at points P and Q in the 
molecule and r conesponds to the distance between P and Q.
The scattering density, p(r), is the probability that two scattering elements ai'e 
separated by a distance r in the particle and is employed by the SAS data analysis 
program GNOM (Semenyuk & Svergun, 1991). The value for p(r) is plotted as a 
function of r showing the probability distribution of the distances between 
scattering elements within a particle. This allows the determination of a value for 
Dmax, the maximum dimension within a molecule.
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4.2.2. Synchotron Radiation
Synchrotron radiation is released when high energy electrons are accelerated.
The energy released by the electrons covers the whole spectral range from 
microwaves to hard X-rays (1-100 keV). Monochromators, which allow the 
selection of a particular energy range, are employed to obtain an X-ray source. A 
diagrammatic representation of a synchrotron source is shown in Figure 4-13. In 
order to alter the direction of the high energy electrons, and thus cause 
acceleration, strong magnets are employed that deflect the electron beam such 
that it maintains an orbit within the synchrotron ring.
Magnets
Electrons
travelling-----
at 98 % of the
speed of light Beam line
Linear
Accelerator Synchrotron
Radiation
X-raysElectrons
Figure 4-13: Diagrammatic representation of a synchrotron radiation
source.
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4.2.3. Detector and Camera
The detector used for the SAXS experiments was a quadrant multiwire 
proportional chamber with delay line readout. A diagrammatic representation of 
the camera setup is shown in Figure 4-14. Camera lengths of 3.4 and 1.9 m were 
used.
Camera (in vacuum)
can be lengthened or shortened
Sample
X-rays
Detector (quadrant)
Figure 4-14: Diagrammatic representation of the camera setup for SAXS 
experimentation.
4.2.4. Data Analysis
SAXS data were collected at EMBL station X33 on the storage ring DORIS III 
of the Deutsches Elektronen Synchrotron (DESY) for samples of ES-62 in PBS 
(5.5 mM potassium chloride, 145 mM sodium chloride, 8 mM disodium 
hydrogen orthophosphate, 1.5 mM sodium dihydrogen orthophosphate) pH 7.4 at 
concentrations of between 8.00 and 0.25 mg ml'. The reference solvent was PBS 
pH 7.4. The sample-detector distances were 3.4 and 1.9 m, covering the ranges of 
momentum transfer of 0.13 nm*' < s < 2.0 nm*' and 0.5 nm*' < s < 3.7 nm*', 
respectively (s = Q/2jt = 1/d).
The data were normalised to the intensity of the incident beam, corrected for the 
detector response, the scattering of the buffer was subtracted and the difference 
curves scaled for concentration. All procedures involved statistical error
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propagation using the program SAPOKO (Svergun & Koch, unpublished). The 
data collected at the two camera lengths were merged to yield the final composite 
scattering curve.
The maximum dimension o f the particle in solution, Dmax, was estimated using 
the orthogonal expansion program ORTOGNOM (Svergun, 1993). The forward 
scattering intensity at zero angle 1(0), distance distribution function p(r) and the 
radius of gyration Rg were evaluated with GNOM (Semenyuk & Svergun, 1991).
For the computation of the Forod (Porod, 1982) volume, Vp, a constant was 
subtracted from the experimental data to ensure that the intensity decayed as a 
function of s'"^  following Porod’s law for homogeneous particles. This procedure 
diminishes the scattering contribution due to the internal particle structure and 
yields an approximation of the “shape scattering” curve (i.e. scattering from the 
excluded volume of the particle filled by constant density).
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4.2.5. Results and Discussion
The scattering curve obtained from merging the data from both long and short 
camera lengths is shown in Figure 4-15. The SAXS data were analysed as 
described above and the Rg of ES-62 at infinite dilution determined to be 4.25 
nm. The Rg values for ES-62 are plotted as a function of concentration in Figure
4-16.
4 . 0 0
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Figure 4-15: Scattering curve for the merged data collected at camera 
lengths of 3.4 and 1.9 m.
Chapter 4: Structural Studies on Native ES-62 168
5.00
4.75
4.50
4.25
4.00
3.75
3.50 10.008.006.004.00
Concentration (mg ml**)
2.000.00
Figure 4-16: Radius of gyration (Rg) of ES-62 as a function of concentration.
Rg characterises the degree of elongation of the molecule under study. 
Determination of Rg at infinite dilution allows an absolute measure of the 
external shape of the macromolecule, free from density fluctuations, to be 
obtained. As discussed previously in section 4.1.5.2, the most compact shape for 
a particle is a sphere. The radius of gyration (Rg) of a sphere with the same 
molecular mass as tetrameric ES-62 was calculated to be 3.1 nm using both 
equations 4-18 and 4-19 from Perkins (1988b) and also Figure 12 of Perkins 
(1988b).
Rg^ Equation 4-18
where the radius of a sphere with a molecular mass of 231.2 k Da and a partial 
specific volume of 0.73 ml g'* was determined to be 4.05 nm.
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For a spherical protein with partial specific volume of 0.73 ml g"*, the Rg at 
infinite dilution is related to Mr (Perkins, 1988b).
1= 0.051466Mr” Equation 4-19
where Ro is the radius of gyration at infinite dilution.
These calculations show, by comparison with the experimentally derived Rg for 
ES-62 of 4.25 nm at infinite dilution, that ES-62 is elongated. This further 
substantiates the findings from SV studies which show that ES-62 is tetrameric 
and elongated in nature (section 4.1.5.2).
The SAXS data collected at both camera lengths were of sufficiently liigh quality 
to allow the ab initio determination of the low resolution structur e of ES-62 
using the programme DAMMIN (Svergun, 1999) as described in section 4.3.2.
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4,3. Structural Modelling
The determination of low resolution structures of proteins from small angle 
scattering data is a relatively new development. Two programs,were used in this 
PhD project to attempt to determine the low resolution structure of ES-62. These 
programmes, DALAI and DAMMIN, employ different techniques in order to 
determine the low resolution structure. DALAI uses a genetic algorithm to 
generate a low resolution model with a scattering curve identical to the 
experimental scattering curve, while DAMMIN employs simulated amiealing to 
achieve the same end goal.
4.3.1. DALAI
DALAI (Chacon et ah, 2000; Chacon et aL, 1998) employs a genetic algorithm 
to obtain a low resolution structure from solution scattering data. Figure 4-17 
shows a diagrammatic overview of the methodology behind DALAI. The 
program works by generating an initial sphere-filled search space, based on the 
experimentally determined Dmax, which encloses the macromolecule of interest. 
Each sphere within the search space can be designated as either particle (1) or 
solvent (0). An initial random population of possible combinations of spheres 
designated as particle or solvent is then generated. Each of the population 
elements are known as chromosomes. Following generation of the initial 
population, the chromosomes are decoded from binary array (1 or 0) into spatial 
co-ordinates and the scattering curve of each calculated and compared to the 
target scattering curve. A fitness value is then assigned to each chromosome 
based on the similarity of its scattering curve to the target scattering curve. Those 
chromosomes assigned higher fitness values have a greater probability of 
reproducing through mutation and crossovers. This process o f generating new 
chromosomes, comparing their scattering curves to the target and assigning 
fitness values continues until convergence is reached where the maximum fitness 
value no longer improves.
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Figure 4-17: Diagrammatic overview of DALAI, reproduced from Chacon et 
al. (1998).
DALAI was used to restore a structure from the merged small angle scattering 
data collected for ES-62 at two camera lengths. Unfortunately, despite assistance 
from the authors of DALAI, the low resolution structure of ES-62 could not be 
determined using this program as the program repeatedly failed to converge 
despite being left to run for weeks at a time.
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4.3.2. DAMM IN
DAMMIN (Svergun, 1999) employs simulated annealing to achieve ab initio low 
resolution shape restoration from solution scattering data. A volume is defined, 
based on D,nax, which encloses the particle and is filled with dummy atoms. Each 
dummy atom is randomly assigned as solvent or particle by the program and the 
scattering cuiwe for the model calculated. The assignation of solvent or particle 
for one randomly chosen dummy atom is then changed and the scattering curve 
for this new model generated and compared to the previous scattering curve. If 
the energy has decreased then the dummy atom change is unconditionally 
accepted, however if the energy has increased then the dummy atom change is 
conditionally accepted with a probability rating. This process is repeated until 
convergence is reached and the energy level stabilises. As this method accepts 
both models with decreased and increased energy through use of a probability 
rating, it allows local minima to be overcome and thus a ti'ue global minimum 
can be attained.
The low resolution shape o f ES-62 was determined ab initio from the SAXS 
curve using the method described by Svergun (1999). A sphere of diameter Dmax 
(determined from the small angle scattering data using GNOM) was filled with 
densely packed small spheres (dummy atoms) of radius i*o «  Dmax- Each dummy 
atom was then assigned as either solvent (0) or solute (1) by the program. The 
scattering intensity (I(s)) from the dummy atom model (DAM) was computed as 
described by Svergun (1999). As solution scattering data aie of low resolution,
DAMMIN searches for a configuration which minimises the fimction f(X) = +
aP(X). is the discrepancy and is defined as follows;
2  Equation 4-20N
where N is the number of experimental points, I(s) is the calculated intensity, 
lex p (s )  is the experimental shape scattering intensity and a(s) denotes the standard 
deviation.
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P(X) is a penalty term which, when taken with a positive weight a  > 0, ensures 
that the DAM has a low resolution with respect to the packing radius ro. The 
minimisation is performed starting from a random configuration using the 
simulated annealing method (Kirkpatrick et ah, 1983). DAMMIN (Svergun,
2000) allows information regarding the point symmetry of the molecule being 
modelled to be taken into account. This can increase the accuracy of the model 
and test the robustness of this modelling method by comparing models obtained 
when appropriate but different point symmetiy conditions are imposed.
The maximum dimension (D^ax) and radius of gyration (Rg) for ES-62 were 
determined from the small angle scattering curve by GNOM to be 13.0 ± 1 nm 
and 4.08 ± 0.03 nm respectively while the Porod volume was calculated to be 
400 ± 20 nm^. The volume of tetrameric ES-62, calculated from its mass and 
partial specific volume, is 280 nm^. From these values it can be calculated that 
the DAM contains 120 nm^ of bound water. The hydration of the model of 
tetrameric ES-62 can thus be estimated. The mass of each ES-62 tetramer is 3.84 
X 10"^  ^g and the weight o f the bound water is 1.20 x 10"^  ^g representing a 
hydration level of approximately 0.31 g water / g protein.
The low resolution shape of ES-62 was determined using DAMMIN under three 
symmetry conditions; either no symmetry (PI), 2 point (P2) symmetry or 222 
point (P222) symmetry was imposed. Several restorations were performed at 
packing radii of ro = 0.4 to 0.5 nm for each of these thr ee conditions and the 
models overlaid to confirm that reproducible results were being obtained for each 
of the thi'ee conditions. The fits to the experimental data when PI, P2 or P222 
symmetry was imposed are shown in Figure 4-18. The calculated scattering 
curve neatly fits the shape scattering pattern and at high angles goes below the 
initial experimental data. This kind of fit is not unexpected as the outer (high 
angle) portion of the experimental scattering pattern contains contributions from 
the internal structure of the molecule which is not modelled by DAMMIN.
Figure 4-19 shows typical models obtained for the low resolution structure of 
ES-62 when either no symmetry, P2 or P222 symmetry is imposed. The greatest 
amount of information regarding the structure of ES-62 can be obtained from the
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model where P222 symmetiy was imposed, Figure 4-19 shows that ES-62 in this 
model appears to consist of 2 dimers tilted by approximately 30 ° with respect to 
the long axis of the particle. Models obtained when PI or P2 symmetry was 
imposed were similar in overall shape to the model obtained when P222 
symmetiy was imposed. Imposing P222 symmetry simply led to a much clearer 
visualisation of the aiTangement o f the dimers in the tetramer.
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Figure 4-18: Composite scattering patterns from ES-62 ( • ) ,  shape 
scattering curve (O) and the scattering from the ab initio restored model (-) 
imposing point symmetries of (a) PI, (b) P2 or (c) P222.
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Figure 4-19: Orthogonal views (top to bottom) of the low resolution dummy 
atom model of ES-62 imposing point symmetries of (left to right) PI, P2 or 
P222. The pdb files for these 3 models are on the CD included as part of this 
thesis along with viewing instructions.
The models obtained for the low resolution structure of ES-62 have a resolution 
of 19.7 Â. This is an order of magnitude lower than the resolution of typical X- 
ray crystallography structures but contains much more information that the Rg, 
the only information obtainable from SAXS before the development of ab initio 
structural determination programs. The resolution of models generated by 
DAMMIN is defined by (Qmax/2ji)'\
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The sedimentation coefficient determined from AUC studies is a valuable tool in 
the assessment of the model obtained for ES-62. The program HYDRO (Garcia 
de la Tone et aL, 1994) was used to determine the sedimentation coefficients of 
the models shown in Figure 4-19. HYDRO requires bead models in a particular 
format as input thus the first step was to determine the radius of the beads in the 
ab initio models. The radius of the beads for each model was determined from 
the protein mass and partial specific volume and the number of beads in that 
model. HYDRO input files were then constimcted using the calculated radius and 
the information in the pdb file generated by DAMMIN for each model. A 
sedimentation coefficient value of 10.0 S was calculated for all the models.
Hydration of the model, by the amount estimated from the DAM data, 0.31 g 
water / g protein, results in a decrease of this value to 8.9 S, which is smaller than 
the value of 9.85 S obtained firom AUC studies of ES-62. However, the 
theoretical hydrated sedimentation coefficient is obtained by uniform expansion 
of the structural model which often leads to “over-hydration” with a 
consequently exaggerated lowering of the sedimentation coefficient. Thus it 
would appear that this low resolution model of ES-62 is substantiated by 
experimental data obtained from AUC studies and is therefore highly likely to be 
a good model for the 3-dimensional structure of wild type ES-62,
In conclusion, the use of AUC and SAXS has lead to the discovery of some 
structural information about ES-62 including the ab initio determination of its 
low resolution structure. These studies demonstrate that ES-62 exists mainly in a 
tetrameric state, as shown by SE experiments, substantiating earlier gel filtration 
studies that suggested that ES-62 was tetrameric. This finding is important, 
especially in view of the results presented in Chapter 3 which suggest a role for 
ES-62 as a peptidase, as many aminopeptidases exist in a dimeric or tetrameric 
state, SV and SAXS studies demonstrated, tlirough determination of the 
sedimentation coefficient and the Rg of ES-62, that ES-62 is likely to have a 
slightly elongated structure, which can be seen in the ab initio determined 
str uctures of ES-62 in Figure 4-19. The biological implications of these structural 
data will be discussed in more depth in Chapter 7.
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5. Expression and Purification of Recombinant ES-62
Native ES-62 is produced and secreted by adult filarial nematodes following 
infection of the rodent host with Acanthocheiîonema viteae. Studies to date on 
the effects induced by ES-62 have been carried out using native ES-62 isolated 
from the secretions of the adult filarial nematodes as described in Chapter 2. 
Native ES-62 has substantial heteroglycosylation (6 %) and has 
phosphorylcholine moieties attached to some of its carbohydrate chains. The 
studies of the effects induced by ES-62 utilising native ES-62 suffers from a 
number of disadvantages. The first is that, while ES-62 is known to be 
immunomodulatory, the contribution made to this role by the carbohydrate and 
PC components of ES-62 is unknown. The second is that native ES-62 is only 
produced in relatively small quantities thus limiting the experiments that can be 
performed.
To overcome these problems two expression systems, bacterial and baculoviral, 
were established for the production of recombinant ES-62 (rES-62). A bacterial 
expression system would allow the study of the protein component of ES-62 
alone while an expression system in a higher organism, such as insect, would 
allow the study of the immunomodulatoiy effects of glycosylated ES-62 without 
the PC moieties. The latter of these is particularly interesting as PC is known to 
have immunomodulatory capabilities and there is evidence to suggest that some 
of the immunomodulatory effects induced by ES-62 can be attributed to its PC 
moieties (Harnett et al., 1999a). In addition, recombinant expression systems 
should yield larger quantities of ES-62 thus removing the quantity limitations 
imposed on experiments, in particular structur al studies.
The production of larger quantities of unglycosylated ES-62, i.e that from a 
bacterial expression system, would enable crystallographic determination of the 
high resolution structure of the protein component of ES-62, which typically 
requires milligrams of protein. Crystallographic studies of native ES-62 are
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hampered not only by the low quantities of protein available, but also by the high 
levels of glycosylation present on the native protein. Glycosylation introduces 
heterogeneity into protein samples used in crystallisation which can hamper 
successful crystal growth, lowering the resolution of any diffraction data.
5.1. Expression in a Bacterial System
The first choice for the production of recombinant ES-62 (rES-62) was a 
bacterial expression system because these systems are usually simple to establish 
and often yield large quantities of recombinant protein easily and cheaply. 
Bacteria cannot perform post-translational modification thus any rES-62 
produced from a bacterial expression system would not be glycosylated and thus 
would lack a PC moiety. This would allow the immunomodulatory capabilities of 
the protein component of ES-62 to be studied without the contributoiy effects 
from the carbohydrate and PC components of native ES-62. The pET expression 
system from Novagen was chosen as this system had a vector available, pET 
19b, that possessed all the features felt to be necessary for the expression of ES- 
62. One of the most important features was a cleavable histidine tag, which was 
attached to the N-terminus of the protein being expressed. The His tag makes 
purification easier, though use of a metal cliromatography column, and the 
cleavable nature of the tag meant that rES-62 could be studied without the 
influence of the tag. An overview of the strategy for cloning ES-62 into the pET 
19b bacterial expression system is shown in Figure 5-1.
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Develop refolding protocol
ES-62 in pBluescript
Develop purification strategy
Miniprep to isolate vector DNA
Test for expression and solubility of rES-62
Identify positives and select 1 for sequencing
Transform sequenced positive into BL21 (DE3) cells
Clone into pET 19b and transform into Novablue cells
Clone into pGEM-T Easy 
and
transform into JM109 cells
Optimise growth temperatures and IPTG concentration for expression of ES-62
PCR to amplify ES-62 from pBluescript and to add Nde I and Bam HI restriction 
digest sites onto the C and N termini of the ES-62 sequence respectively
Figure 5-1 : Overview of the strategy for establishing the bacterial expression 
of rES-62 from the Novagen pET 19b vector expression system.
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5.1.1. Cloning, Ligation and Transformation
The 1.5 kb DNA sequence for ES-62 was amplified from the pBluescript 
construct it had been inserted into during the initial cloning experiments (Harnett 
et aL, 1999b) via PCR, as described in Chapter 2, and inserted into the pET 19b 
vector. Figure 5-2 shows the vector map for pBluescript. The restriction digest 
sites within the multiple cloning site were not suitable for cloning into pET 19b 
thus PCR not only isolated the sequence of ES-62 but attached Nde I and Bam 
HI restriction digest sites to the C and N termini of the sequence respectively.
Figure 5-3 shows a 1 % agarose gel of the PCR product obtained. The markers 
show that the PCR product is of the correct size, 1.5 kb, as expected from the 
sequence.
Sap 1442
Sea 12526 ,
,P w / l5 0 0  
.fV u l l  529P v u  I 2 416
fissH  II 6 19  
■ Sac 16 57
pBluescript
phagemid vector 
2961 bp
Kpn\7S9 
S ssH  11792
P w  II 9 77
Figure 5-2: pBluescript vector map
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non
-PCR product
M 1
Figure 5-3: 1 % agarose gel showing 1.5 kb PCR product amplified, using 
ES-62 specifîc primers, from a construct of pBluescript containing the 
sequence for ES-62. The entire PCR reaction, 25 pi, was loaded onto the gel 
and the PCR product isolated by gel extraction and DNA precipitation as 
described in Chapter 2. M is PCR markers loaded to allow determination of 
the size of the PCR product, 1 is the PCR reaction.
Having obtained a PCR product of ES-62 with restriction digestion sites to allow 
cloning into the pET 19b vector, the insert was ligated into the vector. The pET 
19b vector map can be seen in Figure 5-4. This map shows the multiple cloning 
site including the Bam HI and Nde I restriction digest sites. The vector is 5.7 kb 
in size and the ES-62 insert is 1.5 kb. This gives a construct 7.2 kb in size which 
yields two fragments of 5.7 and 1.5 kb on digestion with Bam HI and Nde I.
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Aat 11(5644) 
Ssp 1(5526)
Sea 1(5202) 
Pvu 1(5092)
Pst 1(4967)
XhO 1(324)
Nco'aXba 1(437)
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EcoN 1(760)
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Sap 1(3713) Bsif107 1(3600) Acc
Ord 11(948)
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Hpa 1(1731)
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PshA 1(2070)
Eag 1(2293)
NfU 1(2328)BspM 1(2408)
Bpu10 1(2935) Bsm 1(2713)Mse 1(2800)
Figure 5-4: pET 19b vector map
Ligation of the digested pET 19b vector and the digested PCR product initially 
proved unsuccessful. This was thought to be due to incomplete digestion of both 
the pET 19b vector and the PCR product by Nde I, a restriction enzyme known to 
be less efficient at digesting DNA. The incomplete digestion may also have been 
exacerbated by the lack of DNA surrounding the restriction digest sites for the 
restriction enzymes to situate themselves on. Figure 5-4 shows that this problem 
arises in the pET 19b vector due to the close proximity of the two digestion sites. 
It is possible that when one restriction enzyme is in place for digestion, it blocks 
the restriction digest site of the second restriction enzyme. This problem was 
overcome by performing sequential digests. Bam HI was incubated alone with 
the vector, allowing digestion of the Bam HI sites, before addition of Nde I. Nde 
I was incubated with the vector DNA for longer than would normally be 
necessary for restriction digestion, adding extra Nde I at various timepoints as 
detailed in Chapter 2.
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Incomplete digestion of the PCR product was thought to be due to a lack of DNA 
for the restriction enzymes to situate on due to the restriction digestion sites 
being at the ends of the PCR product. In order to circumvent this problem, the 
ES-62 PCR product was blunt end ligated into pGEM-T Easy, the vector map of 
which is shown in Figure 5-5. The ES-62 fragment was then digested whilst in 
the pGEM-T Easy vector, which provided sufficient DNA surrounding the 
restriction digest sites on which the restriction enzymes could locate in order to 
digest the DNA at the appropriate restriction digests sites. Sequential digests, as 
performed for digestion of the pET 19b vector, were performed to isolate the ES- 
62 fragment from pGEM-T Easy.
Xmn I 2 0 0 9  
Sea  I 1890
vector
(3 0 1 5 b p )
T7 i
Apa  I 
Aal II Sph  I BstZ  I Nco  I BstZ  I 
Not I Sac  II 
E coR  I
EcoR  I
BstX\
Î  S P 6
1 start
Figure 5-5: pGEM-T Easy vector map
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The digested pET 19b vector and digested pGEM-T Easy vector containing ES- 
62, were run on a 1 % agarose gel to allow separation of linearised pET 19b 
vector from undigested material and the ES-62 insert from pGEM-T Easy vector 
DNA. The linearised pET 19b vector and the ES-62 insert were then extracted 
from the gel using a Qiagen gel extraction kit. This method yielded insufficient 
DNA for ligation, often with a low ratio between the absorbances at 260 nm and 
280 nm, indicating protein contamination of the DNA. Despite many attempts to 
optimise this protocol, a satisfactory yield of DNA was never attained. In order 
to overcome this problem the digests were run on low melt agarose gels, the 
appropriate bands were excised and melted by heating gently and the liquidified 
bands, containing the digested DNA, used as the DNA sources for ligation as 
described in Chapter 2.
The vector constructs, following ligation and transformation into Novablue cells, 
were assessed for the presence of the ES-62 insert within the pET 19b vector by 
sequential digestion with Bam HI and Nde 1. Figure 5-6 shows the success of the 
ligation. A 5.7 kb band, representing the linearised pET 19b vector, and a 1.5 kb 
band, representing ES-62, can be seen in all the colonies screened.
5700bp
p - 6 2 --------^  1500
  1000
M l  2 3 4 5 6 7 M 8 9 10 11 12 13 14 M
Figure 5-6: Diagnostic restriction digest of colonies obtained from the 
ligation of pET 19b with ES-62 and subsequent transformation into 
Novablue cells. M — DNA size markers, 1-14 - pET 19b vector colonies after 
ligation with ES-62 insert. The band seen at 5700 bp is linearised pET 
vector.
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Novablue cells yield high levels of plasmid for identification of plasmids in 
which ligation has been successful, but do not contain the gene for T7 RNA 
polymerase and thus cannot express the gene inserted into the plasmid. DNA 
from six randomly selected colonies (corresponding to lanes 2, 4, 6, 10, 12 and 
14) were transformed into BL21 (DE3) cells which are expression host cells. 
BL21 (DE3) cells possess the T7 RNA polymerase gene and can express the 
gene inserted into the plasmid.
5.1.2. Sequencing of the ES-62 Insert
The ES-62 insert within pET 19b was sequenced as described in Chapter 2. 
Analysis of the sequencing data revealed only 1 error in the sequence of the 
insert. The mutation was that of an amino acid change from an aspartic acid 
residue at position 6 of the mature ES-62 sequence (minus the signal peptide) to 
a glutamic acid residue. This occurred due to a single base change from a C to an 
A, GAC to GAA in the sequence. This construct was used despite the error as the 
mutation is of a conserved nature and only concerns the addition of a CH2 group 
to the side chain of the amino acid as shown in Figure 5-7 below.
00C-CH-NH3^ -------------------► 'OOC-CH-NHa''
CH2 ÇH2
coo* GHz
1COO
Aspartic Acid Glutamic Acid
Figure 5-7: Amino acid change from aspartic acid to glutamic acid 
addition of a CHi group to the side chain.
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5.1.3. Expression
Using the BL21 (DE3) cells containing the ES-62/pET19b constimcts, expression 
trials were performed. Six sets of L-broth (5 ml) containing ampicillin (100 ng 
mf^) were inoculated with the one of six colonies transformed into BL21 (DE3) 
cells. These cultures were grown as detailed in Chapter 2. A sample (1 ml) of 
each culture was taken prior to and post induction with IPTG. The cells from 
these samples were pelleted, lysed and resolved on a 8 % SDS PAGE gel. The 
gel was then stained with Coomassie blue dye to visualise the proteins present in 
each sample. Figur e 5-8 (a) shows a typical result for three of the six colonies. It 
can clearly be seen that expression of a protein following induction with IPTG 
occurs. As ES-62 is the only protein under the control of a promoter induced by 
IPTG, the expressed protein observed is rES-62. Figure 5-8 (b) shows the same 
samples (pre- and post- induction) after Western blotting with polyclonal rabbit 
anti-ES-62 (supplied by W. Harnett) at 100 pg m f \  This blot shows definitively 
that the IPTG induced expressed protein, observed in Figure 5-8 (a), is rES-62.
As set out in the flow chart in Figuie 5-1, having established that rES-62 was 
being expressed, the next step was to determine if the rES-62 expressed was 
soluble, i.e. in the supernatant following lysis of the bacterial cell and not in the 
cell pellet. To determine the solubility of the expressed rES-62, a 500 ml culture 
was prepared as described in Chapter 2 and, following suitable incubation with 
an overnight iimoculant culture and induction with IPTG, the cells were lysed 
and the cell lysate clarified by centrifugation. A sample of the pellet obtained 
following clarification was taken and affinity purification performed on the 
supernatant, again as detailed Chapter 2, with samples taken of the wash tlirough 
from the column and the eluate. A sample of the cell pellet and the samples from 
affinity purification were resolved on an 8 % SDS PAGE gel as shown in Figure 
5-9. The results of this expression trial show that the majority of rES-62 is 
insoluble and located in inclusion bodies (lane 1) which were pelleted by 
centrifugation during clarification of the cell lysate. A very small proportion of 
rES-62 is soluble and can be purified as seen in larie 3 of Figure 5-9.
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Figure 5-8: Pre- and post-induction samples of three of the six colonies 
selected to be transformed into BL21 (DE3) cells. Expression of ES-62 was 
induced by addition of 1 mM IPTG. (a) SDS PAGE gel of the 1 ml pre- and 
post-induction samples of each of these colonies, stained with Coomassie 
blue dye. (b) A Western blot of the pre- and post-induction samples seen in 
(a), using polyclonal rabbit anti-ES-62 at 100 pg ml '.
Expressed ___ ^
rES-62
135 kDa
82 kDa Purified 
rES-62
53 kDa
29 kDa
1 2 3 Markers
Figure 5-9: An 8 % SDS PAGE gel stained with Coomassie blue dye of (1) 
the pellet obtained following clarification of the cell lysate of the induced 
bacterial cells, (2) the wash through (20 pi) from the POROS metal chelate 
affinity purification and (3) the eluate (20 pi) from the POROS metal chelate 
affinity purification column.
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To optimise the amount of soluble rES-62 expressed, a range of growth 
temperatures and IPTG concentrations were tested, as detailed in Table 5-1. The 
possibility of leaky expression, i.e. expression of rES-62 from cells grown over a 
long period of time without the addition of IPTG, was also tested for.
Experimental details are provided in Chapter 2. The cells obtained from these 
test cultures were lysed using sonication, clarified by centrifugation and samples 
of the supernatant and the pellet resolved by SDS PAGE.
Growth Temperature (°C) IPTG concentration (mM) Induction time (hours)
37 1,0.5, 0.25, 0.1 3
30 1,0.5, 0.25, 0.1 4
25 1,0.5,0.25,0.1 5
16 1,0.5,0.25,0.1 -18
Table 5-1: Growth and induction conditions for expression trials of bacterial 
rES-62, Cells were grown in L-broth containing 100 pg ml ' ampicillin at 37 
°C until an optical density at 600 nm of 0,7 was reached. IPTG was then 
added at the appropriate concentration and the growth temperature altered 
accordingly.
Expression of rES-62 following incubation of the cells at 37 °C and induction by 
addition of 1 or 0.5 mM IPTG or incubation at 25 ^C and induction by addition 
of 1, 0.5, 0.25 or 0.1 mM IPTG, yielded the highest levels of soluble ES-62. 
These conditions were repeated in an attempt to identify one condition yielding 
greater amounts of soluble recombinant material than the others. These results 
are shown in Figure 5-10. Optimal expression of rES-62 was attained following 
incubation at 25 °C and induction with 0.1 mM IPTG. This condition was chosen 
for the expression o f rES-62 in bacterial cells. Although this condition yields 
soluble rES-62, the majority of the recombinant material is still insoluble as 
shown in Figure 5-10. The band observed for soluble rES-62 (in the supernatant) 
under these conditions, following staining with Coomassie blue dye, was very 
faint. As the lower level of detection when staining with Coomassie Blue dye is
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approximately 0.3 - 1 pg, the level of soluble rES-62 resolved in Figure 5-10 is 
approximately 0.5-1 pg. Thus the yield of soluble rES-62 obtained was 2.5 mg L'
'. It was decided that while the soluble material would be purified, refolding of 
the insoluble material, isolated from the inclusion bodies, would also be 
attempted and any material obtained purified.
w
4-82 kDa
-rES-62
-52 kDa
37 °C 
1 mM IPTG
37 °C 25 ° C  25 °C 25 °C 25 °C
0.5 mM IPTG 1 mM IPTG 0.5 mM IPTG 0.25 mM IPTG 0.1 mM IPTG
Figure 5-10: 8 % SDS PAGE gels of the pellet and supernatant of lysed 
bacterial cells post induction with IPTG, stained with Coomassie blue dye. 
P- pellet of lysed cells containing insoluble proteins, S - supernatant (20 pi) 
from lysed cells containing soluble proteins. The temperature at which 
induction took place and induction concentration of IPTG used are shown.
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5.1.4. Refolding
Refolding of proteins from inclusion bodies is a complex task, made more so by 
the many protocols available. Proteins that are expressed and found located in 
inclusion bodies are insoluble due to a failure to fold correctly. Few cellular 
proteins are formd in inclusion bodies so purifying expressed protein found in 
inclusion bodies, provided it can be refolded, is often a simple task due to the 
low level of contaminants. There are three important factors in developing a 
refolding protocol: pH, the presence o f redox pairs and protein concentration on 
refolding.
pH affects the charge of amino acids within a protein and thus at the wrong pH 
the protein could fail to fold due to repulsion between amino acids or could 
aggregate due to the presence of hydrophobic patches on the outside of the 
protein. Studies using native ES-62 examining the stability of ES-62 at different 
pH indicated that ES-62 was pH sensitive. A sample (1 ml) of native ES-62 (0.57 
mg mf^) in sodium phosphate buffer at pH 7.0 was dialysed against 1 L of 
sodium phosphate buffer (0.1 M ) at pH 6 for 3 hours, the sample was then 
dialysed against 1 L sodium acetate buffer (0.1 M) at pH 5,5 for 3 hours, further 
against 1 L sodium acetate buffer (O.IM) at pH 5.0 for 3 hours and finally against 
1 L sodium phosphate buffer at pH 7.0 overnight. Samples (2 pg) were taken at 
each pH and resolved on a non-denaturing, non-reducing gel. As shown in Figure
5-11, lower molecular weight bands were observed at pH 6.0, 5.5 and 5.0 than 
those observed at pH 7.0. These lower molecular weight bands were postulated 
to represent monomeric and dimeric forms of ES-62, while the higher molecular 
weight bands observed at pH 7.0 represent tetrameric ES-62. The dissociation of 
tetrameric ES-62 at pH values of less that 7 appears to be reversible by 
increasing the pH back to 7.0. However, measurement of the concentration of 
ES-62 prior to and following the above study indicated that a proportion 
(approximately 50 %) of the native ES-62 is lost, possibly by precipitation. It 
would appear therefore that native ES-62 is not stable at pH values below 7.0.
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tetramer
dimer
monomer
Figure 5-11: 10 % non-denaturing, non-reducing polyacrylamide gel 
(stained with Coomassie blue dye) of samples (2 pg) of native ES-62 at pH 
values of 7.0, 6.0, 5.5, 5.0 and 7.0. M -  markers; 1 - native ES-62 at pH 7.0 
prior to the dialysis experiment; 2 - native ES-62 at pH 6.0; 3 - native ES-62 
at pH 5.5; 4 - native ES-62 at pH 5.0; 5 - native ES-62 at pH 7.0 following 
the dialysis experiment.
Redox pairs such as cysteine and cystine and oxidised and reduced glutathione 
help the protein to refold by allowing disulphide exchange to occur. The 
concentration of the protein is important as at high concentrations aggregation 
can occur even in folded proteins. To aid refolding the protein concentration for 
the final refolding step should be between 10 -  500 pg mf* (Kuhelj et u/., 1995).
In the search for a refolding method that yielded soluble rES-62, two protocols 
were attempted with a number of modifications made to each. These are 
discussed below. The protocol for refolding found to be most successful is 
detailed in Chapter 2. The first protocol attempted used oxidised and reduced 
glutathione as the redox pair. This redox pair can form mixed glutathione -  
protein disulphides and aid the correct pairing of disulphides to allow formation 
of native structures. The buffer used throughout this protocol was 39 mM sodium 
dihydrogen orthophosphate, 61 mM disodium hydrogen orthophosphate, 50 mM 
sodium chloride at pH 7. Additional components were added to this buffer 
throughout the protocol depending on the aim of that particular part of the 
protocol. Isolated inclusion bodies were obtained by lysis of the bacterial cells to
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remove the soluble proteins, and addition of Triton X-100 to the buffer to remove 
the cellular membranes and membrane proteins. The proteins in the inclusion 
bodies were then denatured by addition of urea to the buffer. The proteins were 
refolded by dialysis into buffer containing only the mixed glutathione redox 
pairs. Using this protocol, the majority of the proteins were found to aggregate 
out of solution during the final dialysis step. This aggregation may be due to the 
use of a redox pair to aid refolding, which is an instiumental part of this protocol.
ES-62 is known to have only two cysteine residues, thus use of redox pairs may 
be of little use to the refolding of rES-62. Protein concentration for the final 
dialysis step may also have been a factor in the aggregation. It is possible that the 
dilution step, which forms part of this protocol, was insufficient to lower the 
concentration of the denatui'ed protein to the 1 0 -5 0 0  pg mf^ concentration 
recommended.
The second protocol used for refolding of rES-62 was based on a protocol by 
Kuhelj et al. (1995) as detailed in Chapter 2. Briefly, cells were lysed by 
sonication and the cellular membranes and membrane proteins removed by 
addition of Triton X-100. The insoluble proteins, present in the pellet remaining 
following clarification of the cell lysate, were denatured by addition of urea. The 
protein concentration of the resultant denatured proteins was measured and the 
protein diluted to 0.01-0.5 mg m f \  Protein refolding was achieved by dialysis of 
the denatured proteins against a large volume of 100 mM sodium acetate, 50 mM 
sodium chloride buffer, pH 7.0. This protocol gave the best yield of refolded 
protein although a significant proportion of the proteins still aggregated and 
precipitated. Many modifications to this protocol were attempted to tiy to 
optimise the refolding procedure. These modifications fell into four categories; 
temperature of dialysis, buffer constituents, denaturing agents and protein 
concentration.
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ICP-AES allows analysis of the protein of interest for any elements that are 
constituents of the protein, for example magnesium, sulphur or tungsten. A 
strong magnesium signal was identified in the atomic emission spectrum 
obtained for native ES-62 suggesting the requirement of this divalent cation in 
the native protein. The analysed data obtained from ICP-AES are shown in Table 
5-2. Magnesium has the highest reading at 4 [iM, except for potassium and 
sulphur, which are contaminants from the phosphate buffer. This suggests that 
ES-62 has a requirement for magnesium and raises the possibility that any 
recombinant material would perhaps have the same requirement.
5.1,4,1, Dialysis Temperature
The final dialysis step is important as it is the point at which the dénaturation 
agent is removed and refolding occurs. Altering the temperature at which this 
dialysis step occurred revealed that, while there was always some precipitation of 
aggregated protein, the amount of precipitation could be reduced by perfoiming 
the final dialysis step at room temperature (-20 °C). If dialysis was performed at 
4 °C or at temperatures higher than room temperatui'e then the amount of
precipitation increased. '
£
5,1,4,2, Buffer Constituents
It was known that small molecules can influence the folding of proteins, in 
particular if these molecules, such as metal ions, are required for activity. ES-62 
has been postulated to contain a metal binding site. To determine if metal ions 
were present in native ES-62, inductively coupled plasma atomic emission 
spectroscopy (ICP-AES) was performed.
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Concentration (pM)
Potassimn 458.00
Sulphur 22.60
Magnesium 4.00
Zinc 1.75
Nickel 0.60
Copper 0.41
Iron 0.12
Manganese <1 X lCf4
Cobalt <1 X 10-4
Table 5-2: ICP-AES results for native ES-62.
Magnesium and calcium chloride were added to the buffers described in Chapter 
2 in the hope that supplementing the buffers with a divalent cation would aid 
refolding. Sucrose was added to help mask any hydrophobic patches on the 
protein that may be causing aggregation to occur. Addition of sucrose to the 
dialysis buffer actually resulted in an increase in precipitation of the protein 
while addition of the magnesimn and calcimn chloride had no noticeable effect 
on the refolding of the rES-62. In view of these results, the sodium acetate 
buffers described in Chapter 2 were used with no additional constituents.
5,1,4,3. Denaturing Agents
Use of guanidine hydrochloride (GuHCl) at 2 and 6 M in place of urea at 2 and 8 
M concentrations had no noticeable effect on the amount of precipitation that 
occmTcd, but no refolded protein could be detected following purification. The 
protein may have refolded but in an incorrect manner such that the His tag was 
inaccessible for purification. As a result of these findings, GuHCl was discai'ded 
in favour of the original use of urea.
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5,1,4.4, Protein Concentration
Adjusting the protein concentration prior to the final dialysis revealed that at 
lower protein concentrations, 0.1 mg mf^ compared to 0.3 or 0.5 mg m f \  less 
precipitation of aggregated protein was observed. As a result all refolding steps 
were performed at 0.1 mg m f ^ if  possible.
Despite optimisation of the refolding protocol, refolding of insoluble rES-62 was 
of limited success. Although refolded protein that could subsequently be purified 
was obtained, refolding was complex and time consuming especially considering 
the small yields of rES-62 obtained (see section 5.1.5).
5.1.5. Purification using Affinity Chromatography
Pmification of recombinant protein aims to remove all contaminants and yield a 
pure, concentrated sample of recombinant protein. The development of a 
purification system is dependent on how the recombinant protein is expressed 
and any unique or unusual characteristics that it may possess. Veiy little is 
known about any ES-62 substrates that could be exploited for pmification 
purposes thus the bacterial expression system chosen was selected with 
purification in mind.
The bacterial expression system involved the use of a vector that attaches a 
cleavable 6 x His affinity tag to the N terminus of the protein. This 6 x His tag 
exploits the high affinity of histidine for divalent metals, especially nickel, to aid 
pmification of the protein. The purification of the bacterially expressed ES-62 
was achieved using a POROS nickel charged affinity colmnn and the perfusion 
chromatography pmification system (PerSeptive Biosystems). Perfusion 
chromatography uses POROS particles as the chromatography media. Unlike 
conventional chromatography particles, POROS particles have large through- 
pores that allow for faster transport of the sample molecules into the particles and 
allow contact with internal binding sites of the particles. As a result 
chromatography separations can be carried out more quickly with perfusion 
chromatography than with traditional methods and with little or no loss of
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resolution. The sample was loaded onto the POROS nickel charged affinity 
column and elution achieved by addition o f an imidazole solution that competes 
with histidine for binding to the immobilised metal ions.
Due to problems with precipitation during the refolding experiments and with the 
hypothesis that the lack of glycosylation of the rES-62 may be leading to 
exposure of hydrophobic patches on the outside of the protein, lysis, purification 
and storage of the purified protein was performed at high salt concentrations and 
in the presence of glycerol.
While the presence of 20 % glycerol in the lysis buffer promoted increased yields 
of soluble rES-62 obtained, addition of 10 % glycerol to the purification buffers 
appeared to reduce the amount of rES-62 which could be successfully purified.
Dialysis of purified rES-62 into PBS containing high salt (sodium chloride 150 
mM to 300 mM) and 20 % glycerol prevented precipitation of the purified 
protein. Further, trials were performed in which glycerol was replaced with 
concentrations of 0.01, 0.05 and 0.1 % of the detergent LDAO. No noticeable 
difference in the yields of purified protein was obtained using LDAO.
The best yields of soluble bacterial rES-62 were obtained by lysing the bacterial 
cells in the presence of 20 % glycerol, purifying the soluble protein obtained in 
the absence of glycerol and then dialysing the pure protein into a high salt buffer 
containing 10 % glycerol. Figure 5-12 shows a typical trace from the purification 
of soluble expressed protein when glycerol is present in the resuspension (lysis) 
buffer. Typically, the cell pellet from 6 L of bacterial cell culture was 
resuspended in 150 ml resuspension buffer containing glycerol and then lysed.
The clarified supernatant was then purified using a POROS nickel charged 
affinity column, the fractions containing rES-62 collected, pooled and dialysed 
into a high salt phosphate buffer containing 10 % glycerol. Figure 5-13 shows an 
8 % SDS PAGE gel stained with Coomassie blue dye showing the samples, fiom 
one purification l'un, of the wash thi'ough, eluate and tail highlighted in Figure 5- 
11. Purification using the above protocol typically yielded approximately 8-10 
mg (1.3-1.6 mg L‘ )^ of soluble rES-62. Unfortunately further work, including
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small angle X-ray scattering, analytical ultracentrifugation and dynamic light 
scattering studies, using this recombinant material revealed that the rES-62 was 
highly aggregated and unsuitable for biophysical studies or in vivo 
experimentation.
Load Wash through
(U1
0.9
Eluate
0.7
0.5
Tail
0.3
0.1
Time
Figure 5-12: A typical purification trace from the purification of soluble 
rES-62 using a POROS metal chelate column. Imidazole gradient is shown 
in red.
135 kDa
82 kDa
53 kDa
Figure 5-13: 8 % SDS PAGE gel stained with Coomassie blue dye showing 
the samples, from one purification run. 1 is a sample (15 pi) of the wash 
through , 2 is a sample (15 pi) of the eluate and 3 is a sample (15 pi) of the 
tail.
Chapter 5: Expression and Purification of Recombinant ES-62 199
Load
Wash through
0.8
c  0.6I^ 0.4< Eluate Jail
0.2
0.0
Time
Figure 5-14: A typical purification trace from the purification of refolded 
rES-62 using a POROS metal chelate column.
Purification of refolded rES-62 was carried out using the same strategy as 
outlined above. Figure 5-14 shows a typical example of the absorbance trace 
obtained from purification of refolded rES-62. Typically 500 ml of bacterial cell 
culture was lysed and the inclusion bodies isolated. The insoluble proteins 
present in the inclusion bodies were then refolded and purified as described in 
Chapter 2. Despite the higher levels of insoluble rES-62 expressed, the 
purification of refolded rES-62 typically yielded only 66 pg of soluble rES-62 
(0.132 mg mr').
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5.2. Expression in a Baculovirus System
The ability of expression systems to glycosylate expressed protein was an 
important consideration in the selection of a eukaryotic expression system, as it 
would allow expression of a glycosylated form of rES-62 which lacked the 
phosphorylcholine moieties found on native ES-62 (although glycosylation 
would differ from that in the native). The baculovirus expression system from 
PharMingen was chosen as it is a powerful and versatile eukaryotic expression 
system that allows for expression of the protein of interest in insect cells. The 
expression of rES-62 in insect cells was favoured over that of expression in yeast 
cells as insects ai’e the natural vector of filarial parasites thus it was hoped that 
this system would be closer to the natural lifecycle of the filarial parasites and 
hence the natural environment for production of native ES-62.
The PharMingen baculovirus expression system is easier to use than earlier 
baculovirus expression systems as the baculovirus DNA has been modified such 
that homologous recombination with the vector is essential for viral particle 
production. As a result 99 % of successful homologous recombination yields 
virus particles containing the inserted gene. The vector chosen for expression of 
rES-62, pAcGP67-B, contains a secretion signal sequence which is attached to 
the N-terminus of ES-62 and results in the secretion of the rES-62 into the cell 
media. This aids purification as the insect cells can be grown in protein-free 
media and thus the major protein present in the harvested media following 
infection should be rES-62. In addition, the secretion of rES-62 from the insect 
cells mimics the production of native ES-62, which is secreted by the adult 
filarial worms into the bloodstream of the parasitised host and thus the protein is 
not retained in a cellular environment.
An overview of the sti'ategy for cloning ES-62 into the baculovims expression 
system is shown in Figure 5-15.
Chapter 5 : Expression and Purification of Recombinant ES-62 201
Test for expression of rES-62
ES-62 in pBluescript
Develop purification strategy
Miniprep to isolate vector DNA
Large scale expression of rES-62
Amplify viral stock to ~2 xlO pfu ml
Optimisation of MCI for expression of rES-62
Identify positives and select 1. Isolate vector DNA by miniprep
Identify positives and select 1 for sequencing
Clone into pAcGP67-B and transform into Novablue cells
Clone into pGEM-T Easy and transform into JM109 cells
Homologous recombination o f pAcGP67-B/ES-62 construct 
with BaculoGold DNA
PCR to amplify ES-62 fiom pBluescript and to add Bam HI and Eco RI 
restriction digest sites onto the C and N termini o f the ES-62 sequence
respectively
Figure 5-15: Strategy for the expression of ES-62 in a baculovirus 
expression system.
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5.2.1. Cloning. Ligation and Transformation
The 1.5 kb DNA sequence for ES-62 was amplified, from the pBluescript 
construct (as shown in Figure 5-2) it had been inserted into during the initial 
cloning experiments (Harnett et a l ,  1999b) via PCR. Restriction digest sites 
within the multiple cloning site of the pBluescript vector were not suitable for 
cloning into pAcGP67-B thus PCR not only isolated the sequence of ES-62 but 
attached Bam HI and Eco R1 restriction digest sites to the C and N termini of the 
sequence respectively. The vector map for pAcGP67-B is shown in Figure 5-17.
The PCR product was first inserted into a pGEM-T Easy vector to overcome 
problems of incomplete restriction digestion of the PCR fragment as discussed in 
section 5.1.1. The digested fi*agment was then cloned into the pAcGP67-B vector 
of the PharMingen baculovirus expression system as described in Chapter 2.
Diagnostic restriction digests with Bam HI and Eco RI, which released the insert 
from the vector, were used to identify positive clones. The diagnostic restriction 
digest of the pAcGP67-B clones can be seen in Figure 5-16. The ten colonies 
selected were digested with Bam HI and Eco RI and resolved on a 0.7 % agarose 
gel. Seven of the ten colonies show the presence of the ES-62 insert in the 
pAcGP67-B vector as shown by the 1.5 kb band in lanes 1, 2, 4, 5, 6, 7 & 8.
1.5 kb ES-62 
insert
9.7 kb 
linearised 
pAcGP67-B 
vector
1 8 10
Figure 5-16: Diagnostic restriction digests of pAcGP67-B/ES-62 constructs 
using Bam HI and Eco RI. 10 pi of the restriction digests were run on a 0.7 
% agarose gel containing ethidium bromide. To visualise the 1.5 kb insert 
bands the contrast was adjusted resulting in overexposure of the 9.7 kb 
vector band.
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signal peptide cleavage site
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Figure 5-17: pAcGP67-B vector map
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5.2,2. Sequencing of the ES-62 Insert
The ES-62 insert within pGEM-T Easy was sequenced as described in Chapter 2.
Analysis of the sequencing data revealed the same single error that was observed 
in the sequence of the insert for the bacterial expression system. Again this 
construct was used, despite the eiTor, as the mutation is of a conserved nature as 
shown in Figure 5-7. The sequence of native ES-62 against which both 
sequencing data sets were compared had been previously determined by both 
DNA sequencing and N-terminal amino acid sequencing (Harnett et a l,  1999), 
thus it was most likely that these identical mutations arose through PCR and are 
coincidental.
5.2.3. Optimisation o f Infection
Following confirmation of the presence of the ES-62 insert within the pAcGP67- 
B vector by diagnostic restriction digests, the vector construct was incorporated 
into the baculoviral DNA by homologous recombination as described in Chapter 
2. The virus then underwent several rounds of amplification until a high viral 
titre, in the region of 2 x 10  ^pfu m F\ as assessed by plaque assay, was obtained. 
This high viral titre stock was used to infect SF9 insect cells for the purpose of 
expression. In order to optimise expression of the rES-62, SF9 insect cells were 
infected with high titre viral stock at multiplicities of infection (MOIs) of 3, 7 
and 10. Figure 5-18 shows samples of the supernatants of cells infected at each 
of these MOIs, Western blotted with rabbit polyclonal anti-ES-62 (100 p,g ml'^). 
These blots show that the expressed protein is rES-62, as it reacts positively with 
the anti-ES-62 antibody, and that there is little difference in the level of 
expressed protein at each of these tliree MOIs. A slight increase in the level of 
expression at a MOI of 10 was observed and thus SF9 insect cells were infected 
at a MOI of 10 for expression of rES-62.
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Figure 5-18: Infection of SF9 insect ceils with a high titre virus stock of 
recombinant virus at MOIs of 3, 7 and 10. Samples of the cell supernatant of 
the cells, 3 days post-infection, were resolved on a 10 % SDS PAGE gel, 
transferred to nitrocellulose and Western blotted using rabbit polyclonal 
anti-ES-62 (100 pg ml ) and Amersham anti-rabbit IgG-HRF (1:3000). 1 - 
control lane: uninfected cells; 2 — cells infected with recombinant 
baculovirus at a MOI of 3; 3 -  cells infected with recombinant baculovirus 
at a MOI of 7; 4 -  cells infected with recombinant baculovirus at a MOI of 
10.
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5.2.4. Purification
Unlike the bacterial rES-62, the baculovirus rES-62 has no tag to aid purification. 
However, the recombinant protein is secreted into the protein-free media, 
containing only amino acids, sugars and lipids. Secretion into the media greatly 
reduces the number of contaminants, as there are few cellular proteins present in 
the media. The only other contaminants present at high levels in the supernatant 
should be recombinant virus particles. These should not affect pmification,
(PharMingen., 1999) but were removed by centrifugation for 1 horn' at 50,000 x 
g. Three different methods of purification were used to pmify baculovirus rES- 
62; ion exchange, gel filtration and filtration using size cut-off membranes, as 
used in the purification of the native protein.
5,2,4.1. Ion Exchange
Ion exchange clii'omatography sepai'ates proteins on the basis of their charge. As 
binding and elution conditions of ion exchange chromatography are typically 
mild and this method enables relatively good separation of different proteins, it is 
a popular purification method. Ion exchange chromatography media can be split 
into two groups; cation exchange in which the chiomatography media consists of 
functional groups with a negative charge and anion exchange in which the 
chi'omatography media consists of functional gi'oups with a positive charge.
Elution of proteins from ion exchange columns can be achieved by altering the 
pH of the buffer solution, which in turn alters the charge of the sample molecules 
bound to the column. Elution can also be achieved by increasing the salt 
concentration of the buffer solution, which results in the displacement of the 
bound sample molecules by salt molecules in the buffer solution.
The pi of ES-62 was determined via lEF to be 5.6 (Chapter 2). Figure 5-19 
shows that the resolved bands of both the ES-62 and rES-62 lie between the 5.2 
and 5.85 markers indicating a pi of ~ 5.6. The native ES-62 band is more 
disperse, especially when compared to the tight rES-62 bands. This is thought to 
be due to the heteroglycosylation of the native protein. The pi of 5.6 of ES-62
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means it is negatively charged at pH 7 thus anion exchange chromatography 
using a POROS 20HQ column was used to purify the baculovirus expressed rES- 
62, as discussed in Chapter 2.
M l  2 3 4
Figure 5-19: An lEF gel of native ES-62 and rES-62. Bands were resolved by 
silver staining. M -  Markers; 1 -  native ES-62 (a diffuse band is observed 
due to the heteroglycosylation of native ES-62); 2-4 -  baculoviral rES-62.
Figure 5-20 (a) shows a silver stained 10 % SDS PAGE gel of the fractions 
collected from a typical anion exchange purification following a wash step of 
0.045 M sodium chloride over 10 column volumes, and gradient elution of 0.045 
M sodium chloride to 0.3 M over 30 column volumes. A salt concentration of 
0.045 M was required during the wash step to remove contaminant proteins. 
Unfortunately, this concentration also caused elution of a proportion of the rES- 
62. Reduction of the salt concentration during the wash step was attempted, but 
this did not sufficiently remove contaminants from the sample. Figure 5-20 (b) is 
a Western blot of the samples shown in Figure 5-20 (a) probed with rabbit 
polyclonal anti-ES-62 (100 pig ml"^ ) and Amersham anti-rabbit IgG-HRP 
(1:3000). These gels confirm that the protein purified was rES-62 and that two 
forms of rES-62 were produced. The relative levels of these two forms appeared 
to vary across the fractions collected suggesting that each form might have a 
slightly different pi value. The difference in pi value might be due to 
heteroglycosylation of the protein within the insect cells.
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Figure 5-20: Fractions from a typical anion exchange purification, (a) Silver 
stained gel of the fractions, (b) Western blot of the fractions probed with 
rabbit polyclonal anti-ES-62 (100 pg ml ) and Amersham anti-rabbit IgG- 
HRP (1:3000). 1 -  marker; 2-10 - wash through fractions following 3 loading 
steps; 11-19 - elution fractions; 20 is the clean step (1.5 M NaCl).
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5,2,4,2. Gel Filtration
Gel filtration or size exclusion chromatography separates molecules on the basis 
of size. This is achieved due to the special nature of the beads used as 
chromatographic media, which contain pores of specific sizes. Small molecules 
can fit tlirough the pores and enter the beads, larger molecules are completely 
excluded from entering the beads and those molecules between these two 
extremes can enter the pores to a certain extent. This causes large molecules to 
pass quickly through the column, while smaller molecules take longer as they 
pass tlirough the beads and are retarded on their way though the column. To 
achieve high resolution, a slow flow rate must be employed and the sample load 
should ideally be 1 % of the column volume. Due to these constraints gel 
filtration is often used as the final step in purification when the majority of 
contaminants have been removed and the sample volume is low.
Gel filtration clnomatography was tested as a method of purification both on the 
eluate collected following anion exchange described above and as a first 
purification step of the protein-free media, into which the recombinant 
baculovirus expressed protein had been secreted. The use of gel filtration 
following anion exchange will be described first.
The purified protein obtained from anion exchange was of relatively high purity, 
however, the anion exchange eluate resolved on a non-denaturing, non-reducing 
gel (Figure 5-21) contained high and low molecular weight bands possibly 
relating to monomeric and tetrameric rES-62. To remove contaminants 
remaining after anion exchange and to separate monomeric and tetrameric rES- 
62, fractions eluted from anion exchange (identified as containing rES-62) were 
pooled, concentrated and gel filtration using a Superose 12 (HR 10/30) column 
was performed as described in Chapter 2.
Chapter 5 ; Expression and Purification of Recombinant ES-62 210
135 kDa-►
82 kDa-
53 kDa
wt M 1 2 3 4
135 kDa
82 kDa
53 kDa
Figure 5-21: (a) Silver stained 10 % SDS PAGE gel of native ES-62 and 
fractions eluted from anion exchange purification of baculovirally produced 
rES-62. (b) Silver stained 10 % non-denaturing, non-reducing 
polyacrylamide gel of native ES-62 and fractions eluted from anion 
exchange purification of baculovirally produced rES-62. M -  marker, WT -  
native ES-62; 1-4 show fractions eluted following anion exchange.
Gel filtration fractions were initially identified as containing rES-62 by probing 
dot blots of all fractions eluted with rabbit polyclonal anti-ES-62. Figure 5-22 
shows the fractions from gel filtration identified as containing rES-62. Figure 
5-22 (a) shows silver stained gels while Figure 5-22 (b) shows Western blots of 
these fractions probed with rabbit polyclonal anti-ES-62 (100 (Ag ml'*) and 
Amersham anti-rabbit IgG-HRP (1:3000). Many of the fractions, shown to
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contain rES-62, comprise only 1 band (rES-62) indicating that the protein is pure, 
while others possess a few additional contaminating bands.
82 kDa
53 kDa
29 kDa
rES-62
1 2 3 4 5 6 7 8 9  10 11 1213 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
(b)
rES-62
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
Figure 5-22: Fractions obtained from gel filtration of anion exchange 
purified rES-62 (lanes 1-28) and of crude supernatant from infected cells 
(lanes 29-34). (a) Silver stained gels of the fractions, (b) Western blots of the 
fractions using rabbit polyclonal anti-ES-62 (100 pg ml ) and Amersham 
anti-rabbit IgG -HR? (1:3000). Arrows mark the rES-62 bands.
Silver staining of proteins in a gel can give rise to artefacts, which make pure 
samples appear contaminated. To ensure the contaminant bands seen in Figure 
5-22 above were not artefacts the fractions were assessed by staining with 
Coomassie blue dye. Fractions were pooled into two groups; A and B. Pool A 
contained the fractions that appeared pure from the silver stained gels (fractions 
corresponding to lanes 1, 3, 4, 6, 7, 8, 9, 12, 13, 16, 17, 18, 19, 20, 21, 22, 24, 25 
and 26 in Figure 5-22). Pool B contained the two fractions that appeared to 
contain only a few contaminating proteins (fractions corresponding to lanes 2 
and 5 in Figure 5-22). Samples of pools A and B were resolved on a 10 % SDS 
PAGE gel and stained with Coomassie blue dye. As shown in Figure 5-23, 
samples from pools A and B run at the same molecular weight as native ES-62. 
Pools A and B appear pure, with no evidence of any of the contaminating 
proteins observed in Figure 5-22. This suggests that the contaminant bands 
previously observed in those fractions of pool B were either artefacts or
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contaminating proteins of concentration less than 0.3-1 p,g, the lower level of 
detection when staining with Coomassie blue dye.
rES-62
WT A B
Figure 5-23: 10 % SDS PAGE gels of rES-62 purified by anion exchange 
and gel filtration (lanes A and B) and stained with Coomassie blue dye. 
Native ES-62 was run as a control in the lane marked WT.
Typical yields of rES-62 following anion exchange and gel filtration, determined 
by a BCA protein assay, were approximately 500 pg from 4 flasks of infected 
SF9 cells, each flask contained 2x10^ cells in 30 ml protein-free medium (4 pg 
ml '). To determine the extinction coefficient of rES-62, its absorbance at 280 nm 
was measured. However, a wavelength scan of the absorbance of rES-62 
identified that maximal absorbance occurred at 260 nm rather than 280 nm as 
would be expected for proteins. This was postulated to be due to the presence of 
DNA contaminants. Two strategies were employed to remove this 
contamination. The first was centrifugation of the sample, in a Beckman 
ultracentrifuge, at 50000 x g for 1 hour. This removes baculovirus particles from 
the sample. The second was treatment of the samples with DNase to remove 
DNA contaminants by digestion. Unfortunately, neither of these strategies 
resulted in a shift in the maximal absorbance from 260 to 280 nm. This suggests 
that either rES-62 can bind DNA present in the supernatant from the infected 
cells, thus preventing its removal or that the absorbance peak at 260 nm is 
attributable to another, unidentified source. This made the rES-62 unacceptable 
for experimentation and necessitated another appraisal of the purification 
strategy.
Chapter 5: Expression and Purification of Recombinant ES-62 213
As an alternative purification method, gel filtration was also performed on crude 
protein-free media, into which rES-62 had been secreted. Figure 5-24 (a) shows 
the fractions eluted and resolved on a 10 % SDS PAGE gel subsequently silver 
stained. Figure 5-24 (b) shows these fractions Western blotted with rabbit 
polyclonal anti-ES-62 (100 pg ml"') and Amersham anti-rabbit IgG-HRP 
(1:3000). Fractions obtained from gel filtration of crude material show 
surprisingly few contaminants, in some cases appearing purer than those 
obtained from anion exchange and gel filtration together. However, there was no 
appreciable difference in the yield of rES-62 obtained by gel filtration alone 
compared to that obtained by anion exchange and gel filtration. Similarly to the 
results observed from anion exchange purification (Figure 5-20), there appear to 
be two forms of rES-62 expressed and purified from the baculovirus expression 
system. The two forms of rES-62 may represent heteroglycosylated forms of the 
protein. In order to investigate possible heteroglycosylation of rES-62 by insect 
cells, further work including separation of the two forms of rES-62 and 
examination by mass spectroscopy to compare their carbohydrate content would 
be necessary.
82 kDa-----
53 kDa
rES-62
rES-62
1 2  3 4
Figure 5-24: Fractions obtained from gel filtration of the protein-free media 
from infected cells (lanes 1-4). (a) Silver stained gel of the fractions, (b) 
Western blot of the fractions using rabbit polyclonal anti-ES-62 (100 pg ml
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') and Amersham anti-rabbit IgG -HRP (1:3000). Arrows mark the rES-62 
bands.
Gel filtration appears to improve the purity of the sample obtained both when 
used in conjunction with anion exchange and when used alone. Due to the bed 
volume of the gel filtration colmnn (200 ml), only 200 pi of sample could be 
loaded thus this pmification step, when used on cmde material rather than that 
obtained following anion exchange, was very time consuming and not practical 
for the pmification of large amounts of rES-62. However, in both cases possible 
DNA contaminants, as discussed above, appear to be present thus the rES-62 is 
not acceptable for either biological or biophysical experientation.
5,2,4,3. Filtration
Native ES-62 is pmified using a series of molecular weight cut-off membranes in 
an ultrafiltration stiiTcd cell. A similar strategy was used to remove some of the 
contaminants and separate monomeric and tetrameric rES-62. This was an 
alternative pmification method and allowed emichment and concentration of 
either the crude protein-free media from infected insect cells or the eluate from 
anion exchange.
Two molecular weight cut-off membranes were used, one with a cut-off of 100 k 
Da (YM 100), which should retain only tetrameric rES-62, and a second with a 
cut-off of 30 k Da (YM 30), which should retain anything with a mass above 30 
k Da, as described in Chapter 2. Figure 5-25 shows a SDS PAGE gel stained 
with Coomassie blue dye and a Western blot of the samples of proteins retained 
by the YM 100 and YM 30 filters. The YM 100 filter retains the majority of the 
recombinant material, indicating that it is above 100 k Da in size and not 
monomeric. The recombinant material retained by the YM 30 filter appear s pmer 
than that retained by the YM 100 filter, Tliis difference in purity may be due to 
the existence of degradation products, as some of the bands o f the YM 100 
fraction observed on the gel stained with Coomassie blue dye react positively 
with the anti-ES-62 antibody. Filtration appears to successfully separate
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recombinant monomeric and tetrameric ES-62. However, the presence of 
contaminants indicates that filtration alone is insufficient for purification of rES- 
62. An optimal purification strategy would be a combination of filtration and 
anion exchange.
(a)
rES-62
■135 kDa 
82 kDa
-53 kDa
2 3
(b)
rES-62 ----- ^
-53 kDa
1
Figure 5-25: Purification of baculovirus rES-62 from infected cell 
supernatants using YM 30 and YM 100 filters in an ultrafiltration stirred 
cell, (a) SDS PAGE gel stained with Coomassie blue dye, (b) Western blot 
using rabbit polyclonal anti-ES-62 (100 pg ml ) and anti-rabbit IgG-HRP 
(1:3000). Lane 1 -  crude media from infected cells; lane 2 -  proteins from 
the infected cell supernatant retained by the YM 100 membrane and 
dialysed into PBS; lane 3 - proteins from the infected cell supernatant 
retained by the YM 30 membrane and dialysed into PBS.
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Pui'ification of rES-62 using molecular weight cut off membranes appeared to be 
a hopeful first step however, dui'ing the optimisation of the purification strategy 
for rES-62 the yields of rES-62 being expressed by the baculovirus system were 
found to decrease. To overcome this problem, fresh SF9 cells were brought up 
from storage in liquid nitrogen, fresh TMN-FH and protein-h'ee media were used 
and new infective stock prepared. However, the yields of rES-62 expressed by 
the baculovirus system failed to improve. As a result a number of different 
conditions were then employed both for expression and purification of rES-62.
Infections of SF9 cells were previously canied out at a MOI of 10 following 
optimisation of infection. In order to test if  the decrease in yield of rES-62 was 
due to excessively high levels of expression overloading the cellular post- 
translational modification machinery, infection at a MOI of 1 was compared with 
that at a MOI of 10. It was also proposed that the pH of the SF9 cell medium (pH 
6.2) might be promoting the poor yields of rES-62. ES-62 is known to be stable 
at pH 7 and monomerises at pHs below 7 (section 5.1.4). SF9 cells were thus 
infected at both MOIs in normal medium and in medium adjusted to pH 7. In 
addition, the method employed to clarify the protein free media containing the 
secreted rES-62 was also examined. In all the expression trials, i.e. at MOIs of 10 
and 1 and at pH 6.2 and 7, half the sample was spun at 50,000 x g for 1 hour and 
the other half treated with DNase to remove any virus particle or DNA 
contamination respectively. An illustration of the conditions tested is shown in 
Figure 5-25.
MOI -  1MOL— 10
pH 6.2 pH 7
5 0 , 0 0 0  X  g  D N a s e 5 0 , 0 0 0  X  g  D N a s e
pH 6.2
5 0 , 0 0 0  X  g  D N a s e5 0 , 0 0 0  X  g  D N a s e
s p i n  t r e a t m e n t  s p i n  t r e a t m e n t  s p i n  t r e a t m e n t  s p i n  t r e a t m e n t
Figure 5-26: Conditions tested for baculovirus expression of rES-62.
Chapter 5 : Expression and Purification of Recombinant ES-62 217
The rES-62 obtained from each condition tested was then purified using filtration 
as discussed above (section 5.2.4.3 & Chapter 2). The samples obtained from 
these purifications were then resolved on a series of SDS PAGE and non­
denaturing, non-reducing polyacrylamide gels as shown in Figures 5-27 and 5- 
28. No rES-62 was present in the SF9 cellular pellets however, small amounts 
were present in the pellet obtained following the 50,000 x g ultracentrifuge spin, 
perhaps suggesting that rES-62 can bind viral DNA.
As shown in Figures 5-27 (a) and 5-28 (a), levels of rES-62 obtained following 
purification were again higher following infection of SF9 cells at a MOI of 10 
than at a MOI of 1. This substantiates the earlier optimisation studies, which 
demonstrated that infection of SF9 cells at a MOI of 10 yielded the highest levels 
of rES-62 expression. Adjusting the pH of the SF9 cellulai' medium from pH 6.2 
to 7, not only affected the growth of the SF9 cells which were less adherent and 
no longer round in appearance, but also led to reduced levels of rES-62 obtained 
following purification. As the protein-free SF9 media has presumably been 
optimised for growth of SF9 cells and given the changes in the SF9 cells when 
grown in pH 7 media this finding is perhaps not surprising. The final condition 
tested, the method of clarification of the medium harvested from infected SF9 
cells, appeared to have no effect on the levels of rES-62 obtained following 
purification. Wavelength scans of samples of the purified protein, clarified by 
either the 50,000 x g ultracentifuge spin or by DNase treatment also revealed that 
the maximum absorbance of the samples had not been shifted and remained at 
260 nm. This indicated that the DNA contamination was still present. Figures 5- 
27 (a) and 5-28 (a) show that rES-26 was present, as a very faint band, and that it 
appeal's to have been resolved at a corresponding position on the gel as the native 
protein. The heavily stained band of Figures 5-27 (b) and 5-28 (b) does not 
appear to be rES-62 as it does not run at the same molecular weight as native ES- 
62. The faint staining observed for rES-62 indicates that the levels of rES-62 
resolved on the gels were at the lower limit of detection when staining with 
Coomassie blue dye (0.3-1 pg). The yield of rES-62 obtained from baculovirus 
expression was less than 100 pg per flask of 2 xlO^ SF9 cells in 30 ml medium (3 
mg L'^)
Figure 5-27: Medium harvested from SF9 cells infected with recombinant 
baculovirus particles at MOIs of 1 and 10 in cell culture media at pH 6.2 and 7. 
The medium harvested from SF9 cells infected at different MOIs (10 or 1) and 
at different pHs (6.2 or 7.0) was clarified by either ultracentrifugation or DNase 
treatment and then purified by filtration through molecular weight cut off 
membranes as described in Chapter 2. M -  markers, wt - wild type ES-62,1 
indicates sample was spun at 50000 x g for 1 hour, 2 indicates sample was 
treated with DNase. 100 k or 30 k filter shows samples retained by the 100 k Da 
or 30 k Da filter respectively, (a) Samples resolved by SDS-PAGE, transferred 
to nitrocellulose and Western blotted with anti-ES-62 antibody, (b) Samples 
resolved by SDS-PAGE and stained with Coomassie blue dye.
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Figure 5-28: Medium harvested from SF9 cells infected with recombinant 
baculovirus particles at MOIs of 1 and 10 in cell culture media at pH 6.2 and 7. 
The medium harvested from SF9 cells infected at different MOIs (10 or 1) and 
at different pHs (6.2 or 7.0) was clarified by either ultracentrifugation or DNase 
treatment and then purified by filtration through molecular weight cut off 
membranes as described in Chapter 2. M -  markers, wt - wild type ES-62,1 
indicates sample was spun at 50000 x g for 1 hour, 2 indicates sample was 
treated with DNase. 100 k or 30 k filter shows samples retained by the 100 k or 
30 k filter respectively, (a) samples resolved on non-denaturing, non-reducing 
polyacrylamide gels, transferred to nitrocellulose and Western blotted with 
anti-ES-62 antibody, (b) samples resolved on non-denaturing, non-reducing 
polyacrylamide gels and stained with Coomassie blue dye.
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DNA contamination of the rES-62 was not removed using either of the two 
methods described above. Thus the rES-62 obtained was unacceptable for use in 
biological and biophysical experiments. The DNA contamination would have to 
be overcome before further development of the purification strategy for rES-62 
and biological experimentation utilising rES-62 would be possible.
5.2.5. Testing Recombinant ES-62
Utilising the baculovirus expression and purification strategy described above, 
further characterisation of the rES-62 was performed. As discussed, with 
reference to Figures 5-18, 5-20 and 5-22, Western blot analysis of gels of 
purified rES-62 show that the expressed protein is recognised by the polyclonal 
anti-ES-62 antibody. To determine if the rES-62 was correctly folded, slot blot 
analysis was performed utilising a monoclonal antibody, raised in mouse, known 
to recognise a conformational epitope of native ES-62. Figure 5-29 compares 
recognition of native and rES-62 by the monoclonal antibody. rES-62 is 
recognised by the monoclonal antibody suggesting that at least some of the 
recombinant protein is folded, or at least folded in the region of the 
conformational epitope.
1 2  3 4
Figure 5-29: Recognition of baculovirus rES-62 by monoclonal anti-ES-62. 
Baculovirus rES-62 samples (200 pi) were dotted onto nitrocellulose using a 
slot blotter. The nitrocellulose was blocked with 1 % BSA in TBS for 1 hour 
and then probed with mouse monoclonal anti-ES-62 serum (1:500) and 
Amersham anti-mouse-HRP (1:3000). 1 is native ES-62 control, 2 is pool A 
of rES-62,3 is pool B of rES-62 and 4 is the pool of rES-62 purified from 
crude protein-free media from infected SF9 cells by gel filtration alone. 
Pools A and B are the pooled rES-62 samples discussed earlier and shown in 
Figure 5-23.
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In addition, Western blotting of rES-62 was perfomied with TEPC-15 (anti-PC) 
antibody. Following treatment of the transferred nitrocellulose membrane as 
discussed in Chapter 2, no bands were visualised. This indicates that, as 
anticipated, the recombinant material being produced by the baculovirus 
expression system does not appear to have PC moieties attached to its 
carbohydrate chains.
5.5. Conclusions
Expression of rES-62 was achieved in the Novagen pET 19b bacterial expression 
system. However, the majority of rES-62 produced was insoluble and present in 
inclusion bodies within the bacterial cells. Refolding of the insoluble rES-62 was 
performed, but only a small proportion was successfully refolded. Optimisation 
of expression, lysis and purification of the soluble rES-62 obtained was caiTied 
out and both the soluble rES-62 and the refolded rES-62 purified using metal 
chelate chromatography. Purification of the soluble rES-62 yielded a significant 
amount of recombinant material -  approximately 10 mg Rom 6 L of bacterial 
culture. Unfortunately small angle x-ray scattering and analytical 
ultracentrifugation studies revealed that the rES-62 was highly aggregated and 
unsuitable for biophysical studies or in  vivo experimentation.
Native ES-62 is a tetramer of approximately 230 k Da, 6 % of wliich is 
carbohydrate. Native ES-62 also possesses phosphoiylcholine moieties attached 
to some of its cai'bohydrate chains. The quartemary structure of native ES-62 and 
the post-translational modification that occurs could explain the inability of a 
bacterial expression system to produce soluble, non-aggregated rES-62. Bacterial 
expression systems are incapable of post-translational modification thus the rES- 
62 produced will not be glycosylated and hence will also not possess 
phosphorylcholine moieties. Although this was precisely the reason for selecting 
a bacterial expression system, to allow study of the protein component of ES-62 
alone, it may also be a factor in the inability of this expression system to produce 
suitable rES-62. A number of hypotheses exist as to why the bacterial expression 
system did not appear to yield suitable protein. These include: (1) glycosylation
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in native ES-62 may mask hydrophobic regions and thus the lack of 
glycosylation in rES-62 may result in aggregation of the protein produced. (2) 
glycosylation may be essential for the correct folding of ES-62. Native ES-62 
cannot be deglycosylated without being denatured thus it is possible that the 
carbohydrate chains form an integral part of the structuie of ES-62 and that 
without them the protein cannot fold correctly and thus aggregates. (3) Native 
ES-62 is tetrameric. It is possible that tetramerisation is dependent on 
glycosylation of the monomeric units. The rES-62, which is not glycosylated, 
may not be able to coiTectly form tetrameric units and the deglycosylated 
monomer units may instead aggregate randomly, causing the obseiwed insoluble 
nature of the recombinant protein.
The aggregated nature of the bacterially produced rES-62 prevented study of the 
protein component of ES-62 alone. However, it provided a valuable insight into 
the vital stmctural role that the carbohydrate chains may play in the folding of 
native ES-62 and substantiated the suggestion from attempts to deglycosylate the 
native protein that the carbohydrate chains of ES-62 are an integral part of the 
structui’e of native ES-62.
Expression of rES-62 in the PharMingen baculovirus expression was successful 
and rES-62 was produced and purified. However, DNA contamination of the 
recombinant protein precluded characterisation of rES-62 via biophysical or 
biochemical studies. Optimisation of the purification stiutegy for rES-62 
produced by baculovirus determined that molecular weight cut-off membranes 
were able to sepaiute monomeric and tetrameric forms of rES-62, but were not 
sufficient to remove other contaminants present in the medium to yield pure rES- 
62. The use of anion exchange and gel filtration yielded rES-62 purer than that 
obtained from the use of molecular weight cut-off membranes, however, anion 
exchange was unable to separate monomeric and tetrameric forms of rES-62 and 
gel filtration suffered from restrictions on the sample size which could be loaded 
and successfully resolved. Concentration of the sample to be loaded onto the gel 
filtration column resulted in a loss of rES-62, which was thought to be due to 
rES-62 sticking to the membrane of the concentration device. A combination of
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anion exchange and filtration is considered to be the optimal purification 
strategy. Analysis, by absorbance measurement, of purified rES-62 obtained 
using either anion exchange or filtration indicated that the protein obtained was 
contaminated, possibly by DNA. This contamination would need to be overcome 
before the purification strategy could be developed further.
DNA contamination was shown to remain following either DNase treatment of 
the samples or ultracentrifugation at 50,000 x g to pellet the viral particles.
Studies performed with native ES-62, as discussed in Chapter 6, indicated that 
native ES-62 locates to the nucleus of cells, thus it is conceivable that ES-62 
might bind directly to DNA. Although initial experiments involving the 
incubation of native ES-62 with digested genomic DNA from macrophages and 
WEHI-231 B cells were inconclusive, binding of ES-62 to DNA might protect 
DNA from DNase, preventing digestion of contaminating DNA. The hypothesis 
that ES-62 binds to DNA is supported by additional work discussed in section 
6.3.4 which indicated that ES-62 is translocated to the nucleus. In addition, as 
discussed in chapter 3, ES-62 possesses a leucine rich region (Harnett et a l,
1999b). Leucine rich zipper motifs are known to mediate DNA binding.
Alternatively maximal absorbance at 260 nm may be indicative of the protein 
being incorrectly folded giving rise to anomalous absorbance.
Further work on this expression system would allow the study of the influence of 
the phosphorylcholine moieties on the immunomodulatory capabilities of native 
ES-62. The role of the PC moieties has been studied by comparing the signalling 
occurring in cells following incubation with PC or PC conjugated to BSA, with 
the signalling that occurs following incubation with ES-62 (Harnett et a l,
1999a). These studies show that PC can induce many, but not all of the effects 
induced by ES-62, indicating an important role for the PC moieties of ES-62. 
rES-62 lacking PC moieties would allow the effects induced by the protein 
component of ES-62 to be studied in more depth perhaps identifying a distinction 
between those effects induced by PC and those induced by the protein 
component of ES-62. One hypothesis proposed is that the PC moieties induce 
immunomodulatory effects which allow ES-62 to gain access to the cells where,
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once internalised, ES-62 can induce further longer term immunomodulatory 
effects which mask the presence of the parasite and the microfilariae from the 
infected hosts’ immune system.
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6. Mammalian Cell Response to ES-62
The effects of ES-62 on cells of the immune system, in paiticular the effects on B 
lymphocytes, have been studied in depth (Deehan et al., 1998a; Deehan et a l,
1998b; Goodridge et ah, 2001; Harnett & Harnett, 1999a; Harnett et ah, 1999; 
Harnett & Harnett, 1993; Harnett et al., 1989). These studies have shown that ES-62 
polyclonally activates certain protein tyrosine kinases (PTKs) and MAP Idnase 
signal transduction elements and modulates PKC activity and expression leading to 
desensitisation of both B and T lymphocytes to subsequent antigen receptor 
mediated activity. In addition, effects of ES-62 on antibody production and cytokine 
release lead to a biasing of the immune response to a Tli2 type phenotype which 
appears to be beneficial to the filarial nematode, allowing it to survive for long 
periods within the host. Some of the effects described can be mimicked by treatment 
of cells with PC alone (Harnett & Harnett, 1993) suggesting an important role for 
the PC moieties of ES-62. Although the effects induced by ES-62 have been studied, 
the receptor to which it binds is unknown, as is whether ES-62 requires to be 
internalised to induce its effects.
Previous work examining the binding of ES-62 to the membranes of monocytes, B 
lymphocytes and T lymphocytes and whether this binding was PC dependent had 
been performed using BiaCore technology (M. M and W. Harnett; Unpublished). 
BiaCore technology allows the identification of biomolecules and the monitoring of 
the kinetics of interaction between two biomolecules without the use of labels. It is 
based on surface plasmon resonance. As shown in Figure 6-1, light is directed at and 
reflected from the side of the surface of the BiaCore chip opposite to that which 
biomolecules can bind. Surface plasmon resonance causes reductions in reflected 
light intensity at particular wavelengths and angles. The binding of a biomolecule to 
the surface of the chip alters the refractive index and results in an alteration in the 
surface plasmon resonance (SPR) signal obtained.
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Figure 6-1: BiaCore technology (taken from the BiaCore web site 
httD://www.biacore.comA>iomol/biomol.shtmn Polarised light is reflected off the 
back surface of the sensor chip to which specific molecules can bind. The 
intensity of the reflected light (also known as the SPR signal) is measured by the 
optical detection unit. In the diagram shown, antibody molecules, which can 
recognise and bind a specific molecule (antigen), are attached to the surface of 
the sensor chip. Sample is injected into the flow channel and passes across the 
sensor chip. Binding of the antigen to the immobilised antibody results in a 
change in the refractive index of the chip, leading to a change in the SPR signal 
obtained. This alteration in SPR signal is detected by the optical detection unit 
and provides information on the kinetics of the binding of the antigen to the 
antibody.
Cell membranes from splenic B cells, U937 cells (monocytic cell line) and Jurkat 
cells (T cell line) were injected across a BiaCore chip surface to which ES-62 had 
been covalently attached and the kinetics of binding recorded. Figure 6-2 shows the 
graphs obtained for the binding of ES-62 to the membranes of these three immune 
system cell types.
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Figure 6-2: BiaCore analysis of the binding of membranes of U937 (monocytic) 
cells, B cells and Jurkat T cells to ES-62. -  Monocytic membranes, -  Jurkat (T 
cell line) cell membranes and -Splenic B cell membranes binding to ES-62. ES- 
62 was covalently attached to the sensor chip and the chip inserted into the 
BiaCore machine. The membrane under investigation was then injected into 
the BiaCore machine and washed over the sensor chip. On binding to ES-62 an 
increase in the SPR signal was seen. The rate of the increase in the SPR signal 
gives a measure of the kinetics of binding. Following injection of the sample 
under investigation, the sensor chip was washed in buffer and a decrease in the 
SPR signal was observed which corresponds to the dissociation of the cellular 
membrane from the chip bound ES-62. The rate of this decrease in SPR signal 
corresponds to the kinetics of dissociation. Progress of the different stages of 
interaction (association and dissociation) for splenic B cell membrane is shown.
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As shown in Figure 6-2, binding of ES-62 to the membranes of splenic B cells,
U937 monocytic cells and Jurkat T cells was observed to occur with different 
kinetics. ES-62 bound to splenic B cell membranes with rapid association and 
dissociation kinetics. Binding to U937 cell membranes occurs with much slower 
association and dissociation kinetics to those observed for binding to both splenic B 
and Jurkat T cell membranes. The differences in the kinetics of binding of ES-62 to 
splenic B, Jurkat T and U937 cell membranes implies that each of these cell types 
possess one or more molecules on their surface that ES-62 can exploit to elicit its 
effects and thus different molecules may be exploited as receptors for ES-62 on 
different cell types. Further studies in which TEPC-15 (anti-PC antibody) was 
passed across the BiaCore chips to which ES-62 was attached prior to injection of 
the cell membranes of splenic B cells, U937 monocytic cells or Juikat T cells into 
the flow cell found that binding of ES-62 to its receptors on these cell types was 
inhibited. This inhibition of binding of ES-62 to membranes following blockage of 
its phosphorylcholine moiety suggests that binding of ES-62 to receptors on the cell 
types is PC dependent.
It is known that PC is present on a number of different pathogens and is often 
involved in the entry of these pathogens into the host cells. This, in conjunction with 
the PC dependency of the binding of cellular membranes to ES-62, raised the 
possibility that the PC moiety of ES-62 could be responsible for receptor 
recruitment. A number of receptors, known to be expressed on B, T and monocytic 
cells, are known to recognise PC or act as pattern recognition receptors. The receptor 
for platelet activating factor (PAF) is known to interact with PC-containing bacteria 
(Cundell et aL, 1995) and the toll-like receptor (TER) family are pattern recognition 
receptors. Both TLRs and the PAF receptor demonstrate downstream signalling 
events similar to those induced in response to ES-62.
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6. /. Platelet Activating Factor Receptor
Platelet activating factor (PAF) is a unique phospholipid mediator which possesses 
potent proinflammatory, smooth muscle contractile and hypertensive activities. It is 
crucial in the pathogenesis of bronchial asthma and in the lethality of endotoxin and 
anaphylactic shock (Honda et al., 1991; Seyfried et al., 1992). The platelet 
activating factor receptor (PAF-R), which recognises PAF and through which PAF 
induces its effects, is encoded by a single gene on human chromosome 1 (Honda et 
al., 1991). It is a seven transmembrane G protein coupled receptor (GPCR) of 39 
kDa as shown in Figure 6-3 below.
Extracellular
Cytoplasmic 342 (341)
Figure 6-3: PAF-R structure. Amino acids in coloured characters are conserved 
among guinea-pig, human and rat PAF-R. Images taken from 
httD://www.biochem2.m.u-tokvo.ac.ip/web/contents/PAFR.html
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GPCRs form a large family of proteins with a diverse range of functions, which can 
be separated into distinct sub families on the basis of amino acid sequence. PAF-R 
belongs to the rhodopsin like family of GPCRs and is known to participate in the 
trafficking of leucocytes, generation of broncospasms and inflammation in asthma 
(Cundell et at., 1995).
Following interaction with ligand, the PAF-R modulates certain B cell activation 
responses in a similar fashion to the B cell suppression induced by ES-62, for 
example Erk and p38 forms of mitogen activated kinase are activated but jun is not 
(Marques et al., 2002). In addition, PAF-R rapidly internalises following ligand 
binding (Gerard & Gerard, 1994). The PAF-R is known to be expressed on B, T and 
monocytic cells and has been shown to act as the receptor for Streptococcus 
pneumoniae which expresses PC on its surface (Cundell et al., 1995) allowing S. 
pneumoniae to gain access to host cells through the internalisation of the PAF-R.
These factors raised the possibility of PAF-R acting as the receptor for ES-62, 
binding via the PC moieties (Harnett & Harnett, 1999a; Harnett & Harnett, 1999b).
The use of PAF-R by ES-62 could allow ES-62 to gain entry into the host cells to 
elicit its immunomodulatory effects or alternatively, ES-62 may desensitise cells to 
subsequent activation by abortive signalling via the PAF-R (Harnett & Harnett,
1999a).
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6,2, Toll-like Receptors
Toll-like receptors (TLRs) are human homologues of Toll receptors, pattern 
recognition receptors, first identified in drosophilia. Pattern recognition receptors 
recognise evolutionarily conserved motifs expressed by pathogens and act to 
modulate the host immune system. They have been proposed to initiate and link the 
innate and adaptive immune responses by recognition of conserved motifs such as 
certain groupings of carbohydrates moieties. TLRs play an important role in the 
innate immune system and have been proposed to play a crucial role in linking 
innate and adaptive immunity. TLRs, expressed on the cells of the innate immune 
system, can recognise pathogen associated structures, such as certain groupings of 
carbohydrate or phosphoiylcholine moieties. This leads to activation o f the TLRs, 
which can regulate the production of cytokines in order to polarise the phenotype of 
the adaptive immune response to either a Thl cell mediated, or a Th2 humoral, 
response. TLRs belong to the IL-IR/TLR receptor superfamily which can be split 
broadly into two sub-families, those with thiee Ig domains as their extracellular 
portion and those with a leucine rich extracellular portion. TLRs belong to the 
second of these two subfamilies. The cytoplasmic domain of the TLRs contains a 
region, known as the TIR domain, which is homologous to the IL -lR l cytoplasmic 
domain.
Investigation into the ligands for the TLR receptors have shown that TLR4 acts as 
the receptor for LPS from Gram negative bacteria as well as for a plant product,
Taxol, heat shock protein 60 and a respiratory syncytial virus coat protein F. TLR2 
can act as the receptor for lipopolysaccharide (LPS) from bacteria other than Gram 
negative bacteria and for bacterial lipoproteins, glycolipids and peptidoglycan.
TLRl and TLR6 have been shown to act in association with TLR2 and hence 
respond to some of the same ligands as TLR2. Both TLR2 and 6 are required for 
macrophage TNFa production in response to yeast and Gram positive bacteria 
(Heldwein et at., 2001; Krutzik et ah, 2001).
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As discussed, TLRs can polarise the phenotype of the adaptive immune response.
This is observed by recognition of LPS by CD 14 and its co-receptor TLR4 (Liu et 
al., 2001; Systems, 2000), which promotes polarisation of the adaptive immune 
response to a Thl response. The recognition of LPS by CD14 and TLR4 induces an 
inflammatory response with the release of IL-1, IL-6, IL-8 and TNF as a result of 
activation of NF-kB and AP-1 transcription factors. Activation of TLR2 on dendritic 
cells (DCs) by bacterial products triggers induction of IL-12 and it is believed to 
trigger maturation of DCs. This provides an innate mechanism by which microbial 
pathogens can preferentially activate a cell mediated (Thl) immune response (Hertz 
et al., 2001; Thoma-Uszyaski et ah, 2000). This ability to bias the immune system is 
o f particular interest in the search for the receptor of ES-62, as ES-62 is knovm to 
induce the biasing of the immune response to a Th2 type response.
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Ligand e.g. LPS/LBP
MyD88
MKK3/6 MKK7NIK, IKKs 
NF-kB
Figure 6-4: Signalling cascade of TLRs [adapted from (O’Neill & Dinarello, 
2000). MyD88, which has the TIR domain characteristic of TLRs but no 
extracellular domain, is located in the cytosol. It is believed to play a role in 
connecting TLRs with downstream signalling proteins (Means et aL, 1999; 
O'Neill & Dinarello, 2000) by forming a protein-protein interaction with the 
TLRs via their TIR domains (Xu et al., 2000). MyD88 recruits IRAK-1 and 2 
which recruit TRAF-6. TRAF-6 can then activate two kinases, TAB-1 and 
TAK-1. TAB-1 and TAK-1 are known to phosphorylate and activate NIK and 
IKK which leads to NF-kB activation. They are also believed to play a role in 
the activation of p38 and JNK possibly via phosphorylation and activation of 
MAPKK 3, 6 and 7.
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Based on the results of previous BiaCore studies that had determined that at least 
one receptor for ES-62 was present in the membranes of splenic B, U937 
(monocytic) and Jurkat T cells, the aim was to identify and further characterise the 
receptor employed by ES-62. In addition, the aim was also to determine if the effects 
induced in response to ES-62 were due to receptor binding alone or whether ES-62 
was internalised following receptor binding.
A number of different teclmiques were employed in the search for the receptor and 
in the localisation studies. In particular Far Western blot analysis and 
immunoprécipitations of a number of different B cell lines, Jurkat T cells and U937 
monocytic cells using biotin or FITC labelled ES-62 were employed to identify the 
receptor for ES-62. FACS, microscopy, radiolabelling and cellular fractionation 
were employed in an attempt to identify whether ES-62 is internalised following 
binding to immune system cells and, if internalised, its location within the cell.
In addition. Western blot analysis using a variety of antibodies against components 
of the core signalling pathways of B cells was employed to examine the effects 
induced on B cell signalling by ES-62 alone. Previous studies had examined the 
activation of signalling molecules in B and T cells following pre-incubation with 
ES-62 (4 houi*s) and stimulation with anti-immunoglobulin (anti-Ig). To examine the 
differences in activation of signalling molecules downstream of the BcR following 
stimulation with ES-62 or anti-Ig (which activates the B cell receptor), cells were 
incubated with either ES-62 or anti-Ig alone for various timepoints. These studies 
enabled the comparison of the signalling profile generated in response to ES-62 
treatment of cells with the known signalling profiles generated by ligation and 
activation of putative receptors such as the PAF receptor and the TLRs.
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6,3. Results
6.3.1. Receptor Binding
As mentioned above, work carried out using BiaCore technology revealed tliat 
membranes from U937 cells (a human monocytic cell line), murine splenic B cells 
and Jurkat cells (a human T cell line) bind to ES-62 with receptor like affinity. In an 
attempt to identify the proteins acting as receptors for ES-62, Far Western blot 
analysis of ES-62 binding to whole cell lysates of a number of different cell types 
was performed. As described in Chapter 2, the whole cell lysates were resolved by 
SDS PAGE and transferred to nitrocellulose. ES-62 binding was visualised by 
probing the nitrocellulose using ES-62 labelled by biotinylation. Exposure of the Far 
Western blots to anti-biotin-HRP allowed visualisation of the ES-62 biotin 
conjugate. Biotinylated ES-62 should bind to any proteins in the whole cell lysate 
that ES-62 would bind to in a physiological setting. This allows identification of 
proteins acting as the receptor for ES-62 along with any cytosolic or nuclear proteins 
to which ES-62 can bind. As shown in Figui'e 6-5 (a) two bands were identified as 
binding ES-62 from splenic B cell whole cell lysates resolved by SDS PAGE. These 
bands were of approximately 135 kDa and 82 kDa. In Jurkat whole cell lysates, 
resolved by SDS PAGE, six bands were identified. These bands were of 135 kDa, a 
doublet of 82 kDa, 53 kDa and two bands of lower moleculai’ weights 
(approximately 48 and 40 kDa). In U937 whole cell lysates, resolved by SDS PAGE, 
two bands of 82 kDa and approximately 60 kDa were observed. The band of 82 kDa 
identified in all three cell types may or may not relate to the same 82 kDa protein.
The identification of different banding patterns for the different cell types 
substantiates the hypothesis that different cell types employ different proteins as 
receptors for ES-62, first suggested by the different binding kinetics identified for 
different cell types using BiaCore technology.
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82 kDa -----►
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(b) 290 kDa
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290 kDa
135 kDa 
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53 kDa
Figure 6-5: Binding of ES-62 to proteins from splenic B cells, U937 cells and 
Jurkat cells, (a) Splenic B cell whole cell lysates (lanes 1), 11937 cell whole cell 
lysates (lane 2) and Jurkat cell whole cell lysates (lane 3) resolved on a 10 % 
SDS PAGE gel. (b) Splenic B cell whole cell lysates (lanes I), U937 cell whole 
cell lysates (lane 2) and Jurkat cell whole cell lysates (lane 3) resolved on a 10 % 
non-denaturing, non-reducing gel. In (b) red arrows denoted bands visualised 
by binding of biotinylated ES-62.
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As shown in Figure 6-5 (b) the band pattern observed alters when whole cell lysates 
are resolved under non-denaturing, non-reducing conditions. Under non-denaturing, 
non-reducing conditions a similar banding pattern is observed for splenic B, U937 
and Jurkat T cells, the bands observed are of a greater mass than those observed 
under denatming, reducing conditions. Resolution of splenic B cell and U937 cell 
whole cell lysates yields bands of approximately 200 and 150 kDa. Resolution of 
Jurkat T cell whole cell lysates yields three bands of approximately 290, 200 and 
150 kDa. These bands could correspond to oligomerisation of proteins to form 
receptor complexes. Homo-dimerisation of the protein of 135 kDa, observed under 
denaturing, reducing conditions in splenic B and Jurkat T cells, would give a 
complex of -290 kDa, as observed under non-denaturing, non-reducing conditions 
for Jurkat T cells. Homo-dimerisation of the protein of 82 kDa, observed under 
denaturing, reducing conditions in splenic B, U937 and Jurkat T cells would give a 
complex o f -150 kDa, as observed under non-denaturing, non-reducing conditions 
for splenic B, U937 and Jurkat T cells. Whereas hetero-oligomerisation of the 82 
and 135 kDa proteins, observed under denaturing, reducing conditions in splenic B 
and Jurkat T cells or two 82 kDa proteins and the 60 kDa protein, observed under 
denaturing, reducing conditions in U937 cells would yield a complex of -  200 kDa, 
observed under non-denatuihig, non-reducing conditions for splenic B, U937 and 
Jurkat T cells. Many proteins homo or heterodimerise in order to function as a 
receptor, for example the IE-2 receptor is a hetero-oligomer, as is the TNF-a 
receptor.
To identify whether homo and hetero dimérisation was occurring crosslinking 
studies were performed. WEHl-231 B cells were surface biotinylated, as described 
in Chapter 2, and incubated with an ES-62-FITC conjugate. A cross-linking agent 
(AEDP, Piece) was then added, the cells lysed and immunoprécipitation performed 
using an anti-FITC antibody. A sample of the immunoprécipitation was resolved on 
a 10% SDS PAGE gel under reducing and non-reducing conditions. The addition 
o f (3-merceptoethanoI, to resolve the sample under reducing conditions, resulted in 
the dissociation of the crosslinking bonds and thus allowed visualisation of the
Chapter 6: Mammalian Cell Response to ES-62 238
proteins which constitute the receptor complex for ES-62. Comparison of the stained 
gels obtained under reducing and non-reducing conditions did not indicate any 
differences in the banding patterns obtained. This indicates that no crosslinking 
occurred following ES-62 incubation, which may be attributable to the crosslinking 
reagent employed. Time constraints prevented optimisation of crosslinking agents, 
which may allow this issue to be resolved.
As discussed, previous BiaCore experimentation had shown binding of membranes 
from splenic B, U937 and Jurkat T cells to ES-62 to be PC-dependent. To determine 
if binding of ES-62 to those proteins identified by Far Western blotting (Figure 6-5) 
was occurring in a PC-dependent mamier, whole cells lysates from splenic B, U937 
and Jurkat T cells, resolved by SDS PAGE and transferred to nitrocellulose, were 
pre-incubated with PC prior to Far Western blot analysis with an ES-62-biotin 
conjugate. No bands were visualised following Far Western blot analysis of the pre- 
incubated blots indicating that binding of ES-62 to the proteins identified by Fai- 
Western blotting (Figure 6-5) was PC dependent, substantiating previous BiaCore 
studies.
Due to the observed differences in the proteins binding to ES-62 in murine splenic 
B, human U937 (monocytic) and human Jurkat T cells, the proteins identified as 
binding ES-62 from eells of different levels of maturity were examined to determine 
whether ES-62 exploits different proteins as receptors at different stages of immune 
cell development. The cell lines ehosen for study were from the B cell lineage as 
previous studies ((Deehan et ah, 1998a; Deehan et al., 1998b; Goodridge et ah,
2001; Harnett & Harnett, 1999a; Harnett et ah, 1999; Harnett & Harnett, 1993;
Harnett et ah, 1989)) examining the effects of ES-62 on the signalling pathways of B 
cells have been performed. Eight different cell types were chosen for investigation;
REH cells, Nalm6 cells, 697 cells, 207 cells, WEHl-231 cells, Daudi cells, Ramos 
cells and splenic B cells. REH, Nalm6, 697 and 207 cell lines are human pre-B cell 
lines of increasing maturity with the REH cell line being the most immature and the 
207 cell line being the most mature of these pre-B cells. The WEHI-231 cell line is
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an immature murine B cell line. The Ramos cell line is a mature human B cell line 
which is germinal centre like in character and the Daudi cell line is a mature human 
follicular/germinal centre like B cell line. Splenic B cells are murine naive primary 
B cells and as such are the only cells studied that are not activated or from a cell 
line. The developmental pathway of B cells can be seen in Figure 6-7.
Far Western blot analysis was carried out on whole cell lysates from REH cells, 
Nalm6 cells, 207 cells, 697 cells, WEHI-231 cells, Daudi cells, Ramos cells and 
splenic B cells resolved on a 10 % SDS PAGE gel and transferred to nitrocellulose.
m
135 kDa 
■82 kDa
-53 kDa
Figure 6-6: Binding of ES-62 to proteins from whole cell lysates of splenic B 
cells (lane 1), WEHI cells, (lane 2), Daudi cells, (lane 3), Ramos cells (lane 4), 
Naim 6 cell (lane 5), 207 cell (lane 6), 697 cell (lane 7) and REH cell (lane 8), all 
B cells of different stages of maturation. 20 pg of whole cell lysates from these 
cells were resolved on a 10 % SDS PAGE gel and transferred to nitrocellulose. 
Far Western blot analysis was then performed using ES-62-biotin and anti- 
biotin-HRP as described in Chapter 2.
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Figure 6-7: The developmental pathway of B cells. REH, Nalm6, 697 and 207 
cell lines are human pre-B cell lines of increasing maturity with the REH cell 
line being the most immature and the 207 cell line being the most mature of 
these pre-B cells. The WEHI-231 cell line is an immature murine B cell line. 
The Ramos cell line is a mature human B cell line which is germinal centre like 
in character and the Daudi cell line is a mature human follicular/germinal 
centre like B cell line.
Chapter 6: Mammalian Cell Response to ES-62 241
As shown in Figure 6-6, a band of 82 kDa was identified as binding ES-62 in all the 
B cell types analysed. However, the band of 135 kDa identified in splenic B cells 
and Jurkat T cells as binding ES-62 (Figure 6-4) is only present in splenic B cells 
and WEHI-231 B cells. In whole cell lysates from Nalm6, 697 and REH cell lines a 
band of approximately 125 kDa was identified, in addition to the 82 kDa band 
identified. In 207 cells a band of approximately 145 kDa band was identified in 
addition to the 82 kDa band. In Daudi and Ramos B cell lines, in addition to the 82 
kDa band, some lower molecular weight bands were also identified.
■5;
The differences in banding patterns between the different cell types suggests that a 
protein of 82 kDa, which binds ES-62 and is present in all cell types, perhaps forms 
the core component of the receptor for ES-62. The other proteins present in the 
receptor complex appear to vaiy depending on cell type (Figure 6-4) and on the level 
of maturity of the cell (Figure 6-5). The three earliest precursor B cell lines, REH,
697 and Nalm-6, all show similar banding patterns, different from those observed for 
more developmentally mature cell lines, sharing only the band of 82 kDa. The 207 
cell line which is more mature than the REH, 697 and Nalm6 cell lines, but is still 
classified a pre-B cell line due to cell surface marker expression, again shares the 82 
kDa band but the higher molecular weight protein identified is different fi'om both 
that identified in the more developmental immature and more developmentally 
mature cell lines.
All the analyses described above were carried out on whole cell lysates of cells, thus 
intracellular proteins as well as membranes proteins that bind ES-62 could be 
identified. Although the non-denaturing, non-reducing gels (Figure 6-4 (b)) indicate 
that the bands identified oligomerise, it is possible that some of the bands identified 
and shown in Figure 6-4 (a) and Figui'e 6-6 may not form part of the receptor 
complex for ES-62 but instead be intracellular proteins. To confirm which of these 
bands represent cell surface receptor chains for ES-62, ES-62 bound proteins from 
the surface biotinylated membrane fraction of U937 monocytic cells and WEHI-231 
immature B cells were immunoprecipitated as described in Chapter 2, resolved by
Chapter 6: Mammalian Cell Response to ES-62 242
SDS PAGE, transferred to nitrocellulose and visualised using an anti-biotin-HRP 
conjugate as shown in Figure 6-8.
(a) U937 monocytic cells (b) WEHI-231 immature B cells
135 kDa- 
82 kDa -
53 kDa
135 kDa
82 kDa
53 kDa
Figure 6-8: Immunoprécipitation of surface biotinylated membrane proteins 
that bind ES-62 from (a) U937 monocytic cells and (b) WEHI-231 immature B 
cell membranes fractions. U927 monocytic cells and WEHI-231 immature B 
cells were biotinylated, membrane fractions made and probed for ES-62 
binding using an ES-62-FITC conjugate. Immunoprécipitation was then 
performed using anti-FITC antibodies and protein G-sepharose. This 
immunoprécipitation allowed the isolation of the membrane proteins bound to 
ES-62.
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As shown in Figme 6-7, the immimoprecipitation experiment from WEHI-231 B cell 
membranes identified bands capable of binding ES-62 of 135 and 82 kDa. These 
bands are the same size as those observed following Fai' Western blot analyses 
(Figure 6-5). The immunoprécipitation experiment from U937 cell membranes 
identified a greater number o f proteins that are capable of binding ES-62 than the 
Far Western analyses of U937 cell whole cell lysates. The bands identified as 
binding ES-62 were of 135,100, 90, 82 and -65 kDa (Figure 6-7). Far Western blot 
analysis only identified bands at 82 kDa and -65 kDa (Figure 6-4). The 53 kDa band 
identified from WEHI-231 cell membranes and the 135, 100 and 90 kDa bands 
identified from U937 cell membranes as binding ES-62 (Figure 6-7) suggest the 
presence of a greater number of membrane proteins capable of binding ES-62 than 
were identified from the Far* Western blots. The identification of these bands 
following immunoprécipitation, but not following Far Western blot analysis is 
postulated to be due to protein concentmtion. Only the cellular membrane proteins 
are analysed in the immunoprécipitation experiments whereas all cellular proteins 
are present in the whole cell lysates studied by Far Western blot analysis. As a 
result, the immunoprécipitations were carried out on an enriched membrane protein 
source and thus, it is postulated, the immunoprécipitations allow visualisation of 
proteins capable of binding ES-62, not present in sufficiently high quantities in the 
Far Western blot analyses.
The molecular weights of the bands identified as binding ES-62, approximately 82 
and 135 kDa, could not lead to direct identification of specific proteins, as there are 
many proteins with molecular weights in the range of 80 to 140 kDa. However, the 
molecular weights of the bands identified as capable of binding ES-62 does exclude 
the PAF receptor, which has a molecular weight of 39 kDa. The data from the Far 
Western blot analyses and the ES-62 immunoprécipitation experiments 
demonstrated that the two major proteins to which ES-62 binds are of approximately 
82 and 135 kDa in size. Further, these experiments demonstrated that binding to ES- 
62 is PC dependent. As a result of these studies, two protein families, the integrin
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and toll-like receptor families, were investigated as an initial step in the 
identification of the receptor for ES-62.
6J,1.L Integrins
Integrins are the principal receptors on mammalian cells for binding most 
extracelluar matrix proteins including collagen, fibronectin and laminin. Unlike 
typical cell surface receptors for soluble cell signalling molecules, integrins bind 
their ligand with relatively low affinity (Ka =10^-10^  litres mol'^). In addition 
integrins are typically present at the cell surface at concentrations 1 0 -1 0 0  times 
greater than other receptors (Alberts et al., 1994). Integrins are also involved in the 
immune response. They play roles in leukocyte, neutrophil and dendritic cell 
recruitment and can influence signalling pathways by transducing signals or by 
interfering with the signalling of other receptors. For example, a defect in the 
synthesis of the common integrin (32 chain results in a susceptibility to infection 
with extracellular bacteria (Janeway & Travers, 1996). In addition, integrins are also 
knovm to induce intracellular signalling in response to stimuli (Alberts et ah, 1994). 
In macrophages, the leukocyte integrin GDI lb/CD 18 (as known as CR3) is capable 
of recognising EPS, lipophosphoglycan of Leishmania and structures on yeast such 
as Candida (Janeway & Travers, 1996).
Integrins are heterodimers consisting of an a  and a p subunit, both of which 
contribute to the binding of matrix proteins. Each a p  heterodimer is specific for a 
particular ligand and has a distinct ligand binding specificity. Further, identical 
integrin molecules in different cells types have been determined as having different 
ligand binding specificities. This has been postulated to be due to cell type specific 
factors able to modulate ligand binding. There are 25 known integrins, which consist 
o f various combinations of at least 1 7 a  and 9 p subunits. The a  and p subimits vary 
greatly in size, the a  subunits ranging between approximately 120 to 210 kDa, the p 
subunits ranging between approximately 95 to 220 kDa. These size ranges are 
generally similar to the molecular weights of the proteins identified as capable of
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binding ES-62. This, in conjunction with the involvement of integrins in signalling 
and general immune system modulation, led to the investigation of integrins as 
receptors for ES-62.
Binding of ligands to integrins can be blocked by the presence of molecules such as 
fucose which bind to the integrins and block binding of extracellular matrix proteins, 
intracellular adhesion molecules and complement components. In addition, at least 8 
of the 25 known integrins are known to recognise a sequence motif of Arg-Gly-Asp 
(RGD) (Assa-Munt et a l,  2001). Integrin binding via the RGD (or related) motifs 
has been shown to be blocked by the use of RGD peptides (Kijimoto-Ochiai &
Noguchi, 2000; Rahman et al., 2000).
The use of the RGD motif by pathogens to gain entry into the host cells via integrins 
has been shown for Bordetellapertussus (Hagen & Klager, 2001). Integrin-like 
RGD-dependent cell adhesion has also been shown to be involved in the removal of 
Onchocerca microfilariae within a specific species of the vector for human and 
bovine onchocerciasis, the blackfly, S.damnosum (Ishibashi et al., 2001). Research 
into the integrin-like receptors of the blackfly haematocytes has shown that the 
presence of the peptide sequence RGDS, as a blocking agent, significantly increases 
the survival of Onchocerca microfilariae. This finding raises the possibility that 
integrins, and in particular those recognising the RGD motif, could play a role in 
filarial disease. In addition, the identification of several DDX (Asp-Asp-any amino 
acid) motifs, the complementary motifs of the RGD motifs, within the amino acid 
sequence of ES-62 strengthens the hypothesis that integrins could be acting as the 
receptor for ES-62. To examine the possibility that integrins act as receptors for ES- 
62, WEHI-231 B cells were biotinylated and membrane fractions prepared. The 
biotinylated membrane fractions were pre-incubated with media alone or media 
containing 1 mM fucose, 1 mM PC, 1 mM RGDS (Arg-Gly-Asp-Ser) peptide or 1 
mM RGBS (Arg-Gly-Glu-Ser) peptide prior to incubation with an ES-62-FITC 
conjugate and subsequent immunoprécipitation using anti-FITC and protein G - 
sepharose. The membrane proteins capable of binding ES-62-FITC were resolved by
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SDS PAGE, transfen’ed to nitrocellulose and visualised by probing with an anti- 
biotin-HRP conjugate. Fucose was used to test for the involvement of integrins 
while RGDS and RGBS peptides were used to identify if the integrins involved 
interacted via RGD motifs. Pre-incubation with an RGDS peptide would block any 
binding that was occurring, the RGBS peptide was employed as an irrelevant peptide 
control.
As can be seen from Figure 6-9, pre-incubation with fucose or either of the peptides 
had no effect on binding suggesting that integrins are not involved in the receptor 
complex for ES-62. As a positive control, and for further corroboration, the PC 
dependent nature of ES-62 binding was examined with regard to the membrane 
proteins that ES-62 bound in these assays. Figure 6-9 shows that pre-incubation of 
biotinylated WEHI-231 B cell membranes with PC substantially blocks the binding 
of ES-62 to the membrane proteins of WEHI-231 B cells. This substantiates earlier 
findings from BiaCore and Far Western analyses that ES-62 receptor binding is PC 
dependent.
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Figure 6-9: Effects of phosphorylcholine, fucose, RGDS and RGES peptides on 
binding of ES-62 to membrane proteins from WEHI-231 B cells. WEHI-231 B 
cells were biotinylated and the membrane fraction of these cells then extracted. 
The biotinylated WEHI-231 B cell membranes were then pre-incubated with 
either media alone or media containing 1 mM PC, I mM fucose, 1 mM RGDS 
peptide or 1 mM RGES peptide prior to immunoprécipitation with ES-62- 
FITC, anti-FITC antibodies and protein G-sepharose. Lane 1 contains WEHI- 
231 B cell membranes pre-incubated with media alone and then 
immunoprecipitated with ES 62 FITC. Lanes 2 - 5  contain WEHI-231 B cell 
membranes pre-incubated with media containing 1 mM PC (lane 2), 1 mM 
fucose (lane 3), 1 mM RGDS peptide (lane 4) or 1 mM RDES peptide (lane 5) 
and then immunoprecipitated with ES-62-FITC.
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63 ,L2, Toll-Like Receptors
Following exclusion of the role of the PAF receptor and integrins as receptors for 
ES-62, studies were carried out to ascertain whether any of the TLRs act as a 
receptor for the filarial ES product, ES-62. TLRs, as discussed previously, are 
pattern recognition receptors and as such recognise features such as specific 
carbohydrate motifs and phosphoiylcholine moieties on proteins. TLRs play an 
important role in both the innate and adaptive immune response and ai*e known to 
act as part of the receptor for LFS. Stimulation of the TLRs results in the activation 
of NFkB and MARK activity wliich, as discussed in section 6.3.2, are also induced 
by ES-62. These factors, in conjunction with the mass of the TLRs, which ranges 
between 70-90 kDa, make the TLR family a strong candidate for the role of ES-62 
receptor.
Interestingly, TLR4 is believed to be involved in the induction of inflammatory 
responses by Brugia malayi. These responses are mediated by LPS-like activity from 
the endosymbiotic Wolbachia bacteria which, it is believed, exploits TLR-4 as its 
receptor (Taylor et al., 2000). Wolbachia bacterial LPS may be one of the major 
mediators of inflammatory pathogenesis in filarial nematode disease. However, it 
should be noted that Wolbachia bacteria are not found on A.viteae, which is the 
filarial parasite from which ES-62 is obtained (Kennedy & Harnett.W., 2001;
Werren, 1997).
To investigate if TLR2 or TLR4 were acting as the receptor for ES-62, the blot 
shown in Figure 6-6 above was stripped of antibody, tested for the presence of any 
residual ES-62-biotin and then reprobed with anti-TLR2 and anti-TLR4 antibodies 
in turn (the efficient stripping of each of these antibodies was tested). Probing of this 
blot with the TLR2- and TLR4-specific antibodies in turn produced the banding 
patterns shown in Figure 6-10. This experiment was also repeated with fiesh whole 
cell lysate samples resolved as described previously and probed with anti-TLR2 and 
anti-TLR4 antibodies from a different source. The results obtained were very similar
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to those reproduced in Figure 6-10 (results not shown). The results shown in Figure 
6-10 suggest that the 82 kDa protein identified as binding ES-62 in all cells except 
U937 cells, Jurkat cells and Nalm6 cells is a TLR. Unfortunately both the anti-TLR2 
and 4 antibodies show identical banding patterns. This could be the result of cross­
reactivity which is widely known to occur- between TLR antibodies of common 
sequence specificity. However, as a result it was not possibly to identify which of 
these two TLRs binds ES-62 or whether both are capable of binding ES-62. The 
differences in the level of TLR 2 and TLR 4 detected for each cell type may be due 
to differential recognition of the TLR present by these two antibodies.
Alternatively, the differences in levels of TLR 2 and 4 identified in the different cell 
types may be due to cell type differences, resulting in different levels of TLR 
proteins being expressed at the cell surface. Many of the cell types studied are B 
cells of different levels of maturity; REH cells as the most developmentally 
immature of the pre B cells through 207 cells, more developmental mature pre B 
cells, to WEHI-231 immature B cells and finally Daudi and Ramos follicular B cells. 
Consideration of the levels of TLR 2 and 4 detected in relation to the development 
of the various B cell types indicates that the levels of TLR 2 and 4 identified 
increases as B cells develop. TLRs are involved in the innate and adaptive immune 
response thus an increase in expression of TLRs as the B cells develop could be 
expected, as only fully developed cells play an active role in the host immune 
response and thus have a requirement for TLR cell surface expression.
The identification of only one of the two proteins that bind ES-62 as a TLR suggests 
that either the TLR involved is recruiting a TLR which is not recognised by either 
the TLR2 and 4 antibodies or that the second protein involved in the recognition of 
ES-62 is not a TLR but is recruited and can form a heterodimer with these proteins 
as is the case with the receptor for LPS.
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Figure 6-10: Potential identification of the p82 protein of B cells that binds ES- 
62 as one or more Toll-like receptors. Whole cell lysates of splenic B cells (lane 
1), U937 cells (lane 2), Jurkat cells, (lane 3), WEHI cells, (lane 4), Daudi cells, 
(lane 5), Ramos cells (lane 6), Naim 6 cell (lane 7), 207 cell (lane 8), 697 cell 
(lane 9) and REH cell (lane 10) were resolved on a 10 % SDS PAGE gel, 
transferred to nitrocellulose and (a) Far Western blotted using ES-62-biotin 
and anti-biotin-HRP as described in Chapter 2, (b) Western blotted with anti- 
TLR2 antibody and (c) Western blotted with anti-TLR4.
Chapter 6: Mammalian Cell Response to ES-62 251
6.3.2. ES-62 Effects on Erk, JNK  and p38
TLR receptors couple to NFkB and Erk, Jnk and p38 MAPK signalling. Previous 
work in this laboratory has shown that ES-62 stimulates Erk, MAPK (B cells, T cells 
and macrophages) and NFkB (macrophages) (Deehan et al., 1998a; Goodridge et ah, 
2001). These findings could lend support to the putative identification of TLR 
involvement in ES-62 signalling. To further explore this, the effects of ES-62 on 
MAPK and NFkB signalling was examined in B cells. Splenic B cells were 
stimulated with either ES-62 or anti-Ig for 1, 5,10, 30, 60, 120 and 240 minutes.
Whole cell lysates of the stimulated cells were prepared and resolved by SDS 
PAGE, transferred to nitrocellulose and Western blotted with anti-phospho Erk, anti- 
phospho JNK and anti-phospho p38.
As shown in Figure 6-11, following treatment of splenic B cells with anti-Ig, 
phosphorylated Erk was detected after 30 minutes and was still present (at slightly 
higher levels) after 240 minutes. Treatment of splenic B cells with ES-62 resulted in 
detection of phosphorylated Erk after 5 minutes. Activation of Erk was maximal 
following stimulation of splenic B cells for 30-60 minutes with ES-62. The level of 
phosphorylated Erk detected then decreased with time up to 240 minutes.
Following stimulation of splenic B cells with anti-Ig, phosphorylated Jnk was 
detected after 1 minute. Stimulation of splenic B cells with ES-62 also resulted in an 
increase in the level of activation of Jnk. Similar to the results obtained following 
stimulation with anti-Ig, activation of Jnk following ES-62 stimulation was observed 
after one m inute,. However, splenic B cells stimulated with ES-62 did not exhibit 
the same prominent initial activation and deactivation kinetics as observed in cells 
stimulated with anti-Ig. Following stimulation with ES-62, activated Jnk could still 
be detected after 240 minutes whereas activated Jnk could no longer be detected 
after 60 minutes following stimulation with anti-Ig, indicating that the activation 
induced by ES-62 is less transient than that induced by anti-Ig.
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Phospho p38 was not detected in either the ES-62 or anti-Ig treated cells. The 
absence of detectable phospho p38 may be due to a lack of sensitivity and specificity 
of the phospho p38 antibody rather than a lack of phospho p38 within the cells.
Erk 1/2
Erk 1/2
10 30 60 120 240
ES-62
0 30 60 120 240
Anti-lg
(b)
0 1 5 10 30 60 120 240 1 5 10 30 60 120 240
Control Anti-Ig
1 5 10 30 60 120 240
ES-62
■pJnk
Figure 6-11: ES-62 causes an initial activation of Erk and Jnk followed by a 
rapid deactivation. 6.4 x 10^  control splenic B cells or splenic B cells treated 
with medium containing either ES-62 (2 pg ml *) or anti-Ig (50 pg ml ) for 0 ,1 , 
5 ,10 ,30 , 60,120 or 240 minutes were lysed and resolved on 7.5 % SDS PAGE 
gels, transferred to nitrocellulose and probed with (a) anti phospho Erk or (b) 
anti phospho Jnk antibodies. Probing of the blots in (a) was also carried out 
with anti-Erk, which detects both phosphorylated and non-phosphorylated 
forms of Erk, as a loading control. The bands were visualised through use of 
HRP conjugated secondary antibodies and Amersham ECL technology.
Earlier work (Deehan et al., 1998a) indicated that stimulation of splenic B cells with 
anti-Ig following pre-incubation with ES-62 did not lead to activation of Erk. The
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results above show that stimulation of splenic B cells with ES-62 alone induces an 
initial activation of Erk however, this activation is rapidly switched off. ES-62 
treatment thus appears to desensitise the cells to further activation. It is postulated 
that ES-62 treatment causes the activation, and thus dual phosphorylation, of Erk, 
and that it also recruits a phosphatase which rapidly dephosphorylates the dual 
phosphorylation sites of Erk (Deehan et ah, 2001).
6.3.3. ES-62 Modulates Transcription Factor Activity
NFkB transcription factors are a family of eukaryotic transcription factors that are 
involved in the normal cellular processes including immune and inflammatory 
responses. The NFkB proteins are all related through a highly conserved DNA- 
binding domain known as the Rel homology (RH) domain which contains DNA- 
binding and protein dimérisation motifs and a nuclear localisation signal. However, 
they can be divided into two classes; the first class contains Rel A (p65), RelB and 
c-rel which possess transactivation domains and as such can induce gene 
transcription. The second class, p50 and p52, do not possess this domain and cannot 
directly induce gene transcription. NFkB proteins exist as homo or heterodimers and 
members of the second class can only induce gene transcription when they form a 
heterodimer with a member of the first class. NFkB homo and heterodimers exist in 
an inactive state in the cytoplasm of cells bound to an inhibitory IkB protein. 
Following cellular activation, IkB may be phosphorylated and dissociate from the 
NFkB dimer allowing its translocation to the nucleus and subsequent gene 
transcription as shown in Figure 6-11.
Electromobility shift assays (EMSAs) were performed on nuclear fractions of 
WEHI-231 B cells treated with media alone (control) or ES-62 for a range of times 
from 5 minutes to 48 hours. As shown in Figure 6-13, following ES-62 stimulation 
of WEHI-231 B cells, an initial increase in both E2F and NFkB activity was 
observed at early timepoints. This was followed by a downregulation at later time 
points. This coiTelates with the work discussed in section 6.3.2 and earlier work
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(Deehan et al., 1998a) that showed that ES-62 causes an initial partial activation of 
the signalling pathway downstream of the B cell receptor. This partial activation is 
insufficient to induce a full response however, it results in desensitisation of the cells 
to further exposure to ES-62 and the down-regulation of the PI3K and Ras-MAPK 
signalling pathways. As shown in Figure 6-14, Western blot analysis of the nuclear 
and cytosolic fractions of WEHI-231 B cells stimulated with ES-62 was carried out 
to examine the effects of ES-62 on the localisation and expression of the p65 and 
p50 subunits of NFkB.
SIGNALS
Cytoplasm
IkB Kinase
Nucleus
Figure 6-12: Activation of NFkB and its subsequent translocation to the nucleus 
to induce gene transcription.
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Figure 6-13: EMSA, using labelled probes for (a) NFkB and (b) E2F. 
Following incubation of WEHI-231 B cells with media alone (control) or media 
containing ES-62 (2 pg ml ) for 5 ,10 ,30 , 60,120, 240 minutes or 48 hours, 
nuclear fractions were prepared, incubated with radiolabelled probe and 
resolved on a 6 % polyacrylamide gel. The gel was then fixed (2 methanol : 1 
acetic acid : 1 glycerol : 6 water (v/v)) for 20 minutes, dried in a gel drier for 1-2 
hours at 80 "C and developed using autoradiography.
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Figure 6-14: ES-62 stimulation of WEHI-231 B cells alters the levels of the p65 
and p50 subunits of NFkB. WEHI-231 B cells were incubated with ES-62 (2 pg 
ml ) for 5 ,10 ,30 , 60,120, 240 minutes or 24 hours. Cytosolic and nuclear 
fractions were made of each sample and 30 pg of each of the cytosolic fractions 
and 15 pg of each of the nuclear fractions resolved on a 10 % SDS PAGE gel, 
transferred to nitrocellulose and Western blotted with anti p65 and anti p50 
antibodies. Western blotting with NFkB p50 subunit antibody is shown in (a) 
while Western blotting with NFkB p65 subunit antibody is shown in (b).
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As shown in Figure 6-14, ES-62 stimulation of WEHI-231 B cells results in an 
overall decrease in the level of the p50 subunit of NFkB in the cytosolic fraction, 
compared to the levels of p50 in the cytoplasmic fraction of the control cells. The 
decrease in the p50 subunit is especially noticeable at the 30 minute and 1 hour 
timepoints where only a very low level of p50 was detected. The p50 subunit of 
NFkB was not detected in the control cell nuclear fraction. However, the p50 
subunit o f NFkB was detectable in the nuclear fractions from ES-62 treated cells 
especially at the 30 minute timepoint. This correlates with the decrease in the levels 
of the p50 subunit observed in the cytosolic fractions at 30 minutes and could 
indicate ti'anslocation of the p50 subunit o f NFkB to the nucleus.
A decrease in the level of the p65 subunit of NFkB is also observed in the cytosolic 
fractions of WEHI-231 B cells stimulated with ES-62. This decrease is especially 
noticeable at 30 minutes. In contrast, the level of the p65 subunit in the nuclear 
fractions of WEHI-231 B cells stimulated with ES-62 at 30 minutes is increased 
compared with control cells. Similarly to the results observed for the p50 subunit of 
NFKB, this indicates that translocation of the p65 subunit to the nucleus is occurring. 
Translocation of both the p50 and p65 subunits to the nucleus in response to ES-62 
stimulation of WEHI-231 B cells suggests that ES-62 induces upregulation of 
NFkB. This correlates with the data obtained from the EMSA experiment, shown in 
Figure 6-10 (a), which indicate that upregulation of NFkB occurred following ES-62 
stimulation of WEHI-231 B cells for 30 minutes.
As it appears that ES-62 induces changes in the levels of the two transcription 
factors, NFkB and E2F, it is postulated that this transcription factor modulation 
occurs in order to induce some of the immunomodulatory effects which have been 
attributed to ES-62. The induction of changes in the levels of transcription factors in 
ËS-62 treated cells and, in particular the change in levels of NFkB, lends support to 
the proposition that TLRs could be involved as receptors for ES-62. The modulation 
of E2F by ES-62 could explain the decrease in B cell proliferation observed
Chapter 6: Mammalian Cell Response to ES-62 258
following ES-62 stimulation of B cells as E2F is involved in the regulation of the 
cell cycle and thus in the division of cells.
6.3,4. Subcellular localisation
In addition to identifying the receptors of ES-62, the fate of ES-62 following 
receptor binding was also examined to determine whether ES-62 is internalised 
following receptor binding. Should ES-62 be internalised, ES-62 may bind 
intracellular proteins to induce immunomodulatory effects on immune system cells. 
The concept that ES-62 may be internalised following receptor binding was 
postulated in view of studies (O.Halaas, Keystone Symposium, 2001) which 
demonstrated that at least TLR2 translocates to the nucleus following stimulation. 
As an initial experiment to investigate whether ES-62 was internalised following 
receptor binding, nuclear and cytosolic fractions of macrophages stimulated with 
ES-62 (2 pg ml"*) for 10, 30 minutes, 1, 2, 4, 6, 8, 12 or 18 hours were obtained 
from Dr. H. Goodridge, resolved by SDS PAGE, transferred to nitrocellulose and 
Western blotted with anti-ES-62 antibody. As shown in Figure 6-15, ES-62 was 
detected in both the cytosolic and nuclear fractions of macrophages stimulated with 
ES-62.
As shown in Figure 6-15, with time ES-62 is located in both the cytoplasm and 
nucleus of macrophages incubated with ES-62. ES-62 appears to be present as a 
doublet of approximately p55 and 60 kDa in the nuclear fraction and as a single 
band of approximately 55 kDa in the cytoplasmic fraction. This suggests that ES-62 
is undergoing modification following internalisation. ES-62 has been shown to 
possess aminopeptidase activity as mentioned previously. It is possible that ES-62 
may undergo self digestion, utilising the aminopeptidase activity that it possesses to 
yield a modified form of the protein, which is capable of inducing further 
immunomodulatory effects.
Figure 6-15: ES-62 is internalised by macrophages following receptor binding 
and is located in both the nucleus and cytosol of these cells, (a) Cytoplasmic 
fractions of macrophages incubated with ES-62 (2 pg ml *) for 10,30 minutes, 1, 
2, 4 ,6 ,8 ,1 2  or 18 hours and Western blotted using anti-ES-62 as described in 
Chapter 2. (b) Nuclear fractions of macrophages incubated with ES-62 (2 pg 
ml ) for 10,30 minutes, 1 ,2 ,4 ,6 , 8,12 or 18 hours and Western blotted using 
anti-ES-62 antibody as described in Chapter 2. (c) Blot (b) described above 
stripped following Western blotting with anti-ES-62 antibody, and Western 
blotted with TEPC-15 (anti-PC) antibody. Cytoplasmic and nuclear fractions of 
macrophages incubated with ES-62 were obtained from Dr. H. Goodridge as 
were the scans shown in (a) and (b) above.
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(a) Cytosolic fractions Western blotted with anti-ES-62 antibody.
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(b) Nuclear fractions Western blotted with anti-ES-62 antibody.
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(c) Nuclear fractions Western blotted with TEPC-15 (anti-PC) antibody.
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Figure 6-15: ES-62 is internalised by macrophages following receptor binding 
and is located in both the nucleus and cytosol of these cells.
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Western blotting of the resolved nuclear and cytosolic fractions of macrophages 
stimulated with ES-62 with TEPC-15 (anti-PC) revealed that only one of the two 
bands in the nuclear fractions demonstrated to be PC-containing ES-62 and that the 
ES-62 present in the cytoplasm did not contain PC (not shown). This suggested that 
2 forms of ES-62 were present in the nucleus of ES-62 treated macrophages; wild 
type ES-62 i.e. that containing PC, and a PC lacking form of ES-62. The PC lacking 
form of ES-62 is the form present in the cytoplasm of ES-62 treated macrophages.
The identification of bands by TEPC-15 (anti-PC) similar to those identified by anti- 
ES-62 corroborates the finding that ES-62 is internalised following receptor binding.
One hypothesis is that ES-62 is internalised by macrophages following receptor 
binding and is delivered, by an as yet unknown method, to the nucleus of the cells.
Once in the nucleus it is modified in such a way that the PC moieties are removed 
and the PC lacking form of ES-62 then locates to the cytoplasm. PC is known to act 
as a second messenger and to possess immunomodulatoiy properties (Cuadrado et 
al., 1993). Therefore it is possible that ES-62 is modified to release the PC moieties 
so that the PC moieties can induce various signalling effects within the cell, 
including some of the observed immunomodulatory effects. The PC lacking form of 
ES-62 may translocate to different regions of the cell and induce further 
immunomodulatoiy effects.
Following the discovery that ES-62 was internalised by macrophages and was 
located in both the nucleus and cytoplasm of these cells, the fate of ES-62 following 
receptor binding in B cells was examined using the murine immature B cell line, 
WEHI-231. As a result of the identification of different forms of ES-62 in the 
nucleus and cytoplasm of ES-62 stimulated macrophages, radiolabelled forms of ES- 
62 were employed to allow the quantitative measurement of the different forms of 
ES-62 present. Two radiolabelled forms of ES-62 were made and supplied by 
Professor W. Harnett, Strathclyde. The two forms utilised were [^H]-choline labelled 
ES-62, and [^^S] labelled ES-62. The [^H]-choline labelled ES-62 allowed the 
location of the PC-containing ES-62 to be determined while the f  ^ S] labelled ES-62
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allowed the location of the protein component of ES-62 to be determined regardless 
of the presence or absence of PC moieties. WEHI-231 B cells were incubated with 
either [^H]-choline labelled ES-62 or [^^S] labelled ES-62 over a range of timepoints 
and cytosolic and nuclear fractions prepared for each timepoint. The levels of 
radiolabelled ES-62 present in each sample was then measured using a scintillation 
counter as described in Chapter 2. The data obtained is shovsai in Figure 6-16, 
presented in a graphical format with the background counts subtracted. As shown in 
Figure 6-16, [^H] choline labelled ES-62 was detected rapidly within the nucleus, 
with two peaks, one at 30 minutes and the other at 4 hours. [^H] choline labelled ES- 
62 was also detected in the cytosol of the cells, but at very low levels. Following 24 
hour incubation of [^H] choline labelled ES-62 with WEHI-231 B cells, PC-ES-62 
was not detected in the nucleus and was only present in very small quantities in the 
cytoplasm. This suggests that PC-ES-62 was degraded in a relatively short time 
period either by proteases within the cell or by self-degradation. In vivo, ES-62 is 
secreted by the parasite continually giving rise to a constant level of ES-62 present 
in the host bloodstream. The degradation of PC-ES-62 could be the result of a host 
immune response mounted against ES-62 or it could be a method by which the 
parasite limits the level of immunomodulation induced.
[^^S] labelled ES-62 was detected in both the nucleus and the cytosol of WEHI-231 
B cells. Peak levels of [^^S] labelled ES-62 were detected between 1 and 4 hours. 
Similarly to [^H] choline labelled ES-62, the levels of [^^S] labelled ES-62 were 
undetectable following 24 hours incubation. The levels o f [^^S] labelled ES-62 
detected were greater in the cytosol than in the nucleus. These results demonstrate 
that while the protein component of ES-62 can be shown to reside in both the 
cytosol and nucleus of cells, the majority resides in the cytosol. In contrast, the 
majority of the PC-ES-62 is located in the nucleus. These findings suggest that, like 
macrophages, WEHI-231 B cells internalise ES-62 following receptor binding and 
that two forms of ES-62 are present in the nucleus -  a PC containing and a PC 
lacking form of ES-62, while in the cytosol only the PC lacking form of ES-62 
exists. Macrophages are known to internalise many proteins by receptor mediated
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endocytosis and thus this may be the process by which ES-62 is internalised by 
macrophages. Whether WEHI-231 cells also employ endocytosis to internalise ES- 
62 is unknown. As discussed, TLRs, the putative receptors for ES-62, are known to 
internalise following ligand binding perhaps providing further substantiating 
evidence for the utilisation of TLRs as receptors for ES-62.
To corroborate the location of internalised ES-62 within the cells, murine splenic 
mononuclear cells were incubated with ES-62-FITC for various timepoints, stained 
for either mig (B cells) or CD3 (T cells), fixed and microscopy analysis performed. 
Visualisation of the stained cells allowed identification of the splenic B cell 
preparation as positive for mIg, however, no ES-62-FITC signal was observed. As 
the location of the ES-62-FITC could not be detected using microscopy, FACS 
analysis, capable of detecting a much weaker signal than microscopy but which does 
not provide intracellular localisation information, was employed. For FACS 
analysis, murine splenic B cells were stained with ES-62-FITC alone or in 
conjunction with mig or CD3 stains. FACs analysis allowed detection of B cells 
within the purified splenic B cell samples, but again ES-62-FITC could hot be 
detected. It was postulated that this inability to detect ES-62 bound to or internalised 
by splenic B cells may be due to low receptor numbers on splenic B cells leading to 
a low signal that was undetectable.
The ability of ES-62 to bind DNA was investigated following Western blotting 
analysis of nuclear and cytosolic fractions of macrophages and WEHI-231 B cells 
incubated with ES-62 (Figure 6-14), which showed that ES-62 translocates to the 
nucleus following receptor binding. In addition, earlier EMSA studies had 
demonstrated that ES-62 modulates transcription factor activity (Figure 6-12 and 
Figure 6-13). Genomic DNA from WEHI-231 B cells and macrophages was 
digested with Eco RI or Bam HI and then incubated with [^^S] labelled ES-62 for 30 
minutes. The samples were then resolved on a 6 % polyacrylamide gel, fixed, 
incubated in Amplify (amplifies radioactive signal to aid detection), dried and 
exposed to X-ray film. Visualisation of the radiolabelled ES-62 showed no
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discernible differences between the control sample to which no digested DNA had 
been added and the samples to which digested DNA had been added. In addition, to 
investigate whether ES-62 was capable of binding directly to the NFkB or E2F DNA 
motif, ES-62 was incubated with radiolabelled NFkB or E2F DNA motifs. The 
results from this experiment showed that ES-62 did not bind directly to either the 
NFkB or E2F DNA motif. Thus ES-62 must be inducing its effects on NFkB and 
E2F through activation and suppression of the relevant NFkB or E2F subunits as 
suggested in Figure 6-11.
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Figure 6-16: Localisation of ES-62 in WEHI-231 B cells following receptor 
binding. WEHI-231 B cells were incubated separately with either [^H]-choline 
labelled or [^ S^] labelled ES-62 for specific time periods. Nuclear and cytosolic 
fractions were prepared as discussed in Chapter 2. Scintillant was then added 
to the nuclear and cytosolic fractions to allow determination of the level of 
radioactive protein in each fraction. Red bars represent samples incubated with 
[^H]-choline labelled ES-62. Blue bars represent samples incubated with [^ S^] 
labelled ES-62. CPM values are corrected for background readings.
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6.4. Discussion
These studies have identified a number of cellular proteins of varying molecular 
weights, which bind ES-62. Examination of both whole cell lysates and membrane 
fiactions, resolved by SDS PAGE, identified two cellular surface proteins that 
appeared to bind ES-62. One or more proteins of approximately 82 kDa are present 
in all the cell types tested (splenic B cells, U937 monocytic cells, Jurkat T cells,
REH cells, Nalm6 cells, 207 cells, 697 cells, WEHI-231 B cells, Daudi follicular B 
cells and Ramos follicular B cells). A higher molecular weight protein, 
approximately 135 kDa, was detected in splenic B cells, Jurkat T cells, REH cells,
Nalm6 cells, 207 cells, 697 cells and WEHI-231 B cells. As the higher molecular 
weight protein is not present in all of the cell lines and can vary in size, it would 
appear that different proteins are forming a receptor complex capable of binding ES- 
62 depending on the cell type under eonsideration.
Western blotting and immunoprécipitation techniques demonstrated that ES-62 
bound to the proteins identified in a PC dependent manner mdicating an important 
role for the PC moieties of ES-62 in receptor binding. These findings are 
substantiated by data from BiaCore experiments {Wand MHarnett, unpublished) 
which demonstrated that membranes from splenic B cells, U937 monocytic cells and 
Jurkat T cells bound ES-62 in a PC-dependent manner and with receptor like affinity 
but with different binding kinetics depending on the cell type. It is postulated that 
the different binding kinetics are due to the recruitment of different proteins to form 
an ES-62 receptor complex in different cell types.
Studies carried out to identify the proteins detected as binding to ES-62 revealed that 
the 82 kDa protein identified in splenic B cells, U937 monocytic cells, Jurkat T 
cells, REH cells, Nalm6 cells, 207 cells, 697 cells, WEHI-231 B cells, Daudi 
follicular B cells and Ramos follicular B cells showed reactivity with anti-TLR 
antibodies, reacting positively with both TLR2 and TLR4 antibodies. The 82 kDa 
protein identified in U937 monocytic cells, Jurkat T cells and Nalm6 cells did not 
react positively with either the TLR2 or 4 antibody. As U937 monocytic cells have
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been reported not to express TLR2 on their cell surface (Carlo et al., 2000) this 
finding is not unexpected. However, it is possible that this 82 kDa protein is one of 
the other TLR proteins. The proposal that one of the proteins that constitutes the 
receptor for ES-62 is a TLR is supported by the finding that ES-62 and TLRs induce 
similar downstream signalling events, such as induction of NFkB and modulation of 
the Ras MAPK pathway. Preliminary data from ongoing research carried out with 
Dr. H. Goodridge, using TLR knockout mice suggests that ES-62 may at least in part 
utilise one of the TLRs as a receptor. The liigher molecular weight protein identified 
as binding ES-62 has not been characterised as yet and appears to vary depending on 
cell type. Integrins were investigated as one of the possibilities for the 135 kDa 
receptor chain, however, experiments involving the pre-incubation of biotinylated 
membranes with fucose or RGDS/RDES peptides showed no effect on ES-62 
binding. These results appeared to exclude at least some of the integrins as a 
possible receptor for ES-62.
N-terminal sequencing of the proteins identified as binding ES-62 would be the 
definitive method of identifying the proteins. However, preliminary experiments, 
involving the isolation of the proteins identified to bind ES-62 from SDS PAGE 
gels, revealed obtaining sufficient suitable material to be difficult. Alternatively the 
use of mass spectrometry to analyse small quantities of protein within a 
polyacrylamide gel might enable further characterisation of the identified proteins.
These two techniques would be worthwhile future experiments to carry out in the 
search to definitively identify the proteins that act as a receptor for ES-62.
Studies carried out as part of this PhD project have shown that ES-62 stimulation of 
cells causes as initial activation of the signalling pathways downstream of the B cell 
receptor leading to an early activation of Erk. Erk is then rapidly deactivated in such 
a way that further activation in response to stimulation of the B cell receptor does 
not ocem*. This data corroborated earlier work (Deehan et al., 1998a) that showed 
pre-incubation of splenic B cells with ES-62 prior to stimulation with anti-Ig 
resulted in abortive activation o f B cell signalling. This abortive activation is thought
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to occur by a mechanism in which ES-62 promotes dual phosphorylation of Erk and 
simultaneously primes recruitment of phosphatase. This phosphatase then 
dephosphorylates one of the two phosphorylated sites of Erk. The remaining 
phosphorylated site then blocks rephosphorylation of the second site and hence 
activation of Erk.
ES-62 was also shown to induce effects on the two transcription factors, NFkB and 
E2F, through the use of EMSAs and Western blotting of cytosolic and nuclear 
fractions of cells stimulated with ES-62. The induction of NFkB and the modulation 
of MAP kinase family members in response to ES-62 treatment further supports the 
proposal that TLRs form part of the receptor for ES-62 as TLR stimulation also 
leads to activation of NFkB via recruitment of MAP kinase family members.
The discovery that ES-62 influences transcription factors raises the question as to 
how these effects are induced, i.e. solely through the receptor or tlirough 
internalisation of ES-62 and direct interaction of ES-62 with cytosolic or nuclear' 
proteins. As ES-62 is found within both the cytosol and nucleus of stimulated cells it 
is likely that ES-62 induces at least some of its effects through direct binding with 
cytosolic, nuclear proteins or perhaps even DNA. A bacterial aminopeptidase, Pep 
A, is known to be a sequence specific DNA binding protein capable of regulating 
expression of bacterial genes (Charlier et al., 1995). This raises the possibility that 
ES-62, also known to possess aminopeptidase activity, could regulate gene 
expression by binding directly to DNA motifs that control gene expression. As 
discussed in section 6.3.4, ES-62 does not bind to the NFkB or E2F motifs and 
preliminary studies into the DNA binding capabilities of ES-62, involving the 
incubation of radiolabelled ES-62 with digested genomic DNA, were inconclusive. 
Further work including a DNase protection assay (Charlier et al., 1995), could be 
performed to identify the DNA binding capabilities of ES-62. To carry out this assay 
ES-62 would be incubated separately with radioactively end-labelled DNA from a 
variety of cells. DNase would then added to digest any unprotected DNA, The 
sample would then be resolved polyacrylamide gel. If ES-62 did not bind to DNA
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then a DNA ladder would be observed. However, if ES-62 did bind to DNA then in 
contrast to digested radioactively end labelled DNA to which no protein had been 
added a gap would be observed in the DNA ladder .
Further studies to examine the methods by which ES-62 induces its 
immunomodulatory effects upon cells could include examination of whether ES-62 
affects any other transcription factors and whether it is capable of binding to DNA 
itself. It would also be interesting to attempt to identify whether internalised ES-62 
is capable of binding to cytosolic or nuclear proteins. Identification of these proteins 
would enable elucidation of the signalling pathways employed by ES-62 to elicit its 
immunomodulatory effects.
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7. Conclusions
The aim of this PhD was to obtain structural information about the filarial parasite 
excretory-secretory product ES-62 and to identify the host cellular proteins exploited 
as receptors for this immunomodulatory protein. Three methodologies were used to 
obtain structural information pertaining to ES-62; bioinformatics techniques, 
analytical ultracentrifugation studies and small angle X-ray scattering studies. In 
addition, a range of techniques including far Western blotting, Western blotting, 
immunoprécipitation and localisation studies were employed to deteimine the 
identity of the receptor for ES-62 and to examine the fate of ES-62 following 
receptor binding. Fuifher, two expression systems for the produetion o f recombinant 
ES-62 lacking either the PC component or the PC and carbohydrate components of 
wild type ES-62 were established, to allow both stmctural and biochemical studies 
of the effects of the carbohydrate and PC moieties on ES-62.
Filariasis affects approximately 150 million people world-wide and currently there 
are few effective treatments available. Filariasis has been classified by the W.H.O. 
as potentially erradicable (W.H.O., 1999a; W.H.O., 1999b). Many studies are 
ongoing to determine more effective chemotherapy targets and potential vaccines to 
treat filai'iasis. ES-62 was chosen as the target for study in this PhD as it is the 
excretory-secretory glycoprotein of the rodent filarial parasite A. viteae which is 
widely employed as a model system for the study of human filariasis. It was 
believed that structural studies and further characterisation of ES-62 would lead to a 
better understanding of the mechanism of action of ES-62 and ES proteins in 
general. In addition, it was hoped that identification of proteins homologous to ES- 
62 would further aid elucidation of the immunomodulatory function of ES-62 and 
the methods it exploits.
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On the basis of the information gained from the various methodologies employed 
during this PhD, this chapter presents a putative method of action of ES-62.
Earlier work (Deehan et ah, 1998a; Deehan et a l, 1998b; Goodridge et ah, 2001;
Harnett & Harnett, 1999a; Harnett et a l, 1999a; Harnett & Harnett, 1993; Harnett & 
Harnett, 2001; Harnett et al., 1989) has shown that ES-62 binds, via a unknown 
receptor, to immune system cells, polyclonally activates certain protein tyrosine 
kinases (PTKs) and MAP kinase signal transduction elements and modulates PKC 
activity and expression leading to desensitisation of both B and T lymphocytes to 
subsequent BcR mediated activity. ES-62 signalling promotes BcR activation of 
SHP-1 tyrosine phosphatase. SHP-1 prevents BcR signalling by maintaining the 
IT AM motifs of Iga and Ig(3 in a resting dephosphoiylated state. This prevents 
recruitment of the Shc-Grb2-SoS complexes to the BcR and thus Ras cannot be 
activated. ES-62 signalling also promotes BcR-driven association of the nuclear 
MAP kinase dual (tyr/thr) phosphatase, PAC-1, with Erk to terminate any persisting 
Erk signals. This dual pronged mechanism results in a rapid and profound 
desensitisation of BcR coupling to the RasErk MAP kinases cascade.
7.1. A Proposed Mechanism o f Action of ES-62
7.1.1. Tetrameric Nature o f ES-62
Structural characterisation that revealed the quaternary structure and the overall 
shape of ES-62, was performed using AUC and SAXS. Sedimentation equilibrium 
and sedimentation velocity AUC studies confirmed earlier gel filtration experiments 
that showed that ES-62 exists as a tetramer. SAXS further substantiated the finding 
that the majority of ES-62 exists in a tetrameric state and enabled the generation of a 
low resolution, 19Â, three dimensional model of ES-62.
The three models generated for ES-62, using different point symmetries, were found 
to be similar, indicating that the models generated were robust and likely to be 
correct. As SAXS relies on contrast between the solute under study and the solvent,
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and given that the contrast between cai'bohydrate and solvent is very small, the 
carbohydrate component of proteins is not always fully visualised. This has 
implications for the SAXS determined structiue o f ES-62, as ES-62 is glycosylated 
and the DAMMESf structure may not fully represent the full carbohydrate component 
of ES-62. However, the sedimentation coefficients determined for the modelled 
structures show good correlation with the experimentally derived (AUC) 
sedimentation coefficient supporting the DAMMIN models as the structiu’e of ES- 
62. The low resolution structure of ES-62 also provides phase information, which 
may be of importance in the future if  crystals of ES-62 are obtained for X-ray 
crystallography studies.
The tetrameric nature of ES-62, determined by the AUC and SAXS, is hypothesised 
to be essential for steric purposes such that the PC moieties of ES-62, essential for 
receptor binding, adopt the correct conformation for recruitment and binding to the 
cellular membrane proteins,
7.1.2. Identification of the Receptor of ES-62
As shown in Figui'e 7-1, it is proposed that the tetrameric form of ES-62 binds to a 
cell surface receptor to elicit its immunomodulatory effects. Far Western and 
Western blot analyses and immunoprécipitation experiments of a number of 
different cell types and at different levels of maturity, suggest that one of the 
proteins acting as part of the receptor for ES-62 could be one or more Toll like 
receptors (TLRs). This finding was further substantiated by previous studies on the 
signalling induced in response to TLR stimulation (O'Neill & Dinarello, 2000) 
which revealed strong similarities of TLR signalling to the signalling induced in 
response to ES-62.
The second, higher molecular" weight protein identified as acting in conjunction with 
the TLR as a receptor for ES-62, appeared to vary with cell type. Studies to date 
indicate that the second protein is not TLR2 or TLR4. Initial studies, examining
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whether Arg-Gly-Asp (RGD) peptides could block binding of ES-62 to the higher 
molecular weight protein acting as a receptor for ES-62, suggested that the second 
protein was not a member of the integrin family of proteins, which typically 
recognise the RGD motif. However, as not all integrins bind via these RGD motifs 
(Assa-Munt et a l, 2001), further studies including Western blotting or 
immunoprécipitation using specific integrin antibodies, would be required before 
integrins could be entirely ruled out as plausible receptors of ES-62.
ES-62 receptor binding was shown to be PC dependent thiough far Western blotting, 
immunoprécipitation experimentation and BiaCore analysis. As discussed, the 
existence of ES-62 in a tetrameric state was postulated to provide the correct steric 
arrangement of the PC moieties such that the two receptor chains which bind ES-62 
can be recruited. Future studies involving the stimulation of cells with a monomeric 
form of ES-62 would allow tliis hypothesis to be tested. ES-62 can be induced to 
monomerise by lowering the pH to below 6. However, initial attempts to obtain 
monomeric ES-62 were hampered by low yields of soluble protein. Further 
investigation suggested that a gradual lowering of the pH may increase yields 
allowing these experiments to be carried out, but time constraints inhibited further 
study.
7.1,3, The Fate of ES-62 following Receptor Binding
Studies examining the fate of ES-62 following receptor binding show that ES-62 is 
internalised following receptor binding and is located in both the cytoplasm and 
nucleus of cells as shown in Figure 7-1. Two forms of ES-62 can be identified 
within the nucleus; PC-containing and PC-free forms of ES-62. Within the 
cytoplasm only the PC-free form of ES-62 is present. These findings led to the 
hypothesis that ES-62 is internalised to the nucleus following receptor binding 
where it is modified such that the PC moieties are removed. The putative 
mechanisms by which ES-62 is internalised and the PC moieties are removed are
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suggested by the results obtained through AUC studies, bioinformatics and 
experimental work.
Sedimentation equilibrium AUC experiments showed the presence of a lower 
molecular weight form of ES-62, present in such minute quantities that it was not 
possible to determine whether it was monomer or dimer that was present.
Sedimentation equilibrium experiments performed at increasingly dilute 
concentrations could possibly allow this to be resolved. However, as the protein 
concentration decreases the difference between sample signal and background noise 
also decreases making analysis of data increasingly more difficult.
As ES-62 exists in both a lower molecular weight form (either monomeric or 
dimeric) and a tetrameric state, the question exists as to whether ES-62 is secreted 
by the parasite in a monomeric or dimeric state and then tetramerises or whether it is 
secreted in the tetrameric form and then becomes monomeric or dimeric. As AUC 
studies indicated the majority of ES-62 to be tetrameric, it is posible that ES-62 has 
to be tetrameric to fulfil steric requirements in order to gain entry into host cells.
Once internalised, it may monomerise or dimerise via endocytosis internalisation 
which would expose ES-62 to lower pH levels. ES-62 has been shown to dissociate 
to monomeric and dimeric forms when the pH is dropped below 6. As shown in 
Figure 7-1, internalisation of ES-62 may occur via receptor mediated endocytosis, 
which due to the reduction of pH within the endosome, could allow dissociation of 
the ES-62 tetramer to occur prior to its delivery to the cell nucleus. Once within the 
nucleus ES-62 may undergo modification to create a PC-ffee form. This may be the 
result of self-digestion.
Earlier experimental work (Harnett et al., 1999b) has shown ES-62 to possess 
aminopeptidase activity. Bioinformatic techniques (Chapter 3) identified six proteins 
of 37-39 % identity to ES-62, two of which are classified as aminopeptidases and 
thi'ee of which possess carboxypeptidase activity. All six proteins identified were 
shown to possess a peptidase motif. These findings indicate a role for peptidase
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activity in the induction of immunomodulatory effects by ES-62. It is possible that 
ES-62 utilises this aminopeptidase activity for self digestion which could lead to an 
active foim of ES-62 capable of inducing immunomodulatory effects. Self-digestion 
may also enable release of the PC moieties of ES-62 resulting in a PC-free form of 
ES-62, which is found in the cytoplasm of host cells. To investigate this further, it 
would be necessary to determine if ES-62 possesses aminopeptidase target motifs 
near to glycosylation sites which, if digested, could lead to the removal of the PC 
components of ES-62. The released PC moieties (free PC, PC-glycan or PC-glycan- 
peptide) may induce immunomodulatory effects within the cell, as indicated by 
earlier work (Harnett & Harnett, 1993), which demonstrated that PC alone could 
induce many of the effects on signalling cascades which occur following incubation 
of cells with ES-62.
Alternatively the aminopeptidase activity may allow ES-62 to digest cellular 
proteins either to prevent removal of ES-62 by the host immune response or to 
induce some form of immunomodulation. Further studies including identification of 
target sequences for ES-62 aminopeptidase activity, optimal conditions for digestion 
and the effects of peptidase inhibitors on ES-62 induced effects would be essential in 
order to determine the role of the aminopeptidase activity of ES-62. It would also be 
interesting to incubate ES-62 under optimal conditions for aminopeptidase activity, 
but in the absence of any substrate to determine if self-digestion is feasible.
The PC-free foiin of ES-62 in the nucleus is postulated to translocate to the 
cytoplasm as shown by internalisation studies discussed in section 6.3.4. This 
hypothesis suggests that induction of a signalling cascade following receptor binding 
is not the sole mechanism by wliicli ES-62 modulates the host immune system. The 
location of ES-62 in both the nucleus and cytoplasm and its existence in different 
forms in these two locations suggest that ES-62 is multifunctional.
It is possible that in the nueleus ES-62 binds directly to DNA motifs to regulate gene 
expression. This hypothesis is supported by the possible presence of DNA bound to
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the recombinant form of ES-62 produced using the baculovirus expression system. It 
is also plausible that if  ES-62 is not binding directly to DNA to modify gene 
expression that it is binding, perhaps via its leucine rich regions, to transcription 
factors and inducing its effects in this mamier. The discovery of the modulatory 
effects of ES-62 on NFkB and E2F further support this hypothesis.
The PC-ffee form of ES-62 present in the cytoplasm is postulated to induce distinct 
modulatoiy effects, perhaps acting on signalling cascades such as the Ras-MAPK 
pathway which are known to be affected by ES-62 (Harnett & Harnett, 1999a;
Harnett et al., 1999a). In addition, the PC-free form of ES-62 present in the 
cytoplasm may induce the activation or translocation of transcription factors, such as 
NFkB, to the nucleus as described in section 6.3.3.
Figure 7-1: Proposed mechanism of action of ES-62. ES-62 is recognised and 
internalised by a receptor complex of TLR 2 or 4 and an unindentified co­
receptor. Low pH in the endosome may result in ES-62 dissociation to dimers 
(or monomers) which are delivered to the nucleus. ES-62 may then undergo 
self-digestion to form a PC-free form which translocates to the cytoplasm to 
induce immunomodulatory effects. The free PC moieties also translocate out of 
the nucleus to induce modulatory effects. The ES-62 remaining in the nucleus 
may modulate gene expression either by binding directly to DNA or to 
transcription factors.
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7.2. Future Work
The stiuctural studies of ES-62 earned out as part of this PhD were successful and 
led to the identification of a number of proteins homologous to ES-62, the 
characterisation of ES-62 as a tetramer and the generation of a three dimensional 
model of ES-62. However, there are still many avenues to investigate, not least the 
aminopeptidase activity of ES-62 and its ability to dissociate into monomers or 
dimers. Continuation of these structural studies would ideally address these 
questions as well as encompassing new strategies to further the structural 
characterisation of ES-62. Structural studies, including CD, AUC and SAXS, on a 
monomeric form of ES-62, ideally monomeric ES-62 obtained through the lowering 
of the solvent pH in a solution of wild type ES-62, would allow the determination of 
any differences in the secondary structur e o f monomeric and tetrameric ES-62 and 
whether monomeric ES-62 can exist without aggregation occurring. This would 
provide information as to whether it is plausible that ES-62 can form monomeric or 
dimeric imits following internalisation to induce immunomodulatory effects.
Stiuctural studies of recombinant ES-62, lacking PC and perhaps possessing less 
carbohydrate moieties could lead to a greater understanding of the effects these two 
moieties elicit on the structure of ES-62
Utilisation of new strategies to obtain structural information regarding ES-62 could 
include the use of genetic techniques to selectively knock-out residues conserved 
between ES-62 and the identified homologous proteins to determine if these 
conserved residues play a structural role in these proteins. Similarly it would be 
interesting to further investigate the similarity between ES-62 and C-reactive 
protein, particularly in the PC binding region of C-reactive protein, which has been 
shown to demonstrate similarities to a small region of ES-62 (Harnett et al., 1999a).
Studies to further characterise both the receptors for ES-62 could include isolating 
these proteins for N-terminal sequencing possibly by performing an 
immunoprécipitation, using anti-ES-62 antibodies or anti-FITC antibodies, of 
cellular membranes pre-incubated with either ES-62 or an ES-62 -  FITC conjugate.
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Ongoing work by H. Goodridge examining the effects of ES-62 on TLR Icnockout 
mice will hopefully aid characterisation of the receptors of ES-62 and its mechanism 
of action.
Clearly ES-62 elicits its range of immunomodulatory activities by a variety of 
mechanisms, with the PC and the protein components of ES-62 playing particular 
roles. Further investigation, including detailed structural characterisation of this 
intriguing molecule is essential to understand the signalling mechanisms promoted 
by this molecule and to allow the development of novel agents for the treatment of 
filarial infections.
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Appendix 1: Bioinformatics CD
This appendix explains how to use the CD enclosed in this thesis as a supplement 
to Chapter 3 and Chapter 4. The CD contains 2 folders; Web Page and 
Structures.
The Web Page folder contains a web page consisting of links to the programs 
discussed in Chapter 3. This web page can be viewed by opening through an 
internet browser such as Netscape Navigator.
The structures folder contains a number o f pdb and script files as well as the 
program RasMol (Sayle & Milner-White, 1995) (an Apple Macintosh Version) 
which can be used to view the pdb files. The script files are for use with RasMol. 
Table 1 gives a list of the pdb files supplied, details of the structure and the 
accompanying script file. To view any o f the structures open RasMol and then 
select the open command in the file menu and select the pdb file to view. Next 
open the accompanying script file in a text viewing program such as Microsoft 
Word and copy and paste the contents into the command window within RasMol. 
This will result in the structure being displayed as described in Chapter 3 or 4 
with the relevant sections highlighted. The structure can then be moved using 
either a mouse or the scroll bars on the window. The pdb files generated by 
DAMMIN; DAMMIN_Pl.pdb, DAMMIN_P2.pdb and DAMMIN_P222.pdb, 
when viewed in RasMol, do not appear as shown in Figure 4-20. This is due to 
an inability of RasMol to increase the size of the beads such that they overlap. 
Use of Assa, a modelling program downloadable using anonymous FTP from 
ftp.embl-hamburg.de. directory /sax, to view these files overcomes this problem 
as bead size can be increased so that the beads overlap.
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pdb file Structure Script file
lamph.pdb Residues 74-168 of the leucyl 
aminopeptidase from Aeromonas 
proteolytica (homologous to 
residues 252-343 of ES-62).
lamph. script
D A M M IN Pl .pdb Structure obtained from DAMMIN 
when PI symmetiy was imposed.
DAMMIN. script
DAMMIN_P2.pdb Structure obtained from DAMMIN 
when P2 symmetry was imposed.
DAMMIN. script
DAMMIN_P222.pdb Structure obtained from DAMMIN 
when P222 symmetry was imposed.
DAMMIN. script
Dragon all.pdb All the structures obtained for ES- 
62 in its entirety from the different 
iterations of DRAGON.
Dragon all.script
ES62h.pdb The structure of the region of ES- 
62 (residues 252-343) homologous 
to residues 74-168 of the leucyl 
aminopeptidase from Aeromonas 
proteolytica, generated by 
DRAGON.
ES62h.script
ES62_best.pdb The highest ranked structure of ES- 
62 generated by DRAGON.
ES62_best. script
Table 1: pdb and script files.
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Appendix 2: Input Files for DRAGON
This section outlines the text of the DRAGON input files for the modellmg of 
residues 252-343 of ES-62, homologous to residues 74-168 of the leucyl 
aminopeptidase from Aeromonas proteolytica (Chevrier et al., 1996; Chevrier et 
al., 1994; Schalk et al., 1992). Strictness values where mentioned are between 
0.0 (totally unreliable) and 1.0 (absolute certainty). Lines in input files which 
start with # are comment lines not read by DRAGON. Text on the right hand side 
of the page provides an explanation as to the content of the files.
Alnfnm file: Multiple alignment file
MSF o f :  m u l . a l n  fr o m : 1 t o : 1 0 0
m u l . a l n  MSF: 1 0 0 T y p e  : P 1 3 - .J a n - 9 9  1 1 : 4 5 : 4 C h e c k ; 0
N am e: e s 6 2 h L e n : 1 0 0 C h e c k ;  8 7 8 6 W e ig h t  : 1 .5 5
N am e: h e m a t o p o i e t i c L e n : 1 0 0 C h e c k :  4 6 8 1 W e ig h t  : 1 . 5 5
N am e; B a c t e r i a l L e n : 1 0 0 C h e c k : 3 9 6 7 W e ig h t  : 0 . 6 3
N am e; lAMP L e n : 1 0 0 C h e c k :  3 9 6 7 W e ig h t  : 0 . 6 3
Name : l e u c i n e L e n : 1 0 0 C h e c k :  3 9 6 7 W e ig h t  : 0 .6 3
/ /
e s 6 2 h  N SSN L IF E IT  GSERPSEW L LSAHVDSW.......................... DVGQGALDDGAGCA
h e m a to  DSFUTVAEIT GSKYPEEWL VSGHLDSW.......................... DVGQGALDDGGGAF
B a c t e r i a l  NQKSWMTIT GSEAPDEWIV IGGHLDSTIG SHTNEQSVAPGADDDASGIA
lAMP NQKSWMTIT GSEAPDEWIV IGGHLDSTIG SHTNEQSVAPGADDDASGIA
l e u c i n e  NQKSWMTIT GSEAPDEWIV IGGHLDSTIG SHTNEQSVAPGADDDASGIA
e s 6 2 h  WWSALHSLK KLAERNPKFK PKRTIRGIFW TSEEQGYGGAKHYYITHKND
h e m a to  ISWEALSLVK DLGLR  PKRTLRLVLW TAEEQGGVGASQYYELHK..
B a c t e r i a l  AVTEVIRVLS ENNFQ  PKRSIAFMAY AAEEVGLRGSQDLANQYK8E
lAMP AVTEVIRVLS ENNFQ  PKRSIAFMAY AAEEVGLRGSQDLANQYKSE
l e u c i n e  AVTEVIRVLS ENNFQ  PKRSIAFMAY AAEEVGLRGSQDLANQYKSE
Accfnm file: Residue accessibility file
b  8  2 2  4 3  8 4  R e s i d u e s  8 ,  2 2 , 4 3  a n d  8 4  a r e  p r o b a b l y  b u r i e d  ( b )
s  1  3  1 4  1 5  1 6  1 7  1 8  1 9  3 1  R e s i d u e s  1 ,  3 ,  1 4 - 1 9 ,  3 1 ,  3 8 - 3 9 ,  4 1 , 4 8 ,  5 4 - 5 5 ,  5 7 -  
s  3 8  3 9  4 1  4 8  5 4  5 5  5 7  5 8  6 2 ,  6 4 ,  6 6 - 6 7 ,  7 7 ,  8 0 ,  8 2 ,  8 5 - 8 6 ,  8 9 ,  9 0  a n d  9 2
s  5 9  6 0  6 1  6 2  6 4  6 6  6 7  7 7  p r o b a b l y  l i e  o n  t h e  s u r f a c e  o f  E S - 6 2  ( s ) .
s  8 0  8 2  8 5  8 6  8 9  9 0  9 2
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Restrfnm file: Distance restraints file
#  d i s t . r e s t r
#  1 3 - J a n - 1 9 9 9 .
4 72  4 . 5 0  4 . 7 0  1 . 0  CA CA
4 8 0  9 . 9 0  1 0 . 1  1 . 0  CA CA
9 6 5  8 . 5 0  8 . 7 0  1 . 0  CA CA
14 65  4 . 8 0  5 . 0 0  1 . 0  CA CA
24 3 8  7 . 9 0  8 . 1 0  1 . 0  CA CA
24 72  4 . 1 5  4 . 3 5  1 . 0  CA CA
L i n e s  w i t h  #  s y m b o l s  a r e  c o m m e n t  l i n e s  a n d  a r e  
n o t  r e a d  b y  D R A G O N .
T h e  d i s t a n c e  b e t w e e n  t h e  C a  a t o m s  o f  r e s i d u e s  
4  a n d  7 2  i s  b e t w e e n  4 . 5  a n d  4 . 7  Â  a n d  t h e  
s t r i c t n e s s  v a l u e  i s  1 ,  m e a n i n g  a b s o l u t e  
c e r t a i n t y .  T h e  r e s t  o f  t h e  f i l e  d e l i n e a t e s  
d i s t a n c e  r e s t r a i n t s  b e t w e e n  o t h e r  a t o m s  l a i d  o u t  i n  
t h e  s a m e  w a y  a s  d e s c r i b e d  f o r  t h e  f i r s t  l i n e .
Sstrfnm file: Secondary structure file
# e s 6 2 h
# e s 6 2  h o m o lo g o u s  t o  la m p  
SHEET 0 . 7  
STRAND 4 9
STRAND 6 5  72  ANTI 6 5  9
14 24  PAR 14  65
END
ALPHA 3 8  5 6  
ALPHA 80  91
L i n e s  w i t h  #  s y m b o l s  a r e  c o m m e n t  l i n e s  a n d  a r e  
n o t  r e a d  b y  D R A G O N .
S h e e t  w i t h  s t r i c t n e s s  v a l u e  o f  0 . 7  
F i r s t  s t r a n d  o f  s h e e t ,  r e s i d u e s  4 - 9  
2 ' “ ^ s t r a n d  ( 6 5 - 7 2 )  a n t i  p a r a l l e l  t o  1® *  s t r a n d  r e s i d u e s  
6 5  &  9  h y d r o g e n  b o n d e d ,  3 " ^ ^  s t r a n d  ( 1 4 - 2 4 )  p a r a l l e l  
t o  2 * " * ,  r e s i d u e s  1 4  &  6 5  h y d r o g e n  b o n d e d ,  
a - h e l i x  c o m p r i s i n g  r e s i d u e s  3 8 - 5 6  
a - h e l i x  c o m p r i s i n g  r e s i d u e s  8 0 - 9 1
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This section outlines the text of the DRAGON input files for the modelling of 
ES-62 in its entirety.
Alnfnm file:
N am e;
N am e;
N am e:
N am e:
N am e:
N am e:
N am e:
/ /
E S 62  MLLNSSTFFF LVTLTWLGA AVLPDKTVAP 
p la s m a  MKFLIFAFFG GVHLLSLCSG KAICKNGISK 
a m in o  MKFLIFAFFG GVHLLSLCSG KAICKNGISK 
s w i t c h  MRFLFFLFVA W H L FSL G S6 KAIYKSGVSQ 
l i v e r  MRFLFFLFVA WHLFSLGSG KAIYKSGVSQ 
m o u s e  M RSLFFLFI. .VHLLALGSG KAVFKNGVSQ 
h e m a to  M RSLFFLFI. .VHLLALGSG KAVFKNGVSQ
:: m u l . a l n fr o m : 1 t o : 5 5 5
.n  MSF : 5 5 5  T y p e : P 2 2 - M a r - 0 09 1 1 : 4 5 ; 4 C h e c k : 0
E S62 L e n : 5 5 5 C h e c k : 3 3 1 5 W e ig h t  ; 2 . 6 7
p la s m a L e n : 5 5 5 C h e c k : 8 0 9 7 W e ig h t  : 0 . 7 1
a m in o L e n : 5 5 5 C h e c k : 3 6 3 3 W e ig h t  : 0 . 7 1
s w i t c h L e n : 5 5 5 C h e c k : 4 1 1 3 W e ig h t  : 0 . 3 4
l i v e r L e n : 5 5 5 C h e c k : 4 2 3 7 W e ig h t  : 0 . 3 4
m o u se L e n : 5 5 5 C h e c k : 4 5 6 0 W e ig h t  : 0 . 7 9
h e m a to L e n : 5 5 5 c h e c k : 4 9 9 2 W e ig h t : 1 .4 3
E S 62
p la s m a
a m in o
s w i t c h
l i v e r
m o u s e
h e m a to
E S 62
p la s m a
a m in o
s w i t c h
l i v e r
m o u s e
h e m a to
E S 62
p la s m a
a m in o
s w i t c h
l i v e r
m o u s e
h e m a to
E S 62
p la s m a
a m in o
s w i t c h
l i v e r
m o u s e
h e m a to
IQYITKGEEV
INLAVYGKAQ
INLAVYGKAQ
INLAVYGKYQ
INLAVYGKYQ
INLAVYGKYQ
INLAVYGKYQ
DKVHTEEVPN
EKVHLEPV.R
EKVHLEPV.R
ENVHLEQV.R
ENVHLEQV.R
ENVHLEQV.R
ENVHLEQV.R
VTVIYDLDDV
VLW TSFDEL
VLW TSFDEL
VLW ASFVEL
VLW ASFVEL
VLWASFDEL
VLW ASFDEL
IGVLVKSITS
LASLIRSVAS
LASLIRSVAS
VASLIRSVAS
VASLIRSVAS
VASLIQSVAS
VASLIQSVAS
GLAYQWLSKL
NRSYERLALL
NRSYERLALL
NRSYERLGLL
NRSYERLGLL
NRSYERLGLL
NRSYERLGLL
LPHWVRGNDV
IPHWERGEES
IPHWERGEES
IPHWGRGEES
IPHWERGEES
IPHWERGEES
IPHWERGEES
. . KPDDVRGK 
QRRASEARGK 
QRRASEARGK 
QRRASEARGK 
QRRASEARGK 
QRRASEARGK 
QRRASEARGK
FSINSPHTGT
FSIY SPH TG I
FSIY SPH TG I
FSIYSPHTGH
FSIYSPHTGH
FSIY SPH TG I
FSIY SPH TG I
VDGFGHRMVG
VDTVGPRLSG
VDTVGPRLSG
VDTVGPRLSG
VDTVGPRLSG
VDTVGPRLSG
VDTVGPRLSG
VEMIEPRNQR
AVMLEPRIHK
AVMLEPRIHK
AVMWPRIHK
AVMWPRIHK
AVMLEPRIHK
AVMLEPRIHK
IWTAQTFAG
IW Y N Q PY IN
IW Y N Q PY IN
IWYNQPYTD
IWYNQPYTD
IIVYNQPYTG
IIVYNQPYTG
GAENT. . . T I  
QEYQDGVPKI 
QEYQDGVPKI 
QGYQDGVPKI 
QGYQDGVPKI 
QKYQDGVPKI 
QKYQDGVPKI
K N Y .. IQETF 
RTFEEIKEEI 
RTFEEIKEEI 
RTFQEIKEEI 
RTFQEIKEEI 
RTFREIKEEI 
RTFREIKEEI
SDSLEKSIAF
SKNLEKAIQI
SKNLEKAIQI
SKNLEKAIQI
SKNLEKAIQI
SKNLEKAIQI
SKNLEKAIQI
L N V L A IG .. .  
lA IL G L G SSI 
lA IL G L G SSI 
LAILGLGGSI 
LAILGLGGSI 
MAILGLGSSI 
MAILGLGSSI
YPLTLKYR.R
YSRTVQYRTQ
YSRTVQYRTQ
YGKTVQYRER
YGKTVQYRER
YEKTVQYRVQ
YEKTVQYRVQ
PAACLTIEEA
PTACITVEDA
PTACITVEDA
PTACITIEDA
PTACITIEDA
PTACITVEDA
PTACITVEDA
G K ..E V A E .L  
ASCGDVAKAI 
ASCGDVAKAÏ 
ANYEDVAKAI 
ANYEDVAKAI 
ANYEDVAKAI 
ANYEDVAKAI
LEESLKNDNF
MYQNLQQDGL
MYQNLQQDGL
MYQNLQQDGL
MYQNLQQDGL
MYQNLQQDGL
MYQNLQQDGL
GSEPASATGE
GTPPEGITAE
GTPPEGITAE
GTPPEGITAE
GTPPEGITAE
GTPPGGITAE
GTPPGGITAE
SVKLFEQLGA
GAVEAAKVGA
GAVEAAKVGA
GAVEAAKVGA
GAVEAAKVGA
GAVEAAKVGA
GAVEAAKVGA
EMLERLYRSG
EMMSRMASHG
EMMSRMASHG
EMMSRMASRG
EMMSRTASRG
EMMSRMASRG
EMMSRMASRG
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E S 62
p la s m a
a m in o
s w i t c h
l i v e r
m o u s e
h e m a to
KKIVIRMDMK
IKIVIQLKMG
IKIVIQLKMG
DKIVIHLKMG
DKIVIHLKMG
NKIVIHLEMG
NKIVÏHLEMG
SHYEEPINSS
AKTYPDTDSF
AKTYPDTDSF
AKTYPDTDSF
AKTYPDTDSF
AKTYPDTDSF
AKTYPDTDSF
N LIFEITG SE
NTVAEITGSK
NTVAEITGSK
NTVAEITGSK
NTVAEITGSK
NTVAEITGSM
NTVAEITGSM
RPSEW LLSA  
YPEQWLVSG  
YPEQWI.VSG  
YPEEWLVSG  
YPEEWLVSG  
YPEEWLVSG  
YPE..................
HVDSWDVGQG 
HLDSWDVGQG 
HLDSWDVGQG 
HLDSWDVGQG 
HLDSWDVGQG 
HLDSWDVGQG 
 DVGQG
E S 6 2  ALDDGAGCAV VWSALHSLKK LAERNPKFKP KRTIRGIFWT SEEQGYGGAK
p la s m a  AMDDGGGAFI SWEALSLIKD LGLR............. P KRTLRLVLWT AEEQGGVGAF
a m in o  AMDDGGGAFI SWEALSLIKD LGLR............. P KRTLRLVLWT AEEQGGVGAF
s w i t c h  ALDDGGGAFI SWEALSLVKD LGLR............. P KRTLRLVLWT AEEQGGVGAS
l i v e r  ALDDGGGAFI SWEALSLVKD LGLR............. P KRTLRLVLWT AEEQGGVGAS
m o u s e  ALDDGGGAFI SWEALSLVKD L G L R .. . . .P  KRTLRLVLWT AEEQGGIGAS 
h e m a to  ALDDGGGAFI SWEALSLVKD LGLR............. P KRTLRLVLWT AEEQGGIGAS
E S 62
p la s m a
a m in o
s w i t c h
l i v e r
m o u s e
h e m a to
E S 62
p la s m a
a m in o
s w i t c h
l i v e r
m o u s e
h e m a to
E S 62
p la s m a
a m in o
s w i t c h
l i v e r
m o u s e
h e m a to
HYYITHKNDS
QYYQLHKVNI
QYYQLHKVNI
QYYELHKANI
QYYELHKANI
QYYELHKANI
QYYELHKANI
RLLSRNGIAL
SLLQPLNITQ
SLLQPLNITQ
SLLQPLNITK
SLLQPLNITK
NLLQPLNVTK
NLLQPLNVTK
GDYMTVLKDG
GDTMTVMDPS
GDTMTVMDPK
GDTMTAMDPK
GDTMTAMDPK
GDTMTVMDPK
GDTMTSWIQS
PEKFYFVSET 
.SNYSLVMES 
. SNYSLVMES 
, SKYSLVMEA 
. SKYSLVMEA 
. SKYSLVMEA 
. SKYSLVMEA 
GLINSSVQGD 
.VLSHGEGTD 
.VLSHGEGTD 
-VFNDAEGTD 
.VFNDAEGTD 
.VFSNGEGTD 
.VFSNGEGTD
DTGTFKSTNW 
DAGTFLPTG- 
DAGTFLPTG. 
DSGTFLPTG. 
DSGTFLPTG. 
DSGTFLPTG. 
DSGTFLPTG. 
VTFWAKDGIP 
INFWIQAGVP 
INFWIQAGVP 
INFWIQAGVP 
INFWIQAGVP 
INFWIQAGVP 
INFWIQAGVP
LAHLSFSGDK 
. .LQFTGSE 
. .LQFTGSE 
. .LQFTGSD 
. .LQFTGSD 
. .LQFTGSD 
. .LQFTGSD 
SVNYIPDKAV 
G A SL LD D ..L  
G A SLLD D ..L  
GA SLRD D..L  
G A SLRD D..L  
GA SLRD D..L  
G A SLRD D.,L
KSMLRLKEIT
KARAIMEEVM
k a r a im e e v m
KARAIMKEVM
KARAIMKEVM
KARAIMKEVM
KARAIMKEVM
DYYFYFHHTA
YKYFFFHHSH
YKYFFFHHSH
YKYFFFHHSH
YKYFFFHHSH
YKYFFFHHSH
YKYFFFHHSH
DLEYTTSIFA TLGHVTANMD DWGSDPNQPQ QLNSKQSTTE 
RWMLLLLFGL LFLMLLQTWK KCCLGPRNSK KETFSCFWPG
QMNVAAAVWA VVSYVVADME E M L ..P R S ...................................
QMNVAAAVWA WAYWADME EML. .P R S ..........................
QMNVAAAVWA WAYWADME EML. .P R S ...................................
QMNVAAAVWA W AYW ADMD EML . . PRS  ................................
E S 62  KSDRKKL.............................................................................................................. .. ....................
p la s m a  ILGLQLWKTP L H IT IS S N S S  SKHNSISCFL LLSFLILSKF SDSRKRNHSP
a m in o  ........................................................................................................... ..............................................
s w i t c h ......................................... .. ............................... ............................... .. ..................................
l i v e r  ................................................................ .. ............................... .. ...................................................
m o u s e  ......................................... .. .......................................................................................................
h e m a t o ....................................................... ..  ................................................................................. ..
E S 62  ............
p la s m a  LPPTT 
a m in o  . . . . .
s w i t c h  ............
l i v e r  ............
m o u s e  ............
h e m a to  ............
Appendix 2 313
Accfnm file:
b  10  62  82 1 2 9  1 3 0  1 6 1  1 6 2  2 1 9  
b- 2 3 9  2 4 1  2 5 9  2 7 3  2 9 4  3 3 5  3 5 3
s  19  2 1  2 5  2 6  2 7  2 8  2 9  3 0  3 1  32
s  35  3 6  37  39  4 0  41  4 4  4 7  5 1  53
s  54  5 5  56  60  6 1  64  6 7  71  77  7 8
s  80  81  84 87  8 8  8 9  91  92  93  94
s  96  97  1 0 0  1 0 1  1 0 2  1 0 4  1 0 5  1 0 8  
s  1 1 0  1 1 1  11 2  1 1 2  1 1 4  1 1 7  1 2 0  12 2
s  1 2 4  1 2 5  1 3 3  1 3 5  1 3 6  1 3 7  1 3 8  1 4 8
s  1 5 0  1 5 1  1 5 3  1 5 4  1 5 5  1 5 6  1 5 7  1 5 8
s  1 6 7  1 6 9  1 7 0  1 7 2  1 7 3  1 7 6  1 8 0  1 8 1
s  1 8 3  1 8 6  1 8 7  2 0 3  2 0 9  2 1 0  2 1 1  2 1 2
s  2 1 3  2 1 4  2 1 5  2 1 8  2 2 4  2 2 5  2 2 7  2 3 0
s  2 3 1  2 3 4  2 3 5  2 3 7  2 3 8  2 4 2  2 4 4  2 4 6
s  2 4 8  2 4 9  2 5 0  2 5 1  2 5 2  2 5 4  2 6 5  2 6 6
s  2 6 7  2 6 8  2 6 9  2 7 0  2 8 2  2 8 9  2 9 0  2 9 2
s  2 9 9  3 0 5  3 0 6  3 0 8  3 0 9  3 1 0  3 1 1  3 1 2
s  3 1 3  3 1 5  3 1 7  3 1 8  3 2 8  3 3 1  3 3 3  3 3 6
s  3 3 7  3 4 0  3 4 1  3 4 3  3 4 4  3 4 5  3 4 6  3 4 7
s  3 4 8  3 4 9  3 5 5  3 5 8  3 6 2  3 6 3  3 6 4  3 6 5
s  3 7 1  3 7 3  3 7 4  3 7 5  3 7 6  3 7 7  3 7 9  3 8 1
s  3 8 3  3 8 7  3 9 0  3 9 3  4 0 0  4 0 1  4 0 2  4 0 3
s  4 0 4  4 0 5  4 1 2  4 1 3  4 2 2  4 2 4  4 3 6  4 4 4
s  4 4 5  4 4 6  4 4 7  4 4 9  4 6 4  4 6 6  4 6 7  4 6 9
s  4 7 0  4 7 1  4 7 3  4 7 4  4 7 5  4 7 6  4 7 7  4 7 8
s  4 7 9  4 8 0  4 8 1  4 8 2  4 8 3  4 8 4  4 8 5  4 8 6
s  4 8 7  4 8 8  4 8 9  4 9 0  4 9 1  4 9 2
Restrfiim file:
# J P R E D E S 6 2 .r e s t r  
51  5 7  8 . 5  9 . 5  0 . 5  CA CA 
79  67 9 . 8  1 0 . 8  0 . 5  CA CA 
1 1 6  3 4 2  2 . 5  3 . 5  0 . 5  CA CA
1 1 9  3 3 7  4 . 3  5 . 3  0 . 5  CA CA
3 3 7  3 5 5  2 . 5  3 . 5  0 , 5  CA CA
3 9 9  4 0 7  2 . 5  3 . 5  0 . 5  CA CA
1 4 2  3 2 6  3 . 8  4 . 8  0 . 5  CA CA
1 4 8  1 6 0  4 , 4  5 . 4  0 . 5  CA CA
1 4 8  3 2 0  6 . 3  7 . 3  0 . 5  CA CA
2 2 3  1 6 4  2 - 8  3 . 8  0 - 5  CA CA
2 2 6  1 4 2  4 . 7  5 . 7  0 . 5  CA CA
2 4 4  2 5 8  4 . 2  5 . 2  0 - 5  CA CA
2 5 8  2 7 5  2 . 5  3 . 5  0 . 5  CA CA
2 7 0  2 6 3  7 . 8  8 . 8  0 . 5  CA CA
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Sstrfhm file:
ALPHA 3 8  51
#  5
ALPHA 57  67
#  NO 6 OR 7 
# 1 0 + 2 5 + 2 6 + 3 0  
SHEET
STRAND 1 1 6  1 1 9
STRAND 3 3 7  3 4 2  ANTI 3 4 2  1 1 6
STRAND 3 5 0  3 5 5  ANTI 3 5 0  3 4 2
STRAND 4 2 8  4 3 3  PAR 4 2 8  3 5 0
END
# 8 + 9
ALPHA 79  91
# 2 4 + 1 3 + 1 4 + 1 7
SHEET
STRAND 3 2 0  3 2 6
STRAND 1 4 2  1 4 8  ANTI 1 4 2  3 2 6
STRAND 1 6 0  1 6 4  ANTI 1 6 4  14 2
STRAND 2 1 9  2 2 3  PAR 2 1 9  1 6 4
END
#  15
ALPHA 1 7 4  1 8 7
#  16
ALPHA 1 9 0  1 9 7  
#  1 8
ALPHA 2 2 6  2 3 4
#  NO 19  
# 2 0 + 2 1 + 2 2  
SHEET
STRAND 2 3 8  2 4 4
STRAND 2 5 8  2 6 3  ANTI 2 6 3  2 3 8
STRAND 2 7 0  2 7 5  ANTI 2 7 0  2 6 3
END
#  2 3
ALPHA 2 9 8  3 0 7
#  2 7
ALPHA 3 7 6  3 8 9
# 2 8 + 2 9
SHEET
STRAND 3 9 5  3 9 9
STRAND 4 0 7  4 1 2  ANTI 4 0 7  3 9 9
END
#  31
ALPHA 4 4 8  4 6 7
